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(i)
Summary
The effect of glucose concentration in growth medium on 
biosynthesis of cytochrome P-450/P-448 under aerobic and 
anaerobic conditions was examined. High glucose concen­
tration was required in both cases.
The cytochrome P-450 enzyme from yeast Saccharomyces 
cerevisiae showed a Soret peak in the reduced CO-difference 
spectrum at 448nm, was purified to homogenity and had a 
molecular weight of 55,500. Cytochromes c(P-450) reductase, 
b^, b^ reductase were also purified from the same microsomal 
preparation.
Amino acid analysis of yeast cytochrome P-448 revealed 
the presence of 407 residues per molecule. The sum of 
molecular weight of the polypeptides and other components 
was in good agreement with the molecular weight value 
obtained from SDS-polyacrylamide gel electrophoresis.
A reconstituted system of purified yeast cytochrome 
P-448, NADPH:cytochrome c(P-450) reductase and phospholipid 
showed benzo(a)pyrene hydroxylase activity. The spin state 
of substrate-free and benzo(a)pyrene-bound purified yeast
(ii)
cytochrome P-448 were 94% and 82% low spin at 22°C 
respectively.
Equilibrium gel filtration analysis of the number of 
benzo(a)pyrene binding sites per mole of enzyme monomer 
showed a value of 1 for purified yeast cytochrome P-448 and 
6 for this enzyme in microsomal form.
In addition to benzo(a)pyrene, lanosterol, 
ethylmorphine, dimethylnitrosamine and sodium phenobarbitone 
showed Type I binding spectra with yeast cytochrome P-448.
A more specific and efficient form of benzo(a)pyrene 
hydroxylase was induced by the addition of benzo(a)pyrene to 
the yeast growth medium at zero time.
Based on the effect of modification of various amino 
acids on parameters of yeast cytochrome P-448, participation 
of -SH group(s) and tyrosyl residue(s) in the active site of 
this enzyme is suggested.
( iii )
Various supports were evaluated for immobilization of 
yeast cytochrome P-448. Calcium alginate was found to be 
especially useful.
Cytochrome P-448 f Saccharomyces cerevisiae is 
identified as a distinct enzyme of the cytochrome P-450 
family. This enzyme, however, has many properties in common 
with cytochrome P-448 from mammalian sources.
(iv)
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CHAPTER 1
(2)
1. Introduction
1.1. Cytochrome P-450: Historical Aspects
Cytochrome P-450 is the collective name for a distinct
group of protoheme-containing proteins which show a Soret
absorption band at around 450nm (446 to 454nm) in the C0-
difference spectrum of dithionite-reduced samples. The
occurrence in liver microsomes of this CO-binding pigment
was first reported independently by Klingenberg (1958) and
by Garfinkel (1958). This led to the characterization of
this unique hemoprotein by Omura and Sato (1962, 1964a,
1964b). The first evidence for the participation of
cytochrome P-450 in monooxygenase reactions was reported by
Estabrook et al^  (1963). Using Warburg '*s arrangement for
the photochemical action spectrum, these authors
demonstrated that light of 450nm was optimal for the
reversal of carbon monoxide inhibition of steracd C-21
hydroxylation. By the late 1960s it was realized that
cytochrome P-450 was of major importance in the metabolism
of many foreign chemicals including drugs, carcinogens,
insecticides and in the metabolism of endogenous compounds
$
including steroids and fatty acids.
Much of the early knowledge about the properties of 
cytochrome P-450 came from studies on purified preparations
(3)
of the NADH-dependent soluble cytochrome P-450cam isolated 
from Pseudomonas putida (Katagiri e_t al_, 1968; Peterson, 
1971). Initial attempts to solubilize mammalian cytochrome 
P-450 using different types of detergent resulted in 
conversion to inactive cytochrome P-420 (Omura and Sato, 
1964a). This was overcome by glycerol (Ichikawa and Yamano, 
1967). Solubilization of the membrane bound enzyme led to 
the resolution of three components: cytochrome P-450,
NADPH:cytochrome c(P-450) reductase and phospholipid, which 
when combined would catalyze the hydroxylation of lauric 
acid (Lu and Coon, 1968).
1.2. Distribution of Cytochrome P-450
Cytochrome P-450 was described in mammalian liver 
microsomes and was originally thought to be a curiosity 
occurring only in restricted biological systems. However, 
subsequent studies have revealed that hemoproteins with 
similar spectral properties are distributed very widely in 
nature; they can be detected in almost all forms of life.
In mammals, cytochrome P-450 is found at varying 
concentrations in microsomes (endoplasmic reticulum) of 
liver (Klingenberg, 1958; Garfinkel, 1958; Omura and Sato, 
1964a, 1964b), kidney (Elin et a l , 1972), small intestine 
(Takesue and Sato, 1968), lung (Matusubara and Tochino,
(4)
1971), adrenal cortex (Estabrook e_t al, 1963), skin 
(Poland e_t aJL, 1974), testis (Betz at  aJ, 1976), placenta 
(Meigs and Ryan, 1968), and several other tissues. However, 
microsomes from other organs such as brain, muscle and 
thyroid gland appear to be devoid of this type of 
hemoprotein. Cytochrome P-450 has also been detected in 
microsomes of various tissues, notably the liver, of non­
mammalian vertebrates, i.e. birds, reptiles, amphibians and 
fish (Garfinkel, 1963; Strittmatter and Umberger, 1969).
Mitochondria of mammalian* endocrine glands such as the 
adrenal cortex (Harding e_t ajl, 1964), testis (Puris e_t a l , 
1973) and corpus luteum (Yohro and Horie, 1967) which 
synthesize and excrete steriod hormones, invariably contain 
cytochrome P-450. Although, the mitochondrial localization 
of this groupXhemoproteins is not restricted to steroid 
hormone-producing glands. The occurrence of cytochrome 
P-450 in mitochondria of chicken kidney (Henry and Norman, 
1974; Ghazarian at al_, 1974) and rat liver (Taniguchi at a l ,
1973) has been confirmed, although the concentrations in 
such mitochondria are rather low.
Besides microsomes and mitochondria, the nuclear 
envelope of rat liver has been reported to contain 
cytochrome P-450 (Khaudwala and Kasper, 1973). This does
(5)
not appear to be due to microsomal contamination, since the 
cytochrome, unlike its microsomal counterpart, cannot be 
induced by phenobarbital treatment of ,the animals, although 
it is normally inducible by 3-methylcholanthrene 
administration (Khaudwala and Kasper, 1973).
Studies on the distribution of cytochrome P-450 in 
invertebrates have not been extensive, but in connection 
with the work on insecticide metabolism it has been shown 
that microsomal fractions from whole insects such as the 
housefly and Drosophila contain significant amounts of this 
type of hemoprotein (Morello e£ a l , 1971; Plapp and Casida, 
1970; Capdevila et al, 1975).
In higher plants, cytochrome P-450 has been discovered 
during attempts to elucidate the pathways involved in 
specialized metabolisms such as the biosynthesis of phyto­
hormones, lignins, and alkaloids. To date, the occurrence 
of cytochrome P-450 has been reported in such sources as 
sorghum seedlings (Potts ■ jat ajL, 1974), cauliflower buds 
(Rich and Bendall, 1975), castor bean endosperm (Young and 
Beevers, 1976), Catharanthus roseus seedlings (Madyastha 
e_t al_, 1976), and avocado mesocarp (Markham, 1976). In all 
these plant sources the hemoproteins were reported to be 
localized in the microsomal fraction.
(6)
The occurrence of cytochrome P-450 in yeast 
Saccharomyces cerevisiae was first reported by Lindenmayer 
and Smith (1964). This hemoprotein can particularly be 
found in microsomal fraction of cells grown semi- 
anaerobically (Yoshida et al, 1974a) or under the condition 
of glucose repression (Wiseman ejt al., 1976) (read on). 
Eukaryotic microorganisms such as Candida tropicalis grown 
on tetradecane as carbon source (Duppel et al, 1973) have, 
however, been reported to possess cytochrome P-450 that are 
apparently not membrane-bound and can be recovered in the 
soluble fraction.
Localization in the soluble cytoplasmic fraction seems 
to be a general feature of bacterial cytochrome P-450. All
cychromes of this type so far identified in bacteria, e.g.
■— \
in Pseudomonas putida grown on camphor as carbon source 
(Katagiri e_t al^ , 1968).
1.3. Structure of Cytochrome P-450
Cytochromes are classified into three types: a, b, c,
according to their absorption maxima. Cytochrome P-450 is 
classified as a b-type cytochrome, and in common with other 
b-type cytochromes, contains an iron protoporphyrin IX 
prosthetic group. Cytochrome P-450 differs from other 
b-type cytochromes in that it can react with oxygen, cyanide
(7)
and carbon monoxide, and also in that it has an intense red- 
shifted absorption peak at 450nm when the reduced 
hemoprotein is complexed with carbon monoxide. Treatment of 
cytochrome P-450 with various agents brings about conversion 
to cytochrome P-420, whichKas the spectrum of a typical 
b-type cytochrome, with a Soret band at 420nm. The nature
of these agents, e.g. detergents or lipase, indicates that
is
the heme of cytochrome P-450lbound in a highly lipophilic 
environment (Omura and Sato, 1964a; Imai and Sato, 1967a). 
However, proteases and denaturants such as urea which 
primarily alter the native conformation of hemoprotein, also 
cause the conversion of cytochrome P-450 to cytochrome P-420 
(Mason et_ jal, 1965a) . Thus protein structure and lipid 
environment appear to be important for maintenance of the 
usual spectral properties of cytochrome P-450.
The iron atom of cytochrome P-450 heme has four planar 
ligand interactions with nitrogen atoms of the proto- 
1 porphyrin ring system, and has two axial ligand positions 
available for further binding. Electron spin (paramagnetic) 
resonance spectroscopy (ES(P)R) has been widely used in 
conjunction with optical spectroscopy to study cytochrome 
P-450 and in particular the nature of the fifth and sixth 
ligands. EPR is used to detect unpaired electrons and is 
particularly useful for the study of transition metal
(8)
complexes such as hemoproteins. Cytochrome P-450 has been 
shown to exist in both high spin (5 unpaired electrons) and 
low spin states (Jefcoate and Gaylor, 1969a; Hill ejt a l ,
1970) (read on).
Following the observation of a loss of low spin 
character after treatment of hepatic microsomes with 
p-chloromercuribenzoate, Mason et al (1965a) suggested that-twe, 
sulfur atom was liganded to the heme of cytochrome P-450. 
Subsequent studies using model systems with thiol agents and 
hemoglobin or metamyoglobin showed similar low spinvEPR 
spectra (Jeffcoate and Gaylor , 1969a; Hill e_t al_, 1970; 
Blumberg and Peisach, 1971; Peisach et al, 1973; Collman 
et a l , 1975; Tang et a l , 1976) to those obtained with 
cytochrome P-450 from mammalian (Jefcoate and Gaylor, 1969a; 
Peisach eijt a l , 1973; Stern ejt al, 1973) and bacterial (Tsai 
et al, 1970) sources. Stern and Peisach (1974) demonstrated 
the formation of an absorption maximum at 450nm following 
the addition of carbon monoxide to a model system of reduced 
heme, thiol and a strong base. From this study they 
concluded that a thiolate anion is required to produce the 
characteristic spectrum of cytochrome P-450.
Although cytochrome P-450 has been shown to have a 
heterogeneous ligands field in the vicinity of heme
(9)
"the.
(Peisach et al, 1973), the nature ofxsixth ligand is still 
undecided. Various proposals have been made which include 
the imidazole nitrogen of a histidine residue (Jefcoate and 
Gaylor, 1969a; Tang e_t al, 1976; Chevion e_t al,, 1977), a 
hydroxyl group (Nebert et al, 1976; Kumaki and Nebert, 1978) 
and water (Peterson and Griffin, 1973; Griffin and Peterson, 
1975) (read Chapter 8).
1.4 Spectral Changes of Cytochrome P-450
The first report of a cytochrome P-450 dependent 
spectral change was made by Narasimhulu jet al, (1965), using 
17-hydroxyprogesterone in micros-omes from adrenal cortex. 
Similar spectra were later described by Remmer et al (1966), 
Imai and Sato (1966) and Schenkman et_ al, (1967) following 
the addition of various compounds to microsomal suspensions 
from liver.
These spectral changes were divided into three 
categories by Schenkman el: al (1967): type I, type II and
reverse type I (type R I ) . Type I spectral changes are 
characterized by an absorption maximum at 385-390nm and a 
minimum at about 420nm; type II are characterized by an 
absorption maximum at 420-435nm and a minimum at 390-405nm. 
The type RI spectrum is essentially a mirror image of a
(10)
type I spectral change and is typified byjminimum at 
385-390nm and a maximum at about 420nm.
Schenkman ejt a^ l (1967) suggested that these spectral 
changes were due to interaction between oxidized cytochrome 
P-450 and the added compound. These authors devised a 
method of measuring an apparent affinity constant for a 
given compound analogous to the Michaelis constant (Km ) for 
enzyme substrate complexes. A double reciprocal plot 
(Lineweaver and Burk, 1934) of spectral change versus 
substrate concentration produced an intercept on the ’X* 
axis which the authors termed the spectral dissociation 
constant or K s . This constant is defined as the concen­
tration of reactant that results in 50% of the maximal 
spectral change, and is by definition independent of protein 
concentration. The magnitude of the spectral change is 
dependent not only on the substrate concentration, but also 
on the concentration of cytochrome P-450 in the microsomal 
suspension (Estabrook et^  a_l, 1972). The maximal absorbance 
change (AAmax) is analogous to the maximal velocity (Vmax) 
of enzyme reactions.
The type I spectral change is elicited by a wide range 
of endogenous and exogenous substrates of cytochrome P-450. 
These include steroids, fatty acids, barbituates and
(11)
polycyclic aromatic hydrocarbons. In general, compounds 
which elicit the type I spectral change are lipophilic. 
Schenkman and.Sato (1968) suggested that type I compounds 
interact with apoprotein protein of cytochrome P-450 rather 
than with heme. The role of phospholipids in the type I 
interaction is uncertain. Treatment of microsomes with 
phospholipase c (Chaplin and Mannering, 1970; Eling and 
DiAugustine, 1971) or extraction with isooctane (Leibman and 
Estabrook, 1971) which removed about 70% of the phopholipids 
present, decreased or eliminated type I binding spectra. In 
contrast, Vore et al (1974) reported that extraction of 
microsomes with butan-l-ol and acetone removed about 80% of 
the phospholipids present yet increased the binding of the 
same type I substrates. Various other authors (Narasimhulu, 
1975; Levin e_t al, 1974) have reported that lipid is not 
essential for type I binding. A correlation between Ks 
values and lipid solubility for some type I ligands has been 
demonstrated by Kitigawa ejt a_l (1972) and Al-Gailany (1975).
Type II spectral changes are brought about by 
interaction of amines with cytochrome P-450 (Schenkman 
et a l , 1967) Jefcoate ejt a^ l, 1969; Schenkman, 1970). Other 
compounds containing nitrogen atoms with a lone pair of 
electrons such as pryidine and imidazole also produce the 
type II (Temple, 1971). This type of spectral change is
(12)
thought to be caused by ferrihemochrome formation, involving 
electron transfer between the nitrogen atom of the added 
compound and the sixth ligand position of the heme iron 
(Schenkman ejt al_, 1967), and in which the nitrogen atom is 
primarily an sp or sp hybrid, with a spatially accessible 
lone electron pair (Kulkarni e_t ail,. 1974; Mailman ejt a l ,
1974). Aniline has been reported to compete with carbon 
monoxide for reduced cytochrome P-450 indicating interaction 
at the heme iron (Schenkman e_t aJL, 1967). In addition, 
aniline produces two Soret peaks at 425 and 455 (Imai and 
Sato, 1967b) similar to those produced by ethyl isocyanide 
which has been shown to compete with carbon monoxide (Omura 
and Sato, 1964a).
Few compounds which give rise to type II spectrum are 
metabolized by cytochrome P-450. However, aniline, a 
compound which acts as a substrate for cytochrome P-450 and 
produces a type II spectrum, has been shown to have a type I 
component (Schenkman, 1970). This type I component is 
thought to be related to aniline metabolism.
The type RI (inverse type I or modified type II) has 
often been likened to the type II interaction (Whysner 
et a l , 1970). However, whereas type II compounds can 
displace carbon monoxide, type RI compounds cannot, nor do
(13)
they alter aniline binding to the oxidized hemoprotein 
(Schenkman ej: a_l, 1973). A diverse range of compounds 
produce the type RI spectral change including phenacetin, 
acetanilide, short monohydric alcohols, warfarin and several 
allyl-containing barbiturates. It has been suggested that 
type RI spectrum is a reversal of the type I spectral change 
caused by displacement of bound endogenous substrates (Diehl 
et al, 1970; Schenkman et a l , 1969, 1972, 1973). Diehl 
et al (1970) showed that butanol, when added to microsomes 
containing sufficient cyclohexane to saturate the type I 
binding site, produced a difference spectrum which was the 
exact mirror image of the cyclohexane (type I) binding 
spectrum. Schenkman e_t a_l (1973) found that on solvent 
extraction of microsomes, the type RI spectrum induced by 
phenacetin was reduced. Powis ejt jal (1977) found that the 
addition of bovine serum albumin to microsomal suspensions 
resulted in a type RI binding spectrum, which the authors 
concluded was due to displacement of endogenous substrates 
from cytochrome P-450.
In contrast to the results of Schenkman e_t a_l (1973), 
Vore ert jal (1974) found increased type RI binding for 
phenacetin and ethanol using butanol-acetone extracted 
microsomes. Al-Gailany (1975) proposed type RI binding is 
due to binding at a specific site of cytochrome P-450 rather
(14)
than simply displacing endogenous substrates. This 
hypothesis was based on data using fluorescent probes, which 
suggested that type I, type II and type RI sites were in 
differing environments with respect to their lipophilicity.
It has been suggested that since many compounds which 
give a type RI interaction contain oxygen, the oxygen atoms 
act much like nitrogen atoms as nucleophiles and displace 
the sixth ligand of cytochrome P-450 (Mailman e_t al_, 1974) . 
Yoshida and Kumaoka (1975b) also concluded from binding 
spectral studies that type RI binding is due to a heme' 
ligand interaction between high spin cytochrome P-450 and 
the type RI compound. Kumaki et al (1970) reached a similar 
conclusion from binding spectra and EPR studies.
The causes of the spectral changes observed on binding 
are now interpreted in terms of spin state changes. The 
active cytochrome P-450 molecule contains a heme group with 
iron in the ferric form. This means that the iron atom has 
five electrons in the d-orbitals and depending on the extent 
of spin-pairing of these, can exist in two spin states, high 
spin (total spin of S = 5/2) and low spin (total spin of 
S = 1/2). The low spin form results when four of five 
d-electrons are paired and correspond to a six coordinated 
heme iron. The high spin form results when the five
(15)
electrons are in separate energy levels and not paired, and 
corresponds to a five coordinated heme iron. In intact 
microsomal membranes, a mixture of the two spin states 
occurs, with approx. equal amounts of each, the ratio of the 
two forms being in a temperature-dependent equilibrium 
(Cinti et. aJL, 1979).. Temperature-dependency of spin state 
of cytochrome P-450 is further discussed in Chapter 8 .
The interaction of a type I compound with cytochrome 
P-450 is associated with conversion of the hemoprotein iron 
from low to high spin (Jefcoate and Gaylor, 1970; Tsai 
et a l , 1970; Kumaki et^  a l , 1978). This increase in high 
spin character is thought to be due to displacement of the 
sixth ligand of cytochrome P-450 heme, which in turn 
decreases the ligand field strength of the heme, and results 
in a hypsochromic shift. The formation of type II spectrum 
is associated with the production of a low spin iron species 
which produces a red-shifted absorbance peak. This is 
thought to be caused by an increase in ligand field 
strength. The exact nature of type RI spectrum has yet to 
be fully understood, although it seems likely that the 
mechanism of interaction between cytochrome P-450 and type 
RI compounds may involve one or more of the mechanisms 
mentioned earlier, depending on the nature of the compound 
and the cytochrome P-450 species present. Multiple
(16)
interactions between compounds and various sites of 
cytochrome P-450 are possible (Yoshida and Kumaoka, 1975b). 
It seems that type RI interaction involves the conversion of 
a high spin cytochrome to a low spin cytochrome species, and 
the sixth ligand position of the iron becomes occupied by a 
weak ligand. Whether this weak ligand is the oxygen atom of 
the type RI compound or the intrinsic sixth ligand of the 
protein is a matter for speculation.
It has been shown that the spin state of cytochrome 
P-450 controls the redox potential of the molecule, with the 
high spin form having a less negative redox potential 
(Sligar, 1976). Type I binding (generated by compounds that 
are usually substrates) thus not only results in a 
transition from low to high spin, but also a change in the 
redox potential, making it less negative and hence allowing 
electrons to flow to the cytochrome P-450 molecule more 
easily (Sligar e_t jal, 1979). Thus the' substrate induced 
spin state change results in an acceleration of reduction 
rate of the cytochrome (Misselwitz ejt <al, 1980) . This 
reveals a mechanism whereby the substrate facilitates the 
electron flow to cytochrome P-450, hence enabling the 
reaction to proceed. The role of lipids in the membrane may 
also be important in holding the enzyme in a high spin
(17)
configuration and facilitating the monooxygenase reaction 
(Gibson ejt a_l, 1980) .
1.5. Mechanism of Cytochrome P-450 Linked Oxidation
A wide variety of oxidative reactions mediated by 
cytochrome P-450 occurs in microsomes all reactions 
(aromatic hydroxylation, aliphatic hydroxylation, 
N-dealkylation, o-dealkylation, deamination, sulphoxidation 
and N-oxidation) can be considered essentially as 
hydroxyl*ions . The source of the hydroxyl group for 
microsomal hydroxylation has been shown to be molecular 
oxygen:
RH + 0 -*RQH + % 0
2 2
Such a hydroxylation reaction in which one atom of each 
oxygen molecule is transferred to the substrate is 
’’monooxygenase" as opposed to the ’’dioxygenase" reaction in 
which both atoms of the oxygen molecule are inserted into 
the substrate.
Microsomal cytochrome P-450 linked monooxygenases 
require an external source of electrons such as NADPH or 
NADH for the insertion of oxygen into the substrate and the
A
reaction is thought of as/imechanism whereby NADPH reduces a
(18)
component (A) in microsomes, which reacts with molecular 
oxygen to form an "active oxygen" intermediate which is then 
transferred to the substrate. The overall reaction has been 
envisaged by Gillete et al (1968) as follows:
(1) NADPH + A + hV  — >-tH2 + NADP+
(2) AH 2 + 0 2-v-..... ^ "active oxygen"
(3) "Active oxygen" + RCHj ~  — r R C ^ O H  + A + H20 
(overall reaction) NADPH + H+ + RCH3 +
02<—  : -RCH2OH + NADP+ + h2o
Since this complex enzymatic reaction involves the oxidation 
of NADPH to NADP*, the reaction has been termed a "mixed- 
function oxidase." Cytochrome P-450 linked enzymes are 
therefore frequently referred to as either monooxygenases or 
mixed-function oxidases (E .C .1.14.14.1). The term terminal 
oxidases is also used to denote these enzymes. The key 
microsomal enzymes in the overall reaction are 
NADPH:cytochrome c(P-450) reductase (a flavoprotein 
containing one FAD and one FMN group) involved in NADPH 
oxidation and the reduction of oxidized cytochrome P-450, 
and cytochrome P-450, which is generally considered to be 
component A. These components have been purified and 
reconstituted into an active monooxygenase system by many 
workers. This was first achieved by Lu and Coon (1968) who
(19)
reconstituted a system capable of oxidizing fatty acids, 
steroids, drugs, and other xenobiotics from components 
isolated from rabbit liver microsomes. These authors 
reported that phospholipid is also required for a fully 
functional system, where it may have a structural role in 
associating the protein components together, although the 
actual role of phospholipid is unknown.
The mechanism of the cytochrome P-450 monooxygenase 
reaction is not fully understood, but a major sequence of 
events is known and is shown in Figure 1.1 (Schenkman and 
Gibson, 1981). The mechanism involves firstly binding of 
substrate to the ferric enzyme, followed by one electron 
transfer from NADPH via NADPH:cytochrome c(P—450) reductase. 
The ferrous cytochrome P-450-substrate complex reacts with 
oxygen producing an oxygenated reduced cytochrome P-450- 
substrate complex. The oxycytochrome P-450 complex then 
undergoes a further one electron reduction. The nature of 
the active oxygen species is currently the subject of 
extensive research, but is thought to involve a number of 
radical species (White and Coon, 1980; Castro, 1980). After 
transfer within the complex of one oxygen atom and uptake of 
two protons, the complex dissociates to give oxidized 
cytochrome P-450, water and hydroxylated substrate.
(20)
SOH
SH
P-450 (Fe4+:or)SH
P-450
P-450 (Fe SO) SH
NADPH
NADP
2H
2 +P-450 (Fe
P-
NAD
= cytochrome b^
Fp = NADPH:cytochrome c (P-450) reductase 
a
Fp^ = NADH:cytochrome b^ reductase 
SH = substrate
Figure 1.1. The Cytochrome P-450 Reaction Cycle. e^ is 
transferred from NADPH via NADPH:cytochrome c(P“450) 
reductase without/with cytochrome S 5 as a mediator or from 
NADH via NADH:cytochrome b^ reductase and cytochrome b ^ .
(21)
Several studies have indicated that the second 
reduction can be mediated by NADH:cytochrome b^ reductase 
(containing FAD as a prosthetic group) and cytochrome b^ 
(Hildebrandt and Estabrook, 1971; Estabrook, 1971; Cohen and 
Estabrook, 1971; Sasame et 1973), providing an
explanation for the synergistic effect of NADH on mono­
oxygenation. Studies by Lu e_t a_l (1974) indicated that 
involvement of cytochrome b^ in the NADPH-dependent reaction 
varies with both the substrate and the species of cytochrome 
P-450 present. Imai and Sato (1977) have shown that, 
although cytochrome b^ is not obligatory for this reduction 
step, if NADH, cytochrome b$ and NADH:cytochrome b$ 
reductase are included in a reconstituted system of 
cytochrome P-450, NADPH:cytochrome c(P-450) reductase, 
sodium cholate and NADPH with benzphetamine or 
dimethylaniline as substrate, the second electron is 
supplied almost exclusively by NADH via cytochrome b5 .
As it was mentioned above, the nature of the active 
oxygen intermediate involved in the substrate hydroxylation 
reaction remains uncertain. Hamilton (1964) suggested that 
monooxygenases catalyze their reactions by means of an 
oxygen atom transfer or oxenoid mechanism, because of their 
similarity to nitrene and carbene reactions. Support for 
this mechanism has been provided by the observation of "NIH
(22)
shift" (Guroff ert a_l, 1967) or the displacement of an 
existing ring substitutent to an adjacent position by the 
incoming hydroxyl group. Hrycay and O fBrien (1971a, 1971b) 
provided evidence that cytochrome P-450 could function as a 
peroxidase with organic hydroperoxides following the 
report by Kadlubar et al (1973) the organic peroxides could 
support the oxidative N-dealkylation of a variety of amine 
substrates in rat liver microsomes. Rahimtula and O'Brien 
(1974, 1975) showed that cumene hydroperoxide and other 
hydroperides could sustain the hydroxylation of a variety of 
substrates in rabbit liver microsomes in the absence of 
NADPH and molecular oxygen. Other "active oxygen" 
containing compounds such as sodium periodate and sodium 
chlorite have been shown to support the hydroxylation of 
various steriods and fatty acids in the absence of NADPH and 
lecular oxygen (Hrycay et al, 1975a, 1975b, 1976). During
©tie
of reaction supported by cumene hydroperoxide)is 
or every mol of substrate hydroxylated, and the 
tion product is phenyl-2-propanol (cumenol) 
and O'Brien, 1974). The "NIH shift" also occurs 
roperoxide-dependent aromatic hydroxylation 
et a l , 1978). The appearance of a free radical 
determined by EPR and distinctive optical spectral 
d to the proposal that a ferryl ion complex (in 
with a ferric oxene complex
the course 
consumed f 
major reac 
(Rahimtula 
during hyd 
(Rahimtula 
signal as 
changes le 
resonance
(23)
^  i ^  o ^
Fe 0 ^. • ...>Fe 0) was the active oxygen species involved
in cytochrome P-450 mediated reactions (Rahimtula et^  a l ,
1974).
1.6. The Induction of Mammalian Cytochrome P-450 and the 
Presence of Multiple Forms
The activity of the liver microsomal monooxygenase 
system is increased by the treatment of the animal with a 
wide variety of drugs, pesticides, food additives, 
carcinogens and other compounds. This increased activity 
results from an increase in the concentration of the 
cytochrome P-450 enzyme involved, by de novo protein 
synthesis. This was shown to be by de novo synthesis as it 
can be blocked* by inhibitors of nucleic acid synthesis such 
as actinomycin D (Conney, 1967).
Two of the most widely studied inducers of the 
mammalian liver cytochrome P-450 system are phenobarbital 
and 3-methylcholanthrene. After induction with these 
compounds, different forms of the enzyme are observed in 
each case, with different substrate specificities. Pheno­
barbital induces a form of the enzyme with a very wide 
substrate specificity, the rate of metabolism of many 
substrates (e.g. aminopyrine, benzphetamine and ethyl- 
morphine) being increased. However, these activities are
(24)
unchanged or decreased by 3-methylcholanthrene pretreatment, 
which induces an enzyme with a relatively narrow substrate 
specificity with high activity towards carcinogens such as 
benzo(a)pyrene. The metabolism of some other compounds 
(e.g. acetanilide) is increased by both inducers. These 
observations led to the classification of inducers into two 
broad categories. The first group of these, exemplified by 
phenobarbital, induced cytochrome P-450 with a very wide 
substrate specificity with a peak in the reduced carbon 
monoxide difference spectrum at 450nm (cytochrome P-450).
The second group, including 3-methylcholanthrene and other 
polycylic hydrocarbons, induced an enzyme with relatively 
narrow specifity, particularly aryl hydrocarbon hydroxylase 
activity. This narrow specificity enzyme had a Soret peak 
in the induced carbon monoxide difference spectrum at 448nm, 
and so was termed cytochrome P-448. Initially, it was 
thought that cytochrome P-450 and cytochrome P-448 might be 
interconvertible forms of the same enzyme (Schenkman ejt a l , 
1969), but it was quickly established that these two enzymes 
arose from distinct gene products (Lu et_ al, 1973; Conney 
et al, 1973; Levin ejt alL, 1974).
Several hundred inducers of cytochrome P-450 enzymes 
are now known and some examples are listed in Table 1.1. As 
further work on the induction of microsomal enzymes was
(25)
Inducer Description Structure
H.
Phenobarbital
3-methylcholanthrene
Benzo(a)pyrene
8 -naphthoflavone
Polychlorinated 
biphenyls (arodors)
Sedative
Carcinogen
Carcinogen
Hydrocarbon
analog
Insulators, 
lubricants, 
heat exchange 
fluids
N
C2H5
CeH6 ' '5
OOIOo
oQO
D
Safrole
2,3,7.8-tetrachloro*
dibenzo-p-dioxin
(TCDD)
Pregnenolone
16a~carbonitrile
Carcinogen 
(formerly a 
flavouring 
agent)
Herbicide
impurity
Steroidal
derivative
CH,
I 3
C=0
HO
Table 1.1. Mammalian Cytochrome P-450 Inducing Agents
(26)
carried out, it became apparent that more newly discovered 
inducers were neither phenobarbital-like nor
3-methylcholanthrene-like. For example, ellipticine induced 
its own cytochrome P-450 mediated metabolism better than 
phenobarbital or 3-methylcholanthrene (Lesca e_t aj^ , 1977). 
Similar observations have now been made with more than 60 
inducers (including safrole and pregnenolone 
16a-carbonitrile, see Table 1.1).
These observations are now understood in terms of 
multiple forms of cytochrome P-450. It has become well- 
established that more than two forms of the enzyme exist 
with different yet overlapping substrate specificities. The 
evidence for this has come from several types of study, 
including studies with inducers, isolation and purification 
of different forms, immuological differences and kinetic and 
substrate binding studies (Guengerich, 1979). Also, 
sequencing studies have recently revealed distinct amino 
acid differences between cytochrome P-450 isozymes (Coon 
et a l , 1982; Mizukami et a l , 1983). The discovery of 
multiple forms of cytochrome P-450 has led to considerable 
confusion in the literature. Both cytochrome P-450 and 
cytochrome P-448 are now known to exist as a mixture of 
isoenzymes, and are thus general terms for a range of enzyme 
species.
(27)
The effect of inducers is now thought to be in inducing 
a range of cytochrome P-450 enzymes, the combined properties 
of which make up the characteristic properties of the 
1 induced enzyme. 1 Some of these enzyme species may be 
present in uninduced animals. Ryan et al (1979) purified 
three forms of cytochrome P-450 from rat liver microsomes, 
designated cytochrome P-450a, b and c. These three enzymes 
were distinguished by differences in molecular weight, 
immunological properties and peptide mapping. In addition, 
partial amino acid sequences revealed that these enzymes 
were distinct gene products and not due to post- 
translational modifications of one primary gene product 
(Bothelo ert al, 1979). Cytochrome P-450a and c were found 
after induction with 3-methylcholanthrene. Cytochrome 
P-450b is the major form induced by phenobarbital and 
cytochrome P-450c, the major form induced by 3- 
methylcholanthrene. After induction with aroclor 1254 (a 
mixture of polychlorinated biphenyls, known to induce both 
cytochrome P-450 and cytochrome P-448. activities), 
cytochrome P-450a, b and c were all present. Cytochrome 
P-450a has a Soret peak in the reduced carbon monoxide 
difference spectrum at 452nm, cytochrome P-450b at 450nm and 
cytochrome P-450c at 447nm. These enzymes were observed to 
have different yet overlapping substrate specificities. 
Aniline was hydroxylated equally well by all three enzymes.
(28)
Cytochrome P-450a hydroxylated testosterone at the 7a 
position but had low activity towards benzphetamine, 
benzo(a)pyrene and 7-ethoxycoumarin. Cytochrome P-450b 
hydroxylated testosterone at the 16a position and was very 
active towards benzphetamine demethylation. Cytochrome 
P-450c hydroxylated testosterone preferentially at the 63 
position, had low activity towards benzphetamine 
demethylation but had very high activity for benzo(a)pyrene 
metabolism and 7-ethoxycoumarin O-dealkylation (Ryan et al, 
1979).
Colbert ejt al_ (1979) showed that, cytochrome P—450b, 
induced by phenobarbital, was produced as a result of an 
increased level of mRNA specific for this protein, as early 
as 6h after administration. Similarly, Bresnick a_t al
(1981) showed an increased level of cytochrome P-450c mRNA 
7h after treatment with 3-methylcholanthrene, showing that 
these enzymes are coded by distinct mRNA species which are 
increased on induction.
The mechanism of induction by phenobarbital has been 
studied by several groups. The administration of pheno­
barbital has been shown to result in an increased level of 
mRNA specific for inducible cytochrome P-450 forms (Colbert 
et a l , 1979; Kuman ejt aJL, 1980) . Adesnick e_t a_l (1981)
(29)
found the mRNA level for phenobarbital inducible cytochrome 
P-450 increased 30 fold on induction. Fujii-Kuriyama et al
(1982) have sequenced the coding nucleotides of copy DNA to 
mRNA of phenobarbital inducible cytochrome P-450 from rat 
liver, and have used this to predict the amino acid sequence 
of the cytochrome. The predicted molecular weight and amino 
acid composition agreed with those of the purified enzyme. 
These workers sequenced three copy D N A ’s to phenobarbital 
induced mRNA and one of these, although similar, was not 
identical to the other two. Several amino acid substi­
tutions occur in a limited portion of the sequence,perhaps 
indicating a 1 variable region.!
Vlasuk al_ (1982) have shown that four immuno- 
chemically identical forms of phenobarbital induced rat 
liver cytochrome P-450 exist in unique combinations, which 
characterize different strains of rats and may partially 
explain the well-known strain differences in cytochrome 
P-450 enzymes (Hodgson, 1979). Walz e_t a_l (1982) have 
characterized the mRNA from two of these different 
cytochrome P-450 isozymes and found that they are different
species. When translated iji vitro, they give rise to
£v\
distinct iso^zymes corresponding exactly to the enzyme 
characterizing the group of rats from which they were 
isolated.
(30)
The group of Coon and co-workers have worked 
extensively on the mutliple forms of cytochrome P-450 in 
raabbit liver microsomes (Haugen and Coon, 1976; Coon et al, 
1978, 1980; Koop et a l , 1981, 1982). These have labeled 
their cytochrome P-450 enzymes with numbers, LM1-7 
(LM = liver microsomes) based on their relative electro­
phoretic mobilities, with the lower number given to those 
forms with highest mobility towards the anode. Cytochrome 
P-450LM2 is the major form isolated from phenobarbital 
treated animals and has a peak in the reduced carbon 
monoxide difference spectrum at 451nm and a molecular weight 
of 48,000 (Haugen and Coon, 1976). Cytochrome P-450LM4 is 
the major form induced by 3-methylcholanthrene, 
benzo(a)pyrene, 6 -naphthoflavone and 2,3,7,8- 
tetrachlorodibenzo-p-dioxin (TCDD) and has also been 
detected in small amounts in untreated animals (Coon et_ a l , 
1978, 1980). The enzyme from all of these sources is 
indistinguishable by several criteria, has a molecular 
weight of 54,000 and a Soret peak in the reduced carbon 
monoxide spectrum at 448nm.
The major cytochrome P-450 proteins present in 
uninduced rabbit lever are LM3b and LM3c, a small amount of 
LM3a and LM4 also being detectable (Koop ejt a_l, 1981). LM3c 
is also found alongside LM2 in phenobarbital induced rabbits
(31)
(Coon et al^ , 1980). Cytochrome P-450LM3b and LM3c have 
molecular weights of 52,000 and 53,000 and Soret peaks at 
450nm and 449nm respectively. Other workers have also 
described LM3 enzymes in uninduced rabbit liver (Ingelman- 
Sundberg et al, 1980; Johnson, 1980). Cytochrome P-450LM3a 
has recently been shown to be the major form present after 
induction with ethanol (Koop e_t aJL, 1982) . This enzyme has 
a molecular weight of 51,000, a Soret peak at 452nm and is 
very active in oxidation of ethanol and the p-hydroxylation 
of aniline.
Cytochrome P-450LM6 has been found as a minor component 
after induction with TCDD in adult rabbits, but is the major 
component after TCDD induction of neonatal rabbits (Norman 
et a l , 1978). This enzyme has a molecular weight of 57,000 
and a Soret peak in the induced carbon monoxide spectrum at 
448nm, and is also the major form after induction with 
isosafrole (Koop et al, 1982). Cytochrome P-450LM1 and LM7 
have also been observed, but as yet have not been purified 
and are poorly characterized. The characteristics of the 
major rabbit liver cytochrome P-450 enzymes are summerized 
in Table 1.2. These enzymes have also been shown to have 
different but overlapping substrate specificities.
(32)
Cytochrome
P-450
Molecular
Weight
Soret peak 
(carbon monoxide 
bound)
Reference
LM 2 48,000 451 Haugen & Coon 
(1976)
LM 3a 51,000 452 Koop jet al/ (1982)
LM 3b 52,000 450 Koop ejt a_l (1981)
LM 3c 53,000 449 Koop e_t al^  (1981)
LM 4 54,000 448 Coon et al (1978, 
1980)
LM 6 57,000 448 Norman e_t eJL (1978)
Table 1.2. Major Rabbit Liver Cytochrome P-450 Enzymes
(33)
Although extensive work has already gone into charac­
terization of forms of cytochrome P-450, the exact number of 
isozymes is not known. Current estimates range from 12-20 
enzymes present in rabbit liver microsomes (Koop e_t al t 
1982) and a similar number has been postulated for rat liver 
microsomes and other microsomal systems (Guengerich, 1982). 
Some workers believe that hundreds or even thousands of 
cytochrome P-450 molecules may exist, although not all at 
one time, produced in a manner analogous to antibody 
synthesis (Nebert e_t a_l, 1981) . At any one time, an 
organism may be exposed to 10 -20 important inducers, so that 
10 or 20 forms of induced cytochrome P-450 would exist in 
quantities sufficient to be detected. At a later time, the 
organism might be exposed to a different range of inducers 
and thus a different profile of cytochrome P-450 enzymes may 
be produced (Nebert ejb .al, 1981). For this system it is 
necessary to postulate induction of cytochrome P-450 enzymes 
in control organisms, presumably by endogenous substrates 
such as fatty acids and steroids. Nebert and co-workers 
have also worked extensively on the mechanism of induction 
of cytochrome P-450 by polycyclic hydrocarbons. This occurs 
via the 'Ah locus1; the inducer binds to a cytosolic 
receptor which is translocated to the nucleus where 
cytochrome P-450 structural gene is switched on. This 
model is discussed more fully in Chapter 2.
(34)
1.7. Cytochrome P-450 from Bacteria Species
Cytochrome P-450 has been found in several species of
bacteria. These are listed in Table 1.3 along with the
reported role of the enzyme in each case. By far the best
characterized of these enzymes is from Pseudomonas putida.
This organism produces a cytochrome P-450 enzyme when grown
on D(+)-camphor which metabolizes camphor, hence enabling
growth of the organism on this compound as sole carbon and
energy source (Yu ejt jal, 1974). This enzyme (termed
cytochrome m ) hydroxylates the 5-methylene carbon of
camphor to form the exo-5-alcohol (Gunsalus et al, 1975).
Studies on cytochrome P-450„„„, have been greatly facilitated ■ J cam ° J
as, unlike mammalian cytochrome P-450 enzymes, it is a 
soluble enzyme and not membrane bound. This enzyme has been 
purified to homogeneity and crystallized; it has a molecular 
weight of 44-46,000 and has a Soret peak in the reduced 
carbon monoxide difference spectrum at 446nm (O'Keefe et a l , 
1978).
The electron transport chain of cytochrome P-450J cam
supported by NADPH, contains an extra protein component, 
putidaredoxin, a small iron-sulphur protein. Also the 
flavoprotein reducase contains only one flavin group, an FAD 
(Dus, 1975). In these respects, this system differs from 
microsomal'cytochrome P-450 but is very similar to mammalian
(35)
Organism Role References
Pseudomonas putida camphor hydroxylation Gunsalus et al 
0 ' Keefe ejt al_
1975
1978
Bacillus megaterium 
ATCC 13368
steriod 
15 B-hydroxylation
Berg & Rafter 1981
Bacillus megaterium 
ATCC 14581
hydroxylation of fatty 
acids, alcohols and 
amides
Matson et: al 1977
Corynebacterium sp. 
7E1C
hydroxylation of alkanes Cardini & Jurtchuk 1970
Nocardia NHI p-O-dealkylation Broadbent & Cartwright
1974
Rhizobium iaponicum Role in fixation? Appleby 1978
Escherichia coli p-nitroanisole Edelson & McMullen 1977
Photobacterium 
fischeri
aliphatic hydroxylation 
(in bacterial 
luminescence)
Ismailova e_t al_ 
Danilov e^ t al
1981
1982
Table 1.3. Bacterial Cytochrome P-450 Systems
(36)
mitochondrial cytochrome P-450 systems, which also contain 
an extra iron-sulphur protein and reductase (a soluble 
enzyme) with one flavin group (Suhara et al, 1978).
Dus ej: aJL (1980) have compared the immunochemical properties 
of cytochrome P-450cam with cytochrome P-450gcc, the mito­
chondrial cytochrome P-450 from adrenal cortex of mammals 
responsible for side chain cleavage of cholesterol. 
Antibodies to one of these proteins could inhibit the 
activity of the other, and the two antibodies showed a high 
degree (approx. 75%) of cross-reactivity, indicating one or 
more antigenic determinants in common. In these 
experiments, cytochrome LM2 from phenobarbital induced 
rabbit liver microsomes also showed 60% cross-reactivity 
with antibody to cytochrome Recently, the primary
structure of cytochrome P-450cam has been completely 
elucidated (Haniu et a l , 1982). The enzyme consists of a 
chain of 412 amino acid residues, and detailed comparisons 
with other cytochrome P-450 enzymes will now be possible 
once their sequence becomes available.
Two cytochrome P-450 species with different 
specificites have been reported in different strains of 
Bacillus megaterium. The strain ATCC 14581 produces a 
cytochrome P-450 with co-2 hydroxylase activity towards fatty 
acids (with some w-1 and o)-3 activity) which can also
(37)
hydroxylate corresponding amides and alcohols (Matson e_t al, 
1977). This enzyme can also catalyze the epoxidation of 
unsaturated fatty acids (Ruettinger and Fulco, 1981). 
Substrates of this enzyme were unable to induce the enzyme 
to higher levels, but when phenobarbital was tested, a 28 
fold induction was observed (Narhi and Fulco, 1982).
Bacillus megaterium ATCC 13368 also contains a 
cytochrome P-450 monooxygenase system, which has very 
different properties to that of ATCC 14581 described above. 
This enzyme is mainly a 15 $“"kydroxylase (with some 6 
3-hydroxylase activity) for 3-oxo-A^-steroids such as 
progesterone (Berg ejt a]L, 1977). This cytochrome P-450 
(termed cytochrome P-450 ) is also a soluble enzyme and
LLLtjg
has been purified to homogeneity and found to have a 
molecular weight of 52,000 and an amino acid composition 
similar to that of cytochrome P-450__m . The reduced carbon
Lalu
monoxide difference spectrum reveals a peak at 450nm. This 
system also contains a three-protein component electron 
transport chain similar to that in P_^  putida, as do all the 
bacterial cytochrome P-450 monooxygenase systems 
investigated so far. One difference in the cytochrome P-450 
system is that the reductase contains FMN and not FAD as the 
prosthetic group (Gustafsson e_t a_l, 1980) . Studies on the 
small iron sulphur protein (ferridoxin) component have
meg
(38)
revealed that its molecular weight and amino acid
composition closely resemble those of putidaredoxin and
adrenodoxin, the corresponding proteins in P_^  putida and
mammalian adrenal cortex mitochondria (Berg, 1982). It has
been found that in common with other bacterial systems (and
mammalian mitochondrial systems), the substrate specificity
of this enzyme is very narrow, with only 3-oxo-A^-steroids
acting as substrate (Berg and Rafer, 1981). In addition,
these workers found that no induction of cytochrome P-450
J meg
could be detected with either substrates or classical 
inducers of mammalian cytochrome P-450.
Appleby (1978) purified three cytochrome P-450 enzymes 
from Rhizobium japonicum grown symbiotically on soybean root 
nodules. The three enzymes designated cytochrome P-450a, b 
and c, had Soret peaks in the reduced carbon monoxide 
difference spectrum at 449nm, 449nm and 447nm for cytochrome 
P-450a, b and c respectively. The role of these 
R . .japonicum enzymes is unknown, but they may have a role in 
the removal of oxygen in this strictly anaerobic system, or 
in electron transport at very low oxygen tension to generate 
ATP required for nitrogenase activity (Bergersen and Turner,
1975).
(39)
Edelson and McMullen (1977) examined Escherichia coli 
for cytochrome P-450 activity. This organism contained an 
enzyme, inhibited by carbon monoxide, which could dealkylate 
p-nitroamisole. This activity could be induced by pheno- 
barbital, as is the case for the fatty acid hydroxylase from
B . megaterium described above.
Cytochrome P-450 has also been reported to be involved 
in the bacterial luminescence of Photobacterium fischeri 
(Ismailova ejt ajL, 1981). The luciferase complex of this 
organism is thought to consist of four protein components in 
a multienzyme complex, one of which is cytochrome P-450.
The role of cytochrome P-450 in this process is thought to 
be in hydroxylation of aliphatic aldehydes, substrates of 
luminescence reaction (Ismailova e_t a_l, 1981). Danilov 
et^  al (1982) have shown that the cytochrome P-450 from 
Photobacterium fischeri gives rise to a type I binding 
spectrum with camphor, and that this compound can inhibit 
the luminescence system by competitive inhibition of 
cytochrome P-450.
In addition, the presence of cytochrome P-450 has been 
reported in Corynebacterium species, grown on n-octane which 
can hydroxylate n-octane (Cardini and Jurtchuk, 1970) and 
Norcardia species, grown on iso-vanillate, which can
(40)
O-dealkylate p-alkylphenyl ethers (Broadbent and Cartwright, 
1974).
In all of the bacterial cytochrome P-450 systems 
characterized so far, the cytochrome P-450 is soluble and 
operates via an electron transport chain of three protein 
components.
1.8. Cytochrome P-450 from Yeast
A cytochrome P-450 has been demonstrated in several 
yeast species when grown- on n-alkanes as sole carbon source. 
These organisms use cytochrome P-450 as an alkane 
hydroxylase catalyzing the first step in the degra^tion of 
alkanes for growth, in a fashion similar to the bacterial 
system, in Corynebacterium mentioned in section 1.7. The 
first report of an alkane grown yeast containing cytochrome 
P-450 was for Candida tropicalis grown on n-tetradecane as 
sole carbon source (Gallo et_ aJL,' 1971). This enzyme 
catalyzes the u)-hydroxylation of alkanes and of lauric acid, 
and is also capable of N-demethylation of aminopyrine, 
hexcbarbital, benzphetamine and ethylmorphine (Lebeault 
jet aJL, 1971). This enzyme is dependent on oxygen and NADPH, 
is inihibited by carbon monoxide, is bound to microsomal 
membrane and requires two protein components (cytochrome 
P-450 and its reductase) and lipid for full activity
(41)
(Duppel ejt al_, 1973; Gallo e_t al^ , 1976). Surprisingly, both 
the reductase and the lipid components could be replaced by 
the corresponding fractions from rat liver microsomes 
(Duppel ejt a l , 1973). Hexadecane has also been shown to be 
a potent inducer of this system, as have all n-alkanes 
tested with more than 10 carbon atoms, and also long chain 
alkanes and alcohols (Gilewicz et^  a]^ , 1979). The components 
of the electron transport chain from tropicalis have been 
purified and reconstituted into an active hydroxylase system 
(Bertrand e_t a l , 1979a, 1979b). Mansuy ejt ajL (1980) have 
shown that cytochrome P-450 from tropicalis is in a spin 
state equilibrium similar to that of mammalian microsomal 
cytochrome P-450 and that this enzyme can also undergo 
spectral changes on binding.
A similar enzyme has been described in Candida 
guilliermondii grown on n-alkanes which hydroxylates long 
chain alkanes (preferably hexadecane to octadecane) to their 
primary alcohols (Muller et al, 1974). This microsomal 
enzyme also produces binding spectra with several compounds 
including a type I spectrum with the substrate hexadecane 
(Muller et al, 1979). It was also shown that 
C . guilliermondii could not produce cytochrome P-450 during 
growth on glucose, nor when glucose was added together with 
the hydrocarbon inducer. Mauersberger et al (1980) have
(42)
shown that the level of alkane-induced cytochrome P-450 in
C . guilliermondii is higher when the oxygen level is low. 
These workers suggested that this effect might be due to 
oxygen limitation causing a decreased alkane hydroxylation 
rate, to which the yeast responds by increasing biosynthesis 
of the monooxygenase.
Mauersberger and Matyashova (1980) reported the 
occurrence of cytochrome P-450 also in Candida lipolytica 
grown on n-alkanes and Il'chenko e_t al^  (1980) demonstrated a 
similar system in Torulopsis Candida. Lodderonfces 
elongisporus is also capable of producing a cytochrome P-450 
when grown on n-alkanes, particularly tetradecane 
(Mauersberger e_t al, 1981). This enzyme and its reductase 
have recently been purified and reconstituted into an active 
hydroxylating system which requires phospholipid (Riege 
et a l , 1981; Muller e_t al_, 1982). Saccharomycopsis 
lipolytica also produces a cytochrome P-450 alkane 
hydroxylase when grown on n-alkanes, which is very active 
towards lauric acid hydroxylation (Marchal e_t al^ , 1982) .
The occurrence of cytochrome P-450 in Saccharomyces 
yeasts is now well established. Lindenmayer and Smith 
(1964) were the first to demonstrate the occurrence of this 
hemoprotein in Saccharomyces cerevisiae grown anaerobically
(43)
in a medium containing 4% glucose and to a lesser extent 
when grown aerobically in the same medium. Cytochrome P-450 
has now been demonstrated in several species of 
Saccharomyces and related species of yeast (Table 1.4).
Ishidate et al (1969a) showed that cytochrome P-450 was 
located in the microsomal fraction of S . cerevisiae, and 
that its spectral properties were similar to those of 
mammalian microsomal cytochrome P-450. These findings were 
later verified by Yoshida eHL jal^  (1974a). Ishidate e_t jil 
(1969b) also found that cytochrome P-450 was present in 
yeast grown semi-anaerobically but was lost on exposure to 
aerobic conditions. This loss paralleled the formation of 
active mitochondria within the yeast cells and could be 
prevented by high concentrations of glucose or chlor­
amphenicol, both of which also prevented the development of 
mitochrondrial respiration. Rogers and Stewart (1973) 
showed that no cytochrome P-450 could be detected in yeast 
grown under strictly anaerobic conditions, but found a 
maximum level of cytochrome P-450 was reached at a low 
oxygen concentration (0.25pM) when in 4% glucose media, 
which decreased at higher oxygen concentrations. Subsequent 
work has established that cytochrome P-450 production in 
S . cerevisiae is associated with the exponential growth 
phase under conditions of repression of mitochondrial
(44)
Organism References
Saccharomyces cerevisiae
Saccharomyces uvarum 
formerly carlsbergensis
' Schi2 0 saccharomyces pombe
Saccharomyces bayanus
Saccharomyces chevalieri
Schizosaccharomyces japonicus
r Pichia fermentans
Debaryomyces hansenii
Hansenula anomala
Kluyveromyces fragilis 
(formerly S_;_ fragilis)
Brettanomyces anomalus
Torulopsis dattila
Lindenmayer & Smith, 1964; 
Wiseman ejt al^ , 1975
Cartledge et_ al_, 1972; 
Sauer ejt al, 1982
Poole at ajL, 1974
Karenlampi at al, 1980
Table 1.4. Saccharomyces and Related Species of Yeast which 
Contain Cytochrome P-450 during Growth on Glucose Media.
(45)
cytochromes, and the enzyme is rapidly lost during 
stationary phase, or when formation of active mitochondria 
can occur (Woods, 1979; Wiseman, 1980). Thus cytochrome P- 
450 is produced in S. cerevisiae under conditions which lead 
to repression of mitochondrial cytochromes, such as semi- 
anaerobic conditions or at a high glucose concentration in 
aerobic conditions.
Wiseman e_t aT (1978) have shown that djs novo synthesis 
of cytochrome P-450 in S . cerevisiae is controlled by the 
intracellular concentration of cyclic AMP by repression.
The level of cyclic AMP in the yeast cell is determined by 
the glucose concentration in the medium in an inverse 
relationship (Sy and Richter, 1972). Therefore under 
conditions of glucose repression of mitochondrial 
cytochromes, the cyclic AMP concentration is low and the 
repressive effect of cyclic AMP is removed, allowing d_e novo 
synthesis of cytochrome P-450 to occur (Wiseman e_t a l ,
1978). As expected, cytochrome a+a^ and cyclic AMP show a 
direct relationship to each other and an inverse rela­
tionship to cytochrome P—450 levels at various glucose 
concentrations (Qureshi ej; al, 1980). This inverse rela­
tionship between cytochrome a+a^ and cytochrome P-450 has 
also been noted in S . cerevisiae grown semi-anaerobically 
(Schunk e_t aJL, 1978).
(46)
The production of cytochrome P-450 during growth of
S.. cerevisiae on a range of sugars has been studied by
Karenlampi e_t a_l (1981). These workers found that high
concentrations of cytochrome P-450 were produced during
growth of yeast on high concentrations of a strongly
fermentable sugar such as glucose, fructose and sucrose.
Cytochrome P-450 was also produced to a lesser extent during
growth on galactose or maltose where fermentation and
respiration occurred concomitantly. However, when a non-
fermentable carbon source was used for growth (such as
*
glycerol, lactate or ethanol), no cytochrome P-450 was 
produced. These workers thus linked cytochrome P-450 
synthesis of conditions of rapid growth and fermentation, 
though not necessary to the repression of mitochondrial 
cytochromes. As heme is synthesized during both fermen­
tative and respirative conditions (Lebbe-Bois and Volland, 
1977), it is probable that apoprotein synthesis is regulated 
in these different conditions.
The presence of a complete electron transport chain in 
S . cerevisiae analogous to that in liver microsomes 
(containing only two protein components: a reductase with
two flavin groups, one FAD, one FMN and a cytochrome P-450) 
has been demonstrated by Yoshida e_t al^  (1977). However, 
these workers in addition to purification of yeast
(47)
cytochrome P-450 (Yoshida ejt jal, 1977) and NADPH:cytochrome 
c(P-450) reductase (Kubota e_t al, 1977; Aoyama e£ ajl, 1978), 
have isolated cytochrome b^ (Yoshida et al, 1974b) and 
NADH:cytochrome b^ reductase (Kubota et al, 1977) from this 
species. The purified cytochrome P-450 had a molecular 
weight of 51,000 and a reduced carbon monoxideAat 447-448nm 
(Yoshida et al, 1977). These workers also suggested that 
most of yeast cytochrome P-450 is in the high spin state in 
vivo and may therefore be substrate bound (Yoshida and 
Kumaoka, 1975b). However, the function of cytochrome P-450 
in S. cerevisiae is still uncertain.
S . cerevisiae cytochrome P-450 is thought to be 
involved in the demethylation of lanosterol to zymosterol, 
which is an intermediate in the conversion of lanosterol to 
ergoste.ro!, the major sterol in yeast membranes. This 
process involves three demethylation steps and was inhibited 
57% by carbon monoxide (Alexander ^t al^ , 1974) . It was also 
shown that partially purified low spin yeast cytochrome 
P-450 could be partially converted to high spin by adding 
lanosterol (Yoshida and Kumaoka, 1975b). Aoyama and Yoshida 
(1978a) showed that lanosterol stimulated the oxidation of 
NADPH by purified yeast cytochrome P-450 and reductase and 
demonstrated a type I binding spectrum for lanosterol with 
purified yeast enzyme, indicative of a substrate
(48)
relationship. It was subsequently shown that cytochrome P- 
450 is involved in the 14a-demethylation of lanosterol, the 
other two demethylation steps proceeding via a cyanide- 
sensitive monooxygenase (Ohba ejt jal; Aoyama e_t al, 1981b) . 
This 14a-demethylation step is inhibited by antibodies to 
yeast cytochrome P-450, and a reconstituted system of 
purified cytochrome P-450 and NADPH:cytochrome c(P-450) 
reductase could 14a-demethylate lanosterol in the presence 
of NADPH and oxygen (Aoyama and Yoshida, 1978b). The 
postulation of this endogenous role for cytochrome P-450 
posed the question -of how ergosterol was synthesized under 
conditions of aerobic.growth at low glucose concentrations 
when no cytochrome P-450 could be detected. Recently, 
however, Aoyama et a_l (1981a) have shown that a small amount 
of cytochrome P-450, not detectable by usual methods, may be 
present under these conditions and be responsible for 
ergosterol biosynthesis.
A second role of S_^ cerevisiae cytochrome P-450 in
ergosterol biosynthesis has recently been reported by Hata
et al (1981). These workers claimed that yeast cytochrome
22
P-450 may also be involved in A -desaturation of ergosta-
5,7-dien-3B-ol to form ergosterol, a step later in the same
pathway. This role was postulated on the basis of studies
(49)
with the cytochrome P-450 inhibitors carbon monoxide and 
metyrapone.
The metabolism of benzo(a)pyrene (read on) by the 
cytochrome P-450 monooxygenase system from cerevisiae is 
now well established (Wiseman and Woods, 1979; Woods and 
Wiseman, 1980). Benzo(a)pyrene is hydroxylated by this 
enzyme to a range of products, predominantly 
3-hydroxybenzo(a)pyrene, 9-hydroxybenzo(a)pyrene and
7,8-dihydro-7,8-dihydroxybenzo(a)pyrene (Woods and Wiseman,
1979). The involvement of yeast cytochrome P-450 in this 
activity has been demonstrated by thermal stability 
experiments and inhibition of benzo(a)pyrene hydroxylase by 
carbon monoxide (Woods,1979). Studies using tritium NMR on 
substrate-heme interactions in a partially pure enzyme 
preparation also supported the involvement of cytochrome 
P-450 in benzo(a)pyrene hydroxylation (Libor et al_, 1980). 
The metaboLites of benzo(a)pyrene produced by the yeast 
enzyme are more similar to those produced by a mammalian 
cytochrome P-448 than by a mammalian cytochrome P-450 
(Gozukara e_t ajL, 1981).
Cytochrome P-450 from S_^  cerevisiae has also been 
claimed to activate certain promutagens to active mutagenic 
compounds, as shown by an increased yeast mutation rate
(50)
(Callen and Philpot, 1977). These compounds include 
dimethylnitrosamine, aflatoxin B, 8 -napht hylamine, ethyl 
carbamate and cyclophosphamide. A later report by these 
workers presented spectral evidence for the involvement of 
cytochrome P-450 in these activations , (Callen ejt .al, 1980).
1.9. Metabolism of Benzo(a)pyrene by Cytochrome 
P-450-Dependent Mixed-Function Oxidase System
A number of studies have demonstrated the carcinogenic 
properties of cyclic aromatic hydrocarbons in different 
species, including man, and in different tissues, including . 
the lung and skin (Saffioti _et_ a_l, 1972; Shubik, 1972; Henry 
et al, 1973; Little and 0 fToole, 1974). Benzo(a)pyrene 
seems to be either the most active carcinogenic agent or at 
least the best indicator of the carcinogenicity of the 
complex residues resulting from the incomplete combustion of 
organic fuels (Sterling and Pollack, 1972).
The major pathways for the metabolism of benzo(a)pyrene 
aryl hydrocarbon monooxygenase (hydroxylase) 
system, epoxide hydrase and glutathione S-epoxide 
transferase (Oeseh, 1973).
It has been believed for sometime that the aryl 
hydrocarbon hydroxylase system and microsomal mixed-function
(51)
oxidase system are the same (Conney, 1967). Both these 
systems are localized in the endoplasmic reticulum of rat 
liver and require NADPH and molecular oxygen. Carbon 
monoxide also inhibits both systems and the isolated 
components of the cytochrome P-450 system can be 
reconstituted to give aryl hydrocarbon hydroxylase activity. 
In addition, benzo(a)pyrene and other polycyclic aromatic 
hydrocarbons induce increased levels of both hydrocarbon 
hydroxylase and cytochrome P-450/P-448 in various tissues 
(Alvares ejt al^ 1967; Gram e_t jal, 1967).
There is a large body of evidence that aryl hydrocarbon
hydroxylase (mixed-function oxidase), the first of the
ihfe
enzymes mentioned above, introduces an oxygenjlits substrates 
to produce epoxides (arene oxides) (Oeseh ejt al, 1973; 
Heidelberger, 1975). Tissues in which the aryl hydrocarbon 
hydroxylase system has been demonstrated to metabolize 
polycyclic aromatic hydrocarbons to epoxides or 
dihydrodiols, which arise from the further metabolism of the 
epoxide, include rat liver, lung and skin, mouse skin and 
human liver, lung, lymphocyles, adrenal gland and placenta 
(Gelbion e_t al^ , 1975; Sims, 1975).
The oxidative metabolism of benzo(a)pyrene (Figure 1.2) 
catalyzed by the mixed-function oxidase proceeds initially
(52)
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through the formation of reactive epoxides, as was mentioned 
above. Oxidation may occur at the 4,5-position, the 
K-region position, the 7,8-position, or at the fbay region 1
9,10-position (Jerina and Bally, 1974; Yang et. a_l, 1978). 
These epoxides are reactive species which undergo further 
metabolism. They may be deactivated by the cytosolic 
glutathione S-epoxide transferase to yield glutathione 
conjugates which are excreted in the bile, or further 
metabolized to mercapturates which are excreted in the 
urine. The epoxides can also undergo non-enzymatic intra­
molecular rearrangement into phenols (NIH shift mechanism) 
which are conjugated with glucuronic acid, or sulfate, and 
excreted. Both of these routes lead to the deactivation of 
the epoxides. Phenols and quinones may also form by mixed— 
function oxidase system by direct hydroxylation.
All three epoxides are also substrates of the 
microsomal enzyme, epoxide hydrase, which catalyzes the 
hydration of the epoxides to corresponding trans- 
dihydrodiols. The 9,10- and 7,8-diols, unlike the K-region 
4,5-diol, still contain olefinic bonds which undergo mixed- 
function oxidation to give rise to the diol-epoxides, the 
ultimate carcinogens, of benzo(a)pyrene and of several other 
polycyclic aromatic hydrocarbons.
(54)
The bay region 9,10-epoxide is more readily formed from 
the benzo(a)pyrene-7,8-diol than is the 7,8-epoxide from
9,10-diol (Thakker ejt aJL, 1978). This product, the 
benzo(a)pyrene-7,8-diol-9 ,10 epoxide is considered to be the 
major ultimate carcinogen of benzo(a)pyrene (Levin et a l , 
1976; Yang jet: a l , 1976).
The principal RNA and DNA adducts isolated from tissues 
of animals treated with benzo(a)pyrene arise through the 
interaction of the anti isomer of the 7,8-diol-9 ,10-epoxide 
(diol epoxides of polycyclic hydrocarbons could exist as two 
geometrical isomers, denoted syn and anti) with the 
interacellular macromolecules (Sims et_ al_, 1978; King jelt a l , 
1976). The formation of the diol-epoxides comprises only a 
minute fraction of total metabolism of the benzo(a)pyrene, 
and administration of this compound to animals leads 
primarily to its detoxication to phenols and dihydrodiols 
which are subsequently conjugated and excreted 
(Herbst e_t a_l, 1971).
(55)
CHAPTER 2
(56)
2. Studies on the Biosynthesis of Cytochrome P-450 in 
Saccharomyces cerevisiae |
Since the presence of cytochrome P-450 was first shown
been made to investigate the conditions required for its 
biosynthesis. The initial report of the presence of 
cytochrome P-450 in a baker's yeast strain of Saccharomyces 
cerevisiae found that this enzyme was present under 
anaerobic growth conditions and to a lesser extent when 
grown aerobically at a high glucose concentration (4%, w/v) 
(Lindenmayer and Smith, 1964). The production of yeast 
cytochrome P-450 under semi-anaerobic growth conditions was 
confirmed by Ishidate eMt a_l (1969a) with very little 
cytochrome P-450 (approx. 10% of the semi-anaerobic value) 
produced under fully.aerobic conditions. During aerobic 
growth at low glucose concentration (1%, w/v) no cytochrome 
P-450 was observed. These workers also found that 
cytochrome P-450 in semi-anaerobically grown yeast was 
rapidly lost on exposure to aerobic conditions (Ishidate 
et a l , 1969b). This loss paralleled the formation of active 
mitochondria within the yeast cells and could be prevented 
by high concentrations of glucose or chloramphenicol, both 
of which also prevented the development of mitochondrial
2.1 Introduction
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in the yeast Saccharomyces cerevisiae, several studies have
(57)
respiration. Essentially similiar findings were made by 
Rogers and Stewart (1973), who found a maximum cytochrome 
P-450 level in yeast grown in a medium containing 4% (w/v) 
glucose at the.low oxygen concentration of 0.25y M. The 
cytochrome P-450 level declined at both lower and higher 
oxygen concentrations.
Since these early studies, work on cytochrome P-450 from 
Saccharomyces cerevisiae has been done largely on the enzyme 
from yeast grown under two sets of conditions. Yoshida 
et al (1972, 1975a, 1975b, 1977) have worked on cytochrome 
P-450 produced from a baker's yeast strain grown semi- 
anaerobically in a medium containing 6% (w/v) glucose, 
whereas Wiseman e_t a_l (1975, 1976, 1978) have worked on the 
enzyme produced in brewer's yeast grown aerobically in a 
medium containing 20% (w/v) glucose. Both of these sets of 
conditions achieve repression of mitochondrial cytochromes 
and production of a high level of cytochrome P-450.
It has become well established that cytochrome P-450 
production in yeast is rapid during the exponential phase of 
growth but ceases at the beginning of the stationary phase 
(Woods, 1979; Karenlampi ejt al, 1981). It has also been 
shown that Tween 80 is capable of increasing the level of 
cytochrome P-450 in yeast grown for 48h or more, presumably
(58)
due to the prevention of degradation rather than - to increased 
biosynthesis after this time (Wiseman e_t a_l, 1976).
In this study biosynthesis of cytochrome P-450 growing 
in a range of different glucose concentrations under aerobic
conditions are examined and the results are compared with
a-
those grown underAsemi-anaerobic atmosphere (as reported by 
King, 1983; Blatiak e_t al^ , 1983 who used the same strain 
yeast in experiments carried out in the same laboratory at 
the University of Surrey). Also, a study of genetic 
regulation of cytochrome P-450 production in S. cerevisiae 
is presented. Although cytochrome P-448 is the dominant 
cytochrome P-450-type enzyme in yeast (Chapter 3), for 
simplicity when it is studied in yeast cells in this 
chapter, it is referred to by its generic name cytochrome 
P-450.
2.2. Methods and Materials
2.2.1. Growth of Yeast
Strains of Saccharomyces cerevisiae were maintained on 
slopes of Sabouraud-Dextrose agar which were subcultured at 
regular intervals. The strain S. cerevisiae NCYC No. 240 
was used unless otherwise described. Liquid cultures were 
inoculated directly from slopes with a wire loop. The 
growth medium consisted of yeast extract (1%, w/v),
(59)
mycological peptone (2%, w/v), sodium chloride (0.5%, w/v) 
and glucose at various concentrations. The cultures were 
grown at 30°C in a shaking water bath at constant speed. 
Normally, yeast was grown in 250ml flasks, each containing 
100ml of medium. The yeast growth medium was previously 
autoclaved at 15 p.s.i. for 15min with glucose being 
autoclaved separately to prevent the formation of breakdown 
products which interfere with the cytochrome P-450 assay 
(Lim, 1976).
2.2.2. Measurement of Cytochrome P-450 in Yeast Cells 
Cytochrome P-450 levels in yeast cells were measured by
a modification of the difference spectrum method of Omura 
£t_ a_l (1965). Yeast was suspended to a concentration of 
O.lg wet weight/ml in 0.1M potassium phosphate buffer pH
7.2, and the sample divided into two cuvettes. Sodium
Cov\tfi.v^S qV
dithionite was added to reducejeach cuvette and a baseline 
was drawn in the range 390-500nm using either a SP 1800 (Pye 
Unicam, U.K.) or Cary 219 (Varian, U.S.A.) spectro­
photometer. The sample cuvette was removed and carbon 
monoxide bubbled through it for 30s. The difference 
spectrum was then recorded again between 390-500nm. A 
typical yeast cytochrome P-450 assay is shown in Figure 2.1. 
The concentration of cytochrome P-450 was calculated from 
the difference between 450 and 490nm with reference to the
(60)
baseline
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Figure 2.1. A Typical Yeast Reduced Carbon Monoxide 
Difference Spectrum. A yeast suspension of O.lg/ml (wet 
weight) was used.
(61)
baseline, assuming the same extinction coefficient as for 
mammalian cytochrome P-450 of 91mM ^cm
2.2.3. Measurement of Mitochondrial Cytochromes
Mitochondrial cytochromes were assayed by a modification 
of the method of Williams (1964). Yeast was suspended at a 
concentration of O.lg wet weight/ml in 0.1M potassium 
2rphosphate buffer pH 7.2, and divided into two cuvettes. The
Co*
sample cuvette)was reduced with sodium dithionite and the 
reference cuvettejoxidized by the addition of 50yl of 
hydrogen perioxide (6%, w/v). The spectrum was then 
recorded between 500-640nm using a SP 1800 Pye Unicam 
spectrophotometer. A typical spectrum obtained is shown in 
Figure 2.2. The absorbance between four wavelength pairs 
was measured and used to calculate the concentrations of the 
individual cytochromes, cytochrome c, c ^ , and b and a+a ^ , 
using four simultaneous equations which allow for the 
spectral overlap of the cytochromes.
The four wavelength pairs were: 
= 550-535nm 
a25 = 554-540nm 
a35 = 563-577nm 
a ^  = 605-630nm
(62)
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Figure 2.2. A Typical Yeast Reduced-Oxidized Difference 
Spectrum, showing Mitochondrial Cytochromes. A yeast 
suspension of O.lg/ml (wet weight) was used.
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The cytochromes c(Xx ) , Cj(X2 ), b(X^) and a+a^ (X^) were 
then calculated from the simultaneous equations below.
21.0X1 + 10.3X2 - 3 .12X3 + ° * 63x4 = ai5 
6.51X1 + 1 8 . 8X2 + 2.55X3 + 0.95X4 = a25 
-1.16Xl + 0.91X2 + 1 4 .3X3 -0.3264 = a35
-0.22X1 - 0.59X2 + 0X3 + 12.0X4 = a45
The calculations were considerably speeded up by the use of 
a computer program (Appendix I).
2.2.4. Measurement of Cyclic AMP in Yeast Cells
Considerable difficulty was found in obtaining a 
reproducible sample for cyclic AMP measurement. After 
extensive tests, the following method was found to give the 
most reproducible results. The yeast sample (200mg wet 
weight) was suspended in 2ml of 10% (w/v) trichloroacetic 
acid and sonicated for lmin to help the release of cyclic 
AMP. The mixture was shaken for five min and the yeast spun 
down on a bench centrifuge (lOmin, full speed). The 
supernatant was retained and the yeast was re-extracted with 
a further 1ml of 10% (w/v) trichloroacetic acid. The 
supernatants were combined, 1M hydrochloric acid (1/10 vol) 
and 2 volumes of dimethyl ether were added and the solution 
was shaken in a cold room (8 °C) for lOmin. The ether phase
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was discarded and the solution was re-extracted with ether 
as before, five times. The aqueous phase was then 
evaporated to dryness at 55°C under a stream of nitrogen and 
the residue re-dissolved in 0.05M Tris-HCl buffer pH 7.5 
containing 0.004M EDTA. The cyclic AMP content was measured 
using a competition protein binding assay with tritium 
labeled cyclic AMP as provided in an assay kit from Amersham 
International Ltd.
2.2.5. Materials
Saccharomyces cerevisiae strains NCYC 240, 239 were 
obtained from the National Collection of Yeast Cultures, 
Agricultural Research Council (Norwich, U.K.). Yeast 
extract was obtained from Oxoid Ltd. Mycological peptone 
was from London Analytical and Bacteriological Media Ltd.
The Cyclic AMP assay kit was from Amersham International 
Ltd. Glucose, hydrogen peroxide and all other chemicals 
were from BDH Chemicals Ltd.
2.3. Results and Discussion
2.3.1. Growth Conditions for Cytochrome P-45oBiosynthesis 
in Saccharomyces cerevisiae
Figure 2.3 shows the results of an initial experiment 
to determine the best in .oculum method for cytochrome P-450 
production in the yeast Saccharomyces cerevisiae NCYC 240 in
(65)
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Figure 2.3. Cytochrome P-450 Production in S. cerevisiae 
Grown in 20% Glucose Media after Inoculation by (a) Slope 
Method and (b) Liquid Sub-Culture. Values are the mean of 8 
determinations. Bars indicate stajdard deviations.
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growth media containing 2 0% (w/v) glucose as carbon and 
energy source. The two methods looked at were direct 
inoculation from a Sabouraud-Dextrose agar slope with a wire 
loop and inoculation with 1ml of a yeast culture grown for 
24 hours in 0.5% (w/v) glucose containing media. Very 
little difference was observed in the maximal production of 
cytochrome P-450 (which was approx. 3nmol/g Wet weight of 
yeast)or the position of the peak in the growth. However, 
the yeast grown from slope appeared to give a slightly 
broader peak with more consistent results, and this method 
was therefore used for all subsequent experiments. It 
should be noted here that in later experiments, it was found 
that the yield of cytochrome P-450 produced was variable 
depending on the age of the slopes; as far as possible, 
experiments were conducted on freshly grown slopes.
In an attempt to study the interaction of high glucose 
concentration with aerobic/semi-anaerobic conditions, the 
level of cytochrome P-450 produced at various times of 
growth was measured during growth under aerobic conditions 
at glucose concentrations of 0.1%, 0.5%, 1%, 5% and 20% 
(w/v), and the results were compared with those obtained by 
King (1983) in this laboratory, in which the same strain of 
yeast was grown under semi-anaerobic conditions at the same 
glucose concentrations. When yeast was grown under
(67)
semi-anaerobic conditions by King (1983), the flasks were 
completely filled with growth medium, inoculated with yeast 
and bubbled through with nitrogen for 10 min, after which 
the flasks were sealed and growth was achieved by putting 
each flask into a 30°C room and stirring gently with a 
magnetic stirrer. Semi-anaerobic conditions rather than 
strictly anaerobic conditions were used by King (1983), as 
this was directly comparable with earlier work (Ishidate 
et a l , 1969 a, 1969b; Yoshida e_t aJ^ , 1974a, 1974b). Also a 
small amount of oxygen is required for several biosynthetic 
reactions during yeast growth and other workers have 
reported that cytochrome P-450 is not produced under 
strictly anaerobic conditions but at a low oxygen 
concentration (Rogers and Stewart, 1973).
At glucose concentrations of 0.1% and 0.5% (w/v) no 
cytochrome P-450 was produced under either aerobic or semi- 
anaerobic conditions. At 1% (w/v) glucose, no cytochrome 
P-450 was found after growth in aerobic conditions but under 
semi-anaerobic conditions cytochrome P-450 was produced to a 
maximal concentration at 2 .6nmol/g wet weight of yeast after 
approx. 62h. The relatively late appearance of the peak is 
probably due to the slow growth rate which occurs under 
these conditions, and also to the slowing of degradation of 
the cytochrome which requires oxygen. The lack of any
(68)
cytochrome P-450 produced aerobically in 1% (w/v) glucose 
media is in disagreement with Wiseman £jt al_ (1975, 1976), 
who have described a fast initial synthesis of cytochrome 
P-450 under these conditions which was rapidly lost. In the 
experiments reported here, the first time point is at 24h 
and it is possible therefore that some cytochrome P-450 is 
produced early in growth and lost before 24h.
Figure 2.4 shows the production of cytochrome P-450 in 
yeast growth at 5% (w/v) glucose concentration. Wiseman 
et al (1976) reported that 5% (w/v) glucose was sufficient 
to produce 'high-glucose behavior* at which the cytochrome 
P-450 level was induced maximally after approx. 32h to a 
level of 3.5nmol/g wet weight of yeast. The results 
obtained here show a peak level of cytochrome P-450 of only 
1.2nmol/g wet weight of yeast after approx. 24h in aerobic 
conditions. The apparent discrepancy of these results may 
reflect a higher initial growth rate being achieved here. 
This would result in the cytochrome P-450 reaching the 
maximal value, which occurs at the end of the exponential 
growth, earlier. Under semi-anaerobic conditions at 5%
(w/v) glucose, King (1983) reported that the growth is much 
slower and the cytochrome P-450 peak value is reached later 
in growth at approx. 48h and reaches a higher level. Also 
the semi-anaerobically grown yeast loses its cytochrome
(69)
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P-450 at a slower rate than when under aerobic conditions. 
This probably reflects the oxygen requirement for cytochrome 
P-450 degradation in yeast which has been demonstrated by 
Blatiak ^t al (1980). These growth conditions (semi- 
anaerobic, 5% (w/v) glucose medium) are similar to those 
used by other workers to produce cytochrome P-450 in 
Saccharomyces cerevisiae. Ishidate e_t a_l (1969a, 1969b) 
used a medium of 4% (w/v) glucose under semi-anaerobic 
conditions as did Lindenmayer and Smith (1964) and Rogers 
and Stewart (1973), whereas Yoshida et al (1974a, 1974b) 
have worked extensively on yeast grown semi-anaerob^ically 
at 6% (w/v) glucose.
When yeast was grown aerobically at 20% (w/v) glucose, 
a peak in cytochrome P-450 level was found after 36-40 hours 
at approx. 3nmol/g wet weight of yeast (Figure 2.5). In 
later experiments it was found that with fresher yeast 
slopes a peak level of approx. 4nmol/g wet weight of yeast 
could be reached (results not shown). However, the older 
results are used here to enable a strict comparison with the 
other results presented. These results agree closely with 
those of Wiseman et al (1975, 1976). Under semi-anaerobic 
conditions at 2 0% glucose, very little difference was 
observed in the time course of cytochrome P-450 production
(71)
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with a slightly higher level of cytochrome P-450 (approx. 
3.5nmol/g wet weight) being observed (King, 1983).
As a check that mitochondrial repression was occurring 
in high glucose media, the levels of mitochondrial 
cytochromes were measured after 44h aerobic growth in 20% 
and 0.5% (w/v) glucose media (Table 2.1). In the high 
glucose medium, a very low concentration of cytochrome 
was observed compared to the value observed in 0.5% (w/v) 
glucose medium. This confirms that this yeast was glucose 
repressed.
These results support the theory of cytochrome P-450 
being synthesized in yeast only under conditions of 
repression of mitochondrial cytochromes. Two ways of 
achieving this repression are by a high glucose concen­
tration and by anaerobic conditions. From the results 
observed at 20% (w/v) glucose it seems that these effects 
are not additive, which is consistent with both sets of 
conditions eliciting cytochrome P-450 synthesis through a 
similar mechanism. This mechanism is thought to be 
regulated by the level of intracellular cyclic AMP (Wiseman 
et al, 1978). Intracellular cyclic AMP levels are inversely 
related to the glucose concentration in the growth medium; 
thus at high glucose concentrations when the cytochrome
(73)
Concentration of Glucose Level of Cytochromes
in Yeast Growth Medium (nmol/g wet weight of yeast)
a+a3 b C1 c
P-450
20% 7.8 14.8 2.3 9.4 2.3
0.5% 20.4 14.7 5.3 8.8 0
Table 2.1. Level of Mitochondrial Cytochromes in 
S . cerevisiae Grown Aerobically for 40h.
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P-450 level is high, the cyclic AMP concentration is low. 
This has led to the suggestion that cyclic AMP has a 
repressive effect on cytochrome P-450 synthesis (Wiseman, 
e_t aJL, 1978). These workers also showed a direct effect of 
cyclic AMP in repressing cytochrome P-450 synthesis in yeast 
protoplasts, although 5 1-AMP and 2 ,- ( 3 f)-AMP had no effect. 
This means that under conditions of mitochondrial repression 
by a high glucose concentration in the growth medium, the 
cyclic AMP level is low, therefore the repressive effect of 
cyclic AMP is removed and d_e novo synthesis of cytochrome 
P-450 can occur. As expected, cytochrome a+-a^  and cyclic AMP 
show a direct relationship to each other and an inverse 
relationship to the cytochrome P-450 level at various 
glucose concentrations (Qureshi et al, 1980). An inverse 
relationship between cytochrome a+a^ and cytochrome P-450 
has also been shown in cerevisiae grown semi- 
anaerobically (Schunk ert a_l, 1978).
It has been explained above that semi-anaerobic 
conditions are not able to elicit production of cytochrome 
P-450 at 0.1% or 0.5% (w/v) glucose. It is possible that 
some cytochrome P-450 is produced at times earlier than 24h, 
the first time point in these experiments. However, the
small amount of growth which can occur under these 
conditions makes any measurements of cytochrome P-450 before
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24h extremely difficult. The conclusion must be drawn that 
semi-anaerobic conditions alone are not enough to produce 
cytochrome P-450 without a higher glucose concentration in 
the medium. This may mean that this enzyme is only produced 
at the faster growth rates observed at higher glucose 
concentration. It is also possible that a higher glucose 
concentration is required in order to repress cyclic AMP 
levels sufficiently for cytochrome P-450 synthesis to occur.
Figure 2.6 shows the time course of cytochrome P-450 
production in S_^  cerevisiae NCYC 239 grown in a growth 
medium containing 20% (w/v) glucose. This was observed to 
reach a maximal value of approx. 6nmol/g wet weight of yeast 
at 38-40h of growth. Although the yield of cytochrome P-450 
is high, it does not approach the level of llnmol/g reported 
by Qureshi e_t al^  (1980) . Also, the peak occurs at 38-40h, 
which is similar to NCYC 240, and not at llOh as reported by 
Qureshi e_t ajL (1980.
2.3.2. Genetic Analysis of Cytochrome P-450 Production in 
Saccharomyces cerevisiae
In a study looking at the genetic factors controlling 
cytochrome P-450 biosynthesis in cerevisiae, initial 
experiments were performed to screen 18 haploid strains of 
S_. cerevisiae for cytochrome P-450 production using the
(76)
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reduced carbon monoxide difference spectrum method. Of 
these strains, only 3 were found to produce significant 
quantities of cytochrome P-450 under the growth conditions 
used (growth for 44h at 30°C). From these haploid strains, 
two were selected for tetrad analysis, one of which was 
capable of producing a high level of cytochrome P-450 and 
one which produced no cytochrome P-450. A cross was made 
between these two strains and the resulting diploid 
isolated. This diploid was then transferred to a sporu- 
lation medium and allowed to sporulate. Four resulting asci 
were isolated and the spores of each tetrad were separated 
by micro-dissection and allowed to grow. (Crossing the 
yeast strains and isolating the tetrad yeast strains was 
performed by Dr. Wilkie of University College, London, whom 
I gratefully acknowledge.) The resulting yeasts were 
analyzed for cytochrome P-450 content; the results are shown 
in Table 2.2. These results show that the cross of a 
haploid cytochrome P-450 producing strain with a haploid 
non-producing strain resulted in a diploid non-producing 
strain. When the diploid sporulates and produces haploid 
spores, two of these are cytochrome P-450 producers and two 
are non-producers. Of the two tetrad segregants which 
produce cytochrome P-450, one appears to produce a higher 
level of cytochrome P-450 than the other. It should be 
noted here that the levels of cytochrome P-450 reported in
(78)
Yeast Strain Cytochrome P-450
(nmol/g wet weight of yeast)
B/B °-7
D22 0
Diploid 0
Tetrad Is la 0.6
lb 0.7
lc 0
Id 0
Tetrad 2: 2a 1.35
2b 0
2c 0.44
2d 0
Tetrad 3: 3a 0.9
3b 0
3c 1.75
' 3d 0
Tetrad 4: 4a 0
4b 0.95
4c 1.1
4d 0.9
NCYC 240 0.95
Table 2.2. Tetrad Analysis of Cytochrome P-450 
Distribution. Values are the average of three runs in 
duplicate, with yeast grown for 24 hours in a rotary shaker 
(30°C).
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Table 2.2 are not maximal values for each yeast strain but 
are the level obtained after growth for 24h on a fast rotary 
shaker at 30°C to reduce yeast flocculation. This was 
necessary as several of the isolated strains flocculated 
easily during growth and this flocculation made it 
impossible to record a value for the cytochrome P-450 level 
due to settling of the yeast during the spectral assay. The 
yeast S. cerevisiae NCYC 240 gave a yield of 0.95nmol/g 
under these conditions compared to its optimal yield of 
approx. 3nmol/g. The only exception to this 2:2 distri­
bution of cytochrome P-450 producers to non-producers was in 
tetrad 4 where a 3:1 ratio was observed.
To confirm the difference in cytochrome P-450 levels 
found, one tetrad of yeast strains was subjected to a time 
course of cytochrome P-450 production analysis along with 
the parent strains. The results obtained are shown in 
Figure 2.7. It can be seen that the difference observed in 
the cytochrome P-450 yields of the producing strains of the 
tetrad are real and not due to experimental error. The 
yeasts are observed to have peak levels of cytochrome P-450 
at different times due to the growth characteristics of the 
individual yeast strains. Each yeast reaches a peak 
cytochrome P-450 level at about the end of the exponential 
growth phase. These results for the segregation of
(80)
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cytochrome P-450 production amongst the tetrad yeast strains 
lead to the conclusion that production of cytochrome P-450 
is controlled by a single nuclear gene. This gene is 
obviously under the control of one or more modifying factors 
which result in a small or a larger amount of cytochrome 
P-450 being produced. The fact that the diploid yeast 
produced from the two parents (one of which was a cytochrome 
P-450 producer and one a non-producer) did not produce 
cytochrome P-450 shows that these results do not reflect 
segregation of the cytochrome P-450 structural gene but of a 
regulatory gene. If all that was necessary for cytochrome 
P-450 production was the possession of the structural gene, 
then almost certainly the diploid would produce cytochrome 
P-450. These conclusions lead to the proposal of a genetic 
model for the segregation of a regulatory gene for 
cytochrome P-450 production as shown in Figure 2.8. This is 
the most simple model which could be proposed to account for 
observations made. In this model, the presence of the 
regulatory gene allowing cytochrome P-450 to be produced 
results in production of cytochrome P-450 yet does not 
determine the level produced. This is determined by the 
presence of a modifier gene (more than one may be involved) 
which gives rise to one of the tetrad yeasts having a small 
amount of cytochrome P-450 and one having a larger amount.
(82)
P+- 
( r+m)
haploid
parent
X-
( r+ ) 
haploid
NP .
, + ** 1 \(r r mm )
( r+ m ) 
haploid
( r m^ ) 
haploid
•NP
( r ”m 1)
haploid
parent
diploid
NP NPP+P++
(r m) 
haploid.
P+: cytochrome P-450 producing strain
P++: high level cytochrome P-450 producing strain
N P : non-producing strain
r is regulatory gene, r+ allows cytochrome production, 
r” does not.
m is modifier gene, m^- enables larger amount of cytochrome 
P-450 to be produced, but no effect if r+ is not present.
Figure 2.8. Model for the Segregation of a Gene Controlling 
Cytochrome P-450 Production in S. cerevisiae.
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The identity of the regulatory gene shown to exist in 
these experiments is unknown. However, since cyclic AMP 
regulates the biosynthesis of cytochrome P-450 (Wiseman 
et a l , 1978), the levels of this compound were examined in 
each of the parent, diploid and tetrad yeasts. The results 
are shown in the Table 2.3. The levels of cyclic AMP 
measured are consistent with the general levels obtained in 
Saccharomyces yeasts under similar growth conditions by Sy
and Richter (1972). In general, it was observed that a 
higher level of cyclic AMP was detected in those yeasts not 
producing cytochrome P-450. This work is consistent with 
that of Wiseman et^  jelI (1978) which showed a higher cyclic 
AMP level present under conditions which do not allow 
cytochrome P-450 biosynthesis to occur. As all of these 
yeasts were grown under identical conditions for the same 
time, the difference probably reflects a genetic difference 
between the yeast strains studied. The yeast 2a gave a low 
result which seems out of the pattern observed with the 
other yeasts. These results must therefore be viewed with 
some caution. However, it seems possible that the 
regulatory gene which is involved in controlling the 
presence/absence of cytochrome P-450 may also have an effect 
in regulating the level of cyclic AMP. Indeed it is 
possible that the function of the gene may be to regulate 
cyclic AMP levels which in turn control cytochrome P-450
(84)
Yeast Strain Cytochrome P-450 Level 
(nmol/g wet weight of 
yeast)
Cyclic AMP Level 
(pmol/200mg yeast) 
(wet weight)
D22 0 6.25
B/B 0.8 2.6
Diploid 0 5.2
2a 3.0 3.4
2b 0 3.6
2c 0.5 3.75
2d 0 8.4
Table 2.3. The Level of Cyclic AMP in Yeast Strains from 
Tetrad Analysis.
(85)
levels. In this respect, the gene may be coding for 
adenylate cyclase or phosphodiesterase or some other protein 
involved in regulating the intracellular cyclic AMP levels. 
In an attempt to look at this further, theophylline, an 
inhibitor of cyclic AMP phosphodiesterase was added to 
growing cultures of the tetrad yeasts in an attempt to alter 
the cytochrome P-450 level produced in the producer or non­
producer strains. However, no effect on enzyme level was 
observed after this treatment (Table 2.4). The inability of 
theophylline to influence cyclic AMP levels in yeast has 
been observed before (Mahler and Lin, 1978) and may reflect 
either a property of the yeast enzyme or poor transport of 
the compound into the cell.
It has been shown that multiple forms of cytochrome 
P-450 exist in Saccharomyces cerevisiae, and that an altered 
profile of these forms can be induced by treatment of 
growing yeast with benzo(a)pyrene and several other 
compounds (see Chapter 6). In this respect it was thought 
that the difference observed in the amount of cytochrome 
P-450 produced in the tetrad strains may be due to 
differences in the forms of cytochrome P-450 present. This 
was investigated by attempting to alter the levels of 
cytochrome P-450 in the tetrad yeasts by inducing with 
benzo(a)pyrene (Table 2.4). No cytochrome P-450 could be
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Yeast Strain Cytochrome P-450 Level
(nmol/g wet weight of yeast)
2a 5.70+.34
2b 0
2c 1.10+.22
2d 0
2a + theophylline (1% w/v) 6.15+144
2b + theophylline (1% w/v) 0
2a + benzo(a)pyrene (95yM) 5.14+119
2b + benzo(a)pyrene (95yM) 0
2c + benzo(a)pyrene (95yM) 2.26+^ 06
+CM benzo(a)pyrene (95yM) 0
Table 2.4. Attempted Induction of Cytochrome P-450 in
Tetrad 2 Yeast Strains. Yeast grown 40 hours at 30°C in a 
shaking water bath. Benzo(a)pyrene and theophylline were 
added at the beginning of the growth period. Values are the 
mean of 8 determination + standard deviation.
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induced in the non-producing strains (2b and 2d) after 
benzo(a)pyrene treatment. It would seem therefore that the 
regulatory gene has an on/off mechanism which cannot be 
altered by benzo(a)pyrene treatment. Yeast 2a showed no 
significant difference in cytochrome P-450 level after 
benzo(a)pyrene treatment, although this does not rule out 
the possibility that the profile of forms of the enzyme has 
been altered (see Chapter 6). Yeast 2c which produces a low 
level of cytochrome P-450 gave a significant increase in 
cytochrome P-450 level after growth in the presence of 
benzo(a)pyrene, though still only to less than half of the 
value observed for yeast 2a. It is unlikely that any effect 
of benzo(a)pyrene is occurring at the regulatory gene, 
though benzo(a)pyrene may be altering the effect of the 
modifier gene(s). The fact that 2c could not be induced to 
produce the same level cytochrome P-450 as 2a implies that a 
modifier gene is involved in this regulation. Much further 
work is required before the mechanisms involved are 
discovered.
The absence of cytochrome P-450 in the non-producer 
strains raises an interesting question as to how these 
yeasts* carry out lanosterol demethylation to produce 
egosterol, necessary for growth as mentioned earlier. If 
indeed lanosterol demethylation is catalyzed by cytochrome
(88)
P-450, then it is possible that the absence of the 
regulatory gene allowing cytochrome P-450 production (or the 
presence of a gene not allowing cytochrome P-450 production) 
does not stop its biosynthesis completely. Therefore, a 
small amount of the enzyme not detectable by normal 
techniques is present in a situation analogous to that in 
aerobically grown yeast in low glucose media described 
earlier. It is also possible that other enzymes may take 
the role of lanosterol 14a-demethylation proposed for 
cytochrome P-450. In this respect it is of interest that 
several other monooxygenase enzymes have been shown to be 
involved in the lanosterol to ergosterol conversion in S . 
cerevisiae (Ohba ejt aj^ , 1978; Aoyama e_t ajL, 1981b).
No previous work has been attemped on the genetics of 
cytochrome P-450 production in yeast. However, the group of 
Nebert et al has worked extensively on the genetic 
regulation of cytochrome P-450 activities in the mouse 
(Nebert et al, 1981; Nebert, 1979). These workers have 
looked at the forms of cytochrome P-450 induced in the mouse 
by polycyclic aromatic hydrocarbons such as 3-methyl- 
cholanthrene, 3 -naphthoflavone and benzo(a)pyrene. They 
have demonstrated that induction by these compounds is 
mediated through the ’Ah locus' which is a combination of 
regulatory, structural and possibly temporal genes which may
(89)
or may not be linked. These workers have evidence that the 
process of induction by these compounds occurs by binding of 
the inducer, which passively crosses the cell membrane, to a 
cytosolic Ah receptor protein, regarded as the major 
regulatory gene product (Okey et al, 1979). This complex is 
then translocated into the nucleus and results in the 
activation of structural genes coding for forms of 
cytochrome P-450. A simplified system drawn from the 
results of Nebert et_ al on mouse cytochrome P-450 is shown 
in Figure 2.9. It is of great interest that this scheme 
requires the presence of at least one regulatory gene giving 
rise to a specific regulatory gene product, in this case the 
binding receptor for polycyclic aromatic hydrocarbons. In 
the results described in this chapter it has been shown that 
a regulatory gene product is involved in the biosynthesis of 
yeast cytochrome P-450. Although the nature of the regu­
latory gene product is unknown in the case of yeast 
cytochrome P-450 biosynthesis, it may be involved in cyclic 
AMP regulation. Clearly, much further work is needed to 
characterize this system more fully.
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Figure 2.9. The Ah Complex as Proposed by Nebert et_ a l . 
Adapted from Nebert ejt al_. (1981).
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CHAPTER 3
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3. Solubilization, and Purification of Cytochrome
P-450/P-448 and Other Mixed-Function Oxidase Proteins from
Saccharomyces cerevisiae
3.1. Introduction
Cytochrome P-448, cytochrome c(P-450) reductase, cyto­
chrome b^ and cytochrome b^ reductase from Saccharomyces 
cerevisiae, grown under conditions of glucose repression, 
were isolated, solubilized, separated and purified. A novel 
combination of purification steps were used to purify 
cytochrome P-448 and other above-mentioned proteins. 
Precipitation by polyethylene glycol is proposed for large 
scale isolation of these enzymes without recourse to high g
"Hie-
centrifugation. The stability of cytochrome P-448 in4micro­
somal fraction (in storage and through solubilization) and 
in purified form was studied and optimized. Purified 
cytochrome P-448 proved to be homogeneous by SDS- 
polyacrylamide gel electrophoresis and was free of other 
known components of mixed-function oxidase. Spectral 
properties of purified cytochrome•P-448 were examined and as 
the Soret peak of reduced CO complex was situated at 447- 
448nm (not at 450nm) this cytochrome is called cytochrome 
P-448 hereafter throughout the rest of this study. The 
molecular weight of cytochrome P-448 was estimated also by 
SDS-polyacrylamide gel electrophoresis and along with
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specific content were compared with values for cytochrome 
P-450 and P-448 from yeast, bacteria and mammalian sources 
reported in literature. Based upon this molecular weight 
and the specific content (nmol of cytochrome P-448, 
determined by reduced CO-compound, per mg of protein) the 
degree of purity for cytochrome P-448 was determined. The 
expression cytochrome P-450/P-448 (P-450 or P-448) is used 
in this chapter to refer to both forms of the enzyme i n ^  
microsomal fraction. This expression also used to denote 
this enzyme in general term.
3.2. Methods and Materials 
3.2.1 Growth of Yeast
Saccharomyces cerevisiae (N.C.Y.C. No. 240) was 
maintained on slopes of Sabouraud-Dextrose agar and 
transferred using a platinum wire to growth medium 
containing sodium chloride (5g/L), yeast extract (lOg/L) and 
mycological peptone (20g/L) autoclaved at 15 p.s.i. for 
20min. This medium in addition contained glucose at a. 
concentration of 200g/Lv\autoclaved separately to prevent the 
formation of interfering breakdown pigments. The yeast was 
grown in 100ml of medium contained in a 250ml conical flask 
shaken in a Mickle shaking water bath (Mickle Laboratory 
Engineering Co., U.K.) at 30°C, shaking at 80rpm with a 
stroke of 5cm and was harvested after 44h by centrifugation
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at 5000g for lOmin in a MSE bench centrifuge (Measuring and 
Scientific Equipment Ltd., U.K.).
When yeast was grown on a large scale the medium was 
formulated and autoclaved as described above and yeast was 
grown in a 5 or 10L fermentor (L. H. Engineering, U.K.) from 
an inoculum of 20 grams. The duration of this fermentation 
was 24h while the temperature was maintained at 30°C and the 
medium was stirred at 500rpm. The oxygen concentration and 
pH were set and controlled at minimum and 5.5 respectively. 
Yeast was harvested by centrifugation at 2800g for 15min in 
a M.S.E. Coolspin centrifuge (M.S.E. Ltd., U.K.).
3.2.2. The Preparation of Yeast Microsomes
Harvested yeast was disrupted according to the method 
of Wiseman et al (1975b) in which it was transferred to a 
disrupter (Edmund Buhler Tubingen, W. Germany) where it was 
shaken with approximately 3 volumes of glass beads of 
diameter 1.00 to 1.05mm (B. Braun, Melsungen, W. Germany) 
for a total of 6min, the disrupter being stopped after lmin 
to top up with glass beads. At the end of this time the 
glass beads were washed with a minimum volume of ice-cold 
0.1M potassium phosphate buffer, pH 7.2 containing 0.001M 
ethylenediamine tetra-acetic acid (EDTA), 0.001M dithio- 
threitol and 20% (v/v) glycerol. After removal of the cell
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debris and nuclear material by centrifugation in a MSE High 
Speed 18 centrifuge (M.S.E. Ltd., U.K.) at 7500g for 15min, 
yeast microsomal fraction was obtained by centrifugation at 
160,900g for Ih in a Beckman L5—65 ultracentrifuge (Beckman, 
U.S.A.). In a typical experiment 100ml of medium would 
yield 3g of yeast and from this 0.6g of microsomes would be 
obtained. Microsomal pellet was then resuspended in an 
equal quantity of the above-mentioned buffer by hand using a 
Potter-Elvehjera homogeniser.
In large scale preparation, yeast was suspended in an 
equal volume of 0.1M potassium phosphate buffer pH 7.2 
containing 0.001M-EDTA, 0.001M dithiothreitol and 0.65M 
sorbitol. This suspension was cooled down to 2°C in an 
acetone-ice bath and passed through an APV Gaulin homog- 
enizer (A.P.V. L t d .,U.K.) at 300-400kg/cm^ twice as is 
described by Yoshida et_ al^  (1974).
3.2.3. The Measurement of Cytochrome P-450/P-448 and 
Cytochrome P-420.
Cytochromes P-448 and P-420 levels were measured by the 
method of Omara et_ ai (1965). Microsomal suspension or 
solubilized solution was placed in both reference and sample 
cuvettes. The content of both cuvettes was reduced by 
addition of solid sodium dithionite (lmg/ml) and a baseline
(96)
of equal light absorbance between 390 and 500nm was recorded 
using either a SP1800 (Pye Unicam, U.K.) or a Cary 219 
(Varian, U.S.A.) spectrophotometer. Carbon monoxide was 
bubbled at a rate of one bubble per second for 30 seconds 
through the contents of the sample cuvette and,\difference 
spectrum was recorded (Figure 3.1). The concentration of 
cytochrome P-450/P-448 and P-420 were determined assuming a 
value of 91mM ^cm  ^ for the molar extinction increment 
between 450/448 and 490nm for cytochrome P— 448 (Omura et al, 
1965) and a value of H O m M  ^cm  ^ between 420 and 490nm for 
cytochrome P-420 (Omura and Sato, 1964a).
3.2.4. Solubilization of Yeast Mixed-Function Oxidase 
Proteins
Microsomal suspension was diluted to 30mg protein/ml 
with 0.1M potassium phosphate buffer pH 7.2 containing 
0.001M-EDTA, 0.001M dithiothreitol, 20% (v/v) glycerol. A 
number of ionic and non-ionic detergents were used to 
solubilize cytochrome P-450/P-448. Cytochrome P-450/P-448 
was finally solubilized for purification by selecting one of 
these, the ionic detergent sodium cholate at a final 
concentration of 1% and always in presence 0.1% Triton X-100 
or 0.1% reduced glutathione. Microsomal suspension plus 
sodium cholate and a stabilizer were stirred at 4°C for Ih 
under N 2 atmosphere and was centrifuged at 160,000g for
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Figure 3.1. The Carbon Monoxide-Difference Spectrum of
Yeast Microsomal Fraction.  baseline; _____, C0-
difference spectrum of reduced form.
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50min and the supernatant, the solubilized protein was 
collected.
In large scale preparation, the disrupted yeast was 
diluted the same way and 0.1% (w/v) reduced glutathione and 
1% (w/v) sodium cholate were added. After stirring in 4°C 
under ^  for Ih it was diluted further (3 folds) with the 
above-mentioned phosphate buffer and polyethylene glycol 
(M.W. 6000) from a 50% (w/v) solution was added to this to 
give a final concentration of 16% in the microsomal 
suspension. Protein from 16% polyethylene glycol precipi­
tation was collected by centrifugation at 7500g using a MSE 
High Speed 18 centrifuge for 60min and was dissolved in 0.1M 
potassium phosphate buffer pH 7.2 containing 0.001M-EDTA, 
0.001M dithiothreitol and 20% (v/v) glycerol.
3.2.5. Purification of Yeast Mixed-Function Oxidase 
Proteins
Solubilized protein was diluted with 0.1M potassium 
phosphate buffer pH 7.2 containing 0.001M-EDTA, 0.001M 
dithiothreitol and 20% (v/v) glycerol to adjust the sodium 
cholate concentration to 0.33%. A precipitate at 35-65% 
sat. (NH^)2 S0^ was prepared while the pH was maintained at
7.0 by addition 0.1M NH^OH and centrifugation was performed 
at 7500g for 40min by MSE High Speed 18 centrifuge. . The
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precipitate was then suspended in a minimum volume of 0.02M 
potassium phosphate buffer pH 7.G containing 0.001M-EDTA, 
Q.001M dithiothreitol and 20% (v/v) glycerol and 0.3% (w/v) 
sodium cholate. In a typical preparation run from 500 grams 
of yeast, 100 grams microsomes were isolated and from this 
266nmol of cytochrome P-450/P-448 (along with other 
proteins) was solubilized which after ( N H ^ ^ S O ^  fraction­
ation was readily suspended in the above-mentioned buffer to 
give a final volume of 100ml. This suspension was dialyzed 
overnight against 30 volumes of 0.01M potassium phosphate 
buffer containing 0.001M-EDTA, 0.001M dithiothreitol and 
0.3% (w/v) sodium cholate. It was subsequently centrifuged 
at 160,900g and the supernatant was collected. When Triton 
X-100 was used for stabilization purposes through solubili­
zation, to eliminate the residual amount of this detergent 
still present in preparation, lOg of Bio-Bead SM-2 
(prewashed with methanol and H 2O) was mixed with the 
supernatant and stirred for 30min before addition to the top 
of a 2.0x4.0-cm packed Bio-Bead column. Cytochrome P-450/ 
P-448 and other proteins were eluted from the column by 
washing the column with the dialysis buffer. This eluate 
was applied to a 2.4x12.0-cm, 8-amino-n-octyl-Sepharose 4B 
column which had been preequilibrated with 0.01M potassium 
phosphate buffer pH 7.0 containing 0.3% (w/v) sodium 
cholate, 0.001M-EDTA and 20% (v/v) glycerol (equilibration
(100)
buffer). After washing the column with the same buffer, 
cytochrome P-450/P-448 was eluted with the same buffer also 
containing 0.1% (v/v) Emulgen 911. For elution of NADPH: 
cytochrome c(P-450) reductase the aminoocJiyl-Sepharose 4B 
column was washed with this buffer also containing 0.2%
(w/v) sodium deoxycholate and 2jiM flavin mononucleotide 
(FMN). For elution of cytochrome b^ the 0.001M potassium 
phosphate buffer pH 7.0 containing 0.4% (w/v) sodium 
deoxycholate, 0.2% (w/v) sodium cholate, 0.001M-EDTA and 20% 
(v/v) glycerol. Fractions rich in cytochrome P-450/P-448 
were applied to a 1.6x6.0-'cm hydroxylapatite-cellulose (1:1, 
w/w) column preequilibrated with 0.01M potassium phosphate 
buffer pH 7.0 containing 20% (v/v) glycerol. This column 
was washed with 0.03M potassium phosphate buffer, pH 7.0 
containing 20% (v/v) glycerol and 0.2% (v/v) Emulgen 911, 
and NADH:cytochro me b^ reductase was eluted by 0.05M 
potassium phosphate pH 7.0 containing 20% (v/v) glycerol and 
0.2% (v/v) Emulgen 911. Cytochrome P-450/P-448 was eluted 
by 0.1M potassium phosphate pH 7.0 containing 20% (v/v) 
glycerol and 0.2% (v/v) Emulgen 911. Cytochrome P-450/P-448 
was eluted from the column and were combined and diluted 10 
fold with/isolution of 20% glycerol containing 0.2% (v/v) 
Emulgen 911. This was then applied to a 1.0x5.0-cm 
carboxylmethyl-Sephadex C-50 column preequilibriated with 
0.01M potassium phosphate buffer pH 7.0 containing
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20% (v/v) glycerol and 0.2% (v/v) Emulgen 911. After 
washing the column with 3 volumes of 0.Q4M potassium 
phosphate buffer pH 7.0 containing 20% (v/v) glycerol and 
0.2% (v/v) Emulgen 911, cytochrome P-450/P-448 was eluted by 
passing through 0.1M potassium phosphate buffer pH 7.0 
containing 20% (v/v) glycerol and 0.2% Emulgen 911. 
Cytochrome P-450/P-448 was dialyzed twice against 30 volumes 
of 0.005M potassium phosphate buffer pH 7.7 containing 20% 
(v/v) glycerol and 0.2% (v/v) Emulgen 911, each time 12h, 
diluted 2 fold with a solution of 20% (v/v) glycerol 
containing 0.2 (v/v) Emulgen 911, adjusted to pH 7.7 and 
then applied to an 0.85x7.0-cm DEAE-Sephacel column 
preequilibriated with the above dialysis buffer. Most of 
the cytochrome P-448 did not.bind to the column and was 
eluted by washing the column with some of the equilibration 
buffer. Cytochrome P-450 form bound to the column and was 
eluted with 0.035M potassium phosphate buffer pH 7.7 
containing 20% (v/v) glycerol and 0.2% (v/v) Emulgen 911. 
Both cytochromes P-448 and P-450 were concentrated by 
ultrafiltration using an Amicon ultrafiltration apparatus 
with PM-30 membrane (Chem. Lab., U.K.). Cytochrome P-448 
(with or without Emulgen 911) in 0.1M potassium phosphate 
buffer pH 7.0 containing 20% (v/v) glycerol was stored at 
-70°C before use in this study.
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3.2.6. Further Purification of Cytochrome c(P-450)
Reductase, Cytochrome and Cytochrome b^ Reductase
Cytochrome c(P-450) reductase fractions from the amino- 
n-octyl-Sepharose 4B column was applied directly to 1.2x5-cm 
column of 2*,5 *-ADP-Agarose which was subsequently washed 
with 0.3M potassium phosphate buffer pH 7.7 containing 
0.001M-EDTA, 20% (v/v) glycerol and 0.1% (v/v) Emulgen 911, 
until no more extraneous protein was eluted. This column 
was further washed with 0.03M potassium phosphate buffer pH 
7.7 containing 0.001M-EDTA, 20% (v/v) glycerol and 0.2%
(.w/v) sodium deoxycholate (the intermediate buffer). 
Cytochrome c(P-450) reductase was eluted with the 
intermediate buffer to which 2 f-AMP had been added up to 
0.005M in concentration. Those fractions rich in cytochrome 
c(P-450) reductase were pooled, dialyzed twice (16h each 
time) against 20 volume of 0.1M potassium phosphate buffer, 
pH 7.0 containing 20% (v/v) glycerol and was concentrated 
using an Amicon ultrafiltration cell (PM-30 membrane) and 
was stored in -70°C.
Cytochrome b ^ , eluted from amino-n-octyl-Sepharose 4B, 
was further purified by gel filtrationson a 2.4x48.0-cm 
Sephadex G-75 column (twice) using 0.01M Tris-acetate buffer 
pH 8.1 containing 0.001M-EDTA and 0.47 (w/v) sodium 
deoxycholate. In these gel filtration^the red, hemoprotein
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was partially included and eluted behind a front-running, 
brownish bank of excluded material. After the second gel 
filtration the cytochrome b^ fraction was dialyzed twice 
(24h each time) against 30 volumes of 0.02M Tris-acetate pH
8.1 containing 0.001M-EDTA and was stored in -70°C.
NADH:cytochrome b^ reductase, eluted from hydroxylap&tite 
column, was concentrated by an Amicon ultrafiltration cell 
(PM-10 membrane) 20 folds and was diluted 5 fold with water 
containing 0.2% (v/v) Emulgen 911. It was applied^a 
2.4xl0.0-cm DEAE-Sephacel column preequilibrated with 0.01M 
potassium phosphate buffer pH 7.0 containing 0.2% (v/v) 
Emulgen 911. After washing the column with 0.01M and 0.03M 
potassium phosphate buffer pH 7.0 both containing 0.2% (v/v) 
Emulgen 911 cytochrome b^ reductase was eluted by 0.1M 
potassium phosphate buffer pH 7.0 containing 0.2% (v/v) 
Emulgen 911 and was stored in -70°C.
3.2.7. Purification Cytochrome P-450/P-448 from Rat Liver 
Cytochrome P-450 from phenobarbital-treated and cyto­
chrome P-448 from B-naphthoflavone-treated rat livers were 
isolated and purified in the Department of Biochemisty 
(using a method described by Guengerich, 1978). These 
enzymes were gifted by Mr. P. Tamburini, whom I gratefully 
acknowledge.
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3.2.8. Protein Determination
Protein was determined by a modified method of Lowry 
et al (1951) using bovine serum albumin as standard.
Reagents
- 15% Trichloroacetic acid (TCA)
- 1% (w/v) Hydrated copper sulfate
- 2% (w/v) Sodium potassium tartrate
- 2% (w/v) Sodium carbonate in 0.1M NaOH
- Folin-Ciocalteau phenol reagent diluted with 
water (1:1, v/v)
- Bovine serum albumin in water (lOmg/ml)
Method
One ml of 15% TCA solution was added to an equal volume 
of enzyme samples (microsomal or purified). Precipitate was 
collected by centrifugation at 9000rpm for 15min by a MSE 
bench centrifuge and was suspended in water to give 
appropriate protein concentrations. The protein standard 
was precipitated with 15% TCA in an identical way and was 
suspended in water to give concentrations of 50, 100, 200, 
and 250 Mg/ml. Copper sulfate, sodium potassium tartrate 
and sodium carbonate were mixed in ratio 1:1:100 by volume 
immediately before use (this mixture is called sodium 
carbonate reagent). The protein standards, samples and
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blanks (0.5ml) were mixed with the sodium carbonate reagent 
(2.5ml) and allowed to incubate for lOmin at room 
temperature. 0.25ml of diluted Folin-CiocalteaU phenol 
reagent was added and the solutions were mixed immediately. 
After at least 30min at room temperature, the absorbance was 
recorded at 750nm using a Cecil CE272 spectrophotometer 
(Cecil Instrument, U.K.).
3.2.9. Measurements of NADPH:Cytochrome c(P-450) Reductase 
Activity
This enzyme is thought by Kamataki ejt al_ (1979) to be 
the same as NADPH: cytochrome c reductase (EC 1.6.2.4). As 
the direct measurement of cytochrome P-450 reduction is 
difficult to perform, cytochrome c is used as an alternative 
electron acceptor. The reduction of cytochrome c was 
monitored spectrophotometrically (Pye Unicam SP1800 spectro­
photometer) using a method modified from that of Williams 
and Kamin (1962).
Reagents
- 0.1M Tris-HCl buffer pH 7.5
- O.lmM Cytochrome c in 0.1 Tris-HCl buffer 
pH 7.5
- 0.025M-NADPH in 0.1M Tris-HCl buffer pH 7.5
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Method
Enzyme suspension (0.1ml), cytochrome c (1ml) and 0.1M
Tris-HCl buffer pH 7.5 were placed in each of two cuvettes
to give a final volume of 2.975ml in the sample and 3.0ml in
the reference. The cuvettes were preincubated at 22°C for
5min, and the reaction was started by addition of NADPH
(0.025ml) the sample cuvette. The reduction of cytochrome c
was measured by monitoring the absorbance change of 550nm
-1 -i
and an extinction coefficient of 19.6mM cm (Yonetani, 
1965) was used to calculate the rate of reduction.
3.2.10. Measurement of Cytochrome
Cytochrome b^ was measured by reduction with NADH in 
microsomal and solubilized fractions.
: Reagents
- 0.1M Tris-HCl buffer pH 7.5
- 0.01M-NADH in 0.1M Tris-HCl buffer pH 7.5
Method
Microsomal of solubilized enzyme solution was diluted 
with 0.1M Tris-HCl buffer pH 7.5 to give a final 
concentration of lmg protein/ml and was placed in each of 
the sample and reference cuvettes (2.96ml). A baseline of 
equal light absorbance was established between 400 and
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440nm. NADH (0.04ml) was added to the sample cuvette and 
the spectrum was recorded. The concentration of cytochrome 
bcj was determined by measuring the difference in abosrbance 
between 424 and 409nm, using an extinction coefficient of 
164 mM  ^cm  ^ (Yoshida e_t « 1 1 9 7 4 b ) .
3.2.11. Measurement of NADH:Cytochrome b^ Reductase 
Activity
NADH:cytochrome b^ reductase is shown by Mihara and 
Sato (1975) to be the same as NADH:ferricyanide reductase 
(EC 1.6.2.2.) which was measured by a method modified from 
that of Strittmatter and Velick (1957).
Reagents
- 0.1M Tris-HCl buffer pH 7.5 containing 0.2mM 
potassium ferricynide
- 0.03M-NADH in 0.01M NaHC03
Method
To each of the sample and reference cuvettes 2.955ml of 
0.1M Tris-HCl buffer pH 7.5 containing 0.2mM potassium 
ferricyanide and 0.02ml of enzyme solution were added. Both 
cuvettes were incubated in 22°C for 5min and NADH (0.025ml) 
solution was added to the sample cuvette. Absorbance 
changes at 420nm were measured as a function of time and
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cytochrome bj. reductase activity was determined using 1.02 
mM ^cm  ^ as an extinction coefficient (Schellenberg and 
Hellerman, 1958).
3.2.12. SDS-Pblyacrylamide Gel Electrophoresis of Yeast 
Cytochrome P-448
The method of Laemmli (1970) was used for analysis of 
purified cytochrome P-448. The enzyme sample was initially 
treated with sodium dodecyl sulfate (SDS) and then processed 
on polyacrylamide gel (10%) using a discontinuous buffer 
system.
Reagents
- Gel Stock: 30% (w/v) acrylamide containing 0.8%
(w/v) N , N r-methylenebis-acrylamide.
- Buffer 1: 1.5M Tris-HCl pH 8.8, containing 
0.4% (w/v) SDS.
- Buffer 2: 0.5M Tris-HCl pH 6.8 containing 0.4%
(w/v) SDS.
- Buffer 3: 0.025M Tris-HCl pH 8.3, containing 
0.192M glycine and 0.1% (w/v) SDS.
- Buffer 4: 0.062M Tris-HCl pH 6.8, containing 
2.3% (w/v) SDS, 15% (v/v) glycerol, 5% (v/v) 
2-mercaptoethanol and 0.001% (w/v) bromophenol 
blue.
- Ammonium persulfate solution 10% (w/v).
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Method
A vertical slab gel apparatus made in the workshop of 
the Biochemistry Department was used. The gel was contained 
in a glass and perspex cuvette, with internal dimensions of 
120mm x 100mm x 1.5mm. Electrophoresis was carried out at 
room temperature.
The glass plates of the gel cuvette were washed in 
detergent, rinsed with tap water, distilled water, methanol 
and acetone, and allowed to dry. The cuvette was assembled 
and sealed with 1.5% (w/v) molten agar and then clamped in- 
vertical position. The lower (running) gel was prepared by 
mixing Buffer 1 (10ml), gel stock (13.3ml), water (16.6ml), 
and polymerization was initiated by addition of N , N f- 
tetramethylethylenediamine (0.02ml) and freshly prepared 
ammonium persulfate solution (0.24ml). The solution was 
poured into the glass cuvette to a height of 80mm. A layer 
of distilled water was introduced above the gel mixture to 
insure a flat interface between the separating gel and 
stocking gel after polymerization. When polymerization was 
complete the water layer was removed and the upper 
(stacking) gel, consisting of a mixture of Buffer 2 (2.5ml), 
gel stock (1.0ml), water (6.5ml), ammonium persulphate 
solution (0.06ml), and N ,N 1-tetramethylethylenediamine 
(0.02ml) was added to the cuvette above the running gel.
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A perspex comb was introduced in the stacking gel before 
polymerization was complete and a small amount of Buffer 3 
was introduced into the sample wells to keep them separate. 
The lower spacer was removed from the cuvette, and the 
cuvette was then placed in an electrophoresis tank. Buffer 
3 was added to the upper and lower reservoirs, and air 
bubbles trapped underneath the gel were removed using a 
syringe.
Purified cytochrome P-448 was diluted with Buffer 4 to 
a final concentration of O.lmg protein/ml. A solution of 
marker proteins consisting of bovine serum albumin (M.W. 
68000), catalase (monomeric M.W. 60000), ovalbumin (M.W. 
45000), aldolase (monomeric M.W. 39500), O.lmg of each in 
lml of Buffer 4, was prepared. Cytochrome P-448 sample and 
marker protein mixture were placed in boiling water for 
3min. Both solutions were cooled and applied to the 
stacking gel by placing various volumes of cytochrome P-448 
and marker proteins mixture in alternating wells. A 
constant current of 20mA was used until the bromophenol blue 
entered the separating gel, and then this was increased to a 
constant current of 40mA until the bromophenol blue was 
within 5mm of the end of the gel. The cuvette was removed 
from the tank when electrophoresis was complete. The glass
( I l l )
plates were separated, the stacking gel was removed and the 
gel was stained as described below.
3.2.13. Detection of Proteins on Polyacrylamide Gel
The principal means used for the detection of proteins 
was the Coomassie Blue stain.
Reagents
- Propan-2-ol/acetic acid/water (5:2:13 by 
volume)
- Propan-2-ol/acetic acid/water (1:1:8 by volume) 
Method
Staining of the proteins was achieved by immersing the 
gel overnight in propan-2-ol/acetic acid/water (5:2:13 by 
volume) containing 0.05% (w/v) Coomassie Blue G-250. The 
gel background was destained by immersing in progressive 
changes of propan-2-ol/acetic acid/water (1:1:8 by volume) 
over a period of 48h. The gel was stored in 3% (v/v) 
glycerol at 4°C once the background was cleared.
3.2.14. Spectrophotornery for Thermostability and Spectral 
Studies
The thermostability of microsomal fraction and purified 
cytochrome P-448 was measured by a fluorescence
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spectrophotometric technique based on the ’’normalization” of 
the absorption parameters of tryptophyl residues in 
denatured unhydrolyzed protein. A Perkin-Elmer MPF3 fluor­
escence spectrophotometer (Hitachi L t d ., Japan) was used for 
fluorescence measurement of tryptophan at 295 and 330nm 
excitation and emmission wavelengths respectively.
Absolute and various difference spectra of purified 
cytochrome P-448 were recorded using a Pye Unicam SP1800 or 
a Varian Cary 219 spectrophotometer.
3. 2.15 . Removal of Emu1gen 911 from Yeast Cytochrome P-448
After the final step of the purification procedure, 
Emulgen 911 was removed from cytochrome P-448 (72nmbl) by 
dialysis against 60 volumes of 0.01M potassium phosphate 
buffer pH 7.25 containing 0.005M dithiothreitol and 20% 
glycerol and was applied to a hydroxylapatite column 
(1.5x8cm). The column was washed with the same buffer until 
no absorption at 276nm was detectable in the eluate and the 
enzyme was eluted with 0.5M potassium phosphate buffer pH 
7.25 containing 0.005M dithiothreitol and 20% glycerol.
3.2.16. Lyophilization of Cytochrome P-448
A purified cytochrome P-448 solution free of Emulgen 
911, with protein concentration of 0.4mg per ml was used for
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lyophilization. Reduced glutathione was added to this 
solution to give a final concentration 0.1% (w/v). This 
solution was precipitated by ammonium sulfate (65% of 
saturation), pellet was collected by centrifugation at 
27,750g for 30min and was dissolved in 0.005M potassium 
phosphate buffer pH 7.0 containing 10% sorbitol. It was 
then processed by gel filtration on a Se^^phadex G-25 column 
(1.5x8.0cm) prewashed with the same buffer. To this 
cytochrome P-448 solution which was free of glycerol and 
ammonium sulfate, reduced glutathione was added to give a 
final concentration of 0.1% (w/v). It was lyophilized by a 
high vacuum lyophilizer (Edwards, U.K.) overnight. The 
lyophilized enzyme was stable in storage at 4°C for 3 
months.
3.2,17. Materials
A: Preparation and Regeneration 8-Amino-n-octyl-
Sepharose 4B
8-Amino-n—octyl-Sepharose 4B was prepared according to 
the method of Cuatrecacas (1970) in the following manner in 
a ventilated fume hood. A volume of 400ml of wet Sepharose 
4B, previously washed with 6L distilled water, was stirred 
in 1L of distilled water, with a thermometer and the 
electrode of a pH meter immersed in the suspension. CNBr 
(lOOg) was dissolved in 300ml 1,4-dioxane and was added
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drop-wise to the stirred Sepharose 4B over lOmin. During 
this time the pH was maintained at 11 by the addition of 
8N NaOH and ice was added to keep the temperature between 20 
and 25°C. After an additional lOmin of stirring at pH 11 
and 20-25°C, the reaction was quenched by the addition of 
600ml of crushed ice. The suspension was poured into a 
sintered glass funnel placed over a Buchner flask which was 
attached to an aspirator. The gel Was washed with 4L of 
cold distilled water (4°G) and was added to a solution of 
114g of 1,8-diaminooctane dissolved in 400ml of distilled 
water. The pH of the resulting suspension was adjusted to 
10 using 6N HC1 and the mixture was stirred gently for an 
additional 16h at 40°C. The gel was washed in the sintered 
glass funnel successively with a total of 10L of distilled 
water, 2L of 0.1M potassium phosphate buffer pH 7.25, and 
10L of distilled water. The resulting gel was stored at 4*0 
in a 0.02% (w/v) NaN^ solution.
8-Amino-n-octyl-Sepharose 4B was reused after being 
washed in a batch-wise manner with the following solutions 
(2L of each) as described by Guengerich (1977a).
1 - 0.01M Potassium phosphate buffer pH 7.0 containing 
0.4% (w/v) sodium deoxycholate, 0.2% (w/w) sodium 
cholate and 0.001M-EDTA.
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2 - 0.1M Potassium phosphate buffer pH 7.2 containing
0.4% (w/w) Emulgen 911 and 0.4% (w/w) sodium
deoxycholate
3 - Distilled water
4 - 10% (v/v) Solution of 1,4-dioxane
5 - Distilled water
6 - 0.5M Potassium phosphate buffer pH 7.2 containing
0.5M KC1 an 0.001M-EDTA
7 - Distilled water
8 - 0.1M Potassium phosphate buffer pH 7.2 containing
0.7% (w/w) sodium cholate and 0.001M-EDTA
It was stored in an equal volume of 0.01M potassium 
phosphate buffer pH 7.0 containing 0.3% (w/w) sodium 
cholate, 0.001M-EDTA, 20% glycerol and 0.02% sodium azide.
B ; Other Materials
Sodium cholate, sodium deoxycholate, sodium dodecyl 
sulfate, dithiothreitol, NADH, NADPH, flavin mononucleotide, 
sodium potassium tartarate, albumin, reduced glutathion were 
obtained from Sigma Chemical Ltd. 2*,51-ADP-Agarose and 
2'-AMP were supplied by P-L Biochemicals. Powdered 
cellulose was supplied by Whatman Lab. Ltd. and 
2-mercaptoethanol was obtained from Koch-Light Lab. Ltd-. 
DEAE-Sephacel, CM-Sephadex C-50, Sepharose 4B, Sephadex
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G-75, protein marker kit were purchased from Pharmacia Fine 
Chemical. Potassium persulfate, acrylamide, N , N ’- 
methylenebis-acrylamide, bromophenol blue, Coomassie Blue 
G-250, N , N ’-tetramethylethylenediamine, hydroxylapb-tite, 
were obtained from Bio-Rad Lab. Emulgen 911 and 913 and 
Renex 698 were supplied by Honeywell Atlas Ltd. Sodium 
azide and cyanogen boromide were obtained from Aldrich 
Chemical Co. and cytochrome c was purchased from Calbiochem- 
Behring Co. Triton X-100, Triton N-101, Tween 80, 
ethylenediamine tetra-acetic acid, polyethylene glycol, 
potassium ferricyanide and other chemicals were supplied by 
BDH Chemicals Ltd.
3.3. Results and Discussion
3.3.1. Storage and Disruption of Yeast
Various solutions were used to stabilize cytochrome 
P-448 in yeast cells while in Storage (Table 3.1). Storage 
of yeast cells at 4°C in 0.1M potassium phosphate buffer pH
7.2 containing 0.001M-EDTA, 0.001M 2-mercaptaethanol, 20% 
(v/v) glycerol and 15% (w/v) glucose, prevented the 
disappearance and conversion to cytochrome P-420 of 
cytochrome P-450/P-448. Triton X-100 did not show any 
stabilizing effect on cytochrome P-450/P-448 in yeast cells; 
perhaps due to its large molecular size, it did not pene­
trate through the cell wall. Glucose as a carbon source for
H
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survival of yeast cells and sulfhydryl compounds 
(dithiothreitol, reduced glutathione, 2-mercaptoethanol) 
were essential in stabilizing cytochrome P-450/P-448 in 
yeast cells while in storage.
Disruption of yeast cells by water-cooled Vibro Mill 
produced a great loss in cytochrome P-450/P-448. This loss 
could be the result of localized heat generated during this 
process.
3.3.2. Storage of Microsomes and Solubilization of Yeast 
Cytochrome P-450/P-448
When yeast was grown in small scale, it was necessary 
to store microsomes to be solubilized later in bulk. Table
3.2 shows the stabilization of cytochrome P-450/P-448 in 
microsomal fraction by various compounds. Triton X-100 in 
0.1M potassium phosphate pH 7.2 containing 0.001M-EDTA, 
0.001M dithiothreitol and 20% (v/v) glycerol had a positive 
effect on protecting microsomal cytochrome P-448 in storage 
at -70°C. The disadvantage of Triton X-100 as a stabilizing 
or solubilizng agent is that it has a tight interaction with 
cytochrome P—448 and its complete separation (necessary 
since chromatography on basis of hydrophobic interaction is 
one of the purification steps) involved an extra step, e.g. 
Bio Beads SM-2 (Melcher et a l , 1975) or Biogel A-50
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(Loach et^  al^ , 1970). Reduced glutathione has been
oV
reported to make a small reconversion!cytochrome P-420 to
/ It
cytochrome P-450/P-448 possible (Franklin, 1972a).^stabilized
cytochrome P-448 in microsomal fraction and solu­
bilization by sodium cholate (Tables 3.2 and 3.3).
The main reasons for the difficulty in purification lay 
in the high instability of the cytochrome P-450/P-448 
through solubilization and in that separating the integral 
proteins of microsomal membranes from one another (these are 
likely to associate by hydrophobic binding) without 
denaturation. Unsaturated fatty acids involved in the 
phospholipid as constitutent of microsomal membranes are 
oxidizable with air to produce lipid peroxides, accompanied 
by destruction of the heme (Omura and Sato, 1964a). Thus, 
most of cytochrome P-450/P-448 disappears gradually without 
corresponding formation of cytochrome P-420, when solubili­
zation is carried out aerobically without the proper 
stabilizers being present. On anaerobic treatment the 
majority of cytochrome P-450/P-448 is converted to 
cytochrome P-420 in most solubilization treatments 
especially when stabilizers are not present. Since 
cytochrome P-450/P-448 is firmly bound in microsomal 
membranes and is one of the least solubilizable proteins in 
microsomes against the general procedures used for
(121)
u
0)
OinU_l sr 1
14-1 03 1 0
3 01 0- 4-1 O
pa u
3
>1 CM CJ CJ Sf
0) *o E '"s 14-3 0) 0  00 cura os Ih Sf
x X  Sf CJ
0-^5 u 1 E03 rX 0  o- O
O X u
x  0 X  tH X
CU
•0
0  0 CJ
<y c
X (0 04-1
03
in
-sf 14-4
e 0; 1 0•H > o.•rH 01 B*03 4-1 c CJ v—'
<y• H 0 E /—1
•O •rH 0  00 >1
033X4-1 14 - fx  sr uCl0 CO u 1 >
tH m X 0  a- 0
cj 3 3 X 0•H 1—41—4 x  u CJ
s 0 - 0 O  0 1-4
Ih i—i
Cl I x XX
3 e to q
cjX  u
co H
03 rHO
£ °  T3 
CJ C X <0 x ml 
C <u 
• h  >
03 0).§-o•5m C  o
tH 03O 3 
S  O'
S o J
oin
s f 11 o
h  D O  XCN
cu cj srE  \  1
o  00 a* 
u sr dl
U I Eo a . o
o m
•sf XI o 0*Er-S
0 
E
o  00 X  
U Sf 
X  s f U Io a.
u 
cj 
> 
ox  u 
X  Ih 01O o u
0
in
s f 1
1 0
04 4-1 O
xcm
CJ CJ s f
E x * 1
0  00 0 ,
tH Sf
X  s f 0)
u 1 E
O CU 0
X Ih
>1 u  x
0 0 0
0
in
Sf >4-4
1 0
cu
B-s
CJ w
E
O CO >»
1-4 Sf u
X  s f Cl
u 1 >
0  Oh 04-1 0
>< u CJ
CJ 0 44
o
©
o
o
l-i Ih
to aj CJ
14-4 CJ > >
O E X X
0 4-3 X 4J X X rH
cj m 03 CO 03 CO
u 0 CO a . ® CO AJ AJ
>-4 u CJ CJ CJ aj CO CO
3 U X> > 4 X x OS OS
O X
CO Z
6* /se-c
<—s —4 /—s —4
B* /—i w B-S 1—4
B-S 1—4
r-l B* W CJ s—✓ 03
x m >w/ X AJ
u • 0 CO 0 CO
03 O 0 X 0 rH
•O NX i—4 O —4 O
4-3 0 1 a> X 1 X
c •a cj X u X O
03 4-3 e
CO E co c 01 E e E
1-1 3 X 0 0 0 3 0 3
CJ X O. 4-1 X X AJ •H
4-3 *3 X X 3 •3 X •3
CJ O 3 (4 E O Ih O
© C/3 CO E-i Cd . W E- CO
*o
03
AJ
CO
CO CJ
oj in
E AJ 00
O 1 c
CO rH •H
0 CO cu AJ •H
u •H CO
•H X X
E Ih C
CO OX X u
CO 0
a e CN
a/ OJ •
X X - X
a .
X
E a .
CO Ou tH tH
OJ «4U Cl
N X
•H CO X
rH a) 3•H E XX O
CO CO CJ
4J 0 X
03 Ih CO
CJ XU-l •H a .
0 E CO
0
CJ Ih X
u CJ Ch
c ‘ >
OJ •H E
CO rH 3
X X
<0 •3 to
C CO
•0 CO CO
c X
CO rH 0
E cu
CJ
CJ Ih z
c CJ H^
CJ O.
CO 0
CJ O
1-4 OJ
Om *0- •
1 X
c Oh E
•rt
Cl . Ih
CO E aiAJ O a.
C ■ t4
CJ X O
00 CJ CM
w 0 s f
03 AJ 1
AJ X CU
OJ CJ
a CJ<A4 E
m O O
3 tH
0 rH X
•H O u
tH E 0
CO c X
> CO X
CJ
>1 0
X X
•0 0
CO e
-O' CO f—4Sf O
1 CO E
cu •c C
1 X
0 cu •
m OSJ- 0
1 m •3
b. s f c
1 CO
0) Oh
E 0
0 OJ in
tH E -O’X O 1
CJ Ih cu
0 XAJ u 03
X 0 E
CJ X OX Ih
<A4 0 X
0 CJ
rH 0
c O X
0 E X
•H c uAJ X
CO X
N 0 0
•H E
rH X c
•H iH in
X rH
3 CO X
rH •H
O X •3
CO •H OJ
C c
•H X
CO
CO •a X
<u c
CO c 0
•H CJ
CU O
r»i X CO
X c X
CO 0 CO
E-i U Ih
•o
c
a
03
c
o
X
x
X
COX
3
X00
X
4-3
O
X
X4-3
X
•3
z
(122)
solubilizing membrane proteins, it often is solubilized by 
treatments which cause disruption of the hydrophobic 
interactions accompanying denaturation i.e. conversion to 
cytochrome P-420. Along with disruptions of the hydrophobic 
interactions, attack on natural ligand (a sulfhydryl group) 
induces the conversion of cytochrome P-450/P-448 to 
cytochrome P-420. The destruction of hydrophobic inter­
actions, which protect the integrity of heme environment, 
also causes the displacing of the natural ligand.
Since the beginning attempts have been made
to solubize cytochrome P-450/P-448 from microsomal fraction 
under conditions in which the lipid peroxidation is 
prevented and the natural ligand is not destroyed or removed 
or replaced. Under these conditions almost total recovery 
of cytochrome P-450/P-448 is possible and the ratio of 
cytochrome P-450/P-448 to cytochrome P-420 could actually be 
increased through this process. The cytochrome P-450/P-448 
to cytochrome P-420 ratio during solubilization was also 
dependent on the pH of the medium. The highest ratio was 
obtained at pH 7.2. The presence of EDTA and a sulfhydryl 
compound (reduced glutathione in solubilization process) 
protected the cytochrome P-448 and increased the ratio of 
cytochrome P-448 to cytochrome P-420. This may be 
interpreted as a result of an increased aggregation of
(123)
cytochrome P-420 induced by EDTA in addition to the 
protection offered by a sulfhydryl compound (Autor e_t a l , 
1973). Amongst sulfhydryl compounds, reduced glutathione 
proved to be the best protector of cytochrome P-448 in the 
storage of microsomal fractions(Table 3.3). Dithiothreitol 
which is used most commonly as a stabilizer of cytochrome 
P-450 (Capdevila et_ a^ l, 1975) was not as effective as reduced 
glutathione for yeast microsomal cytochrome P-448, but 
proved to be just as effective (and was used) later in the 
purification process. Ichikawa and Yamano (1967) found that 
glycerol and other polyols are able to stabilize cytochrome 
P-450 by preventing its conversion to cytochrome P-420. 
Glycerol is used most commonly in all handling of cytochrome 
P-450/P-448 and in this study it was replaced with sorbitol 
only in large scale disruption of yeast and in 
lyophilization.
For storage of microsomes in - 7 0 ° ^ 0 . 1 %  (v/v) Triton X- 
100 in 0.1M potassium phosphate buffer pH 7.2 (plus 
additives as described in Table 3.2) produced results 
similar to those of reduced glutathione (0.1%) in the above 
potassiiim phosphate buffer. In comparison cytochrome P-450 
of rat liver microsom&l fraction was very stable at -70°C 
stored in the phosphate buffer (containing 20% (v/v) 
glycerol and 0.001M dithiothreitol) alone.
(124)
Microsomes in the phosphate buffer (plus additives),
v
containing 0.1% Triton X-100 and also in the phosphate (plus 
additives) and 0.1% reduced glutathione were solubilized by- 
various detergents with the release of cytochrome P-450/ 
P-448 (Table 3.3). Good yields in the enzyme were obtained 
with 1% (v/v) Triton X-100 in the presence or absence of 
0.1% (w/v) reduced glutathione and by 1% (w/v) sodium 
cholate in the phosphate buffer (plus additives) and 0.1% 
(v/v) Triton X-100 only. In both cases 100% yield were 
obtained for yeast microsomal fraction, but for rat liver 
cytochrome P—450 the recoveries were 93% (1% Triton X-100) 
and 87% (1% sodium cholate in presence of 0.1% Triton X- 
100). When cytochrome P-450/-448 was solubilized from yeast 
microsomal fraction by 1% sodium cholate in phosphate buffer 
(plus additives) containing 0.1% (w/v) reduced glutathione 
the yield (85%) was lower but the solubilization by or in 
presence of Triton X-100 produced problems in chromatography 
by hydrophobic association, unless its separation from 
soluble enzyme solution was accomplished thoroughly. Sodium 
cholate alone gave a good yield (80%) for rat liver, but 
only 36% for solubilization of yeast cytochrome P-450/P-448. 
Sodium dodecyl sulfate (0.5%, w/v) gave a very poor yield of 
yeast cytochrome P-450/P-448 (Table 3.3). The highest 
cytochrome P-450 or P-448/cytochrome P-420 ratios were 
obtained for solubilization of yeast cytochrome P-448 by or
(125)
in presence of Triton X-100 in the range 22-26, compared 
with only 7 for the rat liver enzyme. 1% (v/v) Emulgen 911 
gave about 50% yield from the yeast microsomal fraction, 
regardless of the presence of 0.1% (v/v) Triton X-100.
Renex 698. Tween 80, Triton N-101, Lubrol WX all in 1% (v/v) 
concentration, had no (or very little) solubilization effect 
on cytochrome P-450/P-448 from yeast microsomes.
Triton X-100 changes the spin state of cytochrome P-450 
from high to low spin (Tamura e_t aJL, 1976), and has been 
shown to stabilize some enzymes (Takeda et <il, 197*2) , by 
formation of micelles, which protect the hydrophobic 
environment of the enzyme. Conversely it has been reported 
that sufhydryl reagents (Murakami and Mason, 1967) or high 
ionic strength of medium (Yoshida and Kumaoka, 1972), cause 
the spin state to change from low to high state and also 
prompt the cytochrome P-450 to cytochrome P-420 conversion 
by destroying or removing the sulfhydryl ligand. This 
suggests that Triton X-100, by changing the spin state from 
high to low state and retaining it in that state, may 
protect the sulfhydryl ligand and make it more accesible to 
heme iron, thus exerting a stabilizing effect on the 
cytochrome P-450/P-448.
(126)
3.3.3. Thermal Stability of Yeast Cytochrome P-448
Yeast cytochrome P-450/P-448 was more stable toward 
thermal denaturation when in the form of microsomes than 
when solubilized but not purified. After incubating 
microsomal enzymes even at 50°C for 5min only 50% of the 
yeast cytochrome P-448 was lost (Figure 3.2). For rat liver 
microsomal cytochrome P-450 no detectable loss was observed 
after 5min at 50°C. This again shows the liver enzyme, to be 
more stable than the yeast enzyme as shown by Wiseman et al 
(1975b). When yeast microsomes cytochrome P-450/P-448 were 
treated with 0.1% (v/v) Triton X-100 although the critical 
temperature (temperature at which 50% of the enzyme is lost) 
remained the same, _  the temperature at which 5min 
incubation caused 100% loss of cytochrome P-448 increased 
from 55° to 60°C.
Solubilized yeast cytochrome P-450/P-448 is far less 
resistant to thermal denaturation than microsomal fraction 
(having a critical temperature of 35°C) as is expected from 
the loss of the lipid membrane. Triton X-100 at 0.1% was 
not able to restore the thermal stability of soluble enzyme 
to that of the microsomal fraction. A possible reason for 
the relative instability of the solubilized enzyme is the 
presence of 1% sodium cholate used for solubilizing the 
enzyme.
(127)
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Surprisingly, purified cytochrome P-448 was more stable 
than solubilized enzyme (even when studied at lower protein 
concentration) as the temperature at which 50% of cytochrome 
P-448 is lost, was 45°C (Figure 3.3). This may have been
of" absence of ionic detergent (sodium cholate) and 
the presence of a residual amount of non-ionic detergent 
(Emulgen 911) which was used during purification. This 
residual Emulgen may have a stabilizing effect due to 
protecting hydrophobic regions of the enzyme from the 
aqueous environment.
Fluorescence spectrophotometry (Figures 3.2 and 3.3) 
showed^only in the case of purified cytochrome P-448 the 
fluorescence increased as the result of a classical 
denaturation of protein, with apoprotein unfolding and heme 
being lost as the temperature was increased. Unfolding 
should have resulted in conversion of cytochrome P-448 to 
cytochrome P-420, but as the temperature was increased this 
conversion was not stoichiometric, probably due to loss of 
heme from the protein completely. Figure 3.4 shows when 
microsomal fraction was incubated in 45°C for more than 
lOmin there is a sharp disappearance in both cytochrome 
P-448 and cytochrome P-420.
(n
m
ol
/m
l)
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Figure 3.3. Thermal Stability of Purified Cytochrome P-448 
from Yeast. Cytochrome P-448 (x), fluorescence (•), 
cytochrome P-420 (a ) . Samples were incubated at various 
temperatures for 5min. Only residual amount of Emulgen 911 
may be present.
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Figure 3.4. Effect of Incubation at 45°C on Microsomal 
Cytochrome P-450/P-448 (x), Cytochrome P-420 (4) and 
Fluorescence (•") .
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More results an thermal stability of yeast cytochrome 
P-448 as measured by benzo(a)pyrene-3-monoxygenase activity 
■«mshown in Chapter 6 .
3.3.4. Purification of Yeast Cytochrome P-448
Ammonium sulfate fractionation (at 35-65% of sat.) 
increased the specific content of yeast cytochrome P-450/ 
P-448 nearly 10 fold with 8 6 % yield. This fractionation 
was best performed at the enzyme pH optimum (pH 7.0) as 
reported by Woods and Wiseman (1979). At lower pH, ( N H ^ ^ S O ^  
denatured cytochrome P-448, and cytochrome P-420 was formed. 
The denaturation of cytochrome P-450 by a high concentration 
of neutral salt has been reported by Imai and Sato (1967b), 
without specifying the pH used. They attributed this 
conversion to the disturbance of the hydrophobic environment 
around the heme moiety, either by primary action of the 
neutral salts or by secondary effects due to conformational 
changes in the cytochrome P-450 molecule. When ammonium 
sulfate fractionation was carried out with a sodium cholate 
concentration of protein solution ^  higher than 0.33% 
the (NH 4) 2S0 4~protein precipitate floated and did not 
separate from the solution by centrifugation. Therefore the 
sodium cholate-solubilized enzyme solution had to be diluted 
before the addition of ammonium sulfate.
(132)
Another limitation of ammonium sulfate fractionation 
was that even at pH 7.0 the cytochrome P-448 precipitate had 
to be collected and redissolved and dialyzed within three 
hours after the addition of the salt, otherwise denaturation 
occurred. This limitation made the large scale fraction­
ation of this enzyme very difficult and therefore it was 
replacedjipolyethylene glycol precipitation. Polyethylene 
glycol was also necessary to precipitate out the cytochrome 
P-450/P-448 and other mixed-function oxidase proteins 
(solubilized but still mixed with membrane material), by
performing the centrifugation . at aji low speed
— -
(7500g).
Ammonium sulfate fractionation has been used mostly in 
purification of microbial cytochrome P-450/P-448 Yoshida 
et al^  (1977) in their purification steps to prepare 
cytochrome P-448 from semi-anaerobically grown 
Sacccharomyces cerevisiae (baker's yeast) have included an 
ammonium sulfate fractionation (at 35-60% sat.) without 
having to maintain the pH at 7.0. Duppel et_ a_l (1973) also 
have used this fractionation to purify cytochrome P-450 from 
Candida tropicalis at 27-45% saturation. In purification of 
cytochrome P-450/P-448 from mammalian systems ammonium 
sulfate fraction is not used as commonly as in purifi­
cations, from yeast systems. Only Takemori e_t al_ (1975) in
(133)
purification of cytochrome P-450 from bovine adrenocortical 
mitchondria and Dialameh (1978) in preparation of this 
enzyme from untreated rat liver have utilized ammonium 
sulfate fractionation. In both cases the degree of purifi­
cation achieved by use of this step was not as high as the 
ones reported for the yeast system, although because of the 
lower molecular weight of these two particular cytochrome 
P-450$the precipitation was completed at lower ammonium 
sulfate concentration.
Fractionation with polyethylene glycol, a nonionic 
hydrophilic polymer, was more widely used in earlier 
attempts to purify highly hydrophobic amino acids containing 
cytochrome P-450/P-448 (Chapter 7 ) especially when purifi­
cations were carried out only by ion exchange and absorption 
chromatographies (Coon et al, 1978; Johnson, 1980; 
Elshourbagy and Guzelian, 1980; Miki et al^ , 1980; Koop 
et a l , 1981; Saito and Strobel, 1981). In all these cases 
to achieve the best results in selective fractionation, 
polyethylene glycol is added in step-wise manner and 
precipitate is collected after each addition.
Figure 3.5 shows the purification pathway mixed- 
function oxidase proteins from a single solution of yeast 
(Saccharomyces cerivisiae) microsomal fraction. It is shown
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in this summary that hydrophobic absorption chromatography 
by n-aminooctyl Sepharose 4B fractionates cytochrome P-448, 
NADPH:cytochrome c(P-450) reductase, cytochrome b^ very 
effectively. Chromatography by this material is used by 
many workers m  this field in recent years. In earlier 
stages of this study attempts were made to use the 
commercially available n-aminohexyl Sepharose 4B (Yoshida 
et a l , 1977). Chromatography with this material gave a 
considerably lower yield (40%) for cytochrome P-448 than 
chromatography with n-aminooctyl Sepharose 4B (70%).
Table 3.4 presents data on purification steps of 
cytochrome P-448 from microsomal fraction of Saccharomyces 
cerivisiae. A novel combination of chromatographic 
techniques were used for the purificationXcytochrome P-448. 
Besides the use of n-aminooctyl Sepharose 4B instead of low 
yielding n-aminohexyl derivative, the fast running 
hydroxylapetite-cellulose column, CM-Sephadex C-50 and 
finally DEAE-Sephacel were involved in the purification 
procedure. Hydroxylapetite-cellulose chromatography 
separated NADH:cytochrome b^ reductase from cytochrome P-448 
succesfully and DEAE-Sephacel was found to increase the 
purity of cytochrome P-448. By DEAE-Sephacel chromatography 
cytochrome P-450 was separated from cytochrome P-448. 
Although the amount of cytochrome P-450 (which bound to
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,!
DEAE-Sephacel) was eluted to be only 2% of cytochrome P-448 
eluate, this was an evidence for existence of yeast 
cytochrome P-450/P-448 in multiform.
i
Purified cytochrome P-448 had a specific content of 
17.6nmol per mg of protein, and overall yield of cytochrome 
P-448 from microsomal fraction was 27%. This highly 
purified enzyme was not found to contain any 
NABPH:Cytochrome c(p—450) reductase, cytochrome b^,
NADH:cytochrome b^ reductase and cytochrome P-420.
Table 3.5 presents a comparison between specific 
content and degree of purity of cytochrome P-448 purified 
from Saccharomyces cerivisiae for this study and other 
recent preparations. Specific content of 17.6nmol/mg 
presents 97% purity in respect to molecular weight of this 
enzyme determined by SDS-polyacrylamide gel electroporesis 
(read on).
Other purification methods such as chromatography with 
known cytochrome P-450/P-448 specific affinity materials 
were examined in order to simplify the procedure shown on 
Table 3.4, but none produced any significant result. 
Laurate-aminohexyl Sepharose 4B used by Gibson and Schenkman 
(1978) did not retain cytochrome P-448 from
(138)
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Saccharomyces cerevisiae. Aniline Sepharose 4B suggested by 
Takemori et al (1975) bound to this enzyme but the recovery 
was very low due to denaturation of cytochrome P-448 by high 
concentration of KC1 in the elution buffer. When 
immobilized cytochrome b^ on Sepharose 4B (Miki et: al., 1980) 
was used as chromatography the retention was insignificant.
3.3.5. Further Purification of Other Mixed-Function Oxidase 
Proteins of Yeast
NADPH:cytochrome c(P-450) reductase eluted from n- 
aminooctyl Sepharose 4B was further purified by 2',5'-ADP- 
agarose column. Table 3.6 presents the purification summary 
of NADPH:cytochrome c(P-450) reductase as a by-product of 
cytochrome P-448. The specific activity of purified 
NADPH:cytochrome c(P-450) reductase obtained from 
Saccharomyces cerevisiae by this procedure was 48 U/mg(one 
unit of NADPH:cytochrome c(P-450) reductase is the amount of 
enzyme that reduces lymol of cytochrome c per min at 22°C). 
NADPH:cytochrome c(P-450) reductase content of microsomal 
fraction (0.08 U/mg) was in agreement with 0.081 U/mg 
reported for Saccharomyces cerevisiae (baker's yeast) by 
Yoshida et_ al_ (1974b). Although the specific activity of 
purified NADPH:cytochrome c(P-450) reductase obtained in 
this study is lower than 60 U/mg and 56 U/mg reported for 
purified enzyme from rat liver (phenoarbital-treated) by
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Guengerich (1977), Gum and Strobel (1979) respectively, it 
was free of cytochrome P-448, cytochrome and 
NADH:cytochrome reductase. Overall yield of 26% (from 
microsomal fraction) is in line with yields reported by the 
above workers on rat hepatic enzyme, despite the fact that 
ammonium sulfate fractionation was optimized only for 
cytochrome P-448.
Table53.7 and 3.8 show the steps performed to purify 
cytochrome b^ and NAD H :cytochrome b^ reductase from 
Saccharomyces cerevisiae again as by-products of cytochrome 
P-448. The specific content of cytochrome b^ was 
74.8nmol/mg which is slightly higher than the value 
(74nmol/mg) obtained for this cytochrome from anaerobically 
grown Saccharomyces cerevisiae (baker's yeast) by Yoshida 
ejt al_ (1974a). These workers purified cytochrome b^ 
exclusively by ammonium sulfate fractionation, gel 
filtration on Sephadex G-75 column and two DEAE-cellulose 
chromatographies with an overall yield of 14% in comparison 
with 21% obtained in this study.
The presence of NADHicytochrome b^ reductase in 
Saccharomyces cerevisiae was reported by Yoshida e_t a_l 
(1974a). This enzyme has been solely purified from bovine 
liver microsomes by Schafer and Hultquist (1980) with
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specific activity of 102 U/mg in comparison to the value of 
70 U/mg (Table 3.8) obtained for yeast enzyme in this study 
(one unit of NAbH:cytochrome b^ reductase is the amount of 
enzyme that reduces lymol of ferricyanide per min at 22°C). 
This enzyme was also purified to homogeniety from rabbit 
liver microsome by an extensive purification procedure 
(Mihara and Sato, 1975). The specific activity of this 
enzyme in homogenous state was shown by these workers to be 
1245 U/mg. In this study cytochrome b^ and NA D H :cytochrome 
b^ reductase were separated from cytochrome P-448 by 
n-aminooctyl Sepharose 4B and hydroxylapatite chromato­
graphies respectively. Each of these proteins were free of 
other components of mixed-function proteins.
3.3.6. Spectral Properties of Yeast Cytochrome P-448
The absorption spectrum shown in Figure 3.6, further 
indicate that the purified yeast cytochrome P-448 is devoid 
of both cytochromes P-420 and b^. The spectra are 
essentially identical with that of solubilized cytochrome 
P-448. The differences between these spectra with that 
reported by Yoshida ejt al_ (1977) were locations of a- and 
8-bands at 565, 578nm revt'W&r 540, 575nm and the fact
that the Soret band (at 418nm) for the cytochrome P-448 
obtained in this study did not shift to 412nm in reduced 
form. Reduction of cytochrome P-448 was found to fuse the
(145)
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Figure 3.6. Absorption Spectra of Yeast Cytochrome P-448. 
Cytochrome P-448 was in 0.005M potassium phosphate buffer,
pH 7.0, containing 20% glycerol. ______, oxidase form;
  _______, reduced f o r m ; ------- , reduced CO-difference
spectrum.
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a- and 3-bands into a single absorption at 565nm. It was 
noted that the spectrum of oxidized form in addition to have 
a Soret Peak at 418nm, showed no absorption in the 650nm 
region which is characteristic of a low-spin cytochrome 
P-450/P-448 (Yoshida, 1978). As mentioned the Soret peak of 
reduced CO-difference spectrum of yeast is situated at 447- 
448nm. In this respect, therefore, yeast enzyme resembles 
the cytochrome purified from liver microsomes of 3- 
methylcholanthrene-pretreated mammals (Kawalek et a l , 1975; 
Hashimoto and Imai, 1976), although the latter preparation 
exhibits a high— spin type- absorption spectrum in the 
oxidized state.
The spectral parameters of cytochrome P-448 from 
Saccharomyces cerevisiae are shown in Table 3.9. Here the 
values of the extinction coefficient were calculated on the 
basis of one mol of cytochrome contains one mol of protoheme 
(Chapter 7).
3.3.7. Molecular Weight of Yeast Cytochrome P-448
SDS-polyacrylamide gel electrophoresis showed the 
homogenous nature of the cytochrome P-448 (Figure 3.7). By 
use of several marker proteins the molecular weight of 
cytochrome P-448 was estimated to be 55,500 (Figures 3.7 and 
3.8). This is similar to the molecular weight of cytochrome
(14?)
Cytochrome P-448 
form
Absorption 
Maxima (nm) (mM  ^.cm ^ )
Oxidised 417, 565, 578 120, 14, 12
Reduced 418, 565 78, 12
CO-complex of 
reduced form 
(absolute spectrum)
446, 560
CO-difference 
spectrum of 
reduced form
44^, 562 92 (447-490nm),;
Table 3.9. Spectral Parameters of Cytochrome P-448 from 
Yeast.
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Cytochrome
P-448
1 2 3 4 5 6 7 8 9 10 11 12
Figure 3.7. Electrophoresis of Purified Cytochrome P-448 
from Yeast. In wells 1, 3, 5, 7, 9, 11 various quantities 
of cytochrome P-448 and in wells 2, 4, 6, 8, 10, 12 various 
quantities of protein markers were used.
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O)o
4.9
4.8
Cytochrome P-448
4.7
4.6
0.50.4 0 j60.3 0.7
Relative Mobility
Figure 3.8. Molecular Weight Estimation of Purified 
Cytochrome P-448. Mobility of cytochrome P-448 on SDS- 
polyacrylamide gel (10%) was compared with the mobility of 
bovine serum albumin (A) M.W. = 68000, catalase (B) 
monomeric M.W. = 60000, ovalbumin (C) M.W. = 45000 and 
aldolase (D) monomeric M.W. = 39500.
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P-448 from liver microsomes of 3-methylcholanthrene or 
3-naphthoflavone treated mammals, 54000-55000 but is larger 
than the molecular weight of cytochrome P-448 from semi-
anaerobically grown bakerTs yeast, 51000 (Table 3.6). This
molecular weight value determines the specific content of a
100% pure cytochrome P-448 as 18nmol per mg of protein.
Therefore, the cytochrome P-448 obtained in this study is
97% pure.
Considering the homogeneous state of this preparation 
shown by SDS-p.olyacrylamide gel electrophoresis, three 
possibilities may be cited to account for this 3% 
discrepancy. First, a considerable amount of apo-cytochrome 
P-448 may be present in the purified preparation. Secondly, 
the SDS-gel electrophoresis method may have given a smaller 
molecular weight because of the strongly hydrophobic nature 
of cytochrome P-448 (Chapter 7). Finally, the purified 
cytochrome may have been contaminated with an impurity or 
impurities having the same or nearly the same molecular 
weight as the yeast cytochrome P-448.
(151)
CHAPTER 4
(152)
4. Time Dependency of Carbon Monoxide Difference Spectrum 
of Reduced Cytochrome P-448 from Saccharomyces cerevisiae: 
Slow Reduction Caused by Presence of Triton X-100 and 
Emulgen 911
4.1 Introduction
Triton X-100, added to microsomal fraction of 
Saccharomyces cerevisiae for the purpose of stabilization or 
solubilization, affects the carbon monoxide difference 
spectrum of reduced cytochrome P-448 and consequently the 
measurement of cytochrome P-448. It has been shown the 
cytochrome P-450/P-448 from Saccharomyces cerevisiae in the 
presence of Triton X-100 has an absolute spectrum identical 
to that of low spin state i.e. Soret peak at 418nm (Yoshida 
and Kumaoka, 1972). Yeast cytochrome P-450/P-448 is known 
to exist in the high and low-spin states and that the 
equilibrium between the two states depends on the environ­
mental conditions (Mitani and Horie, 1969a and 1969b). High 
spin and low-spin cytochrome P-450/P-448 corresponds to the 
Soret peaks of the absolute spectrum at 390 and 418nm 
respectively. Triton X-100 is shown here to behave as a 
type II binding compound (absorption maximum at 418nm and 
minimum at 390nm) and to modulate the spin state of yeast 
cytochrome P-448 from high to low form. Low-spin yeast 
cytochrome P-448 having lower mid-point redox potential, is
(153)
reduced by sodium dithionite more slowly than the high spin 
form.
Although sodium dithionite is routinely used as the 
reagent to reduce the heme iron in the spectrophotometric 
assay of cytochrome P-450/P-448, little has been reported 
about the kinetics or mechanism of this reaction (Omura and 
Sate, 1964b; Peterson, 1971). In the course of studies 
directed toward the determination of extinction coefficients 
for membrane-bound and solubilized cytochrome P-450 and 
P-420, Schenkman e_t al (1973) noted that complete reduction 
of the cytochromes by sodium dithionite required 2min. In 
this chapter experiments were performed to investigate the 
reduction rate by sodium dithionite of cytochromes P-448 and 
P-450 from yeast and phenobarbital-treated rat liver in the 
presence and absence of Triton X-100. As it was observed in 
Chapter 3, cytochrome P-448 accounts for the majority of 
type of enzyme in yeast and therefore is denoted as P-448, 
in microsomal fraction and otherwise, in this chapter and 
thereafter.
(154)
4.2. Methods and Materials
4.2.1. Preparation Microsomal Fraction from Saccharomyces 
cerevisiae
Brewer’s yeast Saccharomyces cerevisiae (NCYC No. 240) 
was grown and microsomal fraction was obtained as described 
in Chapter 3. The microsomal fraction was suspended in 0.1M 
potassium phosphate buffer, pH 7.2, containing 0.001M-EDTA, 
0.001M dithiothreitol and 20% (v/v) glycerol. Triton X-100 
was added to this suspension with a final concentration of
0.1%. The control samples did not contain any Triton X-100.
Solubilization of cytochrome P-448 by Triton X-100 was 
achieved by adding 1% (v/v) of this detergent to the 
microsomal suspension, stirring for lh, centrifuging at 
160,900g for lh and collecting the supernatant, which 
contained the solubilized cytochrome P-448. For deter­
mination of mid-point redox potential of cytochrome P-448, 
purified enzyme, prepared as described in Chapter 3, was 
used.
4.2.2. Measurement of the Reduction Rate of Cytochrome 
P-448 by Sodium Dithionite.
The carbon monoxide difference spectrum of yeast 
cytochrome P-448 was recorded by a spectrophotometric method
(155)
as described in Chapter 3. Spectrophotometry was carried 
out at 22°C unless mentioned otherwise.
The rate of reduction was measured by placing 
cytochrome P-448 (microsomal fraction) in both reference and 
sample cuvettes. Carbon monoxide was bubbled through the 
sample cuvette at the rate of one bubble per second for 30 
seconds, one mg/ml of sodium dithionite was added to the 
sample cuvette and mixed quickly, and absorbance changes at 
448nm were recorded. In some cases carbon monoxide was not 
bubbled through the solution and the rate of reduction was 
measured at 440nm.
4.2.3. Determination of Mid-Point Redox Potential of 
Cytochrome P-448
Mid-point redox potentials of cytochrome P-448 in the 
presence and absence of Triton X-100 were quantified with 
the dye photoreduction technique as described by Sligar 
et al ( 1979) and Sligar e_t a_l (1974). Safranine T, with a 
mid-point potential of -289mV (Clark, 1960), was used as an 
indicator and mediator.
Reagents
- 0.05M Sodium phosphate buffer, pH 7.25
containing 0.01M-EDTA and 20% (v/v) glycerol
(156)
- 0.2M Glucose solution
- 0.15mM Safranine T
- Mixture of glucose oxidase and catalase, 100
I.U. of each per ml of mixture
Method
Buffer (1.4ml) and glucose solution (0.4ml) were placed 
in each of the reference and sample Thunberg cuvettes and 
baseline 390 to 540nm was recorded. Difference spectrum of 
fully oxidized enzyme and dye was recorded (390-450nm) after 
the addition of one ml of purified cytochrome P-448 
(7.2nmol, with or without 1% Triton X-100), 0.06ml of 
Safranine T and 0.1ml of glucose oxidase-catalase mixture to 
the sample cuvette and 0.1ml of glucose oxidase-catalase 
mixture and 1.06 ml of buffer to reference cuvette. Before
the spectrophotometric recording of the spectra, the enzyme
and dye solution was made anaerobic by repeated evacuation 
and flushing of the Thunberg cell with argon that had been 
freed of oxygen using an apparatus described by Meites and 
Meites (1948). The system potential (Ep) was set by 
irradiation for 30s bursts with an 100 watt lamp, causing 
successive reductions. The fraction of cytochrome P-448 and 
dye reduced was determined by the optical density at 420nm 
and 520nm respectively (Sligar, 1976). Absorbance values 
were determined by scanning between these wavelengths and
(157)
were recorded when stable values,! obtained. Finally 100% 
reduction of the enzyme and dye was accomplished by the 
addition of sodium dithionite and absorbances were recorded. 
Safranine T gave a negligible absorbance at 420nm and 
cytochrome P-448 was isosbestic (oxidized-reduced) at 518nm 
rendering deconvolution of cytochrome P-448 and dye 
absorbance at these wavelengths unnecessary. All 
absorbances were measured at 25°C and data were displayed as 
standard Nernst plots.
Materials
Safranine T was purchased from Sigma Chemical Ltd. 
Glucose oxidase and catalase were obtained from Calbiochem- 
Behring Co. Other chemicals were supplied by BDH Chemicals 
L t d .
4.3. Results and Discussion
4.3.1. Time Dependency of Cytochrome P-448 Assay in the 
Presence of Triton X-100
The addition of Triton X-100 (a polyoxyethylene alkyl 
phenol) affected the CO-difference spectrum of yeast 
cytochrome P-448 (reduced CO cytochrome P-448 minus reduced 
cytochrome P-448) (Figure 4.1). It also affected the CO- 
difference spectrum of reduced cytochrome P-448 minus 
oxidized cytochrome P-448. .The difference in absorbance at
0.
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448nm was low and eventually reached its maximum (real) 
value only after approximately 8min delay. The percentage 
of reduction was calculated as described by Gigon e_t a_l 
(1969), Ando and Horie (1971), and the maximal increase in 
absorbance in the presence of excess sodium dithionite was 
taken at 100%. The percentage of remaining oxidized 
cytochrome P-448 was plotted on a logarithmic scale (Figure 
4.2), and shows that the rate of reduction of cytochrome 
resence of Triton X-100 is biphasle with
tion taking 8min.
dependency of the carbon monoxide difference 
iton X-100 treated yeast cytochrome P-448 
ttributed to slow solubilization of CO and 
slow binding to the reduced cytochrome P-448. 
ed by Ando and Horie (1971), carbon monoxide 
ery rapid reaction. When sodium dithionite 
to the sample cuvette 4min after the addition 
xide, the CO-difference spectrum of reduced 
cytochrome P-448 was still time dependent. The same results 
were obtained in the absence of.CO for Triton X-100 treated 
microsomes by measuring the rate of reduction at 440nm and, 
although the difference in absorbance was very small, it 
increased with time as before.
P-448 in the p 
complete reduc
The time 
spectrum of Tr 
could not be a 
therefore its 
As was describ 
binding is a v 
was introduced 
of carbon mono
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Figure 4.2. Effect of Triton X-100 on the Rate of Reduction 
by Sodium Dithionite in the Presence of Carbon Monoxide.
(A) Microsomes treated with Triton X-100 (0.1%). (B)
Control microsomes. The reaction was measured at 448nm. 
Cytochrome P-448 lnmol/ml; sodium dithionite lmn/ml; 22°C.
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In another experiment 
Triton X-100 treated yeast 
after the addition CO. The 
by bubbling oxygen (1 bubble/s 
was oxidized by adding 
the Triton X-100-differ 
difference spectrum sho 
at 390nm, a Soret peak 
displacement of Triton 
the time dependency of 
X-100 treated microsome
Other factors such as the 
CO bubbling through the sample 
eration. At a low temperature 
peak in the carbon monoxide di 
cytochrome P-448 was smaller, 
raised toward 22°C, the peak b 
temperature, the spectrum was 
contained Triton X-100 and was 
of Triton X-100 (control). If 
faster than 2 bubbles/s, a sma 
was converted to cytpchrome P- 
(5min) some of this cytochrome 
P-448. But in the case of Tri
of
CO 
it 
Then 
ed, and the 
e., no peak 
t the slow 
CO, to which 
of Triton
temperature and the rate of 
s were taken into consid- 
(4°C) the height of 448nm 
fference spectrum of 
and as the temperature was 
ecame larger. At a constant 
time dependent when the sample 
not time dependent when free 
carbon monoxide was bubbling 
11 portion of cytochrome P-448 
420, and as the time went by 
was reconverted to cytochrome 
ton X-100 treated microsomes,
the CO-difference spectrum 
microsomes was recorded 4min 
sample cuvette was freed of 
for 30s) through it, and 
^2^2 -*-n concentration),
ence spectrum was record 
wed a type II change, i. 
at 418nm. This ruled ou 
X-100 by the addition of 
the CO-difference spectrum 
s could have been related.
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their reconversion was completed in 5min and then another 
5min was required for the 448nm peak to reach its maximum 
height. This showed that the rate of bubbling CO to the 
sample cuvette is a negligible factor and the time 
dependency of CO-difference spectrum of Triton X-100 treated 
microsomes is due only to the slow rate reduction.
Aniline, a type II substrate (Chapter 5), proved to 
have the same effect as Triton X-100 on the CO-difference 
spectrum of yeast microsomes. The 448nm peak decreased 
considerably in comparison with the control microsomes and 
it reached its real height after approximately 8min 
(Figure 4.3).
Emulgen 911, another non-ionic detergent (a poly- 
oxyethylene alkylaryl ether), used in all the 
chromatography buffers in the purification process, also 
decreased the reduction rate of cytochrome P-448 by sodium 
dithionite. But Emulgen 911 treated microsomes or Emulgen 
911 containing purified cytochrome P-448, needed only 3min 
for their reduction to be completed.
(163)
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Figure 4.3. Carbon Monoxide Difference Spectrum of Aniline 
Bound Reduced Cytochrome P-448. Microsomes were treated 
with aniline (2mM). Curves 1-3 and 8 were recorded 1,2,3 
and 8min after initial scanning.
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4.3.2. Mid-Point Redox Potential and Spin State Equilibrium 
The Nernst equation which uses as a standard plot of 
oxidation-reduction equilibrium, is as follows:
fr fr
En = E (dye) - In — —  = E (Protein) - ~  In —  T ) m w /  F ,-0 m v ■ F
D p
where
f^ is the fraction of dye oxidized (o) or reduced (r) 
f is the fraction of protein oxidized (o) or reduced
(r)
Ep = system potential
Em = mid-point redox potential
R = gas constant
T = absolute temperature
F = Faraday constant
Tables 4.1 and 4.2 show the values of Ep determined 
from 420 and 518nm absorbances at different stage of 
oxidation-reduction in the absence and presence of Triton 
X-100 respectively.
Values of mid-point redox potential for yeast cyto­
chrome P-448 in the presence and absence of Triton X-100 was 
determined by the standard plot of the Nernst equation to be 
-347mV and -308mV respectively (Figure 4.4). The decrease
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in mid-point redox potential in the presence of Triton X-100 
could explain the slow rate of reduction in this case.
As was shown by Yoshida and Kumaoka (1975b) the peak at
394nm of spectral high spin form of hepatic cytochrome P-450 
is shifted to 416nm (reverse type I spectral change), a 
spectral low spin form, upon binding with a compound 
containing a hydroxyl group. The Triton X-100 in this study 
used to stabilize or solubilize cytochrome P-448 in or from
yeast microsomes, also contains hydroxyl groups.
The absolute spectra of Triton X-100 solubilized yeast 
microsomes gave direct evidence for this spectral spin state 
change (Figure 4.5). A major peak at 418nm and no 
absorbance at 650nm showed the existence of low spin 
cytochrome P-448, while the spectrum of the solubilized 
cytochrome P-448 with sodium cholate showed a shoulder at 
390nm, proving a spectral mixed spin form to be present. It 
was not possible to determine the spin content of Triton 
X-100 containing cytochrome P-448 by the temperature- 
dependent spin equilibrium technique (Chapter 8), due to the 
lack of temperature-induced spectral changes (specially in 
4-22°C range).
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It has been clearly demonstrated that cytochrome 
P-450/P-448 redox equilibria vs. regulated via the spin 
state of the heme iron (Sligar e_t al_, 1979; Gigon ejt a l , 
1969; Rein e_t <il, 1979; Ristau ejt a_l, 1979). Therefore, it 
was suggested that the binding of the type I substrate to 
hepatic cytochrome P-450 could increase the rate of electron 
flow from NADPH to the cytochrome by modulating the spin 
state equilibrium of the electron accepting hemoprotein.
Ando and Horie (1971) showed that reduction of cytochrome 
P-450 from adrenocortical mitochondria by sodium dithionite 
or by NADPH-dependent enzymatic system is not completely 
instantaneous. They reported substrates that produce the 
type II spectral changes such as pregnenolone, decrease the 
rate of reduction. They also indicated that when the spin 
state of heme iron is modulated from high to low, the rate 
of reduction is decreased and conversely, when it is changed 
from low to high the rate of reduction increases. These are 
in stark contrast with the Heintz and Peterson (1980) 
findings for cytochrome P-*450cam that the factors 
controlling the reduction of this cytochrome by dithionite 
anion monomer are not simply a function of the spin state of 
the heme iron. They arrived at this conclusion by observing 
the rate constant for the reduction of camphor-free 
cytochrome P-450 (low spin) as being four times greater than
(171)
rate constant for the reduction of camphor-bound cytochrome 
P-450 (high spin).
It may be concluded that Triton X-100 can modulate the 
spin state of yeast cytochrome P-448 (the same as a type II 
or a reverse type I compound). This causes slow cytochrome 
P-448 reduction by sodium dithionite, making the measurement 
of cytochrome P-448 by the CO-difference spectrum method 
time dependent, which indicates the existence of a major 
error in the standard "immediate assay" procedure.
The measurement of the hepatic cytochrome P-450 in 
contrast, was not time dependent with or without the 
presence of Triton X-100. This may be caused by a higher 
mid-point redox potential in hepatic cytochrome P-450 
(phenobarbital-treated rats) and/or due to the fact the 
Triton X-100 behaves like type I substrates (binding through 
its hydrophobic site to the cytochrome P-450 instead of via 
its hydroxyl group) upon addition to microsomal fraction of 
different animal species (Denk et_ a^ l, 1971; Burke et_ a l , 
1975; Takeshige et^  a_l, 1972; Hutterer ej: aJL, 1970; Franklin, 
1972b).
(172)
CHAPTER
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5. The Binding of Compounds to Cytochrome P-448 from 
Saccharomyces cerevisiae
5.1. Introduction
The binding of several putative substances to highly 
purified cytochrome P-448 from yeast was studied. Type I 
spectral interactions were observed with lanosterol, ethyl- 
morphine, sodium phenobarbitone, dimethylnitrosamine, 
perhydrofluorene and benzo(a)pyrene. The most interesting 
of these compounds, benzo(a)pyrene, was found to give a 
spectrum which had the normal type I shape and also an 
additional peak, when interacted with microsomal fraction or 
purified cytochrome P-448 from yeast. Type II spectral 
changes were observed with imidazole, aniline and benz- 
phetamine. The two well-known substrates of this enzyme, 
benzo(a )pyrene and lanosterol, showed high affinity (low 
spectral dissociation constants) for the enzyme.
The binding of benzo(a )pyrene with microsomal fraction 
and purified cytochrome P-448 from yeast, was further 
investigated by means of an equilibrium gel filtration 
method for measuring the association constant and number of 
binding sites. The results from this experiment were 
compared with the results from similar experiments performed 
with cytochrome P-450 from phenobarbital-induced and cyto­
chrome P-448 from B-naphthoflhtrone-induced rats.
(174)
5.2. Methods and Materials
5.2.1. The Spectral Interactions of Compounds with Yeast 
Cytochrome P-448
Spectral changes resulting from the addition of 
compounds to a solution of microsomal fraction or purified 
cytochrome P-450/P-448 (from yeast and rat liver) were 
recorded in a Varian Cary 219 Spectrophotometer. When 
benzo(a )pyrene was the compound added, a double-cell 
technique similar to that described by Goujon ejt a_l (1972) 
was employed in order to remove interference from the 
benzo(a)pyrene which absorbs in the wavelength range used.
In this method one compartment of each double-cell contained 
either 1ml of active cytochrome P-450/P-448 (usually 1M) 
and the other compartment contained 1ml of heat-denatured 
enzyme originally 1/-41 (devoid of cytochrome P-450/P-448 or 
of cytochrome P-420). Benzo(a)pyrene dissolved in 
dimethylformamide (2mg/ml) was added 1 microliter at a time 
to the active-enzyme compartment of the sample cuvette and 
the inactive-enzyme compartment of the reference cuvette.
An equal volume of dimethylformamide was added to the 
sample’s inactive-enzyme and reference’s active-enzyme 
compartments. The difference spectrum was then recorded 
between 350 and 500nm.
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Spectral titrations at fixed wavelengths were subjected 
to double-reciprocal plots, derived from the kinetic 
equation
kl V k3E + sj: — ----- vc , W e + p
where E is enzyme, C is the enzyme-substrate complex and S 
is the substrate. Titrations were performed at room 
temperature and in the absence of cofactor, therefore, the 
reaction does not proceed to product P. The reversibility 
of the first step in such a reaction had been demonstrated 
by Schenkman et al (1967).
The dissociation constant, Kg , termed the "Spectral
Dissociation Constant" (Schenkman e_t £l_, 1967) is
([Ef] - [C]) * [S]
K s " [Cl ~
where E^ . is the total amount of enzyme. By manipulation 
[E. ] [S]
K s = t c i — ' CS]
and
[E,] [S] 
[C] = C
K s + [S]
(176)
The reciprocal of this equation
i K -I -11 _ s 1 ■ ■ - j. 1__
[C] [Et ] ' [S] [Et]
is the equation of a straight line, when the reciprocal of 
the spectral change 1/[C] is plotted against the reciprocal 
of the substrate concentration 1/[S], the Y intercept is 
equal to 1/Et or the reciprocal of [C] and the X intercept 
is equivalent to -(1/K ).
Thus for benzo(a)pyrene, double-reciprocal plots of 
(iA500-418nm) Qr (AA387-377nm + 4A500-418nm } against
benzo(a)pyrene concentration were used to determine values
of K g by means of least squares regression analysis.
A 387-377nm AA500-418nmv J J . . ■ . n
(A A + AA ) was adopted instead of simply
using (AA^^^ 377nm^ tQ a^iow for changes in base-line during
the addition of benzo(a)pyrene. The double-cell technique
was also used for spectral recording of ethylmorphine,
lanosterol and sodium phenobar bitone, but in all three cases
a buffer solution (0.1M potassium phosphate pH 7.0
containing 20% glycerol) replaced the inactive enzyme.
Different wavelengths were used for each compound according
to the shape of the binding spectrum.. For simple spectra
the peak to trough height was normally used. The other
compounds which showed spectral interaction were
(177)
aniline, benzophetamine, dimethylnitrosamine and perhydro- 
fluorene. The other compounds examined were sodium 
hexobarbitone, aminopyrene, ethoxyresorufin,
8-naphthoflavone, lauric acid, ethoxycoomarin, 
benzo(a)pyrene, isosafrole and biphenyl.
5.2.2. Equilibrium Gel Filtration of Benzo(a)pyrene Yeast 
Cytochrome P-448 Complex
A method of equilibrium gel filtration derived from the 
principles outlined by Ferscht (1977) and by Kerridge and 
Tipton (1972) was used to investigate the binding of 
benzo(a)pyrene to purified cytochrome P-450/P-448 from yeast 
and rat liver. This technique was first shown by Hummel and 
Dreyer (1962) and is analogous in principle to equilibrium 
dialysis. A protein, P, is dissolved in a solution of a 
compound I to which it binds. The concentration of free I 
is thereby reduced by an amount equivalent to the P-I 
complex formed. An aliquot of this solution is then placed 
on a suitable Sephadex G-25 column which has been 
equilibrated with the same solution of I as was used to 
dissolve the protein. The column is thereafter eluted with 
the I solution and the concentration of I in the eluate is 
measured. As the P-I complex emerges at the excluded volume 
of the column, the total amount of I in the eluate rises 
above the equilibrium level and correspondingly, at some
(178)
point after the protein peak the concentration of I in the 
eluate is decreased below the base-line level to form a 
trough which extends to the salt volume of the column. The 
amount of free I removed from the solution as displayed by 
this trough is equal the excess concentration of I found in 
the protein peak. Thus as the protein moves down the column 
in the excluded volume, it continues to remove I from the 
equilibrium solution within the Sephadex- G-25 until an 
equilibrium is reached at the base-line concentration of I. 
So far as P and I are in equilibrium with a constant 
concentration of free I as they emerge, even weak 
interactions may be studied provided the concentration of I 
is sufficiently high.
If the initial and equilibrating concentration of 
benzo(a)pyrene is c mol/L and the amount of benzo(a )pyrene 
bound to n sites on the cytochrome P-450/P-448 is p mol, 
then the concentration of the cytochrome P-450/P-448- 
benzo(a)pyrene complex is (p/n)/V where V is the volume of 
the benzo(a)pyrene solution in liters. The concentration of 
free cytochrome P-450/P-448 must be (e-p/n)/V, where e is 
the total amount of cytochrome P-450/P-448. If
(179)
then the apparent association constant for each binding site 
is given by
H r >K = n
(e " ~ § ~ )c
or
therefore
J£- - Kc - 5E
nc n
and
—  . -2- = nK - K . -2-c e e
If we put 
<5 '= e
then
* -  nK - KSc
Hence a plot of X/c against & (a Scatchard plot) is a 
straight line of slope - K , the intercept of which on the 
axis is n, when tf/c = o.
(180)
Gel filtration was carried out on a small column
(Pasteur pipett* with dimensions of 45x5mm) packed with
Sephadex G-25. The column was equilibrated with 0.2M
potassium phosphate buffer pH 7.0, containing 10% dioxane
(v/v) and benzo(a)pyrene, before each experiment. The
benzo(a)pyrene in the buffer consisted of a fixed, known 
3amount of [G- H] benzo(a)pyrene (lOUCi) and various known 
amounts of unlabeled benzo(a)pyrene for each experiment. In 
each experiment after the column was equilibrated with 
benzo(a)pyrene-containing buffer, a 50U1 sample was taken 
and specific radioactivity was determined. In each 
experiment a small volume of purified cytochrome P-450/P-448 
(usually lOyl) was applied to the column and 2-drop (0.06ml) 
samples were collected. These samples were counted for 
radioactivity in LKB1210 Ultrabeta scintillation counter 
(LKB, U.K.) after adding 4ml of toluene-metapol (2:1, v/v) 
scintilant containing 0.5% (w/v) 2,5-diphenyloxdzole (PP0) 
and 0.02% (w/v) . 1,4-bis (5-phenyloxazol-2-yl) benzene 
(P0P0P). The binding of the benzo(a)pyrene to the 
cytochrome P-450/P-448 resulted in an increase in the 
radioactivity when the fraction was eluted, although no 
trough was formed. By using the known specific activity of 
the benzo(a)pyrene, it was possible to calculate the amount 
bound. The experiment was repeated at increasing 
benzo(a )pyrene concentrations (decreasing specific activity)
(181)
and by making a Scatchard plot it was possible to calculate 
the apparent association constant for each binding site and 
the number binding sites per mol of cytochrome P-450/P-448.
5.2.3. Materials
8-Naphthoflavone, aminopyrene, perhydrofluorene and 
benzo(a)pyrene was supplied by Aldrich Chemical Co. 
Imidazole, lanosterol , benzo(a)pyrene , 2, 5-dLphenyloxazole , 
isosafrol, ethoxycojiarin and lauric acid, were obtained 
from Sigma Chemical Corp. Ltd. Ethylmorphine and sodium 
hexobarbitone was supplied by May and Baker Ltd. [G-H]- 
benzo(a)pyrene was obtained from the Radiochemical Centre, 
Amersham ■ (U.K..). Ur. G. G. Gdison of Department of 
Biochemistry, University of Surrey, supplied the benz- 
phetamine. Dimethylnitrosamine was purchased from Phase 
Separation Ltd. (Scotland). Aniline, sodium phenobarbitone 
and biphenyl were supplied by BDH Chemical Ltd.
1,4-Bis-(5-phenyloxazol-2-yl) benzene was obtained from the 
Packard Instrument Co. Metapol was obtained from Durham 
Chemical Distributors Ltd. (U.K.)
(182)
5.3 Results and Discussion
5.3.1. The Spectral Interactions of Benzo(a )pyrene with
Yeast Cytochrome P-448
When the binding spectrum of benzo(a)pyrene to
microsomal cytochrome P-448 from yeast was recorded
previously in this laboratory (Woods and Wiseman, 1979), a
double-cell technique was adapted to remove the interference
of benzo(a)pyrene, which absorbs in the wavelength range )
used (350-500nm). They used a buffer solution in one of the
compartments of both the reference and the sample cuvettes
to complement the enzyme solution in adjoining compartments.
In order to determine the spectral binding dissociation
constant (Kg ), the results of spectral titrations at fixed
wavelength at a range of benzo(a)pyrene concentrations were
subjected to a double-reciprocal plot. In this study both
spectral changes at peak plus trough 
(AA387"377nm + AA500-418nm) and at trough alone
(AA^ 500nm^ were used in the double-reciprocal plot to
establish an accurate method to determine K and the extent
s
of cytochrome P-448 binding to benzo(a)pyrene. Other 
investigators have used the spectral change in trough region 
(AA^^^ 418nm^ Q£ the benzo(a)pyrene binding spectrum but 
with only a single-cell technique (Estabrook e_t a_l, 1978).
Non-specific binding, however, produces a maximum 
absorbance change in the 387-418nm region (determined from
(183)
* a u  i i 4. A .387-377nm 500-418nm>.from double-reciprocal plot of (AA + AA jvs.
benzo(a)pyrene concentration), that is larger than
126 mM \:m V  the theoretical maximum absorption
coefficient, which is used to quantify the spectral change
due to benzo(a)pyrene specific binding in the region (Ciniti
et a l , 1979).
The use of a heat-denatured enzyme (devoid of 
cytochrome P-448 or of cytochrome P-420) was investigated 
instead of the buffer in the double-cell method. In 
addition, another series of readings were made against 
denatured cytochrome P-448 and phospholipid (instead of 
active enzyme) with buffer in other compartments in the 
double-cell method. Results indicated that (1) non-specific 
binding is possibly the binding of benzo(a)pyrene to the 
phospholipid content of the enzyme, and (2) this non­
specific binding to phospholipid increases only the 
absorbance changes in the 367-387nm region (i.e., at peak 
wavelength) and does not effect the spectral changes in the 
500-418nm trough region. Therefore, if AAmax at 418nm was 
taken to determine the concentration of cytochrome P-448- 
benzo(a)pyrene complex by using 57 mM ^cm  ^ as an absorption 
coefficient (Estabrook and Werringloer, 1978), it was not 
necessary to use denatured enzyme as a reference in a 
double-cell system to eliminate the effect of non-specific
(184)
binding. Spectra changes at this trough wavelength (418nm) 
were due only to the binding of cytochrome P-448 to 
benzo(a)pyrene.
Figure 5.1 shows the binding of benzo(a)pyrene (at 
various concentrations) with purified yeast cytochrome 
P-448. As previously pointed out, the binding of 
benzo(a)pyrene to yeast purified, resulted in a spectrum 
which had two peaks (367 and 387nm) and trough at 418nm. In
contrast the peaks for yeast microsomal fraction were
located at 365 and 385nm and the trough was at 415nm.
The spectral binding dissociation constant ( K )  wasO
-p a 4- u u /. A 387~377nm AA 500-418nnkfound to be the same whether (AA + AA jwas
used in the double-re-ciprocal plot against benzo(a)pyrene
concentration or only the (AA^^ ^ ^ nm) values were employed.
(AA500”418nm^ wag uge(j for determination K values and the
s
extent cytochrome P-450/P-448 binding to benzo(a)pyrene in 
all cases (Figure 5.2 and Table 5.1).
Table 5.1 shows the benzo(a)pyrene-binding properties 
of cytochrome P“45Q/P“448 (from yeast and rat liver). The 
values obtained for dissociation constants (K ) were 18yMb
for microsomal fraction and 50yM for purified cytochrome 
P-448 from yeast. In contrast K values for microsomalb
fraction and purified cytochrome P-450 from phenobarbitol
(185)
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Figure 5.1. The Binding Spectrum of Benzo(a)pyrene with 
Yeast Purified Cytochrome P-448. The benzo(a )pyrene 
concentration was in the range of 7.9-39.5yM.
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Figure 5.2. The Double-Reciprocal Plot of Spectral Binding 
Benzo(a )pyrene with Purified Cytochrome P-450/P-448.
Phenobarbital-treated rat liver (x), 3-naphthoflavone-treated 
(•) rat liver, yeast (A ).
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Yeast Rat Liver 
(PB-Treated)
Rat Liver 
(BNF-Treated)
P M  P M P M
% of cytochrome 
P-450/P-448 binding 100 89 53 16 92.5 80
Ks (UM) 50 18 31 5 38 6
Table 5.1. Comparison of the Benzo(a )pyrene-Binding 
Properties of Cytochrome P-450/P-448. Microsomal fraction 
(M) purified form (P).
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(PB)-induced rats were 5yM and 31yM respectively. 
Corresponding Kg values were also determined for microsomal 
fraction and purified cytochrome P-448 from $ -naphthofalone 
(BNF)-induced rats to be 6yM, 38yM. These results should be 
compared with those reported previously, namely 0.8yM 
(Estabrook et al, 1978) and 9yM (Woods and Wiseman, 1979) 
for hepatic microsomal cytochrome P-450 from phenobarbita- 
induced rats and 36yM (Woods and Wiseman, 1979) for 
microsomal cytochrome P-448 from yeast.
The dissociation constant values obtained showed that,
although the affinity of cytochrome P-450/P-448 for
benzo(a)pyrene is relatively high (i.e., low K values), thes
unusual ability to achieve stoichiometric titration of 
cytochrome P-450 by benzo(a)pyrene that was demonstrated for 
rat liver microsomal fraction (Estabrook et_ a_l, 1978) is not 
achieved here (especially for purified enzymes). A 
stoichiometric titration (l:lmolar ratio) would require K s
values of approximately 0.5yM, 0.26yM and 0.46yM for 
purified cytochromes P-448 (yeast), P-450 (phenobarbital- 
induced rat liver), P-448 (3-naphthofalvone-induced rat 
liver), respectively.
It was also found that 100% of yeast purified 
cytochrome P-448, 53% (phenobarbital) and 92.5%
(189)
((3-naphthoflavone) of rat liver purified cytochrome P-450/
P-448 reacted with benzo(a )pyrene, as shown by comparison of
benzo(a)pyrene-binding absorption with CO-binding
absorption. When microsomal fractions were used instead of
purified enzymes the values were 89%, 16% and 80%
respectively. This value for microsomal fraction of
3-methylcholantherent-treated rat liver is 46% as reported by
Estabrook et^  aJL (1978). The absorption coefficient used for
determination of the concentration of the benzo(a )pyrene-
- 1 - 1
cytochrome P-450/P-448 complex was 57mM cm for 
(M^^^ 418nm j(|i;sta|);rooic and Werringloer, 1978). The fact 
that a high percentage of cytochrome P-450/P-448 in purified 
form reacts with benzo(a)pyrene is not surprising as 94% of 
the purified yeast cytochrome P-448 (see Chapter 8) and 82% 
purified cytochrome P-450 from phenobarbital-induced rats 
(Gibson and Tamburini, 1980) were found to be in low spin 
state at room temperature (22°C), which readily combines 
with type I substrates such as benzo(a)pyrene.
Purified cytochrome P-448 from yeast showed less 
affinity for benzo(a)pyrene than microsomal fraction. The 
value of the dissociation constant for purified enzyme was 
calculated to be 50yM in comparison to 18yM for microsomal 
fraction. Thus it would seem that whereas solubilization 
has improved the benzo(a )pyrene metabolism by yeast
(190)
cytochrome P-448 (see Chapter 6) the effect is the reverse 
for spectral binding dissociation constant.
The percentage of purified hepatic cytochrome P-450, 
from phenobarbital-treated rats, which was bound to 
benzo(a)pyrene (53%) was small in comparison to 92.5% for 
purified cytochrome P-448 from (3-naphthoflavone-treated 
rats, reflecting the increased proportion of benzo(a)pyrene- 
binding hemoprotein in spectrally P-448 dominant cytochrome. 
As for hepatic microsomal fractions, these percentages are 
smaller, but in case of cytochrome P-448 from 
(3-naphthof lavone-tr eated rats is still high (80%). This is 
rather surprising in the light of the reported high content 
of the high spin form of hepatic microsomal cytochrome P-448 
(Nebert and Kon, 1973).
5.3.2. The Spectral Interactions of Other Compounds with 
Yeast Cytochrome P-448
The binding spectra of yeast cytochrome P-448 with 
various compounds are shown in Figures 5.3-5.9. Table 5.2 
describes the spectral binding type and parameters of the 
interaction of these compounds with highly purified yeast 
cytochrome P-448. The spectral interaction of lanosterol 
which is thought to be an endogenous substrate for 
cytochrome P-448 in Saccharomyces cerevisiae has previously
(191)
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Figure 5.3. The Binding Spectrum of Lanosterol with Yeast 
Purified Cytochrome P-448. The lanosterol concentration was 
in the range 30-62yM.
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Figure 5.4. The Binding Spectrum of Ethylmorphine with 
Yeast Purified Cytochrome P-448. The ethylmorphine 
concentration was in the range of 60-1000yM.
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\
Figure 5.5. The Binding Spectrum of Sodium Phenobarbitone 
with Yeast Purified Cytochrome P-448. The sodium 
phenobarbitone concentration was in the range of 14-77pM.
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Figure 5.6. The Binding Spectrum of Dimethylnitrosamine 
with Yeast Purified Cytochrome P-448. The
dimethylnitrosamine concentration was in the range of 50- 
250yM.
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Figure 5.7. The Binding Spectrum of Imidazole with Yeast 
Purified Cytochrome P-448. The imidazole concentration was 
in the range of 400-1000]iM.
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Figure 5.8. The Binding Spectrum of Aniline with Purified 
Yeast Cytochrome P-448. The aniline concentration was in 
the range of 2-5mM.
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350 400 450
Wavelength (nm)
Figure 5.9. The Binding Spectrum of Benzphetamine with 
Yeast Purified Cytochrome P-448. The benzphetamine 
concentration was in the range of 2-20mM.
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been described by Aoyama and Yoshida (1978a). These authors 
also found that this compound gave rise to a type I 
interaction with purified cytochrome P-450/P-448 from 
bakerfs yeast grown semi-anaerobically although no value for 
the spectral dissociation constant (K ) was reported.O
In this study, in addition to benzo(a)pyrene and 
lanosterol, type I binding spectra were observed with 
ethylmorphlne (reported as a type I substrate for mammalian 
cytochrome P-450 by Davies et_ al_, 1969; Sasame and Gillette, 
1969), sodium phenobarbitone (also reported as a type I 
substrate by Schenkman et al, 1969; Topham, 1970), dimethyl­
nitrosamine and perhydrofluorine. Yeast cytochrome P-448 
also showed type II spectral changes with imidazole (Imai 
and Sato, 1967a), aniline (Schenkman e_t a_l, 1967) and 
benzphetamine. Benzphetamine is a substrate of mammalian 
cytochrome P-450 which gives rise to a type I spectrum with 
the enzyme (Goujon 1972; Hewick and Fouts, 1970).
When exposed to yeast cytochrome P-448 it is possible that 
the amino group of this substrate binds to the heme, 
producing type II spectrum changes instead of hydrophobic 
interaction which evidently occurs between benzphetamine and 
mammalian cytochrome P-450 as reported.
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Aminopyrine, which causes type I spectral changes with 
hepatic cytochrome P-450 from untreated rats and with 
hepatic enzyme from untreated rabbits, did not bind to yeast 
cytochrome P-448. Sodium hexobarbitone (Shenkman, 1967) 
3-naphthoflavone (Goujon et al, 1972), lauric acid (Orrenius 
and Thor, 1969), biphenyl (Burke and Bridges, 1975), and all 
known type I spectral-producing with untreated mammalian 
cytochrome P-450/P-448 did not produce any measurable 
spectral changes with yeast cytochrome P-448.
7-Ethoxyresorufin, ethoxycoumarin, and isosafrole were also 
tested with the yeast enzyme, but no interaction was 
detected with compounds.
As for benzo(a)pyrene difference spectrum with yeast 
cytochrome P-448 an extra peak was observed in experiments 
with ethylmorphine, lanosterol and sodium phenobarbitone.
Imidazole and aniline, both of which gave rise to type 
II spectral changes, had the highest affinity for yeast 
cytochrome P-448 with spectral dissociation constants (K )O
values of 8yM and 5yM respectively. The extents of binding
of these compounds, as measured by the peakAA values, wasmax 1
lower than benzo(a)pyrene but higher than other type I 
binding compounds. The two known substrates of yeast 
cytochrome P-450/P-448, benzo(a)pyrene and lanosterol showed
(201)
high affinity for the enzyme, although the extent cytochrome 
P-448 binding to lanosterol was not very high (Table 5.2).
5.3.3. The Equilibrium Gel Filtration of Benzo(a)pyrene 
Yeast Cytochrome P-448 Complex
Gel filtration experiments were carried out at 
increasing benzo(a)pyrene concentrations (c) using the same 
amount of cytochrome P-450/P-448 (e). The specific activity 
of labelled benzo(a)pyrene was determined by counting a 50yl 
sample of the equilibrating buffer and this was used to 
calculate the amount of benzo(a)pyrene bound to the 
cytochrome P-450/P-448 (p). Figure 5.10 shows a typical 
result of one gel filtration experiment. From the values of 
p, e and c thus determined, p/e (y ) and y/c were calculated 
and Scatchard plots were constructed (Figure 5.11). The 
values of the number of binding sites (n) and the apparent 
association constant (K) were then estimated by extrapo­
lation. In addition to microsomal fractions this experiment 
was performed using purified cytochrome P-450/P-448 from 
yeast (Table 5.3), liver of phenobarbital-treated rats 
(Table 5.4) and from liver of 3-naphthoflavone-treated rats 
(Table 5.5).
The nearest whole values of n determine for yeast 
microsomal and purified cytochrome P-448 were six (as also
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c
(nM)
e
(nmol)
P'
(nmol)
p/e
(y )
Y/c
(nil"1)
K n 
(nM™1)
1.25 0.01 0.00028 0.028 0.022 0.027 1
7,59 0.01 0.0019 0.19 0.025
13.93 0.Q.1 0.0032 0.32 0.023
20.27 0.01 0.0033 0.33 0.016
26.62 0.01 0.0042 0.42 0.015
29.5 0.01 0.0051 0.51 0.012
Table 5.3. Data from the Equilibrium Gel Filtration of the 
Benzo(a)pyrene Cytochrome P-448 Complex (Purified Enzyme 
from Yeast).
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Figure 5.10. A Typical Result of the Gel Filtration of 
Benzo(a )pyrene Cytochrome P-450/P-448 Complex.
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c
(nM)
e
(nmol)
P
(nmol)
p/e
(y )
y/c
(nM”*1)
K n 
(nM_1)
2.5 0.0036 0.000126 0.045 0.0180 0.023 0.53
8.8 0.0036 0.00055 0.152 0.017
15.2 0.0036 0.000794 0.220 0.013
27.2 0.0036 0.00148 0.310 0.011
Table 5.4. Data from the Equilibrium Gel Filtration of the 
Benzo(a)pyrene Cytochrome P-450 Complex (Purified Liver 
Enzyme from PB-Treated Rats).
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c
(nM)
e
(nmol)
P
(nmol)
p/ e 
(Y)
/—\ 
u 
<—11 
\ 
l
>- 
a
 a
K n 
(nM"1)
5.5 0.0036 0.0082 2.3 0.418 0.112 6.05
10.3 0.0036 0.0122 3.4 0.330
15.2 0.0036 0.0130 3.6 . 0.236
21.5 0.0036 0.0151 4.2 0.195
33.5 0.0036 0.0170 4.7 0.140
Table 5.5. Data from the Equilibrium Gel Filtration of the 
Benzo(a )pyrene Cytochrome P-448 Complex (Purified Liver 
Enzyme from BNF-Treated Rats).
r Y e a s t  and  P B -T re a te d  
.iver E nzym e
y/c  fo r B N F -T re a te d  
R a t L iver E n zym e
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Figure 5.11. The Scatchard Plot of the Equilibrium Gel 
Filtration of the Benzo(a)pyrene Cytochrome P-450/P-448 
Complex. Purified yeast cytochrome P-448 (•), purified PB- 
treated rat liver cytochrome P-450 (o), purified BNF-treated 
rat liver cytochrome P-448 (A ) .
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found by Woods and Wiseman, 1980) and one respectively.
Yeast microsomal and purified enzyme bind 100% to 
benzo(a)pyrene, so that the number of binding is six 
(microsomal) and one (purified) per enzyme molecule binding 
to benzo(a)pyrene. The number of binding sites rat liver 
enzyme (PB-treated) per molecule binding to benzo(a)pyrene 
(only 16% of microsomal cytochrome P-450 and 53% of purified 
form bound to benzo(a)pyrene) were six (0.91 x 100/16) and 
one (0.53 x 100/53) as the n values were 0.91 and 0.53 
respectively. This is a revision of the value of 20 for 
microsomal fractions calculated by Woods and Wiseman (1980), 
which was based on the extent of benzo(a)pyrene binding of 
33% for yeast and 5% for liver enzymes.
As for cytochrome P-448 from the liver of
8-naphthoflavone-treated rats, the number of binding sites 
was ten (microsomal) and six (purified). Multiple binding 
sites could be due to (1) multiple active site with other 
sites facilitating transfer of benzo(a)pyrene to the active 
site, (3) binding of benzo(a)pyrene to the hydrophobic part 
of the molecule with no connection with catalysis.
The apparent association constant (K) obtained1for 
yeast cytochrome P-448 was 0.08nM  ^ (microsomal fraction) 
and 0.027nM  ^ (purified form). These are equivalent to
(208)
dissociation constants (K ) of 1.3 x 10 and 3.7 x 10
s
respectively. For rat liver cytochrome P-450 (PB-treated)
the corresponding K values were 0.064nMY^ and 0.024nM ^
which are equivalent to dissociation constants (Kg) of 
— g _o
1.6 x 10 M (microsomal fraction) and 4.3 x 10 M (purified 
form). For rat liver cytochrome P-448 (BNF-treated) the 
values were 0.096nM  ^ (microsomal fraction) 0.112nM  ^
(purified form) which in turn give dissociation constants 
(K$) values of 1.0 x 10 and 0.89 x 10 respectively.
Low values for all dissociation constant suggests that
the binding affinity is very high. These K g values are much
1
smaller than the spectral Kg 18yM (microsomal fraction) and 
50yM (purified form) for yeast and the corresponding values 
5yM and 3yM for rat liver (PB-treated) and 6yM and 38yM for 
rat liver (BNF-treated).
The extra binding sites found for the bound form of the 
enzymes (microsomal fractions) is clearly due to the high- 
affinity binding of benzo(a)pyrene to the lipid present, as 
this affinity is lower in purified enzymes.
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6. The Induction and Characterization of
Benzo(a)pyrene-3-Monooxygenase Activity of Cytochrome P-448 
from Saccharomyces cerevisiae
6.1 Introduction
The benzo(a)pyrene metabolites formed by action of 
yeast cytochrome P-448 (microsomal fraction) were previously
identified by H P L C  ^ as 7,3-dihydro-7,8-
dihydroxybenzo(a)pyrene, 9-hydroxybenzo(a)pyrene and 
3-hydroxbenzo(a)pyrene (Wiseman and Woods, 1979). The 
fluorometric assay for the formation of the highly 
fluorescent metabolite, 3-hydroxybenzo(a)pyrene, was used to 
measure the Michaelis-Menten parameters of the enzyme in 
both microsomal form after various pretreatments and 
reconstituted system using purified cytochrome P-448. The 
parameters were compared with those of hepatic cytochrome P- 
450/P-448 of mammalian system. Other parameters, such as 
the pH optimum, thermal stability, temperature activity,
time course and the effect of enzyme concentration were also 
measured. It was also found that NADPH as a cofactor may be 
replaced by either cumene hydroperoxide and hydrogene 
peroxide.
The addition of benzo(a)pyrene to the yeast during 
growth caused only a small increase in cytochrome P-448
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levels but resulted in a dramatic improvement in the 
apparent kinetics of benzo(a)pyrene hydroxylase activity of 
microsomal fraction as measured by a decrease in the 
Michaelis constant and an increase in maximal velocity. 
Dimethylnitros&mine, phenobarbital and 3-methylcholantkrene 
also induced this enzyme to various degrees. Yeast 
pretreatment with (3-naphthoflavone did not effect this 
enzyme, yet pretreatment with lanosterol resulted in a 
decreased affinity for benzo(a)pyrene. In this chapter the 
implications of these findings with regard to the presence 
of multiple forms of cytochrome P-448/P-450 in yeast are 
briefly discussed.
The Ames test was used to detect the mutagenic 
metabolites of benzo(a)pyrene after activation with yeast 
cytochrome P-448.
It was found the benzo(a)pyrene hydroxylase activity of 
yeast cytochrome P-448 (reconstituted system) is inhibited 
by compounds which bind to this enzyme. The best inhibition 
was observed with lanosterol and dimethylnitrosamine. These 
results confirm the identity of benzo(a )pyrene hydroxylase 
as a cytochrome P-448 dependent activity. This enzyme was 
also inhibited by the flavonoid compounds, flavone and 7,8- 
benzoflavone, in a non-competitive fashion.
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Attempted hydroxylation with other compounds such as 
aniline, ethoxyresorufin, ethylmorphine, benzphetamine, 
aminopyrene with yeast cytochrome P-448 was not successful. 
Some degree of hydroxylation was observed this enzyme 
when either lanosterol or dimethylnitrosamine were used as 
substrate but the results were not consistent and 
reproducible.
6.2. Methods and Materials
6.2.1. Preparation of Microsomal Fraction of Induced Yeast
Saccharomyces cerevisiae (NCYC No. 240) was grown 
batchwise by a method described in Chapter 3. Growth was 
for 44 hours in a medium containing 1% yeast extract, 2% 
mycological peptone and usually 20% glucose. Inducing 
agents, dissolved in a small amount dimethylfotmamide, were 
added to the growth media at beginning of the growth period 
An equivalent amount of dimethylformamide was added in 
control experiments.
Microsomal preparations were obtained by differential 
centrifugation after disruption of yeast in a Vibro M^.11 
disruptor by a method also described in Chapter 3. 
Microsomal preparations were resuspended in 0.1M potassium 
phosphate buffer pH 7.2 containing 0.001M-EDTA and 0.001M
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dithiothreitol and 20% (v/v) glycerol, by use of a hand held 
Potter type homogenizer.
6.2.2. Preparation of Purified Yeast Cytochrome P-448 
The purified yeast cytochrome P-448 used for
reconstitution of hydroxylation activity of this enzyme 
system, was solubilized from untreated yeast microsomes and 
purified by the method described in Chapter 3.
6.2.3. Measurement of NADPH-Supported Benzo(a)pyrene-3- 
Monooxygenase Activity of Yeast Cytochrome P-448
Benzo(a)pyrene hydroxylase activity of yeast microsomal 
fraction (benzo(a)pyrene-treated and control) and purified 
cytochrome P-448 was measured by the method of Dehnen et: aJL 
(1973) as modified by Wiseman and Woods (1979). In this 
method one of the metabolites of benzo(a)pyrene by mixed 
function oxidase system (involving cytochrome P-450/P-448) 
namely 3-hydroxybenzo(a)pyrene is fluorimetrically measured. 
The term benzo(a)pyrene-3-monooxygenase is used inter­
changeably with benzo(a)pyrene hydroxylase to express this 
activity throughout this report. Each incubation contained 
0.5ml of microsomal suspension (with cytochrome P-448 
concentration of 2yM), 0.5ml of 0.1M Tris-Hcl buffer, pH 
7.0, containing a NADPH-regenerating system giving final 
concentrations of 0.004M of NADP, 0.02M of
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D-glucose-6-phosphate, 6yM MgCl^ and 8 I .U. of glucose-6- 
phosphate dehydrogenase.
The reaction was started by the addition of 
benzo(a)pyrene from a stock solution of 2mg/ml in the 
dimethylformamide to give a final concentration in the range 
of 0-158yM and incubated at 37°C for 15min. The reaction 
was stopped by adding 1ml of ice-cold acetone and the 
precipitated protein removed by centrifugation in a Piccolo 
centrifuge (Heracus Christ, W. Germany) at full speed for 
5min. A 0.6ml sample of this 50% acetone solution was then 
placed with 1.4ml of triethylamine solution (10.7%, v/v) in 
a fluorimeter cuvette and scanned from 500 to 560nm emission 
(467nm excitation) in a Perkin Elmer MPF3 fluorescence 
spectrophotometer to find the peak height at 523nm. The 
fluorescence intensities were measured relative to a 
solution of quinine sulfate (lOmg in 2M sulfuric acid) and 
were corrected against fluorescence intensities of blank 
solutions, prepared by the same method from equivalent 
reaction mixtures in all of which heat-denatured cytochrome 
P-448 were used. The concentration of
3-hydroxybenzo(a)pyrene was determined from a standard curve 
in which the fluorescence intensities of various quantities 
of 3-hydroxybenzo(a)pyrene (in 2ml solution of water,
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acetone, triethylamine, 0.3:0.3:1.4) were plotted against 
the concentrations.
The NADPH-supported benzo(a)pyrene-3-monooxygenase 
activity of purified cytochrome P-448 was usually measured 
by using 0.5ml reconstituted system containing lnmol of 
cytochrome P-448, 1 unit of cytochrome c(P-450) reductase 
(1 unit = lymol of cytochrome c reduced per min. at 22°C) 
and 30yg of dilauroyl phosphatidylcholine, in place of 
microsomal suspension in the above described assay mixture.
The direct fluorometric assay for benzo(a)pyrene 
hydroxylase reported by Yang and Kicha (1978) was attempted, 
but did not produce consistent results in the yeast system, 
probably because it was not sufficiently sensitive.
6.2.4. Measurement of Cumene Hydroperoxide-Supported 
Benzo(a)pyrene-3-Monooxygenase Activity of Yeast Cytochrome 
P-448
When NADPH was replaced by cumene hydroperoxide the 
latter was used at a concentration of 2.4mM. Cytochrome 
c(P-450) reductase and dilauryl phosphatidylcholine were not 
used for reconstitution of benzo(a)pyrene-3-monooxygenase 
activity, when this system was supported by cumene 
hydroperoxide.
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6.2.5. Measurement of Hydrogen Peroxide-Supported
Benzo(a)pyrene-3-Monooxygenase Activity of Yeast Cytochrome 
P-448
When benzo(a)pyreng-3-monooxygenase activity was 
supported by hydrogen per^oxide, this substance was 
generated by a system with final concentrations of 0.001M of 
D-glucose and 2.5 I.U. of glucose oxidase. Cytochrome 
c(P-450) reductase and dilauryl phosphatidylcholine were not 
required for reconstitution of benzo(a)pyrene-3- 
monooxygenase activity when it was supported by 
Although the presence of a small amount of cytochrome 
c(P-450) reductase increased the activity.
6.2.6. Attempt to Detect the Mutagenic Metabolities of 
Benzo(a)pyrene Using the Ames T e s t , after Activation with 
Yeast Cytochrome P-448
The Ames test is a sensitive and simple bacterial test 
for detecting chemical mutagens (Ames e_t al^ , 1975). It 
utilizes especially constructed strains of Salmonella 
typhimurium, which may be reverted specifically from a 
histidine requirement back to prototrophy by a wide variety 
of mutagens (both frameshift and base-pair substitution).
The test is carried out on Petri plates, where the chemical, 
bacteria and usually an activating enzyme system (i.e., 
mixed function oxidase system plus an NADPH generating
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mechanism) are incubated together in a semi-solid agar 
medium at 37°C. After 48h the number of colonies 
(revertants) on both test and control plates are counted.
In addition to the detection of mutagenecity of chemicals, 
the ability of the activating enzyme system to produce 
reactive metabolites from a known carcinogen/mutagen, is 
estimated by the Ames test. This is determined by the 
number of bacteria reverted back from the histidine- 
requiring mutant to the wild form. The inclusion of a trace 
amount of histidine in the agar allows the growth of a 
background lawn of bacteria, as several divisions are often 
necessary for mutagenesis to become evident (especially with 
frameshift mutagens, Ames et a_l, 1975) and also allows any 
cytotoxic effects to be note'd.
Mixed-function oxidase systems examined by this test 
were in the form of microsomes from benzo(a)pyrene-treated 
yeast, solubized enzymes also from microsomes of 
benzo(a)pyrene-treated yeast (containing dilauroyl 
phosphatidylcholine) and finally a reconstituted system 
using purified cytochrome P-448, cytochrome c(P-450) 
reductase (lnmol/1 unit) and dilauroyl phosphatidylcholine. 
The phospholipid was used as much as 30yg per ml of test
(2X8)
solution, and all enzyme systems were sterile filtered on a 
0.45y microfilter before addition to the test system.
Test Mixture
- 0.4ml Of mixed function oxidase system 
(cytochrome P-448 concentration of 2yM in the 
test solution).
- 0.1ml Of NADPH generating system (NADP concen­
tration of 0.004M in the test solution).
- 0.4ml Potassium phosphate buffer (0.1M) 
pH 7.4.
- 0.1ml Of an overnight-grown nutrient broth 
culture of bacterial tester strain TA100.
- 10yl Benzo(a)pyrene (2mg/ml, in
I
dimethylformamide).
Method
The test mixture was incubated at 37°C in a water bath- 
shaker (Mickel Lab. Engineering, U.K.) for 90min before 
being added to 2ml of top agar solution (melted at 45°C) 
containing 0,05mM L-histidine anl0.05mM biotin. The 
contents were immediately mixed and poured onto minimal agar 
plates to ensure the activating enzyme system was not kept 
at the temperature of the melted agar for more than a few 
seconds. Uniform distribution of the top agar on the
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surface of plates was accomplished by gently tilting and 
rotating the plates, before the agar had started to 
solidify. After 30min of incubation at room temperature, 
the plates were incubated at 37°C in the dark for 48h.
Control plates were set to examine the spontaneous 
mutation rate of bacteria in this test. These control 
plates contained buffer in place of mixed-function oxidase 
system. Both the complete and control systems were also 
tested on separate plates for effect of solvent on 
spontaneous mutation rate, where only dimethylformamide was 
used.
After 48h, the colonies on both test and control were 
counted, and the presence of a light background lawn of 
bacterial growth was confirmed. If massive bacterial death 
had occurred, the background growth on test plates was 
sparse, and, as more histidine was available for the 
individual surviving bacteria, these appeared as small 
colonies. Care was taken not to mistake these as 
revertants. Ideally for Ames test to be considered positive 
for a particular system, the number of revertants (colonies) 
in the presence of carcinogen/mutagen should be at least 
twice as many as those caused by spontaneous mutation (Ames
(220)
The number of bacteria present in this Ames test effect 
to some extent (though not by a single relationship) the 
number of revertants which may be formed from them. 
Therefore, it was important to determine the effect of 
components in the incubation mixture on this viability. At 
the end of each incubation lOOyl samples were removed from 
one of triplicate mixtures of each test and control systems, 
were diluted 1:100 three times by nutrient broth and lOO.yl 
of final dilutions were added to sterile plastic tubes 
containing 1.6ml of nutrient agar, 0.2ml of 0.1M L-histidine 
and 0.2ml of 0.5mM biotin. These tubes were shaken and 
poured onto the minimal agar plates, which when solidified 
were incubated at 37°C for 24h. lOOyl Of broth culture of 
bacterial tester (TA100) was also diluted and grown by the 
same method to serve as a control for viability assessment.
6.2.7. Materials
Oxoid No. 2 nutrient broth (made up and autoclaved as 
directed) was purchased from Oxoid Ltd. Top agar (0.6% 
Difco-Bacto nutrient agar containing 0.5% NaCl, autoclaved) 
was obtained from Difco Lab. Ready-poured minimal agar 
plates (Vogel-Bonner E Plates) were obtained from Gibco Ltd. 
Nicotinamide adenine dinucleotide phosphate•(NADP), 
D-glucose-6-phosphate, glucose-6-phosphate dehydrogenase 
flavone, 7,8-benzoflavone, dilauroyl phosphatidylcholine,
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3-methylcholanthrene, L-histidine and biotin were obtained 
from Sigma Chemical Co. Glucose oxidase was purchased from 
Calbiochem-Behring Co. Cumene hydroperoxide (80% in cumene) 
was supplied by Merck and Co. Inc. (W. Germany). 
3-Hydroxybenzo(a)pyrene was a gift from Dr. Diane Bedford of 
the toxicology laboratory, University of Surrey. Quinine 
sulfate and other chemicals were obtained from BDH Chemical 
L t d .
6.3. Results and Discussion
6.3.1. The Induction of Cytochrome P-448 Dependent 
Benzo(a)pyrene-3-Monooxygenase in Saccharomyces cerevisiae 
The addition of benzo(a)pyrene to yeast growing in 
medium containing 20% glucose affected the apparent kinetics 
of benzo(a)pyrene hydroxylation (as determined by 
benzo(a)pyrene-3-monooxygenase activity) and also the level 
of cytochrome P-448 in the yeast (Table 6.1). The level of 
cytochrome P-448 as measured by carbon monoxide-induced 
difference spectra of yeast suspensions was slightly higher 
in yeast treated with benzo(a)pyrene at high concentrations. 
The kinetics of benzo(a)pyrene-3-monooxygenase activity as 
supported by NADPH were investigated in microsomal fraction 
by means of double-reciprocal Lineweaver-Burk plots 
(Figure 6.1). The results show clearly that benzo(a)pyrene 
pretreatment of yeast results in a lower Michaelis constant
(222)
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(Km) i.e., higher affinity for benzo(a)pyrene and a higher
maximal velocity (V ). These effects were clearly
max . 3
dependent on the concentration of benzo(a)pyrene in the 
medium (Table 6.1, Figure 6.2).
Yeast grown in 0.5% glucose containing medium usually 
contains no cytochrome P-448. In an attempt to induce 
benzo(a)pyrene-3-monooxygenase activity in yeast growing at 
low glucose concentration, benzo(a)pyrene was added. The 
production of cytochrome P-448 in this growth medium was not
induced even in the presence of a high concentration (95UM)
of benzo(a)pyrene.
Table 6.2 shows the effect of several other compounds
on yeast cytochrome P-448 levels and the kinetics of
microsomal benzo(a)pyrene-3-monooxygenase. Pretreatment
with dimethylnitrosamine appeared to have a similar effect
to pretreatment with benzo(a)pyrene in that the level of
cytochrome P-448 slightly increased. The K m for
benzo(a)pyrene decreased and the V value increased. rj max
Higher concentrations of dimethylnitrosamine were necessary 
to achieve the same extent of induction as with 
benzo(a)pyrene. Yeast pretreatment with
3-methylcholanthrene was interesting as this resulted in no 
change in cytochrome P-448 levels and no change in the V__vulcL
xeuu 
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1 
czi
(225)
fr-d  euiojyooiAo iom u/u!UJ/0uejAd(B)ozu0qAxojpAq-8 l°w d)
XBUi A
(O coco CMCO COCN CM OCM CO CN CO
o
CN
IO
©
2
a.
E
3
’“5
0
2
5o
k.
0
c
o
f- CO 
u. 
•*-* 
c  
0 
O  
c  o 
O
0 
C 
0 
w. 
>  a
co
o
N
C
0
CQ
oo o
©
©
©
o o
CN
0
0
a)
u
cx
o
N
0
0
PQ
<4-4
O
M
0
4-1
0
E
0
1-4
0
Ph
U
•H
4-1
0
0
•rl
W
0
4->
M -i
O
0
o
•H
4-1
O
0
-a
0
0
0
0
u
04 
✓—\ 
0 
v-/ 
O  
N  
0 
0 
PQ
CN
*
\o
0
Pi
0
00
•H
pH
0
CO
0
pH
>»X
o
u
TO
ffi
(VMT#) ill*
a
1 -H 1
E PUX \O 0 0
ft c a-0 (1)0
>1 h ^ ID COJ-5 -ft rH CO r--
1 CL O • • •>  CO/^  o rH ON rHCO 4-J rH CO corH *>—'' rHo o o
S N
ft C H
w  0 O
E
(226)
ON
in
vO
CN v£>
CO
m
co
o■vf
r-
CN
o
CN
O
CO
CO
i-1 
•
CN
CO
CO
CO
O
m
CN
CO CO r* in CO CN
CN CO CO CN CO CN CO vd"a • * • • • • •
o o o o o O o O
+1 +1 +1 +1 +1 +1 +1 +1
vO CO ■vi­ CO CN o o CN
CO ON vo Ht CO in CO vO
• • « * • • • •
CO CO CO co CO CO co
CU cu
(U cu ft ft
ft ft CU cu
•H •H ft ft
B B -ft .ft 0
ft CO 4-> 4-J ft
co CQ ft ft o
O O cO CO rH >
4-J ft ft^-v 1—1 rH CO CO
ft 4-J 2 4-J 2 O O '-N 4-J ''“N rH
0) •h  Pi •H Pi X  2 -ft 2  . •H 2 1ft 2 rH 2
E O  ft 00 c <r O Pi O 3^- X  Pi CO Pi O ^
4-J i—1 o rH CN rH O rH O ft CN X  o ft ON
cd >-> rH CO >vCO >vON CO co 4-J CO 0 i—1
cu -ft H-x .ft -ft ^ X  VH X  ^ -ft w 4-J W
u 4-> 4-J O 4-J o CL CQ
4-J 0 CU CU CU ft CO O
(U B B 2 2 cu ss ft
ft •rl •H 1 1 ft! i CO
PL. Q CO co CL, CO. X
•
>»
1 4-J
CO •H
1 >
0 *H
ft 4->
0 O
ft CO
>>
CL 0
X
cO 4-Jv_^
O MH
N O •
ft 00
0 ft
CO O I
•rH
rd 4-J ft
ft CO
cO ft •fc
•H ft
CO B o
*vf ft •H
0 4->
1 4-J CO
Ph 0 •H
ra >
0 0
s ft X
o o
ft LH ft
-ft ft
a •ft CO
o 0 ’ft
4-J CQ ft
>> ft cO
o 4-J
0 CQ
ft ' ft
o 0 + 1
£
CQ 'ft
4-J CQ 0
ft ft 4-J
0 O O
00 •H ft
< 4-J eft
CJ
00 CO 0
ft ft ft
•H ift cO
u
ft rH 00
TO CO
ft E si-
H O 1
CQ (X
<4H O
O ft 0
O E
4-J •H o
U 2 ft
0 X
4H o
lh • o
W 0 4-JCQ >v
CO o• ft
CN 0 mh
• 00 o
vO >1
X CO
0 O 0
rH O ft
HC ft rH
CO o CO
Eh 2 >
(227)
value yet a large decrease in for benzo(a)pyrene was 
observed. Phenobarbital also had no effect on yeast 
cytochrome P-448 levels but improved both ^  and Vmax for 
this enzyme.
Pretreatment of yeast with 3-naphthoflavone had no 
effect on either cytochrome P-448 levels or benzo(a)pyrene 
kinetics. The addition of lanosterol to the yeast growth 
medium resulted in a higher Km for benzo(a)pyrene than the 
control value and a slightly higher Vm a x . In this case the 
affinity for benzo(a)pyrene was reduced possibly due to 
induction of a different form of the enzyme to that induced 
by benzo(a)pyrene.
Benzo(a)pyrene is well known as an in’ducer of 
benzo(a)pyrene hydroxylase in mammals, where similar effects 
to those reported here on the kinetics of this enzyme have 
been shown (Gurtoo and Campbell, 1970; Schlede ejt al_, 1970). 
This induction has been shown to be due to the selective 
induction of a form (or forms) of cytochrome P-450 with a 
high activity towards benzo(a)pyrene hydroxylation, 
cytochrome P-448. This form of cytochrome P-450, which is 
also induced by 3-methylcholanthrene, is known to have a 
relatively narrow substrate specificity and to activate 
carcinogens such as benzo(a )pyrene, to metabolically active 
products (results of the Ames test in this chapter).
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The induction of mammalian cytochrome P-450/P-448 
monooxygenase systems by various compounds has been widely 
studied and is now beginning to be explained in terms of 
multiple forms of the enzyme. Two of the most widely 
studied inducers, phenobarbital and 3-methylcholanthrene 
induce different forms of the enzyme. Phenobarbital induces 
a form with a very wide specificity whereas 
3-methylcholanthrene as it was indicated above induces a 
form with a narrow specificity, cytochrome P-448 (Conney, 
1967). It is now know that cytochrome P-450 exists in more 
than two different forms. The evidence for this comes, for 
example, from studies with inducers, isolation and 
purification of different forms, immunological studies and 
kinetics and binding studies (Guengerich, 1979). Multiple 
forms of cytochrome P-450/P-448 exist with different but 
overlapping substrate specificities. The results presented 
in this report suggest the induction by benzo(a)pyrene of a 
similar form of cytochrome P-448 to that of
3-methylcholanthrene induced enzyme in mammals, with a high 
activity towards benzo(a)pyrene in the yeast Saccharomyces 
cerevisiae.
The inability of benzo(a)pyrene to induce cytochrome 
P-448 in yeast grown in a low glucose medium shows that a 
high glucose concentration, or conditions leading to a
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a similar physiological state such as anaerobic conditions, 
is a prerequisite for cytochrome P-448 production. This 
would be as expected if the production of cytochrome P-448 
was being controlled by the presence of cyclic AMP as has 
been suggested (Wiseman e_t srl, 1978; Chapter 2 in this 
report). It would seem therefore that a high glucose 
concentration lowers the level of cyclic AMP which allows 
cytochrome P-448 to be produced. The induction observed 
with benzo(a)pyrene is due to an effect on the amount of a 
particular form of cytochrome P-448 produced.
The addition of dimethylnitrosamine to yeast's growth 
media also showed considerable induction of benzo(a)pyrene— 
3-monooxygenase activity in a similar manner to 
benzo(a)pyrene, suggesting that this compound was inducing 
the same form of the enzyme as benzo(a)pyrene.
3-naphthoflavone has been reported to induce a form of 
cytochrome P-450 in mammalian systems with a very high 
turnover number for benzo(a)pyrene which has an absorption 
maximum in the carbon monoxide-reduced difference spectrum 
at 446-448nm and has been hence termed cytochrome P-448 
(Saito and Strobel, 1980). However, induction of 
benzo(a)pyrene-3-monooxygenase activity by 8-naphthoflavone 
in Saccharomyces cerevisiae was not detected in this study.
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Pretreatment of yeast with 3-methylcholanthrene, a 
classical inducer of the cytochrome P-448 system in 
mammalian liver, was expected to induce benzo(a)pyrene-3- 
monooxygenase also. A large decrease in Km was observed 
suggesting a higher affinity form of the enzyme yet no 
change in maximal velocity occurred. Phenobarbital, a 
classic inducer of the wide specificity cytochrome P-450 
form in mammals induced benzo(a)pyrene-3-monooxygenase to 
some extent.
Lanosterol is the main endogenous substrate for 
cytochrome P-450/P-448 in Saccharomyces cerevisiae (Yoshida 
and Aoyama, 1980). The addition of this compound to yeast 
media during growth resulted in a decreased affinity for 
benzo(a)pyrene, showing that the induction of another form 
of cytochrome P-450/P-448 could be occurring.
The presence of multiple forms of cytochrome P-450/ 
P-448 in Saccharomyces cerevisiae is previously unreported 
although some evidence from purification studies (Chapter 3) 
was given that at least two forms are present in uninduced 
yeast. Furthermore, the results of induction studies 
suggest that multiple forms of cytochrome P-450/P-448 exist 
in Saccharomyces cerevisiae and extend the list of
(231)
properties that the enzyme from this eukaryotic source 
shares with the mammalian system.
6.3.2. Reconstitution of NADPH-Supported Hydroxylase 
Activity of Purified Yeast Cytochrome P-448
Table 6.3 shows a heat stable factor, dilauroyl 
phosphatidylcholine, is needed to reconstitute full 
hydroxylase activity of this system. This heat stable 
factor is reported to cause the association of cytochrome 
c(P-450) reductase and cytochrome P-450/P-448 to form an 
active enzyme aggregate (Strobel et b 1, 1970). Table 6.3 
also shows the residual non-ionic detergent Emulgen 911 
content of cytochrome P-448 seemed to suffice for active 
enzyme reconstitution as had been reported by Ichihara, 
et al (1971). The results shown in Table 6.3 clearly 
demonstrate an absolute requirement for cytochrome c(P-450) 
reductase in NADPH-mediated benzo(a)pyrene hydroxylation.
One complication in the hepatic microsomal system is 
that NADH, although much less effective than NADPH, can also 
act as an electron donor for cytochrome P-450/P-448- 
catalyzed monooxygenase reactions (Gillette et_ a_l, 1972). 
Reconstitution as well as immunochemical studies have 
indicated that the electron transfer in this case is 
mediated by a FAD-containing flavoprotein (NADH:cytochrome b^
(232)
Experimental Condition V
Full system (Emulgen 911 as heat stable factor) 11.3
Full system (dilauroyl phosphatidylcholine 
as heat-stabilizing factor)
11.3
Minus cytochrome P-448 0.2
Minus cytochrome c(P-450) reductase 1.6
Minus NADPH-generating system 1.8
Minus dilauroyal phosphatidylcholine 
or Emulgen 911
5.0
Table 6.3. Reconstitution of Hydroxylase Activity of
Purified Yeast Cytochrome P-448. Concentration of
benzo(a)pyrene used in all experiments was 79yM. V values
are expressed in pmol 3-hydroxybenzo(a)pyrene/min/nmol 
cytochrome P-448. NADPH-generating system constructed a 
described in "Method.” The dilauroyl phosphatidylcholine 
concentration was 30yg/ml of assay mixture and alternatively 
0.1% (v/v) of Emulgen 911 was used in the assay mixture.
(233)
reductase) and a b-type cytochrome, cytochrome b^ (Hrycay 
and Prough, 1974).
It has further been reported that NADH exerts a 
synergistic effect on NADPH-dependent monooxygenase 
reactions catalyzed by liver microsomes (Cohen and 
Estabrook, 1971; Gillette, 1971; Cinti et al, 1972). 
Hildebrandt and Estabrook (1971) have suggested that the 
first of the two electrons required for microsomal 
hydroxylation is donated by NADPH-cytochrome c(P-450) 
whereas the second electron is derived from either NADPH or 
NADH via cytochrome b^. Correia and Mannering (1973) have 
also concluded that cytochrome b^ is an electron transport 
carrier in the NADPH-dependent mixed-function oxidase 
system.
Although much remains unclear about the synergism,
evidence from immunochemical and reconstitution experiments
(Imai and Sato, 1977) suggest that the pathway through 
An
which^electron is transferred from NADH to cytochrome P-450 
via cytochrome b^ reductase and cytochrome b^ is somehow 
involved in the phenomenon. However, the obligatory 
involvement of cytochrome b^ in NADPH-dependent 
hydroxylation reaction is reported to be unlikely (Gillette 
e t a l , 1972; Leven ejt aJ, 1974; Liu et al^ , 1974 and Sasame 
et a l , 1974).
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This synergistic effect was examined in yeast’s 
monooxygenase system using benzo(a)pyrene as the substrate 
(Table 6.4). Neither inclusion of NADH and other components 
of its pathway (cytochrome b^, cytochrome b^ reductase) nor 
just presence of either cytochrome b^ or cytochrome b^ 
reductase in NADPH-dependent reconstituted system had any 
effect on benzo(a)pyrene-3-monooxygenase activity. When 
NADH and other components of its electron transport pathway 
replaced NADPH generating system and cytochrome c(P-450) 
reductase some activity was observed and when cytochrome 
c(P-450) reductase was added back to this system the 
activity increased slightly. These experiments also showed 
that where NADPH is involved as electron donor cytochrome b^ 
reductase and cytochrome b^ may not replace cytochrome 
c(P-450) reductase (Table 6.4). In all, the results showed 
that NADH can also serve as an electron donor for the 
hydroxylation of benzo(a)pyrene by yeast’s cytochrome P-448 
although the rate of hydroxylation is considerably slower 
than with NADPH. When NADH was used as an electron donor it 
was necessary for cytochrome b^ and cytochrome b^ reductase 
to be present. The mechanism of the observed stimulation by 
cytochrome c(P-450) reductase in NADH-mediated yeast's 
benzo(a)pyrene-3-monooxygenase system was not well 
understood. Possibly, cytochrome c(P-450) reductase could 
somehow be enhancing the rate reduction of cytochrome P-448
(235)
Experimental Condition V
Full system plus NADH, cytochrome b5 , 
cytochrome b5 reductase
11.3
Full system plus cytochrome b5 11.3
Full system plus cytochrome b5 reductase 11.3
Full system with NADH, cytochrome b 5 ,
cytochrome b5 reductase in absnece of NADPH 
generation system and cytochrome c(P-450) 
reductase
3.0
Full system with NADH cytochrome b5 ,
cytochrome b5 reductase replacing NADPH 
generating system
5.0
Full system with NADH replacing NADPH 
generating system
1.9
Full system with cytochrome b5 ,
cytochrome b5 reductase replacing 
cytochrome c(P-450) reductase
1.6
Table 6.4. Reconstitution of Hydroxylase Activity of 
Purified Yeast Cytochrome P-448 Supplemented with Components 
of NADH Electron Donating System. Full system consisted of 
cytochrome P-448, cytochrome c(P-450) reductase, NADPH 
generating system, dilauroyl phosphatidylcholine. 
Concentration of components of NADH electron donating system 
was 4mM (NADH), cytochrome (one nmol per nmol of 
cytochrome P-448), cytochrome b^ reductase (one unit per 
nmol of cytochrome P-448). Concentration of benzo(a)pyrene 
used in all experiments was 79pM.
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by NADH via cytochrome b^ reductase and cytochrome b5 or 
perhaps functioning as an effector rather than as an 
electron carrier, analogous to the proposal of Guengerich 
e_t a^ l (1976) for the role of cytochrome b$ in the reaction 
of oxygen with reduced cytochrome P-450.
In a similar reconstitution study by West and Lu (1977) 
using hepatic cytochrome P-448 and other components from 
3-methylcholanthrene-treated rats, the rate of NADPH- 
supported benzo(a)pyrene hydroxylation was observed to be 
30-40 fold higher than the NADH-supported in contrast with 
approximately 4 fold difference shown here for the yeast 
system.
6.3.3. Parameters of Yeast Benzo(a)pyrene-3-Monooxygenase 
Activity
NADPH-Supported benzo(a)pyrene hydroxylase was charac­
terized as indicated in the accompanying diagrams using a 
benzo(a)pyrene concentration of 79pM. The time course 
(Figure 6.3) shows the production of 3-hydroxybenzo(a)pyrene 
occurs linearly over a period of 15min, then for the next 
30min the rate of this production decreases by a function of 
time and stops after 45min. In both the cumene hydro­
peroxide and iii situ t hydrogen perioxide-suppor ted systems 
the production of 3-hydroxybenzo(a)pyrene (fluorescent
(237)
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Figure 6.3. The Time Course of the NADPH-Supported (• ) , 
Cumene Hydroperoxide-Supported (x) and Hydrogen Peroxide- 
Supported Yeast Reconstituted Benzo( a) pyrene Hydroxylase (+.) • 
The v values are expressed in pmol of 3-
hydroxybenzo(a)pyrene/nmol of cytochrome P-448 per various 
time intervals. Benzo(a)pyrene concentration was 79yM in all 
measurements.
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emission peak at 523nm) reaches its maximum after 15min and 
a peak at 540nm begins to show. This 540nm peak is 
identified as a mixture of benzo(a)pyrene metabolites 
including phenols, diols and quinones (Rho, 1980). This 
agrees with results obtained upon using cytochrome P-450 of 
phenobarbital pretreated rats, described by Renneberg et al 
(1981). These authors reported that the production of 
quinones from peroxide-supported hydroxylase systems was 
much higher than the production of these metabolites in a 
NADPH-supported system. The results compare favourably with 
the time course published by Nebert and Gelboin (1968) in 
which the 3-hydroxybenzo(a)pyrene production on NADPH- 
supported system was completed after 45min.
The pH optimum was also determined (Figure 6.4) and 
yeast benzo(a)pyrene hydroxylase was found to have a broad 
pH optimum in the region from 6.5 to 7.0 which is lower than 
that found in mammalian systems. For example, Nebert and 
Gelboin (1968) found the pH optimum in mammalian cell 
culture to be pH 7.5 and this pH was also used by Robie 
et al (1976) in experiments using rat liver microsomes. 
Alvares ejt al^  (1967) and Gurtoo e_t al_ (1968) used pH 7.4 for 
their experiments with rat liver microsomes. Cumps ej: aJL 
(1977) showed that the pH optimum for rat liver microsomes
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Figure 6.4. pH-Stability (•) and pH-Activity (x) 
Reconstituted NADPH-Supported Benzo(a)pyrene Hydroxylase 
System of Yeast. In pH-activity studies incubations were 
performed at the given pH. In pH-stability studies 
cytochrome P-448 was exposed for 60min at 22°C to the pH 
shown followed by determination of activity at pH 7.0. 
Benzo(a)pyrene concentration was 79yM in all measurements.
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system often is assumed to be the same as the one for the 
microsomes. In situ hydrogen peroxide (glucose 
oxidase/glucose) supported system had a better rate at 
slightly higher (pH, 7.2) than the optimal pH for the cumene 
hydroperoxidase and NADPH-supported systems which was at 
6.5-7.0. This is in spite of glucose oxidase having a pH 
optimum at 4-7 (Bright and Appleby, 1969) and G-6PDH, which 
was used in NADPH generating system having it at 9.2 
(Domagk e_t al_, 1969).
Changing the protein (cytochrome P-448) concentration 
in the incubation mixture resulted in the relationship shown 
in Figure 6.5. The degree of metabolism of benzo(a)pyrene 
was approximately linear for cytochrome P-448 concentration 
up to about lyM after which point, the degree of metabolism 
remained mainly constant, presumably as a result of some 
other factor, such as cofactor concentration becoming 
limited.
The optimum concentrations of NADPH-generating 
components was measured (in this laboratory) by Woods and 
Wiseman (1979) to be 0.004M for NADP,. 0.02M for D-glucose-6- 
phosphate and 8 I .U. for glucose 6-phosphate dehydrogenase 
in the system. These authors found that any increase in 
these values resulted in no further increase in the extent 
of benzo(a)pyrene metabolism, presumably since the enzyme
v 
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m
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Figure 6.5. The Effect of Cytochrome P-448 Concentration on 
Reconstituted NADPH-Supported Benzo(a)pyrene Hydroxylase 
System of Yeast. The v values are expressed in pmol of 
3-hydroxybenzo(a )pyrene/min per various concentration of 
cytochrome P-448. Benzo(a)pyrene concentration was 79uM in 
all measurements.
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concentration was limiting. These concentrations were 
routinely used in all studies of benzo(a)pyrene metabolism.
The thermal stability of the benzo(a)pyrene hydroxylase 
was compared with that of cytochrome P-448 as measured 
spectrophotometrically by the carbon monoxide-binding 
spectrum (Table 6.5, Figure 6.6, Figure 3.3 in Chapter 3). 
The resemblance between the thermal stability of cytochrome 
P-448 and benzo(a)pyrene hydroxylase proved that these are 
the same enzymes and this activity is cytochrome P-448 
dependent. The thermal stability of yeast benzo(a )pyrene 
hydroxylase was very similar to that of the same enzyme 
measured in mammalian microsomal fraction by Nebert and 
Gelboin (1968). Temperature-activity curve of yeast 
benzo(a)pyrene hydroxylase (Figure 6.6) gives 37°C as an. 
optimal temperature. This was in spite of cytochrome P-448 
not being fully stable at this temperature (also 
Figure 6.6).
In an attempt to increase the thermal stability of 
cytochrome P-448 dependent benzo(a)pyrene hydroxylase system 
of yeast, Triton X-100 and benzo(a)pyrene were examined 
using the least stable form of this enzyme, solubilized 
cytochrome P-448. As it is shown in Table 6.5, the
(243)
0
0) ■ 1 0 E
X  0 P Ph 0 O
o 0 CO O 4H P
•H P O 0 •H O X
X  tOrH a P O
£ O* 0 0 T3 0 O
/-N CO p P 0 P 0 P
P  0 0 X 0 0 O •H
( 0 ^  ^ 0 0 rH 0 O
0 ■ 0 0 T3 0 P
0 N 0 p P 0 O
P 0 0 O C\ m rH Kf >> 0 rH P •
3 (U CO m CO Kf Kl­ Kf 0 O • 0 rH
P  PQ rH 0 O >* S
CO p a U P .
P <P X 0 x •H • 00
Q) O O 0 N r > 0 E
0  P /-v 0 0 U •H 0 in
6&>S x) U >•* 0 O P P 0
0 O  t*>o m O O •
Eh m  hj w m 0 ik 0 0 0
0 X I P
Eh 0 0 P 0
0 0 0 0
0 0 0 0 •H
0 0 0 • 0 rH O 4H
P 0 •H e p X O •H
3 £ P 0 0 X P
P 0 p p 0 0 0
0 m  co P 0 0 p P 0 •
P O Kf 0 x p X) 0 0
0 Kf 04 CO 0 to £ P
06-S 1 0 0 X r—i 0
a 0  0 P 0 E 0 E 0
00 m in 0 in m Ph 0 0 0 P E
Eh rH 0 m Ki- vO Kl­ vO 0 P 0 0 00 •rH
a ^ 4H rH 0 P E P
H J 3  O O O X m p 0 CO 0
0 CJ P O X 0 >» P CN 0
O -rl Xi 'H 0 O 0 0 X
•H X  O 0 P 0 0 0 0
P  £ O P 0 T3 0 0 E 0
•H P  0 X >. •H 0 N 0
P p  >», O Eh trS P O P •H X
U  0 O H 0 N rH P
P 0 0 0 0 •H
0 0 0 0 X rH
0 0 0 X 0 0 rH
P P P rH 0
4-1 0 X 0 X 0 O
O 4H 0 •H 0 > CO 0
00 4H <r-\ 0 •H&-S Kf •H 0 0 rH •*
O  "O' « 0 rH 0 rH 0
in 1 O P 0 > E E
0  O 4H N 0 > 0 \ 00) 0 O 0 0 0 rH 00 0
P 0 0 •H rH E
s s to PQ E 00 m 0
P O P 0 in AO in m P 00 Kf • X
0 P 0 m co CO co Kf •H *0 0 Kf Kf vO P
P X  0 rH 0 > Kf 1 CM
0 O H p •H I 0 0
04 O xa p MH 0 rH P
E p  CO 0 0 0 0 0
0 >1 0 P 0 P 0 E E £
Eh  O  £ CO 0 O E O O
0 4H O P 0 0
rH CO P X O 0
S'S S 0 1 -0 -0 O P O
rH 0. a w 0 O O O •H
CO • 0 0 p 0 P O P •H P
P  Kf 0 CO 0 0 0 P X E 0
m -o- 0 0 -0 •< X X O P
0 1 +  0 +  P Eh s 0 O 0 P
0 Oh rH X O 0 P 0
>-t "0 T3 1 *0 0 0 0 P 0 0 0
0 rH 0 0 X 0 f—s • p •H O 0 £ U
4H S 0 N N N 0 m •H 1 m 0
O O E •H •H 0 •H '■—' -0 • 0 X 0 O
P O rH rH O rH O 0 vo TO P •0 P P O
a xi 0 •H •H P •H N •H 0 0 0 •H 0
p 0 O X xa -H X  0 4H 0 0 >1 > 0 00
0 0 P 0 0 P 0 0 •rl rH 0 0 •H P Kf
Oh p O rH rH Eh rH PQ P X 00 P 0 P 0 Kft>, •H O O O 0 0 Kf 0 0 O O 1
O ss CO CO CO 0 Eh Kf > 0 0 O 0
(244)
100 100
Tem p eratu re  ( C ° )
Figure 6.6. Heat-Stability and Temperature-Activity Curves 
of Reconstituted NADPH-Supported Benzo(a )pyrene Hydroxylase 
System of Yeast. Activity of enzyme was measurec at given 
temperatures (x). In heat-stability studies (•), the 
activity was measured at 37°C after 5min incubation at the 
given temperature. Benzo(a)pyrene concentration was 79yM in 
all measurements.
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benzo(a)pyrene hydroxylase activity stabili 
degree in the presence of Triton X-100, but 
benzo(a)pyrene did not significantly affect 
this activity. The stabilization effect of 
probably due to the detergent substituting 
during solubilization and hence protecting 
of the enzyme.
The kinetics of yeast reconstituted benzo(a)pyrene 
hydroxylase system were determined by least squares linear 
regression analysis of double-reciprocal Lineweaver-Burk 
plots in which the rate of 3-hydroxybenzo(a)pyrene formation 
was platted against benzo(a)pyrene concentration as is shown 
in Figure 6.7. This linear plot showed that the Michaelis 
Constant (K ) for NADPH-supported of yeast reconstituted 
benzo(a)pyrene hydroxylase system was at 33yM (Table 6.6). 
This value is much smaller than lllyM for cytochrome P-448 
measured in situ in the yeast microsomal fraction as shown 
in Table 6.1. This K m value is similar to that reported for 
liver enzyme (23yM) by Rickert and Fouts (1970) compared 
with the value of lyM also for liver enzyme reported by 
Robie e_t jal (1976). ^max f°r t i^e same system was found to 
be 16.7 pmol of 3-hydroxybenzo(a)pyrene per min per nmol of 
cytochrome P-448. This is greater than V max value of 
ll.lpmol 3-hydroxybenzo(a)pyrene/min/nmol of cytochrome
zes to some 
the addition of 
the stability of 
Triton X-100 is 
for lipid removed 
the conformation
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Figure 6.7. Lineweaver-Burk Plots of NADPH-Supported (•), 
Cumene Hydroperoxide-Supported (x) and Hydrogen Peroxide- 
Supported (a ) of Yeast Reconstituted Benzo(a)pyrene 
Hydroxylase System. The v values are expressed in pmol of 
3-hydroxybenzo(a)pyrene/min/nmol of cytochrome P-448.
(247)
Support System Vmax Km(yM)
NADPH 16.7 33
Cumene Hydroperoxide 21.9 125
h 2°2 33.7 200
Table 6.6. The Values of the Michaelis-Menten Parameters of 
Yeast Benzo(a)pyrene Hydroxylase System. Vmax values are 
expressed as pmol of 3-hydroxybenzo(a)pyrene/min/nmol 
cytochrome P-448.
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P-448 in microsomal fraction (Table 6.1), indicating the 
problem in using an immobilized enzyme (i.e., microsomal 
fraction) which includes a diffusion effect, when compared 
with a successfully reconstituted system.
The value determined here for agrees with
dissociation constant (K ) value of 50yM (presented ins
Chapter 5) which was determined for benzo(a)pyrene binding 
to yeast cytochrome P-448. The K g value for the microsomal 
cytochrome P-448 from yeast was 18yM. Even in purified 
systems, any disagreement would be due to the complexity of 
the benzo(a )pyrene-metabolizing system, and the K m values 
for this system are the aggregate of several components. In 
a case reported by Kratz and Staudinger (1968) the K_ value* b
for coumarin binding is found to be 100 times greater than 
the Km for its metabolism in an animal system.
Table 6.7 gives various literature values for Vmax and
Km of the mammalian microsomal benzo(a)pyrene hydroxylase
system. It can be seen that the values for Vmax are in the 
-6 -9
region of 10 to 10 mol of benzo(a)pyrene metabolite 
formed per h per mg protein (or g of liver). These V mo„
lllaX
values are higher than the- that for NADPH-supported yeast 
microsomal fraction (6.0pmol 3-hydroxybenzo(a)pyrene/h/mg of 
protein).
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Reference Pretreatment ••m
(MM)
^max
Nebert and Gelboin (1968) Co n t r o1 0.6 —
Alvares e_t a_l (1968) Control 14.0 3.00*
Kintzman e_t al (1969) 3-MC 2.0 10.80*
PB 14.0 7.30*
Rickert and Fouts (1970) Control 23.0 8.40**
BP 52.0 27.60**
Hansen and Fouts (1972) Control 100.0
BP 20.0
_ _
Robie et al (1976) Control 1.0 —  —
3-MC 0.3 --
Cumps e_t aJL (1977) Control 2.5 0.63***
3-MC 0.2 0.37***
PB 3.5 0.22***
Table 6.7. A Comparison of the Literature Values of the
Michaelis-Menten Parameters of Mammalian Benzo(a)pyrene 
Hydroxylase.
* moles hydroxybenzo(a)pyrene formed/h/g liver 
** nmoles 8-hydroxybenzo(a )pyrene formed/h/mg protein 
*** moles 3-hydroxybenzo(a)pyrene formed/h/mg protein
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From Table 6.7 it can also be seen th at while it is
generally agreed that pretreatment with a po lycyclic
aromatic hydrocarbon will decrease the Km of benzo(a) pyrene
hydroxyla se the actual numerical va lue of Km seems to vary
according to which group of workers measur e it. The most
likely ex planation for this is the strain di fferences in the
rats used or possibly variations in diet.
The Km and Vmax values for reconstituted NADPH- 
supported benzo(a)pyrene hydroxylase systems of cytochrome 
P-448 from 3-naphthoflavone-induced cytochrome P-450 from
by least squares 
urk plots shown in 
eriments 
purified from the 
for cytochrome 
46yM (Km) and 
of cytochrome 
ponding values, 33 
turnover of 
448 of
d from Vmax of 
per pmol of 
than those of PB- 
reported more than
phenobarbital-induced rats were determined 
linear regression analysis of Lineweaver-B 
Figures 6.8 and 6.9. In each of these exp 
cytochrome c(P-450) reductase isolated and 
respective source, was used. These values 
P-450 from phenobarbital-induced rats were 
21pmol of 3-hydroxbenzo(a)pyrene/min/nmol 
P-450 (V m ax) roughly resembling the corres 
and 16.7 for yeast cytochrome P-448. The 
benzo(a)pyrene metabolism by cytochrome P- 
$-naphthoflavone-induced rats as determine 
61pmol of 3-hydroxybenzo(a)pyrene per min 
cytochrome P-448 was considerably greater 
induced and yeast. Gozukara et al (1982)
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Figure 6.8. Lineweaver-Burk Plot of Reconstituted NADPH- 
Supported Benzo(a)pyrene Hydroxylase System of 
Phenobarbital-induced Rat Liver. The v values are expressed 
in pmol of 3-hydroxybenzo(a)pyrene/min/nmol of cytochrome 
P-450.
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Figure 6.9. Lineweaver-Burk Plot of Reconstituted NADPH- 
Supported Benzo(a)pyrene Hydroxylase System of 
B-Naphthoflavone-Induced Rat Liver. The v values are 
expressed in pmol of 3-hydroxybenzo(a)pyrene/min/pmol of 
cytochrome P-448.
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100 fold greater turnover for the BNF-induced cytochrome 
P-448 in comparison to PB-induced cytochrome P-450 as 
determined by the formation of 3-hydroxybenzo(a)pyrene from 
benzo(a)pyrene used only at 50yM concentration level. The 
value for Km of this system (BNF-induced cytochrome P-448) 
was 22.7yM which is slightly lower than the Km values of the 
other two systems. Saito and Strobel (1981) have reported a 
similar turnover (50pmol 3-hydroxybenzo(a)pyrene/min/pmol) 
value for benz'o(a)pyrene metabolism by cytochrome P-448 from 
B-naphthoflavone-induced rats also using only one level of 
benzo(a)pyrene concentration (80yM).
Figure 6.7 also shows the Lineweaver-Burk plots of 
cumene hydroperoxide and hydrogen peroxide-supportedAof 
yeast reconstituted benzo(a)pyrene hydroxylase system. The 
parameters of these hydroxylase systems are shown in 
Table 6.6. The Vmax values obtained for cumene hydro­
peroxide and hydrogen peroxide-supported systems (21.9 and 
33.7pmol/min/nmol) are considerably higher than that of 
NADPH-supported system (16.7pmol/min/nmol). In spite of V max
values, the comparison of K values for systems showed that 
yeast cytochrome P-448 has a higher affinity for the 
substrate benzo(a)pyrene.when hydroxylation is supported by 
NADPH and oxygen than those supported by peroxides. The
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peroxide-supported systems may have been caused by the 
effect of these molecules on cytochrome P-448. It has been 
shown that a higher concentration of cumene hydroperoxide 
(Woods, 1979) or hydrogen peroxide (White and Coon, 1980) 
causes destruction of the enzyme and it may be that at low 
concentrations it reacts with the enzyme to chemically 
modify the active site or to produce conformational changes 
in the protein thus changing the Km . In this study when 
hydrogen peroxide was generated 111 situ by glucose/glucose 
oxidase system the value of decreased in comparison to 
the direct addition of this substance to the hydroxylation 
system.
The higher V values for cumene hydroperoxide and ° max J r
hydrogen peroxide-supported systems may be d.ue to the fact 
that both these molecules by-pass the electron transport 
chain which must be used when NADPH is the cofactor thus 
increasing the efficiency of the overall reactions.
For microsomal enzymes from both PB- and BNF-treated 
rats the turnover of 3-hydroxybenzo(a)pyrene is reported to 
be higher for NADPH-supported system than that of cumene 
hydroperoxide (Capdevila e_t aJL, 1980). This may be due to 
the difference in metabolite profile when epoxide hydrase 
is present (microsomal fraction).
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6.3.4. The Inhibition of Yeast
Benzo(a)pyrene-3-Monooxygenase Activity
Table 6.8 shows the percentage of inhibition of 
cytochrome P-448 (purified) dependent (NADPH-supported) 
benzo(a)pyrene hydroxylase activity by binding compounds and 
flavonoids along with the corresponding Kc values. ThisO
table shows that dimethylnitrosamine and lanosterol result 
in a high degree of inhibition at 2.5mM and 77yM 
respectively. Both of these compounds result in type I 
interactions with purified yeast cytochrome P-448 with 
spectral dissociation constants (K values) of 220yM andb
80yM respectively. Dimethylnitrosamine is an inducer of 
cytochrome P-448 and binding studies (Chapter 5) showed 
evidence of its high affinity for this enzyme, although its 
rate of demethylation, using the Nash assay technique, was 
not reproducible (read on).
9-Hydroxyellipticine did not inhibit the yeast 
benzo(a)pyrene hydroxylase activity. This compound has been 
found to inhibit mammalian cytochrome P-448 in vitro 
(Delaforge ejt jal, 1980).
The interaction of falvonoid compounds with 
benzo(a)pyrene hydroxylase system from mammalian liver has 
been studied by Huang (1981a, and 1981b). These workers 
found the flavone stimulated benzo(a )pyrene hydroxylase
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Inhibitor Concentration % Control Benzo(a)- K s
Added of Inhibitor pyrene Hydroxylase (Ch. 5)
Activity
None — - 100 - -
Imidazole ImM 79 8yM
Aniline 0. 5mM 78 5yM
Phenobarbital 77yM 80 66yM
Lanosterol 77y M 55 80 yM
Ethylmorphine 1.25mM 73 166 yM
Dimethylnitrosamine 2. 5mM 50 220 yM
Benzphetamine 20mM 81 1.66mM
9-Hydroxy & lipticine 600yM 100 —
F|4vone 600yM 50 —
7,8-Benzoflavone 176yM 50 —
Table 6.8. Inhibition of NADPH-Supported Yeast 
Benzo(a)pyrene Hydroxylase System. The one ml asays 
mixtures contained lnmol of cytochrome P-448, 1 unit of 
cytochrome c(P-450) reductase and 30yg of
dilauroyl phosphatidylcholine. Benzo(a)pyrene concentration 
was 79pM :in all measurements.
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activity of cytochrome P-450LM3c or LM4, yet inhibited the 
same activity catalyzed by cytochrome P-450LM2, LM3b and 
LM6. 7,8-Benzoflavone stimulated benzo(a)pyrene 
hydroxylation by cytochrome P-450LM3c, yet inhibited 
cytochrome P-450L6 . It was found in this study that both 
7,8-benzoflavone and flavone inhibit benzo(a)pyrene 
hydroxylase activity of yeast cytochrome P-448 strongly in a 
non-competitive fashion. 7,8-Benzoflavone is a more potent 
inhibitor than flavone. Double-reciprocal plots of velocity 
versus benzo(a)pyrene concentration at various concen­
trations of 7,8-benzoflavone showed that the inhibition by 
this compound is non-competitive, as the for 
benzo(a)pyrene is unchanged while maximal velocity is 
lowered. The inhibition constant, for 7,8-benzoflavone 
was determined as 176yM (benzo(a)pyrene was used in the 
range 40-158yM).
The inhibition of benzo(a)pyrene hydroxylase by 
cytochrome P-448 binding compounds once again confirms the 
identity of this enzyme as a cytochrome P-448 dependent 
activity. The difference between mammalian cytochrome P- 
450LM4 (a cytochrome P-448) and yeast cytochrome P-448 is 
shown by the effect of flavonoid compounds on benzo(a )pyrene 
hydroxylation by these systems. In this respect the yeast 
enzyme used in this study appears to resemble cytochrome
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P-450LM6 which is produced in rabbit liver after induction 
with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TGDD).
6.3.5. The Detection of Mutagenic Metabolites of 
Benzo(a)pyrene Using the Ames Test after Activation with 
Yeast Cytochrome P-448
Table 6.9 shows the result of the Ames test using 
solubilized cytochrome P-448 from benzo(a)pyrene-induced 
yeast. When the yeast microsomal fraction was used the test 
system became contaminated and sterilization was not easily 
possible due to the high concentrations of lipid and protein 
in this fraction.
The carcinogenic and mutagenic effects of many 
polycyclic aromatic hydrocarbons are generally believed to 
be mediated through epoxides (Jerina and Daly, 1974; Lehr 
et a l , 1978; Gelboin e_t a_l, 1972). Microsomal cytochrome 
P-448-dependent mixed-function oxidase metabolizes 
benzo(a)pyrene, initially to the 7,8-oxide which is hydrated 
to the trans 7,8-dihydrodiol by the closely coupled epoxide 
hydratase ( E C . 4. 2 .1. 63) , as shown by Lu ejt £l_ (1978).
Mixed-function oxidase system then oxidizes the benzylic 
ring at the sterically-hindered bay region to give a diol 
epoxide with its oxirane ring in a position important in the 
production of active intermediate (Lehr e_t aJL, 1978). The
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Plate Content Viability Counts Test Counts 
(Revertants of 
per Plate)
TA100
TA100 alone 125* 118* -- ' — —
Buffer + DMF 3 7 50** 71 76
Buffer + BP 10 15 62** 44 82
Complete system 
+ DMF
8 8 112** 82 48
Complete system 
+ BP
9 18 157** 147 100
Table 6.9. The results of Ames Test. Crude solubilized 
cytochrome P-448 from benzo(a)pyrene-induced yeast was used 
in this test.
* As a result of 1:10 dilution of TA100 in the test systems 
the control viability counts should be 10 fold greater 
than that of blank and complete system.
** From which plates the viability samples were taken. For 
viability duplicate and for the test triplicate 
experiments were conducted. DimethyIformamide (DMF) is a 
solvent usually used to dissolve benzo(a)pyrene.
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diol epoxide is believed to be a proximate carcinogen, as it 
reacts with DNA (Brookes, 1977) and is mutagenic (Wislocki 
et a l , 1976; Huberman e_t a_l, 1976), a tumor initiator 
(Slaga e_t al, 1977) and a complete carcinogen (Kapitulnik 
et a l , 1978). The mutagenicity of diol epoxide is not 
effected by the presence of epoxide hydratase, as it is a 
poor substrate of this enzyme (Wood e_t a_l, 1976; Levin 
et al, 1977).
The reconstituted yeast mixed-function oxidase system 
of yeast (benzo(a)pyrene hydroxylase) consisted of highly 
purified cytochrome P-448 and cytochrome c(P-450) reductase 
(both devoid of epoxide hydratase), did not show any effect 
in converting benzo(a)pyrene to its reactive metabolite in 
the Ames test. When this system was used the number of 
revertants in the test plates were not greater th&n that of
blank plates. It is reported by Levin e_t al_ (1977) that in
the absence of epoxide hydrate* the reconstituted cytochrome 
P-448 containing mixed-function oxidase system metabolizes 
benzo.(a) pyrene to phenols and quinones.
As it can be seen in Table 6.9 when solubilized 
cytochrome P-448 from microsomal fraction of benzo(a)pyrene- 
treated yeast was used in the Ames test, the number of
induced revertants was higher than the blank (in this
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experiment complete system plus DMF). The fact that the 
number of the induced revertants was not at least two 
fold larger than the spontaneous, could be due to the 
presence of benzo(a)pyrene bound cytochrome P-448 in the 
blank. This number in two of the test plates was two fold 
larger than the number counted for blank plates using buffer 
plus solvent or buffer plus benzo(a)pyrene.
In all, yeast cytochrome P-448 showed some mutagenic 
act i y ^ a t i o n  effect of benzo(a)pyrene in the Ames test and 
could be further tried in this test to examine the 
mutagenicity of other compounds.
6.3.6. Attempted Hydroxylation of Other Compounds such as 
Lanosterol, Aminopyrene, Aniline, Dimethylnitrosamine,
Ethy1morPhine, Benzphetamine and Ethoxyresorufin with Yeast 
Cytochrome P-448
The possibility of demethylation of lanosterol (I) was 
investigated by measuring formaldehyde formation by the 
method of Nash (1953). A NADPH-supported reconstituted 
system using purified cytochrome P-448 (as described in 
Section 6.2.3.) was used to achieve the demethylation of 
lanosterol. Incubates consisted of 0.5ml of reconstituted 
cytochrome P-448 system 50yl of 20mM lanosterol (in DMF), 
1.95ml of 0.1M Tris-HCl buffer, pH 7.0 containing NADPH
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generating system (also as described in Section 6.2.3 .),
0.1M MgCl^ and 0.02% (w/v) semicarbazide hydrochloride. The 
mixture was incubated at 37°C for lh and the reaction was. 
terminated by the addition of 1ml of 15% (w/v) ZnSO^ 
followed by 1ml of 2:1 mixture of standard solutions of 
Ba(0H)2 and Na2B^0y. The precipitated protein was removed 
by centrifugation and 2ml of Nash reagent (0.4% 
acetylacetone (w/v) in AM ammonium acetate) was added and 
the mixture was incubated at 37°C for 40min and the colour 
was read at 412nm in a Cecil CE272 spectrophotometer (Cecil 
Instruments, U.K.) and concentration of formaldehyde was 
calculated against a standard curve.
HOHO
(I)
The 14 y-demethylation of lanosterol by a reconstituted 
cytochrome P-450 s.ystem from yeast has been demonstrated 
(Aoyama and Yosida, 1978b) and it was hoped that the Nash 
reaction for measuring formaldehyde could be used to show 
this demethylation in the yeast system used in this study.
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Although some demethylation activity was observed using the
show a productible rate of demethylation.
The same method was used to determine N-demethylation 
of aminopyrine (II), ethylmorphine (III), dimethyl- 
nitrosamine (IV) and benzphetamine (V) by yeast cytochrome 
P-448 reconstituted system.
Nash reaction, this method was not sufficiently sensitive to
h2n or
N.CH3^ N K
g h3
ch3^ n^n
J I 
H
(ID
C2H5C c2h5o
o, O,
N-CH3 N-H
HO (III)
HO
H
CH3-N-NON-NO
(IV)
o CH^CHCHrCH-N-CH ■CH,-
(V)
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The Nash method for determination of formaldehyde
o[
formed from N-demethylation^aminopyrine, ethylmorphine, 
benzphetamine showed that there was more formaldehyde in the 
blank than in the test incubates. A time course was 
attempted in all three cases but there was no difference 
between the zero min and 60min samples. It must be 
concluded, therefore, that there was no N-demethylation of 
these three substrates. Some N-demethylation activity was 
detected when dimethylnitrosamine was used as a substrate, 
but again as it was observed for lanosterol the results were 
not consistent and reproducible.
The ethoxyresorufin O-deethylation activity of 
reconstituted yeast cytochrome P-448 (VI) was measured by 
the method of Burke e_t al^  (1974), improved from that of 
Burke and Mayer (1971).
OH
(VI)
Ethoxyresorufin is O-deethylated to yield resorufin, 
these compounds are fluorescent with excitation maxima at 
456 and 560nm and emission maxima at 570 and 586nm 
respectively. Therefore when the fluorimeter was set at
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excitation and emission wavelengths' of 510 and 586nm 
respectively, the metabolism of the ethoxyres/ufin can be 
measured by a progressive increase in fluorescence. This is 
proportionate to the concentration of product in the range 
0.5-400nM and there is no interference from amino acids and 
NADPH at these wavelengths.
The reaction mixtures consisted of 0.5ml of 
reconstituted cytochrome P-448 system (as in Section 6.2.3.) 
10yl of O.OlmM ethoxyresorufin and 1.5ml of 0.1M Tris-HCl 
buffer pH 7.8. . The fluorimeter, set at 37°C‘, was first 
calibrated by adding 10^1 aliquots of resorufin (O.OlmM in 
ethanol) successively to 2ml of buffer. The reaction 
mixture was then placed in the fluorimeter, the baseline was 
recorded, then the reaction was started with the addition of 
10yl of 50mM NADPH solution and the initial rate was 
measured from the increase in fluorescence.
Neither reconstituted cytochrome P-448 system nor the 
microsomal fraction of benzo(a)pyrene-treated yeast showed 
any ethoxyresorufin 0-deethylase activity.
Aniline is hydroxylated by mammalian hepatic cytochrome 
P-450 to p-aminophenol (VII) as reported by Imai and Sato 
(1974).
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N l-L NH
OH
(VII)
Aniline hydroxylase activity of reconstituted 
cytochrome P-448 system was determined by a method of 
Guarino et al (1969). Incubation mixture consisted of 0.5ml 
of reconstituted cytochrome P-448 system, 0.5ml of 0.04M 
aniline hydrochloride (pH 7.6) and 1ml of 0.1M Tris-HCl 
buffer, pH 7.6 containing NADPH generating system (as in 
Section 6.2.2.). After incubation for 15min, reaction was 
stopped by adding lg of NaCl. 12ml Of peroxide free ether 
containing 1.5% (v/v) isoamylalcohol was added and 
P-aminophenol was extracted in a rotary shaker, for 20min. 
10ml Of ether aliquots were subsequently added to 4ml of 
alkali phenol (0.5M tripotassium orthophosphate,containing 
1%, w/v, phenol) and extracted on a rotary mixer for 30min. 
The blue colour was measured at 620nm. Suitable blanks and 
standards (0.2-0.5raM in HC1) were carried through the same 
procedure. The colour in the test mixture was identified to 
that of blank, therefore no hydroxylation of aniline to 
p-aminophenol by reconstituted cytochrome P-448 system was 
detected.
(267)
CHAPTER
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7. Structural Analysis of Cytochrome P-448 from 
Saccharomyces cerevisiae
7.1. Introduction
Structural components of cytochrome P-450/P-448 are 
predicted by Gunsalus and Coon (1980). In this chapter 
amino acid, heme carbohydrate and phospholipid content of 
yeast cytochrome P-448 is measured. The content of amino 
acid tryptophan in cytochrome P-448 was determined by an 
analytical ultraviolet fluorescence method in which the 
fluorescence intensity scale was calibrated using standard 
solutions of free tryptophan and a correlation coefficient 
between the fluorescence of cytochrome P-448 tryptophanyl 
residues and of free trytophan was estimated in testing 10 
well-characterized proteins. Cysteine content of this 
enzyme was also measured separately. Oxidation of this 
amino acid to cysteic acid (which contains sulfur in a 
stable oxidation state) made possible its accurate analysis 
in acid hydrolyzate of cytochrome P-448. The total amino 
acid residues present in yeast cytochrome P-448 was 407 
which is less than those of mammalian cytochromes P-448 
reported at this time. These values and the values for the 
other known structural components of various cytochrome 
P-450/P-448 are compared in this chapter.
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7.2. Methods and Materials
7.2.1. Amino Acid Analysis of Yeast Cytochrome P-448
Highly purified cytochrome P-448 free of Emulgen 911 
(7.2nmol) was twice dialyzed against 60 volumes of distilled 
water at 4°C and lyophilized in an Edwards High Vacuum 
lyophilizer (Edwards, U.K.). Three portions of this 
preparation were subsequently hydrolyzed by adding 2ml of 5*1 
"N HCL (under N^) and incubating in sealed evacuated tubes 
at 100°C for a duration of 24, 48, 72h respectively. The 
tubes were then cooled and opened and their HC1 content was 
removed by a Bucke rotary evaporator (Orem Scientific,
U.K.). The amino acid content of these tubes was analyzed 
by a Beckman 121MB Amino Acid Analyzer (Beckman, U.S.A.). 
Final values for serin$ threonine and methionine were 
obtained upon extrapolation to zero time hydrolsis.
The tryptophan content of cytochrome P-448 was measured 
by a fluoresence method shown by Pajot (1976). A 3ml 
solution of highly purified cytochrome P-448 free of Emulgen 
911 but containing 0.03M of 2-mercaptoethanol was denatured 
by the addition of guanidine-HCl. The final concentrations 
of cytochrome P-448 and guainidine-HCl in the test solution 
were lyM and 6M respectively. This solution was incubated 
at room temperature for 30min and its fluorescence was 
measured by a Perkin-Elmer MPF3 fluorescence
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spectrophotometer (Hitachi, Japan) at 353nm emission 
wavelength (295nm excitation). A sample of quinine sulfate
Wv£-
was used to adjust the fluori^ter to zero. Internal
calibration was achieved by three successive additions of
%
45 yl^ the stock solution of tryptophan (0.36mM). The 
internal calibration curve is constructed (Figure 7.1).
This curve allows one to estimate by extrapolation the ’’free 
tryptophan fluorescence equivalent" of protein sampler. In 
order to determine the best coefficient relating the actual 
tryptophan content of the protein sample to the observed 
fluorescence expressed in "free tryptophan fluorescence 
equivalent," measurements were carried out on 10 proteins, 
the amino acid compositions of which are all well- 
established (Figure 7.2.)
The cyteine (or half-cyteine) content of cytochrome 
P-448 was determined after performic acid oxidation of this 
amino acid to produce cysteic acid according to the method 
of Hirs (1967) modified from that of Moore (1953).
Performic acid solution was prepared by mixing 5 volumes of 
30% hydrogen peroxide and 95 volumes of 99% formic acid and 
was permitted to stand in a closed container at 25°C for 
120min. To 2mg of cytochrome P-448 (35nmol), 2ml of the 
performic acid solution was added and the reaction mixture 
was permitted to stand at 0° for 4h. Then 0.3ml of a 48%
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Figure 7.1. The Internal Calibration Curve for Deter­
mination of Tryptophan Content of Yeast Cytochrome P-448.
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Cytochrome P - 448
5
15105
Tryptophanyl Residues/Molecule
Figure 7.2. Correlation of the Tryptophan Content of 
Proteins with the Free Tryptophan Fluorescence Equivalent 
after Denaturation with Guanidine Hydrochloride. Proteins 
are cytochrome c (1 ), soybean trypsin inhibitor (2 ),
3 -lactoglobulin (3), bovine serum albumin (4), trypsin (5 ), 
pepsin (6 ), lysozyme (7), chymotrypsin (8 ), chymotrypsinogen 
(9), aldolase (10).
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(v/v) HBr solution was added while swirling the reaction
tube in the ice bath. The tube was attache d to a rotary
evaporator and 20ml of IN NaOH was added to the condense
absorb the bromine whi ch distills over. It was then
concentrated to dryness at a bath temperature of 40°C. 
Hydrolysis was achieved by adding 3ml of 5.7N HCL to the 
residue (under ^ ) and incubating in a sealed evacuated tube 
at 110°C for 18h. HC1 was removed on the rotary evaporator. 
The residue was dissolved in 5ml of 0.2M sodium citrate 
buffer pH 2.2 and a 2ml alt quo.t was used for analysis by an 
analyzer equip^&lwith a 150cm Ami ber'lite IR-120 column. The 
integration constant used for cysteic acid was the same as 
that for aspartic acid (Hirs, 1967).
7.2.2. Heme Analysis of Yeast Cytochrome P-448
The heme content of the highly purified cytochrome 
P-448 was measured by a method described by Omura and Sato 
(1964b). The heme was converted to pyridine-hemochromogen 
by the addition pf pyridine to cytochrome P-448 solution up 
to 20% (v/v) in final concentration in the presence of NaOH 
(0.1N). The sodium dithionite-reduced spectrum of pyridine 
hemochromogen was recorded at 500-575nm and its concen­
tration was calculated by using an extinction coefficient of 
32.2mM ^cm  ^between 557 and 575nm (Omura and Sato, 1964b).
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7.2.3. Carbohydrate Analysis of Yeast Cytochrome P-448 
For determination of the carbohydrate content of
cytochrome P-448, a sample of this enzyme (20nmol) was 
hydrolysed in 6N HC1 in sealed tubes for 4h at 100°C (Spiro, 
1973). The hydrolysate was taken to dryness at 30°C in 
Vacuo and the residue was dissolved in water, adjusted to pH 
7.0, and applied to a column made by mixing equal amounts of 
Ag 50-X8 (H+ form) and Ag 1-X8 (OH form) resins. The 
column was washed with water and then with methanol to elute 
neutral sugars and with IN HC1 to elute amino sugars. The 
acid eluate was taken to dryness, dissolved in 0 .2M sodium 
citrate buffer, pH 2.2, and applied to the long column of an 
amino acid analyzer for characterization and quantitative
determination of hexosamines.
\
For determination of neutral sugars, another sample of 
purified cytochrome P-448 was hydrolyzed and analyzed by 
gas-liquid chromatography using a Perkin-Elmer Gas-Liquid 
chromatograph (Hitachi, Japan) according to the method of 
Lehnhardt and Winzler (1968).
7.2.4. Measurement of Phospholipid Content of Yeast 
Cytochrome P-448
Following extensive dialysis of purified cytochrome 
P-448 (20nmol) against distilled water to remove phosphate
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buffer, phospholipids were extracted by the method of Folch 
ejt a^ l (1957). In this method phospholipid was first 
extracted by a mixture of chloroform and methanol (2 :1 ) and 
was washed by the same solvent solution twice, filtered and 
washed by the addition of KC1 once and then by a mixture of 
chloroform, methanol, and water (3:48:47) three times. The 
phospholipid content of the protein then was estimated by 
determination of the phosphorus content according to the 
method described by Chen e_t al_ (1956). The extracted 
phospholipid was dried down under N 2 in a water-bath at 30°C 
and was redissolved in distilled water (lOOyl). To this 
solution 0.5ml of perchloric acid (70%) and 0.2ml of 
hydrogen peroxide were added. The mixture was placed in a 
water-bath (25°C) and then was heated to 180-200°C for 20min 
and was cooled to 25°C immediately. To this 1ml of a 
reagent consisting of 6N sulfuric acid, water, 2.5% (w/v) 
ammonium molybdate, 10% (w/v) ascorbic acid (1 :2 :1 :1 :) was 
added and after lOmin the absorbance was measured at 405nm 
against an appropriate blank. The concentration of 
phosphorus was determined in relation to a standard solution 
(disodium hydrogen phosphate).
7.2.5. Materials
Albumin (bovine), chymotrypsin (bovine), chymo- 
trypsinogen (bovine), pepsin (porcine), were all obtained
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from Mann Research Laboratories. Aldolase (rabbit muscle), 
lysozyme (egg), cytochrome c (horseheart, type VI), trypsin 
inhibitor (soybean), guanidine^HCl were purchased from Sigma 
Chemical Ltd. Trypsin was obtained from Worthington 
Biochemical Corp. 3 -Lactoglobulin was a Koch-Light 
Laboratories product. Araberlite IR-120 was obtained from 
Rohm and Haas Company. Ag 50-X8 and Ag 1-X8 were purchased 
from Bio Rad Laboratories. Tryptophan, Pyridine, HBr and 
other chemicals were supplied by BDH Chemicals Ltd.
7.3. Results and Discussion
7.3.1. Structural Analysis of Yeast Cytochrome P-448
The amino acid composition of yeast cytochrome P-448 is 
shown in Table 7.1 along with the amino acid compositions of 
cytochrome P-448 from untreated rat liver (Miki et_ a_l, 1981) 
and cytochrome P-448 from 3 -naphthoflavone-pretreated rat 
liver (Saito and Strobel, 1981). It was found that yeast 
cytochrome P-448 contains 407 amino acid residues per 
molecule in comparison to 469 for both mammalian cytochrome^ 
P-448 (untreated and 3 -naphthoflavone-pretreated) . Although 
the number of amino acids is smaller than the total for the 
two mammalian cytochrome P-448Ts mentioned above, the 
hydrophobic residue content was almost identical with values 
43%, 44% and 45% for yeast cytochrome P-448, rat liver
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Amino Acid Cytochrome 
P-448 Yeast
Cytochrome 
P-448 Rat Liver 
(Untreated)
Cytochrome 
P-448 Rat Liver 
(B NF)
Asx 41 33 41
Thr 21 22 25
Ser 24 30 33
Glx 37 48 47
Pro 23 36 28
Gly 42 27 33
Ala 27 30 24
Val 30 31 33
Met 7 8 7
H e 13 22 26
Leu 23 53 52
Tyr 15 11 12
Phe 20 31 27
Lys 27 22 26
Mis 17 13 14
Arg 20 20 24
Trp 12 8 7
Cys 8 6 8
Total 407 469 469
Polypeptide
molecular
weight 53,045 53,600 52,545
Table 7.1. Amino Acid Composition of Yeast Cytochrome P-448 
Compared with Cytochrome P-448 from Untreated and 
3-Naphthoflavone Pretreated Rat Liver.
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cytochrome P-448 (untreated) and rat liver cytochrome P-448 
(3-naphthoflavone-pretreated) respectively.
The heme content of yeast cytochrome P-448 was, as 
expected, found to be one per polypeptide chain, arising 
from the experimental value of 1.09nmol heme/nmol cytochrome 
P-448. Phospholipid was present at very low levels not 
exceeding 0.5nmol/nmol cytochrome P-448. Phospholipid is 
reported to be present in 3 -naphthoflavone induced rabbit 
liver cytochrome P-450 enzymes as much as 0.3nmol/nmol of 
cytochrome P-450LM2 and 0.5-1.6nmol/nmol of cytochrome P- 
450LM4 (Haugen and Coon, 1976). The analysis for neutral 
sugars and amino sugars did not indicate the presence of 
these materials in appreciable amounts in yeast cytochrome 
P-448. Perhaps the method used for the determination of 
these compounds was not sensitive enough to measure neutral 
sugars and amino sugar in nmol scale.
Table 7.2 shows the structural analysis of yeast 
cytochrome P-448, as determined in this study, in comparison 
with those reported in literature for other cytochrome 
P-450/P-448 enzymes.
When the polypeptide chain molecular weight of 53,045 
derived from the amino acid content is added to the
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Cytochrome
P-450/P-448
Amino
Acid
Heme Neutral
Sugar
Amino
Sugar
Phopholipid
Cytochrome P-448 
from yeast (in 
this study)
407 1.09 0.15 0.08 0.5
Cytochrome
P-450
(Katagira and 
Suhara, 1980)
0.9 2.8 2.5 2.9
Cytochrome
P-450
(Katagiri and 
Suhara, 1980)
0.8 2.6 1.9 5.2
Cytochrome 
P-450LM2 
(Haugan and 
Coon, 1976)
424 1 2 1 0.3
Cytochrome 
P-450LM4 
(Haugan and 
Coon, 1976)
482 1 2 1 1.6
Table 7.2. A Comparison of the Known Structural Components 
of Various Cytochrome P-450/P-448. All data are expressed 
as mol/mol of cytochrome.
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molecular weight of a ferro-protoporphrin IX group (approx. 
1000) along with an estimated 2-4 hexose and heosamine (Dus 
e_t _al, 1970; Katagiri and Suhara, 1980; Haugen and Coon, 
1976) and molecular weight of phospholipid, the calculated 
molecular weight of cytochrome P-448 is in good agreement 
with the experimental value of 55,500 determined by SDS- 
polyacrylamide gel electrophoresis (Chapter 3).
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CHAPTER
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8. Chemical Modification of Amino Acid Residues in 
Cytochrome P-448 from Saccharomyces cerevisiae: The Effect 
on its Reduced CO-Difference Spectrum, Benzo(a)pyrene- 
3-Monooxygenase Activity, Binding Parameters and 
Temperature-Induced Spin State Equilibrium.
8.1. Introduction
Many attempts have been made to identify the nature o.f 
ligands of cytochrome P-450/P-448. One of these ligands, 
known as the fifth ligand is trans to the bound carbon 
monoxide in the ferrous carbonyl- state of cytochrome 
P-450/P-448. Recent studies on some synthetic model heme 
complexes and on cytochrome P-450 itself, suggested that the 
unique spectrophotometric characteristic of this enzyme 
(showing a Soret band at around 450nm upon binding with CO 
in the ferrous state) is due to thiolate ligation at the 
fifth coordination position of heme iron (Shimiza ejt a l , 
1973). This ligand is probably present throughout the cycle 
of the enzyme. The more recent data on thiolate heme 
ligation and Its spectral impact are reported by Hanson 
et al ( 1976), Champion et al^  (1982) and Hahn et_ al_ (1982).
Cytochrome P-450/P-448 in its native low-spin form 
undergoes spectral changes upon binding with a substrate 
(Imai and Sato, 1966; Murray e_t a_l, 1982; Sheets and
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Vickery, 1983). Even in the absence of exogenous added 
substrate, temperature-induced spectral changes can be 
observed (Cinti ejt ajL, 1979). These spectral changes, 
indicative of a spin state shift, are caused by the removal 
of one of the native axial ligands in the active site of the 
free enzyme (Yoshida and Kumaoka, 1975a). This removable 
ligand may be the sixth ligand, trans to thiolate, where 
substrate binds. The removal of the bonding to thiolate may 
cause the conversion of the cytochrome to the inactive, 
cytochrome P-420 form. The nature of the ligand trans to 
thiolate (the sixth ligand) is not fully established yet.
Two general types of ligands have been proposed, depending 
on whether coordination to iron occurs through a nitrogen or 
oxygen atom. A nitrogen for the sixth ligand is most 
frequently pictured as being from the side chain imidazole 
of a histidyl residue of the protein (Shimiza ejt ajL, 1973; 
Jefcoate and Gaylor, 1969b; Tang £_t ajL., 1976; Lipscom and 
Gunsalus, 1973; Chevion e_t ajL, 1977). The oxygen ligation 
would be derived from species such as serine, threomine 
(Jillrich e_t a l , 1979), tyrosine (Ruckpaul et^  ajL-, 1980) and 
water (Griffin and Peterson, 1975).
In this study the influence of -SH groups, and the 
candidates for the sixth ligand such as histidine, arginine, 
tryptophan and tyrosine on benzo(.a)pyrene-3-monooxygenase
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activity, binding parameters and the spin state equilibrium 
of yeast cytochrome P-448, is investigated. The results of 
chemical modification studies indicated the participation of 
-SH group(s) (other than the fifth ligand thiolate) in the 
catalytic ability of the enzyme and noted the possibility of 
a tyrosine residue as the ligand of this hemoprotein enzyme.
8.2. Methods and Materials
8.2.1. Preparation of Cytochrome P-448 for Chemical 
Modification
After the final step of the purification procedure, 
Emulgen 911 was removed from cytochrome P-448 (80nmol) by 
the method described in Chapter 3. When the storage time of 
this preparation at -70°C exceeded one week, the titratable 
sulfhydryl groups of the cytochrome P-448 preparation were 
decreased. To regenerate the free -SH group, the stored 
preparation prior to sulfhydryl modification was treated 
under N£ at room temperature for 15min, with 10 fold in 
molar excess of sodium sulfite followed by the addition of 
50 fold in molar excess of dithiothreitol as described by 
Kawalek jet_ al_ ( 1977). The mixture was stirred under N£ at 
room temprature for 15min, and the sulfite-dithiothreitol 
treated cytochrome P-448 was then dialyzed overnight against 
200 volumes of 0.1M potassium phosphate buffer pH 7.4 
containing 20% (v/v) glycerol followed by another 12-24h
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dialysis with a fresh buffer to remove the sulfite and 
dithiothreitol completely.
8.2.2. Preparation of Sulhydryl Reagents
p-Chloromercuribenzoate (PCMB) was prepared in 0.33M
sodium acetate buffer according to the method described by
-1 “ 1
Boyer (1954) and was quantitated using ^23311111 = 17mM cm
5,5T-Dithiobis (2-nitrobenzoic acid) (DTNB) and 4,4'-
dipyridinedisulfide (PDS) were dissolved in 0.01M potassium
phosphate buffer pH 7.4 and standardized using the known
extinction coefficients = 16.6mM ^cm ^for PDS;373nm *
^247nm = 16«3mM ^cm ^f°r DTNB (Kawalek a_l, 1977).
2-Nitro-5-thiocyanobenzoic acid (NTCB) was synthesized 
according to the method of Degani and Pathchornik (1971) , 
dissolved in 0.1M potassium phosphate buffer pH 7.4 and was 
standardized using ^29211111 = ^cm
8.2.3. Modification of Sulfhydryl Groups in Yeast 
Cytochrome P-448
In a typical titration, aliquots of standardized 
sulfhydryl reagent (up to 50 1) in 0.01M potassium phosphate 
buffer were added to one ml of purified cytochrome P-448 
(usually lyM in 0.1M potassium phosphate buffer containing 
20%, v/v, glycerol). The pH of buffers varied from 7.0 when 
PCMB to 7.4 when other sulfhydryl reagents were used. To
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measure the degree of modification the absorbance changes at 
the selected wavelength pair were followed until there were 
no changes, using a Perkin-Elmer 356 spectrophotometer 
(Hitachi, Japan) in the split-beam mode. Appropriate 
reagent blanks were used to account for any nonspecific 
chemical breakdown of the reagents. The thiopyridine 
released when PDS was used to modify the sulfhydryl groups, 
was estimated from the absorbance change between 324 and 
390nm using an extinction coefficient of 19.8mM ^cm  ^
(Grassetti and Murray, 1967). Thionitrobenzoate produced by 
modification of -SH groups by DTNB and NTCB was determined 
from absorbance changes between 412 and 500nm using an 
extinction coefficient of 13.6mM ^cm  ^ (Ellman, 1959). When 
PCMB was used to modify the cytochrome P-448, the protein- 
mercuribenzoate complex was measured from the absorbance 
change at 250nm in the difference spectrum, using an 
extinction coefficient of 7.6mM ^cm  ^ (Boyer, 1954) .
8.2.4. Modification of Histidyl Residues of Yeast 
Cytochrome P-448
A solution of lOmM diethylpyrocarbonate in ethanol was 
standardized by the addition of 5yl to one ml of lOmM 
imidazole at pH 7.5 in a cuvette having a 1-cm length path. 
The increase in absorbance at 230nm due to formation of N- 
carbethoxyimidazole was determined using an extinction
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coefficient of 3.0mM ^cm  ^ (Miles, 1977). To measure the 
extent of the modification of histidyl residues in yeast 
cytochrome P-448 by diethylpyrocarbonate, two cuvettes 
containing 1ml of aliquots of this enzyme (lyM in 0.1M 
potassium phosphate buffer pH 6.5 containign 20%, v/v, 
glycerol) were placed in the sample and reference 
compartments of a double-beam Pye Unicam SP 1800 spectro­
photometer at 4°C. Difference spectra were recorded between 
230 and 330nm before and at various time intervals after the 
addition of an amount of lOmM diethylpyrocarbonate in 
ethanol to the sample cuvette (an equal volume of ethanol to 
reference cuvette) to give a final concentration of 0.75mM. 
Absolute spectra are also recorded of the enzyme solution 
before and after treatment for 30min with 0.75mM diethyl­
pyrocarbonate using a buffer blank. The number of histidyl 
residues modified at each time interval is calculated from 
the absorbance changes at 243nm using an extinction 
coefficient of 3.2mM ^cm  ^ (Miles, 1977).
8.2.5. Modification of Arginyl Residues of Yeast Cytochrome 
P-448
Arginyl residues were modified according to the method 
of Lu e_t al^  (1981). 2,3-Butadione was diluted to 1M in
concentration with 0.05M sodium borate buffer, pH 8.0 and 
was added to the cytochrome P-448 (lyM in 0.05M sodium
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borate buffer containing 20%, v/v, glycerol), up to 10,000 
fold that of the enzyme on a molar basis. Excess 2,3- 
butadione was removed by gel filtration on a Sephadex G-25 
column preequilibrated with 0.05M sodium borate pH 8.0. The 
quantitation of modified arginyl residues by 2,3-butadione 
were conducted by amino acid analysis as described in 
Chapter 7. The arginine content of the enzyme decreases 
upon modification, since 2, 3-butadioner-ar ginine complex is 
degraded in acid hydrolysis, and thus the number of arginine 
residues modified is determined.
8.2.6. Modification of Tryptophyl Residues of Yeast 
Cytochrome P-448
The modification of tryptophyl residues in cytochrome 
P-448 (7yM in 0.05M sodium borate buffer pH 8.0 containing 
20%, v/v, glycerol) was conducted according to the method 
described by Lu ejt al^  (1981). In this modification up to 25 
equivalents of N-bromosuccinimide (0.01M in H 2O) per enzyme 
were added and the extent of the modification was determined 
as described by Spande and Witkop (1967) using 5.5mM ^cm  ^
as an extinction coefficient. This method makes use of the 
fact that indole chromophore of tryptophyl, absorbing 
strongly at 280nm, on oxidation with N-bromosuccinimide,. is 
converted to oxindole or an intermediate which are much 
weaker chromophores at this wavelength.
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8.2.7. Modification of Tyrosyl Residues of Yeast Cytochrome 
P-448
Nitration of cytochrome P-448 with tetranitromethane
(TNM) was conducted according to the method described by
Yoshinega and Sano (1980). Cytochrome P-448 (3.5yM in 0.1M
Tris-HCl pH 8.0 containing 20%, v/v, glycerol) was treated
with TNM up to 50 fold that of enzyme on a molar excess.
The extent of modification of tyrosyl residues was monitored
by measuring an absorbance increase of nitroformate ion at
350nm (10-60min after each treatment) and using an
-1 -1
extinction coefficient 14.4mM cm for the determination of 
the concentration of this product (Riordan et al, 1966). At 
pH 8.0, nitration displaces two protons and produces one mol 
of nitroformate per mol of tyrosine, suggesting the 
formation of 3-nitrotyrosine (Riordan et_ a_l, 1966) . The
reaction was stopped by the addition of 8-mercaptoethanol up 
to 0.1M in final concentration. Then the solution was 
passed through a Sephadex G-25 column to remove both the 
nitroformate and 8-mercaptoethanol. 0-Acetylation of 
tyrosine with N-acetylimidazole was performed according to 
the method described by Riordan and Vallee (1972).
Cytochrome P-448 (3.5yM in 0.1M potassium phosphate buffer 
pH 7.5 containing 20%, v/v, glycerol) was treated with 
N-acetylimidazole up to 200 fold that of enzyme on molar 
basis. The extent of tyrosine modification (10-60min after
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each treatment) was calculated from the increase in 
absorbance at 278nm due to reversing the acetylation by 0.5M 
hydroxylamine (using extinction coefficient 11.6mM x m  ^), 
after the excess N-acetylimidazole had been removed by gel 
filtration.
8.2.8. Spin Equilibrium Analysis of Yeast Cytochrome P-448 
Spin equilibrium constant and subsequently spin content 
of various modified and control cytochrome P-448 were 
determined using a temperature-dependent spin equilibrium 
analysis method described by Cinti e_t al (1979) . At any 
physiological temperature, the ferric cytochrome P-450/P-448 
is considered to exist as a mixture of high spin (total 
spin, S = 5/2) or low spin (S=l/2) forms corresponding to 
the order of the five d-orbital electrons. Each of the high 
and low-spin forms correspond to a unique optical spectrum. 
Thus, at any wavelength the total absorbance may be 
expressed as
A £HS "£P 448HS^ + €LS ^P“448LS^
where and refer to the extinction coefficients and
[P-448^g] and [P-448-^g] to the concentrations of high and
low spin forms respectively. In addition, at all
wavelengths there exists' a maximum, A , and a minimum.max *
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A * „ , value of absorbance which correspond to the limiting min* r °
cases when the cytochrome P-448 molecule is in either the
complete high spin or complete low spin state. When
cytochrome P-448 exists as a mixture of spin states, the
absorbance will fall between the limiting values, A max and
A , with the distance from the upper and lower limits m m  r r
being directly proportional to the high and low spin
fractions. For example, at 387nm the fraction of high spin
material is given by the ratio (^nin (V a x  ~Amin) while
the proportion of low spin is (A-Am a x )/(Am a x -Am i n ) .
Defining an equilibrium constant for the processes
cytochrome P-448 ^ g (" ■ cytochrome . P-448jjg by
_ [P-448hs] 
" [P-448ls]
yields the following expression for spin equilibrium
constant:
£ _ m m
A - Amax
Here A is an observed absorbance difference at 387-418nm at 
a given temperature measured by the dual wavelength mode of 
a Perkin-Elmer 356 spectrophotometer. If this is assumed tc
follow the standard van't Hoff behavior it may be written:
i Tr _ i /Amin A n _ AH AS
- In (j -^-j ----- ) - r t  " R“
max
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which describes the spin equilibrium constant as a function
of temperature. Since the values of A and A • cannot be 
/ max m m
determined prior to the experiment, they are used as 
parameters in a regression fit to the variation in the 
observed absorbance value as a function of temperature.
Using the correlation coefficient as a convergence parameter 
for the least-squares straight line fit of
ln (Amin"A)/(A‘Am a x ) v s ‘ S T ’ the values Amax and Amin which 
give the best fit to the observed absorbance as well as the
slope AH and intercept -AS/R may be calculated. The best
fit was determined by the use of a computer program
presented in Appendix II.
8.2.9. Determination of Benzo(a )pyrene-3-Monooxygenase 
Activity and Apparent Binding Parameters of Modified Yeast 
Cytochrome P-448
Various modified and control samples of cytochrome 
P-448 (usually lnmol) were used in one ml of assay mixture 
also containing 1 unit of cytochrome c(P-450) reductase and 
30yg of dilauryl phosphatidylcholine. The NADPH-supported
3-hydroxbenzo(a)pyrene activity was determined as described 
in Chapter 6.
The apparent spectral dissociation constant (Kg ) and 
maximum spectral interaction of cytochrome P-448 and 
benzo(a)pyrene in 387-418nm region in each case was
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determined using denatured cytochrome P-448 as reference in 
a double-cell system as described in Chapter 5.
8.2.10. Materials
P-Chloromercuribenzoate (PCMB), 4 , 4 1-dipyridine- 
disulfite (PDS), 5 , 5 1-dithiobis (2-nitrobenzoic acid)
(DTNB), 2,3-butadione and N-bromosuccinimide were purchased 
from Aldrich Co. Diethylpyrocarbonate and sodium sulfite 
were obtained from BDH Chemical Ltd. N-Acetylimidazole, 
tetranitromethane were purchased from Sigma Chemical Co.
8.3. Results and Discussion
8.3.1. Titration of Sulfhydryl Group in Yeast Cytochrome 
P-448
The sulfhydryl reagents were used to quantitate the -SH 
groups in freshly prepared cytochrome ,P-448 (Figure 8.1).
PDS alkylated all the sulfhydryl groups, present in 
cytochrome P-448 as determined by amino acid analysis. In 
the absence of 6M guanidine-HCl, 7.5, 7.6 and 7.75 
sulfhydryl groups were titratable per mol of fresh 
cytochrome P-448 preparation by DTNB, PCMB and PDS 
respectively and the titrations were somewhat stoichiometric 
(Table 8.1 and Figure 8.2). Twenty fold excess of NTCB was 
required to titrate all eight of the sulfhydryl groups of 
cytochrome P-448. Normally four -SH groups were modified by
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R-SH+
N
S-S
N
R-S-S- / . N + |l
'N'
4,4-Dipyridinedisulfide (PDS)
S-SR-SH + NO.
COO“COO
COO
NO,
5,5^Dithiobis (2-nitrobenzoic acid) (DTNB)
R-SH + N^C-S -/ \ n 0 2 —  R-S-C=N +\ — / _ v^coo
— ‘ coo
n o2
2-Nitro-5-thiocyanobenzoic acid (NTCB)
R-SH + CIHg -/ \  C O O " =  R-S-Hg -/ \  + HCl
'— ' ^ - ^ C O O ~
P-Chloromercuribenzoate (PCMB)
Figure 8.1. Reactions Between Free Sulfhydryl Groups 
Protein and the Sulfhydryl Modifying Reagents.
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Reagents nmol of -SH Group per nmol of Cytochrome P-448
y no Guanidine-HCl with Guanidine HC1
PDS 7.75 8.1
DTNB 7.5 8.0
PCMB 7.6 7.8
Performic 8 -
acid
oxidation
Table 8.1. Titration of Sulfhydryl Groups of Yeast
Cytochrome P-448.
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1 53 4 6 82 87 1110
nmol of -SH Reagent/nm ol of Cytochrome P-448
Figure 8.2. Titration of Yeast Cytochrome P-448 with 
Sulfhydryl Reagents: PDS (x), PCMB (•), DTNB (o).
f
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this reagent (Table 8.2). Titratable -SH groups in stored 
yeast cytochrome P-448 (at -70°C) were treated with excess 
DTT and sodium sulfite followed by extensive dialysis all 
the sulfhydryl groups were titratable in the same mode as 
the fresh cytochrome P-448 preparation. Kawalek et al 
(1977) have indicated that the loss of titratable -SH groups 
in the stored preparation might be due to the formation of 
intramolecular and/or intermolecular disulfide bonds. Table 
8.1 shows the number of sulfhydryl groups titrated by 
various reagents. The number of sulfhydryl groups in 
cytochrome P-448 as determined by the use of these reagents 
is in agreement with the results obtained by half-cystine 
analysis performed according to the method of Hirs (1967).
8.3.2. Effect of Sulfhydryl Modification on 
Benzo(a )pyrene-3-Monooxygenase Activity and Binding 
Parameters of Yeast Cytochrome P-448
When Cytochrome P-448 was titrated with PCMB all the 
benzo(a)pyrene-3-monooxygenase activity was lost when more 
than six -SH groups per mol of the enzyme were modified. In 
titration with PDS and DTNB, NTCB 70-80% of enzymatic^was 
lost when four or more of sulfhydryl groups were modified. 
The apparent binding parameters (K_ and AA ) were not
o I I I  a.
altered appreciably upon these modifications, as it is shown 
for NTCB in Table 8.2. In all cases when benzo(a)pyrene was
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Form of
Cytochrome
P-448
Cytochrome 
P-448 
content 
(% of 
control)
BP-3-Mono- 
; oxygenase 
activity 
(% of 
control)
Ks
(yM)
^^nax
Control 100 100 50 0.122
Four -SH Groups 
modified by NTBC
90 28 47 0.11
All histidyl 
residues modified
100 40 210 0.07
All arginyl 
residues modified
98 93 51 0.118
All tryptophyl 
residues modified
97 80 107 0.082
Five tyrosyl 
residues modified
100 15 54 0.12
Table 8.2. Effect of Modification of Some Amino Acids on 
Catalytic Activity and Binding Parameters of Yeast 
Cytochrome P-448.
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added to cytochrome P-448 solution prior to the modifi­
cation, the loss of benzo(a)pyrene-3-monooxygenase was not 
prevented. If DTT was introduced into the modified 
cytochrome P-448 solution before addition of this enzyme to 
the monooxygenase assay mixture, 50% of its activity was 
restored. The loss of activity caused by modification of 
-SH groups by these reagents and the recovery of some of 
this activity upon addition of DTT suggests that sulfhydryl 
group(s) in yeast cytochrome P-448 may participate in 
catalysis. There is always a possibility of steric
hindrance or conformational change in the enzyme molecule
& \ ' 
due to the introduction of a reagent with^bulky, charge\
■ • ■ ‘ \ ■ -'
■ \
functional group. This would also result in the loss ofy 
enzymatic activity. For this reason it was essential to ^ e 
several sulfhydryl reagents with different substitutent si\ 
in this study. NTCB is one of the best reagents for the Y 
modification of sulfhydryl groups, since its -CN substituent 
which binds to the -SH group is smaller than the bulkier 
substituents of other reagents. Modification of the 
sulfhydryl groups by NTCB significantly inhibited the 
hydroxylation of benzo(a)pyrene which could then be reversed 
up to a certain degree by DTT. Since stoichiometric amounts 
of sulfhydryl reagent (except for NTCB) were used up to 
modify the cytochrome P-448 itself, NADPH: cytochrome 
c(P-450) reductase, the other component of benzo(a )pyrene
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hydroxylase system, was not affected. As for NTCB-treated 
cytochrome P-448, the excess reagent was removed by gel 
filtration prior to reconstitution of the hydroxylase 
activity.
Modification of up to six -SH groups per mol of yeast 
cytochrome P-448 by PDS, NTCB, DTNB caused no conversion to 
cytochrome P-420 as determined by the CO-difference 
spectrum. As most of catalytic activity of cytochrome P-448 
was lost after modification of four -SH groups by these 
reagents, it may be concluded that the loss of catalytic 
activity is not due to conformational change of cytochrome 
P-448 in the heme binding region.
In the case of PCMBj this conversion was parallel to the 
loss of benzo(a)pyrene-3-monooxygenase activity. Kawalek 
et al (1977) have indicated that modification of sulfhydryl 
groups in cytochrome P-448 causes extreme instability of 
this enzyme in reduced form. However, unmodified cytochrome 
P-450/P-448 is also less stable when it is fully reduced 
(Imai and Sato, 1974).
Earlier studies by Mason e_t a^ L (1965b) have shown that 
modification by PCMB induces the conversion of cytochrome 
P-450/P-448 in oxidized and reduced form to cytochrome
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P-420. These authors further concluded that the compound 
that displaysAcharacteristic ESR signal is the sulfide of 
cytochrome P-420 and cytochrome P-450 is the phospholipid 
complex of sulfide of cytochrome P-420. Furthermore, CO 
displaced the sulfide but continues to interact with it and 
with phospholipid in the CO complex. Thus it is apparent 
that modification of all -SH (or half cystine residues) in 
cytochrome P-450/P-448 causes conversion to cytochrome 
P-420.
In all, when four -SH groups in cytochrome P-448 were 
modified, the binding parameters of benzo(a)pyrene to 
cytochrome P-448 was not impaired and a decrease in 
activity, except perhaps for modification with PCMB, was not 
due to conversion to cytochrome P-420 (i.e., modification of 
thiolate as a fifth ligand), thereby suggesting the 
existence of sulfhydryl groups in or near the active site of 
this enzyme in yeast. However, it was not determined in all 
cases whether loss of catalytic activity is caused by 
modification of -SH group(s ) , or indirectly, is due to the 
steric blockage (by added substitutent) and/or confor- 
mational changes in the protein. Furthermore, the generally 
accepted scheme of cytochrome P-450/P-448-catalyzed 
hydroxylase cycle does not clearly show the participation of 
sulfhydryl group(s) in the process of catalysis.
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8.3.3. Effect of Modification of Histidyl, Arginyl, 
Tryptophyl, Tyrosyl Residues on
Benzo(a)pyrene-3-Monooxygenase Activity and Binding 
Parameters of Yeast Cytochrome P-448
Figures 8.3 and 8.4, and Table 8.3 show the 
modification of these amino acids with respective reagents. 
Modification of histidyl residues in cytochrome P-448 was 
performed as described in "Method" and the carbethoxylation 
was completed when 0.75mM diethylpyrocarbonate was used for 
30min. Analysis of data indicated that 15 histid^yl 
residues were modified per mol of cytochrome P-448, two less 
than 17 histidyl residues present in the molecule as 
determined by amino acid analysis (Chapter 7). Modification 
of all the histidyl residues did not affect the C0- 
difference spectrum of the reduced cytochrome P-448. This 
modification decreased the benzo(a)pyrene-3-monooxygenase 
activity by 60%. It was apparent that modification of the 
histidyl residues interfered with benzo(a)pyrene binding to 
cytochrome P-448 since a significant decrease in affinity, 
an increase in apparent spectral dissociation constant (Ks ) 
and a dec'rease in maximum spectral interaction 
(AA ), was also observed. The value of K. increased from
I Q c l X  o
50 M to 200 M and AA__„ decreased from 0.122 to 0.07.
I I l c L X
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Figure 8.3. Reaction Between Histidyl, Arginyl, Tyrosyl 
Residues in Protein and Modifying Reagents.
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Figure 8.4. Oxidation Pathway of Tryptophyl Residue in 
Protein with N- Bromosucccinimide.
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Modified Amino 
Acid
Max. Quantity of 
Reagent Used 
Expressed as 
[Reagent]/
[Enzyme]
Number of 
Amino Acids 
Modified
Number of 
Amino Acids 
Present
Histidine 750 15 17
Arginine 10,000 20 20
Tryptophan 25 11.2 12
Tyrosine:
0-acetylation 200 5 15
Nitration 50 5
-
Table 8.3. Quantitation of Titration of Histidine, 
Arginine, Tryptophan and Tyrosine Residues of Yeast 
Cytochrome P-448 with Modifying Reagents.
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It has been proposed that the initial product of the 
reaction of 2,3-butadione with the guanidino group is a 4,5- 
dimethyl-4,5-dihydroxy-2-imidazole that can be stabilized by 
esterification with borate (Lu e_t al_, 1981). Amino acid 
analysis showed that only arginyl residues were affected by 
2,3-butadione modification of cytochrome P-448. When 2,3- 
butadione in sodium borate, was added to cytochrome P-448, 
up to lOmM in concentration, all the arginyl residues were 
destroyed. The effect of this modification on 
benzo(a)pyrene-3-monooxygenase activity before and after the 
removal of borate by gel filtration was the same. The 
residual activities were 93% of the activity of the 
unmodified enzyme. Modification of arginyl residues did not
have an appreciable effect on CO-difference spectrum of
reduced cytochrome P-448.
When cytochrome P-448 was treated with 
N— bromosuccinimide, 25 equivalents of this reagent were 
needed to oxidize 11.2 out of 12 tryptophyl residues of this
enzyme as determined by loss of absorption at 280nm. A
proposed oxidation pathway of tryptophan by 
N-bromosuccinimide in acidic media is shown in Figure 8.4.
It has been reported that N-bromosuccinimide cleaves the 
tryptophyl bonds of peptides in an acidic pH (Spande e_t a l , 
1970). However, at pH 8.0, although a considerable loss in
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280nm absorption due to oxidation of tryptophyl residues 
were observed, there was no cleavage as determined by 
analytical gel filtration. It is possible that at pH 8.0 
the oxidation pathway of tryptophan, in which the indole 
chromophore of this amino acid is converted to oxindole is 
not completed and only an intermediate is formed. However, 
in product and intermediates the electron configuration of 
nitrogen in the indole group is changed by this 
modification.
The titration of tryptophyl residues decreased the 
benzo(a)pyrene-3-monooxygenase activity of cytochrome P-448 
by 20% while the effect on the CO-difference spectrum of 
reduced form was negligible. The elimination of borate by 
gel filtration did not increase the benzo(a)pyrene-3- 
monooxygenase activity of N-bromosuccinimide-modified 
cytochrome P-448. Both K and-.AA_av were influenced when
S IllaX
tryptophyl residues were modified progressively (Table 8.2) 
Amino acid analysis of the N-bromosuccinimide-modified 
cytochrome P-448 (when 11.2 tryptophyl residues were 
modified) indicated that 10-15% of cysteine and histidine 
residues were also destroyed.
Cytochrome P-448 was modified by N-acetylimidazole and 
tetranitromethane, which preferentially react with the 
tyrosyl residues, to identify other amino acids which are
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involved in substrate binding and catalysis. Only five out
of fifteen tyrosyl residues of cytochrome P-448 were
accessible to be modified by both O-acetylation and
nitration. O-Acetylation was successfully reversed by
treatment with 0.5M hydroxylamine. No denaturation was
observed (determined by CO-difference spectrum of reduced
form) upon this modification, but 85% of benzo(a)pyrene-3-
monooxygenase activity of the cytochrome P-448 was lost
while K and AA remained virtually unchanged (Table 8.2). s in 3.x
When benzo(a)pyrene was added prior to the modification the 
loss of benzo(a)pyrene-3-monooxygenase activity was not 
prevented. In cytochrome P-448 treated with N- 
acetylinddazole, no S-acetylation of -SH groups was observed 
as the titration of all 8 -SH groups of 
acetylated protein by PDS, was still possible.
8.3.4. Effect of Modification ofCysteinyl, Histidyl,
Arginyl,Tryptophyl and Tyrosyl Residues on Spin State
Equilibrium of Yeast Cytochrome P-448
When the recorded temperature-induced absorbance
changes were fitted to an equilibrium constant, a van't Hoff
plot was obtained (Figure 8.5). From the values of spin
equilibrium constant the spin content of the control and
each of the modified cytochromes P-448 were determined at
K
various temperatures using the expression P-448jjg = j—  +~K*
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Figure 8.5. Equilibrium Constant for Unmodified, Substrate- 
Free (x) and Tyrosine-Modified (•) of Yeast Cytochrome 
P-448. For unmodified and tyrosine-modified cytochrome 
P-448 correlation coefficients used as convergence 
parameters in the fitting analysis, were 0.99455 and 0.99998 
respectively.
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At 22°C the low spin content of unmodified substrate-free 
cytochrome P-448 was 94% (Table 8.4). As is demonstrated by 
the van *t Hoff plot there was not an appreciable amount of 
spin state modulation by temperature changes after 
modification (acetyiation) of five tyrosyl residues by 
N-acetylimidazole. When the -SH groups in cytochrome P-448 
were modified the temperature-induced spin state shift was 
not observed due to total conversion of cytochrome P-448 to 
cytochrome P-420. Modification of four -SH groups did not 
result in any changes in the pattern of temperature-induced 
modulation from that of unmodified cytochrome P-448. For 
each of histidine-modified and tryptophan-modified 
cytochrome P-448 (maximum number of amino acid modified in 
both cases), low spin content differed slightly from that of 
the control at all temperatures. At 22°C the low spin 
contents were 95 and 97 percent for histidine-modified and 
tryptophan-modified cytochrome P-448 respectively. For 
arginine-modified cytochrome P-448 (all residues modified 
the spin state modulation was somewhat the same as the one 
of the control enzyme.
8.3.5. Tyrosine, A_ Possible Sixth Ligand of Yeast 
Cytochrome P-448
The amino acids with nitrogenous functional groups 
viewed as a possible sixth ligand of cytochrome P-448 
(histidine, tryptophan, arginine) were modified as
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Temperature (°C) Substrate 
% Low Spi
Free 
n K
In Presence 
% Low Spin
of BP 
K
18 95.8 0.044 87.4 0.144
22 94.0 0.064 81.9 0.221
26 91.7 0.091 74.8 0.337
30 88.6 0.128 67.5 0.481
34 85.7 0.166 58.5 0.711
38 81.5 0.226 48.2 1.077
Table 8.4. Spin State Equilibrium of Cytochrome P-448 at 
Various Temperatures in Presence and Absence of 
Benzo(a)pyrene. Benzo(a)pyrene was added to give final 
concentration 158yM. K is the spin equilibrium constant as 
defined in the text.
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described. Modification of histidine's imidazole side 
chain, which has been frequently pictured as the sixth 
ligand of cytochrome P-450/P-448 (Shimiza e_t al_, 1973; 
Jefcoate and Gaylor, 1969b; Tang et al,' 1976; Lipscomb and 
Gunsalus, 1973; Chevion et_ a_l, 1977), had an appreciable 
effect on benzo(a)pyrene-3-monooxygenase activity.of 
cytochrome P-448. This impairment of the catalytic activity 
may have been caused by a decrease in binding affinity and 
the extent of interaction of benzo(a)pyrene with modified 
cytochrome P-448. The temperature-induced spin state 
modulation pattern of histidine-modified cytochrome P-448 
was different from that of substrate-free unmodified enzyme, 
but the low spin content decreased with the rise of the 
temperature indicating the probable presence of a sixth 
ligand despite this modification.
The modification of arginyl residues did not alter the 
binding parameters or the catalytic activity of cytochrome 
P-448 with benzo(a)pyrene. The spin state equilibrium was 
not changed by this modification.
A slight decrease in benzo(a)pyrene-3-monooxygenase 
activity of tryptophan-modified cytochrome P-448 is possibly 
due to a decrease in binding affinity. The data indicates 
that this amino acid, along with histidine, is important in
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substrate binding to the hemoprotein. The possibility of 
tryptophan being the sixth ligand is ruled out since spin 
state equilibrium of tryptophan-modified cytochrome P-448 
was temperature dependent, although the low spin content at 
various temperatures differed from that of . the unmodif ied 
hemoprotein.
Nitration and O-acetylation of tyrosyl residues of 
cytochrome P-448 revealed that only five of these residues 
are accessible to modification. O-Acetylation of these 
tyrosyl residues inhibited almost all of the cytochrome 
P-448 catalytic activity without denaturing the enzyme 
(450nm peak). The loss in activity was not caused by 
alteration of the binding site as there were no changes in 
the binding parameters of benzo(a)pyrene to tyrosine- 
modified enzyme. The data presented in this chapter 
indicates the yeast cytochrome P-448 possibly contains 
tyrosyl residue(s) in its active site.
According to current concepts (Gunsalus and Sligar, 
1978; Yoshida e_t ail, 1982) the high spin content of 
cytochrome P-450/P-448 is increased when the sixth ligand 
has been removed or replaced by ligand with a weaker field 
strength. In this study O-acetylation of the tyrosyl 
residues influenced greatly the temperature-induced spin
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state modulation. As it is shown in Figure 8.5 there are 
virtually no changes in spin equilibrium constant K upon 
increasing the temperature. This indicates the possibility 
that modification of tyrosyl residues may have resulted in 
the removal of the sixth ligand.
Recently several workers have shown evidence that 
tyrosine is the sixth ligand in cytochrome P-448 (Ruckpaul 
et al, 1980; Janig e_t a3, 1982), while others (Jillrich 
et a l , 1979; Dawson e_t aJL, 1982) have simply indicated that 
the native sixth ligand might contain oxygen.
Ruckpaul jet: al (1980) have reported the pH-dependent 
decrease of the tyrosine absorbance bands in the medium 
ultraviolet region, with an increase in pH, is accompanied 
by a concurrent decrease of the heme absorbance in the Soret 
region. Based on this finding, they have postulated the 
existence of a heme-linked tyrosine as one of the axial heme 
iron ligands in cytochrome P-450.
In a study similar to the one presented here, Janig 
et al (1982) have indicated that N-acetylimidazole 
modification of tyrosyl residues in cytochrome P-450LM2 
inhibits the N-demetkylation of the benzphetamine, and "the 
spin equilibrium in the presence of benzphetamine exhibits a
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more pronounced shift to the high spin state than the 
control.11
The loss of benzo(a)pyrene-3-monooxygenase activity due 
to N-acetylation cytochrome P-448 (aimed at tyrosine 
residues) does not necessarily imply that tyrosine(s) is 
located at the active site. However, this loss of activity 
agrees with the view that this amino acid is the sixth 
ligand, since the oxygen atom incorporated into the 
substrate comes from a dioxygen molecule that is bound to 
the heme iron on the same side of the porphyrin as the sixth 
ligand. Therefore, this ligand could play an important role 
in the overall catalytic process.
(316)
CHAPTER
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9. Evaluation of Immobilized Cytochrome P-448 from 
Saccharomyces cerevisiae Using Permeabilized Whole Cell, 
Microsomal Fraction and Purified Reconstituted Forms, with 
Benzo(a)pyrene-3-Monooxygenase Activity
9.1. Introduction
Immobilization prior to application of cytochrome 
P-450/P-448 has been attempted by various workers. Schubert 
et al (1980) have immobilized hepatic microsomal cytochrome 
P-450 by gelatin to construct an enzyme electrode for 
measurement of oxygen uptake by this enzyme system. Brunner 
et al (1980) have immobilized purified reconstituted 
hydroxylase enzyme system to BrCN-activated Sepharose 4B and 
also by co-polymerization in acrylamide for the purpose of 
increasing the stability. The simultaneous immobilization 
of cytochrome P-450 monooxygenase system and glucuronyl 
transferase to achieve the hydroxylation and subsequent 
glucuronidation of lipophilic compounds has been reported by 
Lehman e_t al_ (1981). Several other workers have also 
immobilized this enzyme in microsomal form on to solid 
supports (Sofer ejt a_l, 1975; Janig et^  suL, 1977; Lu and West, 
1978).
In this study some procedures for the immobilization of 
yeast cytochrome P-448 in permeabilized whole cell, in
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microsomal fraction and in purified reconstituted mono­
oxygenase system are reported. The feasibility of these 
methods is evaluated by comparison of the parameters of 
benzo(a)pyrene-3-monooxygenase activity and the stability in 
storage of these immobilized forms^which are derived from 
preparations at different levels of purification effort on 
this cytochrome P-448 from Saccharomyces cerevisiae.
9.2. Methods and Materials
9.2,1. Permeab ?'lization of Yeast Cells
Harvested yeast cells were permeab*lized using a method 
described by Murakami e_t al (1980), in which to lg of packed 
yeast suspended in 4ml 0.1M potassium phosphate buffer 7.4, 
containing 0.4M sorbitol, 15ml ml of toluene was added. The 
suspension was shaken at 40°C for 5min and then cooled in 
ice. The cells were collected by centrifugation at 10,000g 
for lOmin, resuspended and washed in 0.02M sodium cacodylate 
buffer, pH 7.1, containing 0.4M sorbitol. The toluenized 
cells were finally suspended in the above buffer to a 
concentration corresponding to 200mg of original yeast 
per ml.
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9.2.2. Immobilization of Yeast Cytochrome P-448 on Calcium 
Alginate
Permeabilized yeast cells, microsomal fraction and 
purified reconstituted system (the latter two prepared as 
described in Chapters 3 and 6) were entrapped by calcium 
alginate using a method modified from that of Kierstan e_t al^  
(1977). In each case, 5ml of suspended cells, microsomes or 
purified reconstituted hydroxylase system (at lnmol 
cytochrome P-448 per ml) was mixed with 15ml of 1% (w/v) 
sodium alginate and the total suspension was slowly extruded 
into a 0.05M C a C ^  solution containing 10% (w/v) glucose 
using an Oxford Laboratories sample pipette with a tip 
having an orifice 1mm in diameter. The fibers formed were 
separated from the solution by filtration and were dried off 
before use. When this enzyme, in all three forms, was 
immobilized by calcium alginate, because of the quick 
settling of enzyme-calcium alginate beads, the retention 
yield could not be directly determined by CO-difference 
spectrum of reduced form. Therefore, retention was measured 
by the amount of cytochrome P-448 which remained free.
9.2.3. Immobilization of Yeast Cytochrome P-448 in 
Polyacrylamide, by Co-Polymerization with Acrylamide Monomer
Co-polymerization of cytochrome P-448 in all three 
forms was carried out according to the method of
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Brunner ejt al^  (1980). 4.5ml of enzyme solution (7.2nmol/ml)
or yeast suspension (lnmol/ml) with 2.0ml of 0.2M Tris-HCl, 
pH 7.4 and was bubbled through for 20min at room
temperature. The solution was then cooled down in an ice 
bath and 0.5g acrylamide and 0.034g N ,N-methylene- 
bisacrylamide were added. The solution was stirred under 
^-atmosphere until these two compounds were completely 
dissolved. Co-polymerization was started by the addition of 
0.25ml 5% (v/v) dimethylaminopropionitrile and 0.25ml of 5% 
(w/v) ammonium persulphate solution. The mixture was 
stirred under ^-atmosphere at 4°C and, after the formation 
of the gel, was granulated or meshed.
9.2.4. Immobilization of Cytochrome P-448 on BrCN-Activated 
Sepharose 4B
Purified reconstituted monooxygenase system was 
immobilized by BrCN-activated Sepharose 4B by a method 
modified from that reported previously (Brunner et al, 1980; 
Cuatrecasas e_t aJL, 1968). Sepharose 4B (decanted) was mixed 
with an equal volume of water and cyanogen bromide (lOOmg 
per ml of settled Sepharose 4B) was added in an equal volume 
of water. The pH was immediately adjusted to, and 
maintained at, .11 by titration with 4N Na.OH. When the 
reaction had ended, the Sepharose 4B beads were washed with 
approx. 20 volumes of cold 0.1M NaHCO^ on a .Buchner funnel
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under suction. The beads then were suspended in cold 0.1M 
potassium phosphate buffer, pH 7.5 containing 0.001M 
dithiothreitol and 20% (v/v) glycerol in a volume equal to 
that of the original Sepharose 4B, and the enzyme 
preparation (lnmol per ml) was added with a ratio of 6nmol 
cytochrome P-448 per g beads. The mixture was stirred 
overnight and beads were then washed thoroughly and 
suspended again in 0.1M potassium phosphate buffer, pH 7.5, 
containing 0.1M glycine, 0.001M dithiothreitol and 20% (v/v) 
glycerol. This buffer was used to deactivate all the 
remaining binding groups on the beads. The beads were 
finally stored until use in 0.1M potassium phosphate buffer, 
pH 7.0, containing 20% (v/v) glycerol.
9.2.5. Immobilization of Yeast Cytochrome P-448 by 
Microcrystalline Cellulose, Cross-Linking by Use of 
Glutaraldehyde
To 10ml of purified reconstituted hydroxylase system in 
0.1M potassium phosphate buffer, pH 7.0, containing 20%
(v/v) glycerol (lnmol per ml cytochrome P-448), 1.5g of 
cellulose (microcrystalline) was added and mixed on a 
roller-mixer for lh. Cross-linking was accomplished by 
adding glutaraldehyde to give the final concentration of 
0.5% (v/v) and stirring for another hour. Enzyme system 
bound to cellulose was then collected by centrifugation at
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12000g for lOmin and was washed and resuspended in 0.1M 
potassium phosphate buffer, pH 7.0 containing 20% (v/v) 
glycerol. Ethanolamine was added to the immobilized enzyme 
suspension up to 0.5M in concentration to deactivate the 
remaining functional groups of glutaraldehyde. The 
immobilized enzyme system was washed and resuspended in 0.1M 
potassium phosphate buffer, pH 7.0 containing 20% (v/v) 
glycerol.
9.2.6. Immobilization of Cytochrome P-448 by 
Agarose-Concanavalin A , Cross-Linking by Use of 
Glutaraldehyde
3.3ml Of purified reconstituted hydroxylase system 
(lnmol per ml cytochrome P-448) in 0.2M potassium phosphate 
buffer, pH 7.4 containing 0.15M NaCl was stirred with lg of 
packed Agarose-concanavalin; A at 4°C for 30min. The gel 
was washed with 300ml 1M K C 1 . Cross-linking of the Agarose- 
concanavalin A cytochrome P-448 enzyme system conjugate 
with glutaraldehyde was accomplished by adding 0.01ml 0.1M 
potassium phosphate buffer, pH 8.0, and glutaraldehyde to 
give the final concentration of 0.5% (v/v), and stirring for 
30min. The immobilized enzyme system was washed and 
resuspended in the 0.1M potassium phosphate buffer pH 8.0 
and ethanolamine was added up to 0.5M in concentration to 
deactivate the remaining functional groups of
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glutaraldehyde. The immobilized enzyme system was washed 
and resuspended in 0.1 potassium phosphate buffer pH 7.0 
containing 20% (v/v) glycerol.
9.2.7. Measurement of Benzo(a)pyrene-3-Monooxygenase 
Activity of Immobilized Cytochrome P-448
This measurement was carried out by the method 
described in Chapter 6, modified for use of immobilized 
enzyme. A known amount of immobilized enzyme (usually 
1.5nmol cytochrome P-448) was placed in a magnetically- 
stirred flask at 37°C, and therefore approximates to a 
typical batch stirred tank reactor. Tris-HCl buffer, 0.1M, 
pH 7.0 containing NADPH-regenerating system was added to 
give a final concentration of 0.004M NADP, 0.02M D-glucose- 
6-phosphate, 6yM M g C ^ a n d  8 IU of glucose-6-phosphate 
dehydrogenase. The reaction was started by the addition of 
benzo(a)pyrene from a stock solution of 2mg/ml in dimethyl- 
formamide, to give final concentrations in the range 0-158yM 
benzo(a)pyrene. Incubation was at 37°C with stirring for 
15min. The reaction was stopped by separating the 
immobilized enzyme by centrifugation of filtration. The 
supernatant (or filtrate) was diluted 1:1 by addition of 
ice-cold acetone. A 0.6 ml aliquot of this 50% acetone 
solution was added to 1.4ml 10.7% (v/v) triethylamine 
solution in a fluorimeter cuvette and scanned on the range
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500-560nm (emission) at 467nm (excitation) in a Perkin-Elmer 
MPF3 fluorescence spectrophotometer to find the peak at 
523nm. Fluorescence was calculated relative to lOyg quinine 
sulfate/ml in 2M I^SO^, which was calibrated against a 
standard 3-hydroxybenzo(a)pyrene solution.
9.2.8. Materials
Sodium cacodylate and BrCN were purchased from Aldrich 
Chemical Co. Microcrystalline cellulose, dimethylamino- 
propionitrile, Agarose-concanavaline A were obtained from 
Sigma Chemical Co. Sodium alginate, glutaraldehyde and 
other chemicals if not mentioned in the "Material" section 
of previous chapters were supplied from BDH Chemicals Ltd.
9.3. Results and Discussion
9.3.1. Evaluation of Immobilized Yeast Cytochrome P-448
Using Permeabilized Whole Cell
The parameters (K , V ) of benzo(a)pyrene-3- r m max' v
monooxygenase activity for all three forms of cytochrome 
P-448 immobilized by various supports were obtained by the 
Lineweaver-Burk plot (Figure 9.1) and shown in Table 9.1.
The stability of immobilized cytochrome P-448 in storage at 
4°C is shown in Figure 9.2.
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Form of Enzyme Vmax
(pmoi . 
min 1 nmol” -1- )
Km
(yM)
Activity 
After 4 
Storage
Remaining
Weeks
at 4°C (%)
Permeabilized 
yeast cells 
immobilized on 
calcium alginate
11.1 222 20
Microsomes
I "Free" enzyme 
II Immobilized on 
calcium alginate
11.1
8.3
111
200
0
60
Purified
reconstituted
monooxygenase
system
I Free enzyme 16.7 33 7
II Immobilized on 
calcium alginate
12.3 50 15
III Immobilized on 
BrCN-Sepharose 
4B
11.1 66 58
IV Immobilized on 
acrylamide
9.0 33 40
Table 9.1. Parameters of Benzo(a )pyrene-3-Monooxygenase 
Activity in Immobilized Cytochrome P-448. ^max values are 
expressed in pmol of 3-hydroxybenzo(a )pyrene per min per 
nmol of cytochrome P-448.
(327)
>
'5 ioo 
|  80
CO
c
40
«+—o
1 2 3 4
Weeks at 4°C
Figure 9.2. Storage Stability of Immobilized Cytochrome 
P-448 on Various Supports. Permeabilized yeast cells on. 
calcium alginate (•), microsomes on calcium alginate (■), 
highly purified reconstituted system on calcium alginate 
(o), highly purified reconstituted system on Sepharose 4B 
(x), highly purified reconstituted system on acrylamide (a ). 
All immobilized enzymes were stored in 0.1M potassium 
phosphate buffer pH 7.0 containing 20% glycerol as 
stabilizer. In free enzymes stored at 4°C all the 
benzo(a )pyren-3-monooxygenase activity was lost for 
permeabilized yeast cells and microsomes after two weeks and 
for purified cytochrome P-448 after four weeks.
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The permeabilization of the yeast cells resulted in a 
retention of 40% of the cytochrome P-448 peak, measured by 
CO-difference spectrum of reduced form, and 100% of this was 
retained upon immobilization. When these cells were 
immobilized in calcium alginate they showed almost normal 
benzo(a)pyrene-3-monooxygenase activity compared with the 
highly purified enzyme, with a Vmax of ll.lpmol of 
3-hydroxybenzo(a)pyrene per min per nmol cytochrome P-448. 
Immobilized whole yeast cells or protoplast (prepared by 
incubation of cells in the presence of snail enzyme 
according to the method of Wiseman and Woods, 1978) did not 
show any benzo(a)pyrene-3-monooxygenase activity. 
Immobilization of permeabilized yeast cells in gelatin 
(Schubert e_t al_, 1980) was not feasible as the gel 
depolymerized in a batch stirred tank reactor during 
incubation at 37°C. Permeabilized yeast cells lost their 
benzo(a)pyrene-3-monooxygenase activity when co-polymerized 
with acrylamide and they did not absorb onto cellulose or 
BrCN-activated Sepharose 4B. Permeabilized yeast cells 
immobilized by calcium aglinate lost most of their 
benzo(a)pyrene-3-monooxygenase activity after 4 weeks 
storage at 4°C.
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9.3.2. Evaluation of Immobilized Yeast Cytochrome P-448 
Using Microsomal Fraction
Cytochrome P-448 in microsomal fraction is membrane- 
bound immobilized enzyme and is not easily immobilized to 
other supports. However, its entrapment by calcium alginate 
resulted in retention of all the cytochrome P-448 and much 
of the benzo(a)pyrene-3-monooxygenase activity (V_ov 8.3pmol
l U u X
“ 1 -1
min nmol ) and it lost only 40% of this activity after 4 
weeks of storage at 4°C. The results (Table 9.1) indicated, 
however, a considerable diffusion limitation in this system, 
with lowered Vmax and raised Km values. Recently Schubert 
e_t aJL^ (1982) have reported that the entrapment of rabbit 
liver microsomal cytochrome P-450 by calcium alginate, 
increases the stability of its aminopyrine demethylase 
activity (as compared with crude microsomes). These authors 
have employed a fixed bed recirculation reactor, where 
aminopyrine was continuously demethylated.
9.3.3. Evaluation of Immobilized Yeast Cytochrome P-448 
Using Purified Reconstituted System
Purified reconstituted monooxygenase system was 
successfully immobilized by a number of supports.
Entrapment by calcium alginate (with 90% retention yield) 
gave a high Vmax of 12.3pmol min "^nmol  ^ compared with the 
free purified reconstituted monooxygenase system, which had
(330)
V of 16.7pmol ^min u n m o l . The apparent K (50uM) wasmax m x M '
also close to that of the free enzyme system (33yM).
Immobilization of the highly purified form on cellulose
by absorption and cross-linking by glutaraldehyde gave the
same results as previously obtained with the crude
solubilized form of the enzyme (Woods and Wiseman, 1980).
Eighty percent of the cytochrome P-448 did not bind to this
support (or was denatured in the process of immobilization) .
The enzyme which bound to the cellulose lost some of its
activity. Immobilization of the solubilized crude form of
this enzyme on cellulose using the same procedure had
resulted in a doubling of K and a 35% decrease in V° m max
(Woods and Wiseman, 1980).
Attempts were made to immobilize the purified 
reconstituted monooxygenase system through its carbohydrate 
side-chain to Agarose-concanavalin A. Cytochrome P-450 type 
enzymes are reported to be glycoproteins, containing 2-4 
molecules of sugars such as mannose, glucose or glucosamine 
per molecule of the cytochrome (Haugen and Coon, 1976). As 
shown in Chapter 7, only 0.2mol of carbohydrate per mol of 
cytochrome P-448 was detected in this study. It was found 
here that only 50% of cytochrome P-448 was bound to 
Agarose-concanavalin A and most of the
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benzo(a)pyrene-3-monooxygenase activity was lost. Glutaral­
dehyde seems to have a deleterious effect on cytochrome 
P-448, and it may impose a high degree of steric hindrance 
onto the active site of this enzyme in purified form.
Highly purified reconstituted monooxygenase system
along with NADPH has been immobilized by BrCN-activated
Sepharose 4B (Brunner e_t al^ , 1980; Breckenridge ejt a l ,
1977). The intended application was for use as an
extracorporeal shunt for blood detoxication. This support
proved to be the most effective for this highly purified
enzyme. Almost all the cytochrome P-448 used was retained
on these beads, although NADPH did not bind, and it was
necessary to add this each time to the reaction mixture.
V was relatively high (ll.lpmol min ^nmol )^ and avail- 
max .
ability of the enzyme for binding benzo(a )pyrene was 
demonstrated by the low value obtained (50yM).
Immobilized highly purified reconstituted cytochrome P-448 
on this support also showed a considerable degree of 
stabilization in storage at 4°C, and after 4 weeks only 42% 
of the enzyme activity was lost, instead of 93% for this 
enzyme preparation prior to immobilization.
The co-polymerization of purified reconstituted mono­
oxygenase system with acrylamide resulted in the production
(332)
of an entrapped enzyme system (cytochrome P-448 retention, 
60%) with a Km for benzo(a)pyrene the same as that of the 
free enzyme (33yM), but with a 46% decrease in Vm _v . The
IUclX
low V m - (with unchanged K ) might be due to the diffusional max  ^ ° nr °
limitation imposed by this support on the
3-hydroxybenzo(a)pyrene availability in the assay mixture in 
the presence of the swollen gel that forms during the assay.
9.3.4. Possible Applications of Immobilized Cytochrome 
P-450/P-448
Immobilization of cytochrome P-448 highly purified 
reconstituted enzyme system using an effective support in a 
stirred tank and other enzyme reactors will improve the 
proposed applications of this enzyme, including the 
construction of an accurate enzyme electrode. Preliminary 
work in this direction was carried out during this study.
The objective was to build an enzyme electrode for detection 
and measurement of benzo(a)pyrene and assess its viability 
for analytical application. Glucose oxidase and yeast 
cytochrome P-448 were co-immobilized by polyacrylamide gel, 
using the method described in this chapter. This 
immobilized bienzyme system was coupled to an oxygen 
electrode, in which the oxygen uptake for production of 
hydrogen peroxide by glucose/glucose-oxidase system, which 
ultimately is utilized for hydroxylation of benzo(a )pyrene
(333)
by cytochrome P-448, was measured. Although traces of 
benzo(a)pyrerie (75 p.p.m.) were detected using this 
electrode, a linear response to benzo(a)pyrene concentration 
was not observed. An improved electrode as such could 
provide a rapid and specific assay for benzo(a)pyrene or 
other possible substrates of this enzyme which are present 
in foodstuffs and the environment.
Immobilization permeabilized yeast may be useful also 
in large scale application such as the removal of 
polyaromatic nuclear hydrocarbons from water and air. For 
some purposes (such as detoxication of blood), the use of 
the immobilized microsomal system may prove convenient and 
appropriate with high stability (but with diffusional 
limitation problems). Further studies using other types of 
enzyme reactors are required. The packed-bed type may prove 
to be more useful in the use of these enzymes for production 
of quantities of metabolites or for carcinogen removal, and 
the replacement of expensive cofactors by co-immobilized 
enzymes will be essential for large-scale applications.
(334)
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order to repress cyclic AMP levels sufficiently for 
cytochrome P-450/P-448 synthesis to occur (Chapter 2).
Recently King (1983) showed that when a yeast culture 
growing exponentially is made semi-anaerobic, the 
biosynthesis of cytochrome P-450/P-448 is inhibited with an 
increase in cytochrome P-450/P-448 level between 24 and 48 
hours of less than 10% of that in the aerobic control. This 
effect is not due to an altered growth rate, as very similar 
growth rates were observed under both sets of conditions, 
with sufficient glucose still present (at 24h) to ensure 
actively fermenting yeast cells under glucose repression.
One effect of oxygen may be in acting as a substrate inducer 
of yeast cytochrome P-450/P-448. This may also explain why 
cytochrome P-450/P-448 cannot be detected in yeast grown 
under strictly anaerobic conditions (Rogers and Stewart, 
1973). However, much further work is required to test this 
idea with experiments at a range of carefully controlled 
oxygen concentrations.
King (1983) has further shown that when yeast is grown 
aerobically to stationary phase (48h) and-then made semi- 
anaerobic and incubated further, cytochrome P-450/P-448 does 
not appear to be lost as quickly. At stationary phase, the 
yeast cytochrome level is already falling and the removal of
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oxygen at this time is unlikely to effect cytochrome 
P-450/P-448 biosynthesis. The slowing of cytochrome 
P-450/P-448 loss under semi-anaerobic conditions is due to 
protection of the enzyme from degradation as was described 
by Blatiak e_t a_l (1980).
The strain of Saccharomyces cerevisiae used for 
production of cytochrome P-450/P-448 in this study was NCYC 
No. 240. The strain NCYC No. 239 produced 6nmol of 
cytochrome P-450/P-448 per g of wet weight of yeast but due 
to lower yeast cells mass production, the overall yield of 
this enzyme was not higher than that from strain NCYC 
No. 240 (both strains grown in similar media). Recently it 
has been observed that strain NCYC No. 754 produced 6-7nmol 
of cytochrome P-450/P-448 per g wet weight of yeast in a 
pattern similar to that of NCYC No. 240 (D. King, personal 
communication). Unfortunately the purification of cyto­
chrome P-450/P-448 from Saccharomyces cerevisiae was carried 
out before the genetic analysis (Chapter 2) and induction 
studies (Chapter 6). Therefore, cytochrome P-448 charac­
terised in this study was from untreated Saccharomyces 
cerevisiae NCYC No. 240.
Cytochrome P-448, cytochrome b^, NADPH:cytochrome 
c(P-450) reductase and NADH:cytochrome b^ reductase were
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purified from the same preparation of microsomes as shown in 
Chapter 3. Using this novel combination of purification 
steps, a small quantity of cytochrome P-450 (Soret peak of 
CO-difference spectrum of reduced form at 450nm) was 
separated from yeast’s major cytochrome P-450-type isozyme, 
cytochrome P-448. Although cytochromes , b^ reductase and 
c(P-450) reductase purified by this method, did not show the 
homogeneity demonstrated by cytochrome P-448, they were free 
of each other and the cytochrome P-450/P-448.
Although cytochrome P-450/P-448 was first discovered in 
the yeast Saccharomyces cerevisiae by Lindenmayer and Smith 
in 1964 this enzyme system was still poorly characterized 
and its role dji vivo is not even now fully understood. This 
study has established that yeast cytochrome P-448 is a 
distinct cytochrome P-450 isozyme but with many properties
in common with cytochrome P-448 from mammalian sources. The
of"
molecular weight^the yeast enzyme (55,500) and its amino 
acid composition are closer to a mammalian hepatic 
cytochrome P-448 form than to a hepatic cytochrome P-450 
form.
The amino acid composition of yeast cytochrome P-448 
was determined and is shown in Chapter 7 along with the 
amino acid compositions of cytochrome P-448 from rat liver
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(Miki ert ajL, 1981) and cytochrome P-448 (Soret peak at 446nm 
but more commonly called P-448) from 3"*naphthoflavone 
pretreated rat liver (Saito and Strobel, 1981). It was 
found that yeast cytochrome P-448 contains 407 amino acid 
residues per molecule, with a content of hydrophic residues 
of 43%. Although the number of amino acid residues is 
smaller than 469, the total for the two mammalian 
cytochromes mentioned above, the hydrophobic residue content 
was almost identical, with values of 43%, 44% and 45% for 
yeast cytochrome P-448, rat liver cytochrome P-448 and 
3-naphthoflavone-induced rat liver cytochrome P-448 
respectively. Recently the amino acid sequence of 
phenobarbital-induced rat liver cytochrome P-450 has been 
deduced from the nucleotide analysis of cloned DNA giving a 
total of 491 residues (Mizukami ejt ajL, 1983). Lower proline 
and higher glycine contents of the yeast enzyme in 
comparison to the above mentioned mammalian enzymes may 
favour intermolecular packing.
In addition to benzo(a)pyrene,type I binding spectra to 
purified yeast cytochrome P-448 were observed with 
lanosterol, phenobarbitone, ethylmorphine, dimethyl- 
nitrosamine and perhydrofluorene. Of these, lanosterol, 
ethylmorphine, and phenobarbitone gave a similar extra peak 
at 367nm to that found in the binding spectrum of
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benzo(a)pyrene (or in the case of ethylmorphine at 355nm).
This double peak is not therefore specific for the
interaction of benzo(a)pyrene with cytochrome P-450/P-448.
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A type I spectral interaction for purified cytochrome 
P-448 from a baker1s yeast strain of S_. cerevisiae with 
lanosterol has previously been detected by Aoyama and 
Yoshida (1978a) although no K value was quoted. Lanosterol
O
is thought to be the endogenous substrate for yeast
for
cytochrome P-448 but demethylation activity.j^the enzyme used 
in this study, towards this compound (using the rather 
insensitive Nash assay technique) was not detected.
Rou^Ye.v'* in addition to showing a type I binding spectrum 
with yeast cytochrome P-448, lanosterol strongly inhibited 
the benzo(a)pyrene hydroxylase activity of this enzyme 
(Chapter 6). Recently, D. King has observed the lanosterol 
demethylation activity of this very enzyme, using an assay 
which involves radioactive sterols (D. King, personal 
communication). The postulation of an endogenous substrate 
role for lanosterol requires the presence of cytochrome 
P-448 under all yeast growth conditions because the 
synthesis of ergos^terol for incorporation into membranes 
including endoplasmic reticulum itself, would always be 
necessary if no ergosterol is added to the growth medium. 
Recently, evidence has been presented for the presence of 
small amounts of cytochrome P-448 in yeast even under 
conditions of growth in anerobic media at low glucose 
concentrations. This enzyme was reported to be capable of 
demethylation of lanosterol (Aoyama e_t al_, 1981a) .
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King (1983) also has shown evidence, based upon the 
construction of second derivatives, of reduced carbon 
monoxide difference spectrum of this yeast cytochrome P-448, 
which allow the resolution of overlapping spectral bands, 
that a small amount of yeast cytochrome P-448 is present 
under these conditions.
Type II spectral interactions were observed for this 
enzyme with aniline, imidazole, and weakly with benz- 
phetamine. Aniline and imidazole bind to yeast cytochrome 
P-448 with very high affinities (K values of 5yand 8yMb
respectively). These results show that the enzyme is also 
capable of undergoing a type II spectral change due to 
binding of a compound directly to the heme iron. Although 
aniline bound very tightly,the metabolism of this compound 
in a reconstituted system was not detected.
Equilibrium gel filtration studies of the binding of 
benzo(a)pyrene to purified yeast cytochrome P-448 and 
phenobarbital-induced rat liver cytochrome P-450 showed one 
binding site for each of these enzymes. In the case of the 
purified enzyme from |3-naphthof lavone-induced rats the six 
binding sites may be due to some residual lipid or detergent 
in the purified preparation. However, it is also possible 
that this highly active enzyme molecule does indeed have six
(343)
benzo(a)pyrene binding sites per monomer, and is funda­
mentally different in its interaction with substrate and 
cytochrome c(P-450) reductase (Chapter 5).
It was established that benzo(a)pyrene hydroxylase 
activity from yeast is cytochrome P-448-dependent by several 
criteria including heat denaturation/deactivation studies 
(Chapters 3 and 6), inhibition studies with binding 
compounds (Chapter 6) and the reconstitution of an active 
benzo(a)pyrene metabolizing system from only cytochrome 
P-448, NADPH:cytochrome c(P-450) reductase and phospholipid 
(Chapter 6.) The omission of either of the enzymic 
components of this system results in loss of activity when 
NADPH is used as an electron donor. The omission of 
phospholipid also leads to a large drop in activity, 
although some hydroxylation still occurs. This requirement 
for phospholipid can also be fulfilled by the non-ionic 
detergent Emulgen 911, suggesting a structural role of 
phospholipid in associating the two enzymic components 
together. Including cytochrome b^ and NADH:cytochrome b^ 
reductase, in the presence and absence of NADH as a cofactor 
in the reconstituted system did not enhance the 
benzo(a)pyrene hydroxylase activity.
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The NADPH-supported reaction using a reconstituted
system (from untreated yeast) has a of 16.7 pmol of
3-hydroxybenzo(a)pyrene/min per nmol of cytochrome P-448 and
a K of 33uM. This value for Michaelis constant is somewhat m
similar to 22.7yM and 46yM for hepatic enzymes from 
3-naphthoflavone and phenobarbital-induced rats 
respectively. The rate of yeast enzyme is low compared with 
3-naphthoflavone (Chapter 6) and 3-methylcholanthrene-induced 
(Ryan ^t al^ , 1979) forms of cytochrome P-448 from rat liver 
but it is similar to cytochrome P-450 activities from 
uninduced (Hashimoto e_t a_l, 1977) and phenobarbital-induced 
rat liver (Chapter 6).
The Km of purified yeast enzyme, 33yM, was in good
agreement with the spectral dissociation constant K , values
of 50yM. The small difference in these values is presumably 
due to the complexity of the multicomponent benzo(a )pyrene 
hydroxylase system. Larger differences observed with 
microsomal enzyme are attributed to the diffusional 
limitation of this immobilized enzyme system.
this system for NADPH as a cofactor 
cumene hydroperoxide or a glucose 
enerating hydrogen peroxide 
gen peroxide generated from glucose
The requirement of 
could be replaced using 
oxidase/glucose system g 
(Chapter 6). Both hydro
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oxidase and glucose and the cumene hydroperoxide systems 
give higher maximal velocities than the NADPH-supported 
system. However, the apparent affinity of the enzyme for 
benzo(a)pyrene was lowered, as indicated by an increased Km 
value. In both the cumene hydroperoxide and iji situ 
hydrogen peroxide-supported systems the production of 
3-hydroxybenzo(a)pyrene (fluorescent emission peak at 523nm) 
is slowed after a few minutes and a peak ot 540nm begins to 
show. This 540nm peak is identified as a mixture of 
benzo(a)pyrene metabolites including phenols, diols, and 
quinones (Rho, 1980). This agrees with results obtained 
using cytochrome P-450 of phenobarbital-induced rats, 
described by Renneberg et al (1981). These authors reported 
that the production of quinones from peroxide-supported
/
cytochrome P-450 systems was much higher than the production 
of these metabilites in an NADPH-supported system. The 
optimal temperature benzo(a)pyrene hydroxylation was the 
same for all three systems (with yeast cytochrome P-448) at 
approximately 37°C, although the in situ hydrogen peroxide- 
supported system has a better rate at a slightly higher pH 
than the optimal pH for the cumene hydroperoxide- and NADPH- 
supported cases which is at 6.5-7.0.
The finding of inhibition iji vitro of yeast P-448 by 
flavonoid compounds is unlike the finding for the major
(346)
rabbit liver cytochrome P-448 (LM4) in that this is 
stimulated by flavone. The pattern of flavonoid inhibition 
of yeast benzo(a)pyrene hydroxylase (Chapter 6) shows more 
resemblance to rabbit liver cytochrome P-450LM6, a form 
induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 
particularly in neonatal rabbits, which also has a Soret 
peak at 448nm in the reduced carbon monoxide difference 
spectrum (Norman et^  al, 1978) . It is of interest that TCDD 
induces both cytochrome P-450LM4 (major component) and 
cytochrome P-450LM6 (minor component) in adult rabbits, but 
only cytochrome P-450LM6 in neonatal rabbits. Cytochrome P- 
450LM6 has a molecular weight of 57,000 and a high activity 
in benzo(a)pyrene hydroxylation (Norman ejt aJL, 1978). In 
neonatal rabbits also, it has been shown that 
3-methylcholanthrene induced a form of cytochrome P-450 
which seems to be LM6 on the basis of its molecular weight 
and catalylic activities (Atlas e_t al_, 1977). This form of 
the enzyme may therefore be more closely related to the 
yeast cytochrome P-448 (the subject of this study) than 
major adult rabbit liver cytochrome P-448.
The novel finding of a concentration dependent 
induction of more efficient forms of the benzo(a)pyrene 
hydroxylase should be pursued with other yeast strains and 
with other inducers. Discoveries of fundamental biochemical
(347)
interest seem likely in this area, as little is known of 
induction of these enzymes in yeast. In this study 
(Chapter 6) this was investigated by growing S_. cerevisiae 
under conditions of glucose repression in the presence of 
several inducers of the mammalian system. When yeast was 
grown in the presence of benzo(a )pyrene only a small 
increase in cytochrome P-448 levels was observed (at the 
most 30%: at 95yM benzo(a)pyrene) which seems to be
insufficient to account for the much more dramatic induction
of benzo (a)py rene hydroxylase found, as indicated by a
greatly increased affinity for benzo(a) pyrene, with K r m
decrease 2-3 fold (also V increased v max approx. 3 fold) .
Unfortunately the induction experiments were performed
towards the end of this study and with the exception of the
Ames tes t, cytochr ome P-448 from benzo( a)pyrene-treated
yeast was not appl ied in other various investigations. For
example, immo bilized cytochrome P-448 from BP-treated yeast
could ha ve pr oduce d the needed higher activity required for
construe tion of a more sensitive enzyme electrode for
detection of envir onmental benzo(a)pyre ne (Chapter 9).
The induction of hydroxylase activ ity was also obs erve'
in a similar manner af*ter growing yeast in the presence of 
dimethylnitrosamine and sodium phenobarbitone. 
3-Methylcholanthrene was also found to decrease the K for
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benzo(a)pyrene yet in this case no effect on V wasv J max
observed. ft-Naphthoflavone, a compound which induces a
cytochrome P-448 form of cytochrome P-450 with a very high
turnover for benzo(a)pyrene in mammals had no effect on the
yeast cytochrome P-448. The addition of lanosterol to yeast
during growth resulted in no change in cytochrome P-448
concentration yet caused an enzyme to be produced with an
increased K for benzo(a)pyrene. m
The results indicate that at least one new form of 
enzyme was being produced in the presence of the inducing 
compound which seems likely to occur with compensating non­
production of the existing form of the enzyme. By analogy 
with mammalian system it can be expected that this is due to 
the biosynthesis of a different form of cytochrome P-450 
with a greater specificity for benzo(a)pyrene. Although 
induction of different forms of cytochrome P-450 in yeast 
has not been shown, some evidence from purification studies 
was obtained for the presence of at least two forms of 
cytochrome P-450 in uninduced yeast. The results from this 
induction study show that more than one form of cytochrome 
P-450 can exist in £[. cerevisiae and that the production of 
a more specific form for benzo(a )pyrene is likely to occur 
at the expense of the less specific form. Assuming that 
these effects occur at a transcriptional level, this leads
(349)
\
to a model whereby a high concentration of benzo(a )pyrene is 
responsible for switching off one gene and’ switching on 
another through binding to a repressor protein causing its 
activation or inhibition respectively. This would therefore 
represent both a positive and negative control exerted by 
the inducer over the different operators responsible for the 
functioning of the structural genes for synthesis of the 
corresponding forms of mRNA. Positive and negative effects 
on transcription have been reported previously in bacteria 
(Adhya and Miller, 1979) for effects of cyclic AMP on the 
promoter of the gal operon in IS. coli. The partial 
repression of cytochrome P-450 synthesis in S_. cerevisiae by 
cyclic AMP has been reported in studies on yeast protoplasts 
(Wiseman e_t a_l, 1978).
An alternative explanation might involve the effect of 
benzo(a)pyrene as a mutagenic agent, activated ill situ by 
the cytochrome P-448 system in the yeast. It seems unlikely 
however that more efficient forms of the enzyme would be 
produced from mutant genes. Moreover, the efficient binding 
of benzo(a)pyrene, yet low catalytic activity, of the yeast 
cytochrome P-448 would tend to protect the yeast from the 
mutagenic effects associated with activation of 
benzo(a)pyrene.
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The absolute spectrum of highly purified yeast 
cytochrome P-448 showed a characteristic low spin spectrum, 
i.e. with a Soret peak at 417nm and no absorbance in the 
650nm region. This matter was pursued further by studying 
the temperature-dependent spin state equilibrium of this in 
the presence and absence of benzo(a)pyrene (Chapter 8). The 
purified enzyme was 94% low spin at 22°C. This compares 
with a value of 82% low spin at 22°C for purified hepatic 
cytochrome P-450 from phenobarbital pretreated rats (Gibson 
and Tamburini, 1980). The non-ionic detergents (Triton 
X-100 in particular) used for its stabilization and/or 
solubilization effects during the purification process, 
bound to yeast cytochrome P-448 possibly in same manner as a 
reverse type II binding compound and modulated the spin 
state to its low spin form. This resulted in lower mid­
point redox potential and therefore the reduction of yeast 
cytochrome P-448 by sodium dithionite was time-dependent 
(Chapter 4). Although attempts were made, to eliminate the 
non-ionic detergents prior to the spin state studies a 
residual amount may have resulted in the difference between 
the low spin contents at 22°C of yeast and hepatic enzymes. 
The hepatic cytochrome P-450/P-448 (from both phenobarbital- 
and $-naphthoflavone-induced rats) did not show any change 
in their spectra in the presence of Triton X-100 or any
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other non-ionic detergent and their reduction by sodium 
dithionite was not made time-dependent by these compounds.
The binding of the substrate benzo(a)pyrene to yeast 
cytochrome P-448 results in a shift to a higher spin state, 
18% high spin at 22°C. The modulation of the spin state, to 
high spin, by substrate is thought to be important in the 
catalylic mechanism of cytochrome P-450 enzymes by 
controlling the redox potential, hence allowing electrons to 
flow to the cytochrome P-450 molecule more easily in the 
reduction of its ferric form by the cytochrome c(P-450) 
reductase (Sligar e_t al_t 1979). The change in mid-point 
redox potential of yeast cytochrome P-448 upon binding 
benzo(a)pyrene should be included in further studies on this 
subject. The mid-point redox potential of yeast cytochrome 
P-448 in the absence of substrate was reported in Chapter 4. 
Yeast cytochrome P-448 has previously been shown to be 
modulated from low to high spin state by the addition of 
lanosterol, although no quantitative measurement was 
attempted (Yoshida and Kumaoka, 1975b).
In attemp ts to imp rove the work ing characteristics of
yeast cytochrome P-448 the cyste2inyl , ar ginyl, histidyl,
tr ypt ophyl and tryrosyl residues3 wer e mo dified. Modifi-
catio n of four or more out of eiLght cyst einyl residues in
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this enzyme resulted in the loss of more than 70% of 
benzo(a)pyrene hydroxylase activity, while the CO-difference 
spectrum peak of reduced form (at 448nm) remained unchanged. 
Modification of cysteinyl residues did not alter the binding 
parameters and temperature-induced spin state equilibrium. 
Therefore, participation of -SH group(s) (other than the one 
known as the 5th ligand and is responsibile for forming the 
CO-reduced cytochrome P-450/P-448 complex) in the active 
site, is proposed.
Only five tyrosyl residues were accessible to chemical 
modification. O-Acetylation of these amino acid residues 
resulted in inhibition of benzo(a )pyrene hydroxylase activity 
and prohibition of temperature-induced spin state 
modulation, while the binding parameters of benzo(a)pyrene 
to cytochrome were not greatly altered. Recently tyrosyl 
modification results presented in this study have been 
confirmed by Janig e_t aJL (1982 and 1983) (the results of 
modification studies presented in this thesis were obtained 
in the latter part of 1981 and early 1982). These authors
reported that three tyrosyl residues in cytochrome P-450LM2 
are accessible to chemical modification with tetra- 
nitromethane. They also reported that the nitration of two 
tyrosyl residues inactivates the enzyme to about 20% and 
that the modification in the presence of the inhibitor
(353)
metyrapone (which is coordinated via one of its pyridine 
nitrogen to the heme iron of cytochrome P-450) results in 
the protection of at least one tyrosyl residue from 
nitration, suggesting the location of one tyrosyl residue in 
the vicinity of heme iron (6th coordinate).
Based upon the results presented for modification of 
tyrosyl residues of yeast cytochrome P-448 in this study 
(Chapter 8), the participation of a tyrosyl residue in the 
active site of this enzyme (possibly as the 6th ligand) is 
suggested.
(354)
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Appendix _I
OK. BA5ICV 
BAS I C V KEV18.2 
>
>01 P SOLVE 1'
>1 1ST
SOLVE 1 THU j FEB n  1982 1 5 :3 0 :09
SO PRINT "A * PROGRAM TO SOLVE A SYSTEM OF FOUR LINEAR EGIUAT10NS" 
100 DIM A (4,4) >8(4-,4).. C (4*. 1) 1 )
1 10 DATA 21,10,3*-3,l2,.63 
120 DATA 6 # 51 j 18 . 8 > 2L *5 5> . 95 
130 DATA -1. 16, .91>14.3,-.326 
14 0 DATA -.22,-.59,0,12
150 MAT READ A 
16 0 MAT B=INVI A)
170 PRINT "TYPE IN DATA PO1NTS»ONE NUMBER PER ROW"
180 MAT INPUT C
190 MAT X = 8 * C
191 PRINT"THE SOLUTIONS,IN THE ORDER C.Cl.BtAi ARE!"
2 90 HAT PRINT X 
2 10 ENO
> R UN
S O L V E  i T H U ,  F E B  11 1 9 8 2  15 :3 Q ;52
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Appendix II
Return/Quit [PRINT Rev 2.01
\
190 PRINT-QUART OF OIL AND SOME (MICRO) CHIPS!*1 
200 DIM A(40),X(40),T(40),Y(40)
210 PRINT ."NUMBER OF DATA POINTS"
220 INPUT N 
230 FOR K=1 TO N 
240 READ A(K),T(K)
250 X(K) = 1/<.002*<273+T(K)))
260 NEXT K
270 PRINT "INPUT EXTINCTION COEFF";
280 INPUT A3 
290 LET P=10000
300 PRINT "INPUT STARTING VALUE FOR AMIN";
310 INPUT A2 ~
320 LET A2sA2+.0005
330 Al=A2+A3
340 S1=0
350 S2=0
360 S3=0
370 S4=0
380 S5=0
Return/Quit [PRINT Rev 2.03
390 FOR J=1 TO N
400 Y(J)=LOG((A(J)-A2)/<A1-A(J)))
410 S1=S1+X(J)
420 S2=S2+Y(J)
430 S3=S3+X(J)*Y(J)
440 S4=S4+X(J)*X(J)
450 S5=S5+Y(J)*Y(J)
460 NEXT J
470 D3=SQR((S4-S1*S1/N)/(N-1))
480 D4=SQRUS5-S2*S2/N
)/(N-1)) .
490 H=(S3-S1*S2/N)/(S4-S1*S1/N)
500 R=H*B3/D4 
510 B=(S2-H*S1)/N 
520 IF P<R THEN 580 
530 LET P=R 
540 LET C=A2 
550 LET H 1=M
560 LET B 1 =B ,
570 G0T0320 
580 LET H2=-1*M1
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Appendix II 
(continued)
Return/Quit [PRINT Rev 2.03
590 LET B2=B1*1.98
<500 PRINT "CORRELATION COEFF
<510 PRINT P
620 PRINT "ENTHALPY=";M2;"KCAL MOL-1"
630 PRINT " E N T R O P Y ^ ' ^ r e . u "
640 A1=A2+A3
650 PRINT"1/RT Keq LnK X HIGH SPIN"
660 FOR J=1 TO N
670 Y=(A(J)-C)/(A1-A(J))
680 L=LOG(Y)
690 Q=X(J)
700 T= <1/(.002*X(J)>)—273 
710 P=(Y/(1+Y))*100 
720 PRINT G,Y,L,P 
730 NEXT J
740 PRINT "TEHP A(390-420)'*
750 FOR H=1 TO N 
760 2=T(H)
770 S=A(H)
780 PRINT Z,S
Return/Quit CPRINT Rev 2.03
790 NEXT H •
795 PRINT C
800 BATA .0205,5.5,.0357,19.2,.0425,25*5,.053,31.8,.061,36.8,.0707,42
820 END
OK, COHO -END
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Table 1. Requirements fo r  cytochrome P-450 biosynthesis in 
Saccharomyces cerevisiae 
Repression of cytochrome P-450 was achieved by addition of 
cyclic AMP to growth medium (demonstrated for yeast proto­
plasts by Wiseman et al., 1978)
Growth condition 
High glucose concentration 
(4-20%) in growth medium 
Anaerobic growth conditions 
Addition of inhibitors of 
mitochondria] protein biosynthesis 
(e.g. chloramphenicol, erythromycin 
etc.) to growth medium 
Use of respiratory-deficient mutants
Mitochondrial 
cytochrome 
a + a, 
Absent
■Absent
Absent
Absent
C yclic
AMP
concentration
Low
the high glucose concentrations or assisted excretion of cyclic 
AMP out through the cell membrane could account for the 
glucose effect in repressions of many enzymes, and on the 
production of cytochrome P-450.
The subcellular location of adenylate cyclase in S. cerevisiae 
is dependent on the growth conditions of the yeast. Growth in 
5% glucose-containing media was associated with the finding of 
adenylate cyclase in a microsomal fraction (Wheeler et al..
1974), rather than a cell envelope fraction (Londesborough Sc 
Nurimen, 1972). Location of this enzyme in a membrane 
fraction (unspecified) was reported recently (Varimo & 
Londesborough. 1979). A critical approach is essential to all 
such studies after various disruption procedures on yeast. The 
available evidence suggests that there is room for doubt as to the 
subcellular location of various adenylate cyclases, although it 
does not seem to have been reported as associated with a classic 
mitochondrial fraction from S. cerevisiae. Location o f some of 
the adenylate cyclase in the membrane of the limited number of
713
large mitochondria present would be analogous to  the position in 
bacteria where the location is in the membranes surrounding the 
cell. This would directly relate the mitochondrion in yeast to 
events in the cytosol through the regulation o f cyclic AMP 
producuon. Many effects in the yeast cell are now thought to 
interrelate mitochondrial and other cell organelles, including 
effects at the cytoplasmic membrane related to uptake of 
nutrients, and the loss of flocculence in respiratory-deficient 
petite mutants (Egilssonet al., 1929).
We thank Or. D. Wilkie, Department of Botany and Microbiology, 
University College London, for advice on whole-cell regulating effects 
of mitochondria in yeast. ’
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Solubilization of cytochrome P-450 in high yield from Saccharomyces cerevisiae microsomal 
membranes by 1% Triton X-100: stabilization effect
MAHMOOD R. AZARI and ALAN WISEMAN 
Biochemistry Division, Department o f  Biochemistry, University 
o f  Surrey. Guildford, Surrey GUI 5XH. UJC.
Cytochrome P-450 from anaerobically grown baker’s yeast has 
been solubilized and purified by Yoshida et al. (1974aJt, 1977). 
Our cytochrome P-450 from brewer’s yeast (which has 
benzol a Ipyrene hydroxylase activity: Woods & Wiseman, 1980) 
was mainly converted into cytochrome P-420 during the 
solubilization of microsomal fraction by sodium cholate by the 
method described by Yoshida et al. (1977). Attempts were made 
therefore to stabilize cytochrome P-450 in yeast microsomal 
fraction, during and after solubilization, in order to improve the 
yield for large-scale purification studies in progress.
Saccharomyces cerevisiae (N.C.Y.C. no. 240) was grown for 
44 h under glucose repression in medium containing 20% 
glucose and mycological peptone by the method described 
previously (Wiseman & Lim. 1975).
Yeast microsomal fraction was obtained by centrifugation at 
100000/j for lh  after disruption of the yeast by Vibro Mill 
(Wiseman et al.. 1975). Microsomal fraction was suspended in 
0.1 M-potassium phosphate buffer (pH 7.2). This buffer always 
contained as'additives. 20% glycerol. 0.001 m-EDTA, 0.001m- 
dithiothreitol. Solubilization was achieved by adding various 
detergents to the suspension of microsomes. stirring for lh .
centrifuging at 50000rev./min (100000g) for 1 h and collecting 
the supernatant, which contained the solubilized cytochrome 
P-450. The concentration of cytochrome P-450 and cyto­
chrome P-420 was determined by a spectrOphometric method 
(Wiseman et al. 1978). modified from that of Omura et al. 
(1965). assuming extinction coefficients of 91 cm-1 -m M '1 for 
cytochrome P-450 and 111 cm-1 • itiM"1 for cytochrome P-420.
Storage of the whole yeast containing the cytochrome P-450 
was done in the phosphate buffer containing the additives 
described above and additionally made 15% to glucose. Other 
protective agents were needed to successfully store the frozen 
microsomal fraction from yeast. Triton X-100 in 0.1% con­
centration plus the additional use of 0.1% reduced glutathione in 
the phosphate buffer (plus additives) prevented the conversion of 
cytochrome P-450 into cytochrome P-420 in yeast microsomal 
fraction during storage at —40°C  for several weeks. Rat liver 
microsomal fraction in comparison was very stable at —40°C  
stored in the phosphate buffer (plus additives) alone.
Microsomes in the phosphate buffer (plus additives) and also 
in the phosphate buffer (plus additives) containing 0.1% Triton 
X-100 were solubilized by various detergents with release of 
cytochrome P-450 (Table 1). Good yields in the enzyme were 
obtained with 1% Triton X-100 and 1% sodium cholate in the 
0.1% Triton X-100-containing phosphate buffer (plus additives) 
only. Here 100% yield was obtained from yeast microsomal
V ol. 8
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Table 1. Solubilization o f  cytochrome P-4S0 from  microsomes by various detergents, with and without 0.1% Triton X-100 
Yeast microsomes contained initially 0 .7nmol of cytochrome /M 50/m l and 0.3 nmol of cytochrome / ’•420/ml. and rat liver 
microsomes contained 1.5nmoI o f cytochrome / ’-450/ml and 0.1 nmol of cytochrome P-420/ml. No cytochrome P-450 was lost 
after 3 weeks o f storage in —40°C  in all preparations which were solubilized in the presence of 0.1% Triton X-100.
Microsomes in the phosphate buffer 
(plus additives)
Microsomes in the phosphate buffer 
(plus additives) containing 0.1% Triton X-100
Cytochrome P-450/ Cytochrome P-450/
Source of Cytochrome P-450 cytochrome P-420 Cytochrome P-450 cytochrome P-420
Detergents microsomes (nmol /ml) ratio (nmol/ml) ratio
Sodium dodecvl sulphate 0.5% Yeast 0.15 1 0.25 0.3
Triton X-100 i% Yeast 0.65 22 0.70 26
Emulgen 913 1% Yeast 0.35 10 0.4Q 4
Sodium cholate 1% Yeast 0.25 1 0.70 18
Triton X-100 1% Rat liver 1.40 7 1.40 7
Sodium cholate 1% Rat liver 1.20 6 1.30 6
fraction, whereas that from the rat liver microsomal fraction was 
93% and 87% respectively. Sodium cholate (1%) alone gave a 
good yield (80%) from rat liver microsomal fraction, but only 
36% from the yeast microsomal fraction. 1% Emulgen 913 gave 
about 50% yield from the yeast microsomal fraction, regardless 
of the presence of 0.1% Triton X-100. Sodium dodecyl sulphate 
(0.5%) gave a very poor yield o f cytochrome P-450 (Table 1). 
The highest cytochrome P-450/P-420 ratios were obtained from 
yeast microsomal fraction with 1% Triton X-100. in the range 
22-26, compared with only 7 for the rat liver. Renex 698. 
Tween 80. Triton N-101. all in 1% concentration, had no (or 
very little) solubilization effect on cytochrome P-450 from yeast 
microsomes.
Triton X-100 changes the spin state o f cytochrome P-450 
from high to low spin (Tamura et al., 1976). and has been 
shown to protect some enzymes (Takeda et al.. 1972). by 
formation of micelles, which protect the hydrophobic environ­
ment of the enzyme. Conversely it has been reported that 
sulphydryl reagents (Murakami & Mason. 1967). or high ionic 
strength o f medium (Yoshida & Kumaoka, 1972). cause the 
spin state to change from low to state to high state and also 
prompt the cytochrome P-450 into cytochrome P-420 con­
version by destroying or removing the sulphydryl ligand. This 
suggests that Triton X-100, by changing the spin state from high 
to low state and retaining it in that state, may protect the
sulphydryl ligand and make it more accessible to haem iron, 
thus exerting a stabilizing effect on the cytochrome P-450.
Mahmood R. Azari is a Lecturer oh sabbatical leave from Jundi 
Shapur University, Ahvaz, Iran. v
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Enhancement of substrate-induced deactivation of penicillinase by cross-linking with dimethyl
suberimidate
MARTYN FARRER and RICH ARD  VIRDEN 
Department o f  Biochemistry, University o f  Newcastle upon 
Tyne, Newcastle upon Tyne N E I 7RU, U.K.
Staphylococcal penicillinase (EC 3.5.2.6) undergoes slow 
reversible deactivation in the presence of cephaloridine or of 
certain other substrates, giving an exponential decrease in the 
rate o f hydrolysis to a low value. This suggests that there is slow 
interconversion of active and less active (or inactive) con­
formational states (Virden et al.. 1978: Pain & Virden. 1979). 
Covalent intramolecular cross-linking of penicillinase would be 
likely to affect the interconversion between these states by 
stabilizing certain conformational features.
Purified penicillinase (Robson & Pain. 1976), 4 mg/ml. in 
0.43m-K,SO4 and sodium acetate buffer l0.5mM-EDTA (di­
sodium sail) and 50mM-sodium acctnte/27mM-ncctic acidt. 
pi 15.0. was mixed with an equal volume of 0 .1 m  V ethyl 
morpholine and then adjusted to pH 8.4 with acetic acid. 
Dimethyl suberimidate (0.5m) was added (final concn. 20mM). 
After incubation at 20°C  for 90min a further portion of fresh
reagent was added (total concn. 0.1 2 m ). In a control, dimethyl 
suberimidate was omitted. The reaction was stopped by lowering 
the pH (Coggins et al„ 1969). Analysis o f the product by 
electrophoresis in 12% (w/v) polyacrylamide gel containing 
0.1% sodium dodecyl sulphate (Laemmli & Favre. 1973) 
showed no oligomers, although there was small decrease in 
mobility that was almost constant after 90min o f treatment. 
Subsequent results are for the control and ISOmin-treated 
proteins, unless otherwise stated. The N H ? group content/mol of 
protein (Habeeb, 1966) was 41 and 33 in the control and treated 
proteins respectively. These results are consistent with an 
' average binding o f four reagent molecules, assuming that each 
formed a cross-link.
Optical rotation (at 238 nm) o f protein in 50mM-KjSO4 and a 
2-fold dilution of acetate buffer, pH 5.0. decreased progressively 
when the temperature was raised from 24° C in increments of 
approx. I0°C  and held at each temperature until rotation 
became constant. At 80°C . rotation in untreated and sub 
stituted protein was 73 and 82% respectively o f the initial values. 
On cooling, the rotation o f the treated protein increased to 103%
1980
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Error in Assay due to Time Dependency of Carbon Monoxide Difference 
Spectrum of Reduced Yeast Cytochrome P-450: Slow Reduction 
Caused by Triton X-100 Present
M a h m o o d  R. A zari a n d  A l a n  W i s e m a n
Biochem istry Division, Department o f  Biochemistry, University o f  Surrey,
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Triton X-100, added to yeast Saccharomyces cerevisiae for the purpose o f stabilization or 
solubilization affects the carbon monoxide difference spectrum of reduced cytochrome P-450 
and consequently the measurement o f cytochrome P-450. Eight minutes is needed for 450-nm  
peak to reach its maximum height. Triton X-100 is shown to behave as a Type II substrate 
(absorption maximum at 418 nm and minimum at 390 nm) and to modulate the spin state 
of cytochrome P-450 from high to low form. Low-spin yeast cytochrome P-450 is reduced 
more slowly than the high-spin form.
It has been reported by Yoshida and Ku- (5) on the hepatic cytochrome P-450 system
maoka (1) that yeast Saccharomyces cer- (reduced enzymatically) and Sliger et al.
evisiae cytochrome P-450 in the presence of (6) in which they have concluded that the
Triton X-100 has an absolute spectrum iden- binding of Type I substrate ( absorption max-
tical to that of the low-spin state (Soret peak imum at 390 nm and minimum at 418 nm)
at 416 nm). It has also been reported by to hepatic cytochrome P-450 could increase
Mitani and Horie (2,3) that yeast cyto- the rate of electron flow from NADPH-re-
. chrome P-450 can exist in the high- anditow- ductase to cytochrome P-450 by modulating
spin states and that the equilibrium between the spin state from low- to high-spin form,
the two states depends on the environmental
conditions (high-spin and low-spin cyto- EXPERIMENTAL PROCEDURES
chrome P-450 corresponds to the Soret peaks
of the absolute spectrum at 395 and 416 nm, Brewer’s yeast, Saccharomyces cerevisiae 
respectively). (NCYC NO. 240), was grown for 44 h under
Ando and Horie (4) showed that reduction glucose repression in medium containing
of cytochrome P-450 from adrenocortical 20% glucose and mycological peptone by the 
mitochondria by sodium dithionite or by method previously described by Wiseman
NADPH-dependent enzymatic system is not and Lim (7).
completely instantaneous. Substrates that Yeast microsomal fraction was obtained
produce the Type II spectral changes such by centrifugation at 160,900g for 1 h, after
as pregnenolone decrease the rate of reduc- disruption of the yeast by Vibromill, de-
tion. They also reported that when the spin scribed by Wiseman et al. (8). The micro­
state of heme iron is modulated from high somai fraction was suspended in 0.1 M po-
to low. the rate of reduction is decreased and, tassium phosphate buffer, pH 7.2, containing
conversely, when it is changed from low to 20% glycerol, 0.001 M EDTA, 0.001 M di-
high the rate of reduction increases. This is thiothreitol. Triton X-100 was added to this
in agreement with reports from Gigon et al. suspension with a final concentration of
0 0 0 3 - 2 6 9 7 /8 1 /1 6 0 4 0 6 -0 4 5 0 2 .0 0 /0
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CARBON MONOXIDE DIFFERENCE SPECTRUM 407
0.20 r  A
0.18 0.18
0.18
0.14
0.12 0.12
0.1
420 440 460 480 500420 440 460 480 500
Ylmnttricph (nm)
0.08 L 0.08
F ig. 1. Carbon monoxide difference spectrum of reduced cytochrome P-450. (A ) Microsomes treated 
with Triton X-100 (0.1%), Curves 1-3 and 8 were recorded 1, 2, 3, and 8 min after initial scanning. 
(B ) Control microsomes recorded 20 s after addition o f CO. Cytochrome P-450 1 nm ol/ml; sodium  
dithionite i  m g/m l; 22°C.
0.1%. The control sample did not contain 
any Triton X-100.
In one case, solubilization was achieved, 
by adding 1% Triton X-100 to the suspension 
of microsomes, stirring for 1 h, centrifuging 
at I60,900g for 1 h, and collecting the su­
pernatant, which contained the solubilized 
cytochrome P-450.
The carbon monoxide difference spectrum 
of yeast cytochrome P-450 was recorded by 
a spectrophotometric method of Wiseman 
et al. (9), modified from that of Omura et 
al. (10). A 1-ml sample of solution was 
placed in each of two spectrophotometer cu­
vettes and reduced by I mg/ml sodium di­
thionite. The baseline between 390 and 500 
nm was recorded using a Pye-Unicam SP 
1800 spectrophotometer, carbon monoxide 
was then bubbled (at a rate of I bubble/s 
unless mentioned otherwise) through the 
sample cuvette for 30 s, and the scanning 
was repeated. The peak height at 450 nm 
above the baseline was used to calculate 
the concentration of cytochrome P-450 as­
suming an extinction coefficient of 91 
cm -1 m M "'.
Spectrophotometry was carried out at 
22°C unless mentioned otherwise. The rate 
of reduction was measured by placing cy­
tochrome P-450 (microsomal fraction) in 
both reference and sample cuvettes. Carbon 
monoxide was bubbled through the sample 
cuvette at the rate of 1 bubble/s for 30 s. 1
mg/ml sodium dithionite was added to the 
sample cuvette and mixed quickly, and ab­
sorbance changes at 448 nm were recorded.
In some cases carbon monoxide was not 
bubbled through the solution and the rate 
of reduction was measured at 440 nm..
RESULTS AND DISCUSSION
The addition of Triton X-100 affected the 
carbon monoxide difference spectrum of 
yeast cytochrome P-450 (reduced CO cy­
tochrome P-450 minus reduced cytochrome 
P-450) (Fig. 1). It also affected the differ­
ence spectrum of reduced CO cytochrome 
P-450 minus oxidized cytochrome P-450. 
The difference in absorbance at 448 nm was 
low and eventually reached its maximum 
(real) value only after approximately 8 min 
delay. The percentage of reduction was cal­
culated as previously done by Gigon et al. 
(5) and Ando and Horie (4), and the max­
imal increase in absorbance in the presence 
of excess dithionite was taken at 100%. The 
percentage of remaining oxidized cyto­
chrome P-450 was plotted on a logarithmic 
scale (Fig. 2), and shows that the rate of 
reduction of cytochrome P-450 in the pres­
ence of Triton X-100 is biphasic with com­
plete reduction taking 8 min.
The time dependency of the carbon mon­
oxide difference spectrum of Triton X-100 
treated yeast cytochrome P-450 could not 
be attributed to slow solubilization of CO
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and therefore its slow binding to the reduced 
cytochrome P-450. As was described by 
Ando and Horie (4), carbon monoxide bind­
ing is a very rapid reaction. When sodium 
dithionite was introduced to the sample cu­
vette 4 min after the addition of carbon 
monoxide, the CO difference spectrum of 
reduced P-450 was still time dependent. The 
same results were obtained in the absence 
of CO for Triton X-100 treated microsomes 
by measuring the rate of reduction at 440 
nm and, although the difference in absor­
bance was very small, it increased with time 
as before.
In another experiment the CO difference 
spectrum of Triton X-100 treated yeast mi­
crosomes was recorded 4 min after the ad­
dition of CO. The sample cuvette was freed 
of CO by bubbling oxygen (1 bubble/s for 
30 s) through it, and it was oxidized by add­
ing H202 (4mM in concentration). Then the 
Triton X-100 difference spectrum was re­
corded, and the difference spectrum showed
100
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F ig. 2. Effect of Triton X-100 on rate of reduction 
by sodium dithionite in presence of carbon monoxide. 
(A ) Microsomes treated with Triton X-100 (0.1%). (B) 
Control microsomes. The reaction was measured at 448 
nm. Cytochrome P-450 1 nmol/ml; sodium dithionite 
I mg/ml; 22°C.
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Fig. 3. Carbon monoxide difference spectrum of re­
duce cytochrome P-450. Microsomes were treated with 
Aniline (2  m M ). Curves 1-3 and 8 were recorded 1, 2, 
3, and 8 min after initial scannirig.
a Type II change, i.e., no peak at 390 nm 
and a Soret peak at 418 nm. This ruled out 
.the slow displacement of Triton X-100 by 
the addition of CO, to which the time de­
pendency of CO difference spectrum of Tri­
ton X-100 treated microsomes could have 
been related.
Other factors such as the temperature and 
the rate of CO bubbling through the samples 
were taken into consideration. At a low tem­
perature (4°C) the height of the 450-nm 
peak in the carbon monoxide difference 
spectrum of cytochrome P-450 was smaller, 
and as the temperature was raised toward 
22°C, the peak became larger. At a constant 
temperature, the spectrum was time depen­
dent when the sample contained Triton X- 
100. The sample was not time dependent 
when free of Triton X-100 (control). If car­
bon monoxide was bubbled faster than 2 
bubbles/s, a small amount of cytochrome P- 
450 was converted to cytochrome P-420, and 
as the time went by (5 min) some of this P- 
420 reconverted to P-450. But in the case 
of Triton X-100 treated microsomes, their 
reconversion was completed in 5 min and 
then another 5 min was required for the 450- 
nm peak to reach its maximum height. This 
showed that the rate of bubbling CO to the 
sample cuvette is a negligible factor and the 
time dependency of CO difference spectrum 
of Triton X-100 treated microsomes is due 
only to the slow rate of reduction.
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F ig. 4. Absolute spectrum o f solubilized cytochrome P-450. — —, Treated with Triton X -100 (1%); 
 , treated with sodium cholate ( I %).
Aniline, a.Type II substrate, proved to 
have the same effect as Triton X-100 on the 
CO difference spectrum of yeast micro­
somes. The 450-nm peak was decreased con­
siderably in comparison with the control 
microsomes and it reaches its real height 
after approximately 8 min (Fig. 3).
As was shown by Yoshida and Kumaoka 
(II), the absorption peak at 394 nm of the 
spectral high-spin form of hepatic cyto­
chrome P-450 is shifted to 416 nm (the mod­
ified Type II spectral change), a spectral 
low-spin form, upon binding with a com­
pound containing a hydroxyl group. The 
Triton X-100 used to stabilize cytochrome 
in yeast microsomes (12) also contains hy­
droxyl groups.
The absolute spectra of Triton X-100 sol­
ubilized yeast microsomes gave direct evi­
dence for this spectral spin state change 
(Fig. 4). A major peak at 418 nm and no 
absorbance at 650 nm showed the existence 
of low-spin P-450, while the solubilized P- 
450 with sodium cholate also had a peak at 
390 nm. showing a spectral mixed spin form 
to be present.
It can be concluded that Triton X-100 can 
modulate the spin state of yeast cytochrome 
P-450 (the same as a Type II substrate). 
This causes slow P-450 reduction by sodium 
dithionite, making the measurement of cy­
tochrome P-450 by the CO difference spec­
trum method time dependent, which indi­
cates the existence of a major error in the 
standard “immediate assay” procedure.
The measurement of the hepatic cyto­
chrome P-450, in contrast, was not time de­
pendent with or without the presence of Tri­
ton X-100. This may be due to a higher 
midpoint redox potential in hepatic cyto­
chrome P-450, which will be the subject of 
future studies.
REFERENCES
1. Yoshida, Y., and Kumaoka, H . (1972) J. Biochem.
(Tokyo) 71, 915-918.
2. Mitani, F., and Horie, S. (1969) J. Biochem. (To­
kyo) 65, 269-280.
3. Mitani, F., and Horie, S. (1969) J. Biochem. (To­
kyo) 66, 139-149.
4. Ando N., and Horie, S. (1971) J. Biochem. (Tokyo)
70, 557-570.
5. Gigon, G., Gram, E., and Gillette, J. (1969) M ol.
Pharmacol. 5, 109-122.
6. Sliger, S., Cinti. B., Gibson, G., and Schenkman,
J. (1979) Biochem. Biophys. Res. Commun. 90, 
925-932.
7. Wiseman, A., and Lim, T.-K., (1975) Biochem.
Soc. Trans. 3, 974-977.
8. Wiseman, A., Gondal, J., and Sims, P. (1975)
Biochem. Soc. Trans. 3, 278-281.
9. Wiseman, A., Lim, T.-K.. and Woods, L. (1978)
Biochim. Biophys. Acta  544, 615-623 .
10. Omura, T., Sato, R.. Cooper, D., Resenthal, O,,
and Estabrook, R. (1965) Fed. Proc. 24, 1181- 
1189.
11. Yoshida, Y.. and Kumaoka, H. (1975) J. Biochem.
(Tokyo) 78, 455-467.
12. Azari, M. R., and Wiseman, A. (1980) Biochem.
Soc. Trans. 8, 713-714.
ANALYTICAL BIOCHEMISTRY 122, 129-138 (1982)
(392)
Purification and Characterization of the Cytochrome P-448 Component 
of a Benzo(a)pyrene hydroxylase from Saccharomyces cerevisiae
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Cytochrome P-448, a type of cytochrome P-450, from brewer's yeast {Saccharomyces cer­
evisiae) grown under conditions of glucose repression was isolated and purified. Triton X-100  
in very low concentration proved to be very effective in stabilizing P-448 in the microsomal 
fraction and later prevented its conversion to cytochrome P-420 through solubilization with 
various ionic and nonionic detergents..Highest yields were obtained with 1% sodium cholate, 
in the presence of 0.1% Triton X-100 and reduced glutathione. A novel combination of hy­
drophobic adsorption and other chromatographic techniques was used for the purification of. 
cytochrome P-448. These involve the use of amino octyl-Sepharose 4B, instead of the low- 
yielding aminohexyl derivative, followed by the fast-running hydroxyapatite-cellulose column.
Finally, the use of DEAE-Sephacel was found to increase'greatly the purity o f the cytochrome 
P-448 obtained. The molecular weight of this preparation was estimated by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis ( M„ 55,500). Using the known molar extinction 
coefficient of the carbon monoxide-differcnce spectrum the estimate o f degree of purity o f 
cytochrome P-448 obtained by this purification procedure was between 88 and 97%. Electro­
phoresis also showed that this preparation was completely homogeneous and assays showed 
that it was also completely free of cytochrome 65, cytochrome c  reductase and cytochrome 
P-420. Purified cytochrome P-448 reconstituted with cytochrome P-450 (cytochrome c) re­
ductase, isolated from yeast, showed 10-fold higher aryl hydrocarbon hydroxylase activity 
with benzo(o]pyrene as a substrate than the corresponding microsomal fraction enzyme. Ki­
netics of benzo(a]pyrene hydroxylation were determined: K m (33 jim) was comparable with 
that reported for purified hepatic cytochrome P-448. The number o f binding sites o f microsomal 
and purified cytochromes P-450 (from liver of phenobarbital-induced rats) and yeast cyto­
chrome P-448 with benzo[a]pyrene has been determined using an equilibrium gel filtration 
method. There is one binding site in each case (contrast with six sites for microsomal enzymes).
The Scatchard plot gives number of binding sites, apparent association constants (AT), and the 
equivalent dissociation constants ( K,). Comparison is made with spectral dissociation constants 
for these enzymes and benzo[a]pyrene. Thus the proportion bound, dissociation constant (K ,), 
and stoichiometry of rat liver (phenobarbital induced) and yeast cytochrome P-448 with 
benzo(o]pyrene were compared with corresponding values for microsomal fractions o f both 
systems. Purified enzymes had higher K, values in both cases, and the proportion o f enzyme 
that bound benzo[a]pyrene was high (53%) for liver and this value is 100% for purified enzyme 
from yeast, which is the same as the value obtained for the microsomal enzyme from yeast.
We have reported previously our prelim- tochondrial repression are associated with
inary studies on a cytochrome P-448-linked low levels of cellular cyclic AMP in the
benzo[n]pyrene hydroxylase in membrane- yeast, and it is here that an endoplasmic re­
bound form (microsomal fraction) from a ticuium-located enzyme of the cytochrome
disruptate of brewer’s yeast, Saccharomyces P-450 type is produced.
cerevisiae, grown aerobically at 20% glucose The enzyme in Saccharomyces cerevisiae
concentration (1-3). Such conditions of mi- is similar to the cytochrome P-448 of liver
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in the formation of metabolites of ben- 
zo(a]pyrene, expecially the 7,8-dihydro- 
7,8-dihydroxybenzo[a]pyrene formed via the 
corresponding epoxide (2). Assay of the en­
zyme was achieved by measurement of the 
rate of formation of the highly fluorescent 
metabolite, 3-hydroxybenzo[u]pyrene (4).
Previous attempts to solubilize yeast cy­
tochromes P-450 which contain both the P- 
450 and P-448 forms of the enzyme have 
resulted in low yields and heterogeneous 
products. Preliminary studies on a partially 
purified enzyme from an aerobically grown 
baker's yeast were reported by Yoshida (5- 
7), involving a purification procedure using 
aminohexyl Sepharose 4B. We now report 
a method of solubilization and purification 
that involves a novel combination of hydro- 
phobic adsorption and other chromato­
graphic techniques. These use the much 
more efficient affinity material, aminooctyl 
Sepharose 4B, followed by a fast-run­
ning hydroxyapatite-celluiose column. Much 
higher yields are obtained and much less 
conversion to the inactive form (cytochrome 
P-420) occurs in the rapid method employed. 
Preferential elution of the cytochrome P-448 
form of the enzyme was-obtained by the in­
troduction of a final step in the purification 
using DEAE-Sephacel. The cytochrome P- 
450 form of the enzyme remains bound to 
the column, and for its elution a buffer with 
higher ionic strength was needed. Greatly 
enhanced purity of the isolated cytochrome 
P-448 is thereby obtained.
MATERIALS AND METHODS
Preparation of microsomes. Brewer’s yeast 
S. cerevisiae (NCYC 240) was grown at 
30° C for 44 h under glucose repression in 
medium containing 20% glucose, 2% my- 
cological peptone, 1% yeast extract, and 
0.5% NaCl using the method of Wiseman 
and Lim (8). Yeast cells were harvested by 
centrifugation at 2500g for 5 min. They were 
disrupted by a Vibro Mill (9) and then sus­
pended in 0 .1  m potassium phosphate buffer
(pH 7.2), 20% glycerol, 0.001 M EDTA, and 
0.001 M dithiothreitol (hereafter, all phos­
phate buffers are potassium phosphate and 
contain 20% glycerol, and 0.001 m  EDTA 
plus 0.001 m DTT1 are called the additives). 
After removal of the cell debris and nuclear 
material by centrifugation at 7500g for 15 
min, yeast microsomal fraction was obtained 
by centrifugation at 160,900g for 1 h. Mi­
crosomal fraction was suspended in 0.1m 
phosphate buffer (pH 7.2), 0.001 M EDTA, 
and reduced glutathione was added to this 
supension to 0.1% final concentration.
Solubilization method. Microsomal frac­
tion was diluted to 30 mg protein/ml with 
phosphate buffer, pH 7.2> containing the 
additives. A number of ionic and nonionic 
detergents were used to solubilize .cyto­
chrome P-448 in the presence or absence of 
0.1% Triton X-100. Cytochrome P-448 was 
finally solubilized for purification by select­
ing one of these, the ionic detergent sodium 
cholate at a final concentration of 1%-and 
always in the presence of 0.1% Triton X-100. 
Microsomal fraction plus sodium cholate 
was stirred at 4°C for 1 h and was centri­
fuged at 160,900g for 50 min and the su­
pernatant, the solubilized cytochrome P- 
448, was collected.
Purification method. Solubilized cyto­
chrome P-448 was diluted (X3) with 0.1 M 
phosphate buffer (pH 7.2) plus the additives. 
The precipitate at 35-65% sat (NH4)2S04 
(at pH 7.0) was prepared and then sus­
pended in 100 mi of 0.02 M phosphate buffer 
(pH 7.0) plus the additives, 0.5% sodium 
cholate. This suspension was diaiyzed over­
night against 30 vol of 0.01 M phosphate 
buffer (pH 7.0) plus the additives and 0.3% 
sodium cholate. It was subsequently centri­
fuged at. 160,900g and the supernatant was 
mixed with 10 g Bio-Bead SM-2 (prewashed 
with methanol and H20) and stirred for 30 
min before addition to the top of a 2.0 X 4.0- 
cm packed Bio-Bead column. Cytochrome
1 Abbreviations used: DTT, dithiothreitol; SD S. so­
dium dodecyl sulfate.
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TABLE I
S o l u b i l i z a t i o n  o f  C y t o c h r o m e  P-448 f r o m  M i c r o s o m e s  b y  V a r i o u s  D e t e r g e n t s  
w i t h  AND WITHOUT 0.1% TRITON X-100
M icrosom es in the phosphate buffer 
(plus additives)
M icrosomes in the  phosphate buffer (plus 
additives) containing 0.1% T riton  X-100
Detergent
Source of 
microsomes
Cytochrom e F-448 
(n m o l/m l)
1 C ytochrom e P-4 4 8 / 
cytochrom e /*~420
Cytochrom e /M 4 8  C ytochrom e P-4 4 8 / 
(n m o i/m l) cytochrom e P-420
Sodium  dodecyl sulfate. 
0.3% Yeast 0.15 1 0.25 0.3
Triton X-100, 1% Y east 0.65 22 0.7 26
Emulgen 913. 1% Y east 0.35 10 0.40 4
Sodium  cholate, 1% Y east 0.25 1 0.7 18
Triton  X -100, 1% R at liver 1.4 7 1.4 .  7
Sodium  choiate, 1% R at liver 1.2 6 1.3 6
Note. Y east microsomes contained initially 0.7 nmol cytochrom e P -448 /m l and 0.3 nmol cytochrom e / ’-4 2 0 /m l. and liver 
microsomes from  phenobarbital-induced ra ts  contained 1.3 nmol cytochrom e / ’-4 4 8 /m l and  0.1 nmol cytochrom e / ’-4 2 0 /m l.
P-448 was eluted from the column .by wash­
ing it with 1 column vol of the dialysis buffer. 
The sodium cholate concentration in the cy­
tochrome P-448 solution collected from the 
Bio-Bead column was adjusted to 0.5% and 
this was applied to a 2.4 X 12.0-cm, 8-amino- 
n-octyl-Sepharose 4B column which had 
been preequilibrated with 0.01 M phosphate 
buffer (pH 7.0) plus 0.3% sodium cholate, 
0.001 M EDTA (equilibration buffer). After 
washing the column with the same buffer, 
cytochrome P-448 was eluted with this same 
buffer containing 0.1% Emulgen 911. For 
elution of cytochrome P-450 reductase the 
aminooctyl-Sepharose column was washed 
with this buffer also containing 0.2% deoxy- 
cholate and 2 y.M FMN. Fractions rich in 
cytochrome P-448 were applied to a 1:6 
X 6.0-cm hydroxylapatite-celiulose (1:1, w/ 
w) column preequilibrated with 0.01 m phos­
phate buffer (pH 7.0). The following buffers 
all contained 0.2% Emulgen 911. This col­
umn was washed with 0.03 M phosphate 
buffer (pH 7.0) 4- Emulgen 911, and cyto­
chrome P-450 was eluted with 0.1 m phos­
phate buffer (pH 7.0) 4* Emulgen 911. Cy­
tochrome P-448 fractions eluted from the 
column were combined and diluted (X10) 
with 20% glycerol 4-0.02% Emulgen 911. 
This was then applied to a 1.0 X 5.0-cm car-
boxy methyl-Sephadex C-50 column pre­
equilibrated with 0.01 m phosphate buffer 
(pH 7,0) + Emulgen. After washing the col­
umn with 3 vol of the equilibration buffer 
and also with 3 vol 0.04 m  phosphate buffer 
(pH 7.0) 4- Emulgen, cytochrome P-448 was 
eluted by passing through 0.1 M phosphate 
buffer (pH 7.0) 4* Emulgen. Cytochrome P- 
448 was dialyzed twice against 30 vol 0.005 
M phosphate buffer (pH 7.7) 4- Emulgen, 
each time, for 12 h diluted (X2) with 20% 
glycerol 4* Emulgen, adjusted to pH 7.7, and 
then applied to an 0.85 X 7.0-cm DEAE- 
Sephacel column preequilibrated with the 
above dialysis buffer. Most of the cyto­
chrome P-448 did not bind to the column 
and was eluted first by washing the column 
with some of the equilibration buffer. The 
cytochrome P-450 form bound to the col­
umn and could be eluted with 0.035 M phos­
phate buffer (pH 7.7) 4- Emulgen. Cyto­
chrome P-448 was concentrated by ultra- 
filtration (Amicon PM-30 membrane). 
Emulgen 911 and 913 and Renex 698 were 
applied by Honeywill Atlas Ltd., Surrey, 
United Kingdom.
Assays and electrophoresis. Cytochrome 
P-448 and cytochrome P-420 were measured 
by a method modified from that of the 
Omura and Sato (10) using 91 m M  and 111
(395)
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TABLE 2
P u r i f i c a t i o n  o f  C y t o c h r o m e  P-448 f r o m  Y e a s t  M i c r o s o m a l  F r a c t i o n
Step
Protein
(m g)
Total am ount 
(nm ol)
Cytochrom e P-448
Specific content 
(nm ol/m g protein)
S tage
yield
(% )
T otal 
cytochrom e bj 
(nm ol)
T otal cytochrom e 
P -450 reductase 
(un its)
M icrosom al fraction 7200 266 0.036 100 295 600
(N H 4),SO« 600 230 0.38 86 290 520
Aminooctyl •»
Sepharose 48 20 160 8 70 2.5 4
H ydroxyapatite-
cellulose 10 120 12 75 0.5 1
C M -Sephadex C-50 6.9 100 14.5 83 0 * 0
DEAE-Sephacel 4.1 72 17.5 72- 0 0
•O vera ll yield 27% of microsom al fraction.
cm-1 r a M '1 as extinction coefficients for cy- absorbance changes, used for construction
tochrome F-448 and cytochrome P-420, re- of double-reciprocal plots were those at the
spectively. trough (A^4t5-500 nm).
Cytochrome b5 and cytochrome c reduc- Equilibrium gel filtration of the benzo- 
tase were measured using the method of [a]pyrene cytochrome P-450 complex. Gel
Yoshida et al.(6). filtration was carried out on a small column
SDS-polyacrylamide gel electrophoresis (Pasteur pipet) packed with Sephadex G-25.
(10% gel) was carried out by the method of The column was equilibrated with 0.2 M
Laemmli (11), and protein was determined phosphate buffer (pH 7.0), containing 10%
by the method of- Lowry et al. (12). dioxan (v/v) and benzofajpyrene, before
The measurement of* aryl hydrocarbon each experiment. The benzo[ajpyrene in the
hydroxylase was carried out by the method buffer consisted of a fixed, known amount
of Woods and Wiseman (1) modified from of [G-3H]benzo[a]pyrene and various known
that of Dehnen et al. (4). Instead of micro- amounts of unlabeled benzo(a]pyrene for
somal fraction, a mixture of purified cyto- each experiment. In each experiment after
chrome P-448 and cytochrome P-450 re- the column was equilibrated with benzo-
ductase (1 nmol of cytochrome P-450 to 1 [ajpyrene containing buffer, a 50-/xl sample
U of reductase) was used. was taken and specific radioactivity was de-
Spectral studies on the binding of termined. In each experiment a small volume
benzo[a]pyrene to cytochrome P-448. Bind- of microsomal suspension or purified cyto-
ing spectra of benzo[a]pyrene to microsomal chrome P-450/P-448 (usually 10 pi) was
and purified cytochrome P-450/P-448 were applied to the column and 2-drop (0.06-ml)
recorded using the double-cell technique samples were collected. These samples were
(double-compartment cuvette) in order to counted for radioactivity in a LKB 1210
remove interference from the benzofa]- Ultrobeta Scintillation Counter after adding
pyrene, which absorbs in the wavelength 4 ml of toluene/metapol (2/1, v/v) scintil-
range used (350-500 nm) (3). Spectral ti- lant containing 0.5% 2,5-diphenyIoxazole
trations at fixed wavelength were subjected and 0.2% l,4-bis(5-phenyloxazol-2-yl)-
to a double-reciprocal plot and the spectral benzene (w/v). From the specific radio­
dissociation constant (Ks) and maximum activity of benzo(a]pyrene, the amount bound
absorbance changes were determined. The to enzyme (p) was calculated. The same
(396)
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C ytochrom e P-448 A b so rp tion G
fo rm M axim a (am) (n M " 1 .cm * 1)
' O xidised  • 417, 565, 578 120, 14, 12
R educed 418, 565, 578 78, 12, 11
0 .08 C O -com plex  of
red u ced  fo rm 446, 560 45, 12
0.06 (absolute sp ec tru m ) 
j \  ^ C O -d iffe ren ce
0 .04 V  . . /  \  /  \  sp ec tru m  of 
\  J  V \  red u ced  fo rm
447 -  448, 562 ■92, 20
0 .02
A \
V  / \ \
V  /  \  \
*
400 4S0 500
W avelength (am)
550 600 650
Fid. I. Absorption spectra o f purified Cytochrome P-488 from yeast. Cytochrome P-488 was in 0.005
M potassium phosphate buffer. pH 7.0, containing 20% glycerol, 0.2% Emulgen 9 1 1 .------ , Absolute
spectrum: — , CO-difference spectrum of the reduced form.
amount of cytochrome P-450/P-448 (e) was 
used in repeated experiments as the amount 
of benzo[aJpyrene (c) was increased. Un­
labeled benzo(a]pyrene was obtained from 
the Sigma Chemical Company (London). 
[G-3H]Benzo[d}pyrene was supplied by the 
Radiochemical Centre,. Amersham, Buck­
inghamshire.
RESULTS AND DiSCUSSION
Approximately 1.3 kg yeast was used for 
isolation of purified enzyme. Cytochrome P- 
448 in harvested yeast kept in storage at 4°C 
in 0.1 m phosphate buffer (pH 7.2), 0.001 
M EDTA, 0.001 m mercaptoethanol, and 
15% glucose. This medium prevented dis­
appearance and conversion of cytochrome P- 
448 to cytochrome P-420.
The greatest loss of cytochrome P-448 in 
the presentation of the microsomal fraction 
occurred during the disruption stage, which 
used the water-cooled Vibro Mill.
Cytochrome P-448 in microsomal fraction 
was kept in storage at -40°C for several 
weeks in 0.1 m phosphate buffer (pH 7.0), 
0.001 m EDTA. 0.1% Triton X-100, 0.1% 
reduced glutathione. In comparison, cyto­
chrome P-450/P-448 from rat liver micro­
somal fraction was very stable at —40°C,
when stored only in 0.1 m phosphate buffer 
(pH 7.0) plus the additives.
The thermal stability of cytochrome P- 
448 was greatly improved in the presence of 
Triton X-100 such that its content was un­
changed after incubation at 50°C for 10
TABLE 3
R e c o n s t i t u t i o n  o f  H y d r o x y l a s e  A c t i v i t y  o f  
P u r i f i e d  Y e a s t  C y t o c h r o m e  P - 4 4 8  U s i n g  
BENZO(a)PY R E N £ (7 9  jiM ) AS A SUBSTRATE
Experimental condition V
Full system (Emulgen 911 as a heat
stabilizing factor) 142
Full system (dilauroyl phosphatidylcholine
as a heat-stabilizing factor) 138
Minus cytochrome P-448 10
Minus cytochrome P-450 (c) reductase 13
Minus NADPH-generating system 24
Minus dilauroyl phosphatidyl choline or
Emulgen 911 75
Note. V values are expressed in pmol 3-hydraxy- 
benzo(a)pyrene/h/nmol cytochrome P-448. N A D PH - 
gencrating system consists of N A D P, 4  m M ; glucose 6- 
phosphate, 20 m M : plus 8 units o f  glucose-6-phosphate 
dehydrogenase/ml of the assay mixture. The dilauroyl 
phosphatidylcholine concentration was 30 Mg/ml o f as­
say mixture and alternatively 0.1% (v /v )  of Emulgen 
9 11 was used in the assay mixture.
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Fig. 2. The binding spectrum of benzofajpyrene with purified yeast cytochrome P-448. The 
benzofajpyrene concentration was in the range of 7.9-39.5
min. Without Triton X-100, however, 50% 
of cytochrome P-448 was converted to cy­
tochrome P-420 after incubation at 40° C for 
10 min. Cytochrome P-450/P-448 content 
from rat liver microsomes, in phosphate 
buffer containing the additives, was almost 
unchanged after incubation at 60°C for 
10 min.
Microsomes in phosphate buffer (pH 7.0) 
plus the additives, and also in phosphate 
buffer (pH 7.0) plus the additives and 0.1% 
Triton X-100,' were solubilized by various 
detergents (13), with release of cytochrome 
P-448 as shown in Table I. Good yields of 
enzyme were obtained with both 1% Triton 
X-100 and 1% sodium cholate in the 0.1% 
Triton X-100 containing phosphate buffer 
(pH 7.0) plus the additives only. Using this 
technique, a 100% yield was obtained from 
the yeast microsomal fraction, and the yield 
from the rat liver microsomal fraction was 
93 and 87% with these two detergents, re­
spectively. Sodium cholate (1%) alone gave 
a good yield (80%) from rat liver microsomal 
fraction, but only 36% from the yeast mi­
crosomal fraction. Emulgen 913 (1%) gave 
about 50% yield from the yeast microsomal 
fraction, regardless of the presence of 0.1% 
Triton X-100. Sodium dodecyl sulfate (0.5%) 
gave a very poor yield of cytochrome P-448 
(Table 1). The highest cytochrome P-448/ 
P-420 ratios in the range 22-26 were ob­
tained from yeast microsomal fraction with
1% Triton X-100 compared with a ratio of 
only 7 for the rat liver. Renex 698, Tween 
80, Triton N-101, all at 1% concentration, 
had no (or very little) solubilization effect 
on cytochrome P-448 from yeast micro­
somes. •
Triton X-100 is known to change the spin 
state of cytochrome P-450 from high to low 
spin (14), and has been shown to protect 
some enzymes by formation of micelles, 
which protect the hydrophobic environment 
of the enzyme. Conversely, it has been re­
ported that sulfhydryl reagents (15), or high 
ionic strength of medium (16), cause the spin 
state to change from low to high spin and 
also accelerate the cytochromes P-450/P-
TABLE 4
D a t a  f r o m  t h e  E q u i l i b r i u m  G e l  F i l t r a t i o n  o f  
THE B EN ZO (a)PY REN E CYTOCHROM E P -448  
C o m p l e x  ( P u r i f i e d  E n z y m e  f r o m  Y e a s t )
- c 
(nM )
e
(n m o l)
P
(n m o l)
p/c
(7 )
7 / c
(n M " ‘)
1.25 0.01 0.00028 0.028 0.022
7.59 0 .0 1 0.0019 0.19 0.025
13.93 0.01 0.0032 0.32 0.023
20.27 0.01 0.0033 0.33 0.016
26.62 0 .0 1 0.0042 0.42 0.015
29.50 0.01 0.0051 0.51 0.012
Note, c is concentration of benzo(a)pyrene, e is the 
quantity of cytochrome P-450, and p  is the concentra­
tion of the product.
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448-to-cytochrome P-420 conversion, by 
destroying or removing the suifydryl ligand. 
This suggests that Triton X-100, by chang­
ing the spin state from high to low state and 
retaining it in that state, may protect the . 
suifydryl ligand and make it more accessible 
to heme iron, thus exerting a stabilizing ef­
fect on the cytochromes P-450/P-448.
(NH4)2SO,t fractionation was carried out 
while maintaining the pH at the enzyme pH 
optimum (pH 7.0), as reported by Woods 
and Wiseman (1). At lower pH, (NH^SC^ 
denatured cytochrome P-448, and cyto­
chrome P-420 was formed. The denaturation 
of cytochrome P-448 by high concentration 
of neutral salt was reported by Imai and Sato 
(17); without specifying the pH used, they 
attributed this conversion to the disturbance 
of the hydrophobic environment around the 
hememoiety, either by primary action of the 
neutral salts or by secondary effects due to 
conformational changes in the cytochrome 
P-448 molecule.
Purified cytochrome P-448 had a specific 
content of 16-17.5 nmol/mg protein and 
overall yield of cytochrome P-448 from mi­
crosomal fraction was 27% (Table 2).
There were no changes in the 448-nm peak 
size of the reduced CO-difference spectrum 
after 6 weeks storage of this preparation at 
—40°C, and there was no loss of aryl hy­
droxylase activity after this time.
SDS-polyacrylamide gel electrophoresis 
showed the homogeneous nature of the cy­
tochrome P-448. Using several marker pro­
teins, the molecular weight of cytochrome 
P-448 was estimated to be 55,500. This is 
similar to the molecular weight of cyto­
chrome P-450/P-448 from liver microsomes 
in 3-methylcholanthrene-treated rats (18), 
but is larger than the molecular weight of 
cytochrome P-450 from semianaerobically 
grown baker’s yeast, 51,000 (7). Our mo- 
lecular-weight value defines the specific con­
tent of a 100% pure cytochrome P-448 
as 18 nmol/mg of protein. Therefore, 
the cytochrome P-448 obtained by our pro­
cedure was 88-97% pure and it was found
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D a t a  f r o m  t h e  E q u i l i b r iu m  G e l  F il t r a t io n  o f  
B e n z o (£j ) p y r e n e - C y t o c h r o m e  P - 4 5 0  C o m p l e x  
( P u r i f i e d  L iv e r  E n z y m e  f r o m  P h e n o b a r b i t a l -  
I n d u c e d  R a t s )
c
(nM)
e
(nmol) p  (nmol)
p /c
(7 )
y f c
(nM‘ ‘)
2.5 0.0036 0.000126 0.045 0.018
8.8 0.0036 0.000550 0.152 0.017
15.2 0.0036 0.000794 0 .2 2 0 ’' . 0.013
27.9 0.0036 0.00148 0.310 0.011
Note, c is concentration o f bcnra(a)pyrene, e is the 
quantity of cytochrome P-450, and p  is the concentra­
tion of the product.
not to contain any NADPH-cytochrome 
P-450 reductase, cytochrome bs or cyto­
chrome P-420.
The absolute spectrum of the preparation 
had a Soret peak at 417 nm and showed no 
absorption in the 650-nm region (Fig. 1). 
These features are known to be character­
istic of the low-spin state in cytochrome P- 
450/P-448. Because the Soret peak of the 
reduced CO complex is situated at 447-448 
nm (not at 450 nm), this suggests a simi­
larity between this cytochrome and that 
which is induced by polycyclic hydrocarbons 
in hepatic microsomes. It has been reported 
by Jefcoate et al. (19,20) that cytochrome 
P-448 in an hepatic microsomal fraction 
from 3-methycholanthrene-induced animals, 
predominantly consists of a high-spin form. 
In our work, the cytochrome P-448 was ini­
tially in a mixed-spin state, but as has been 
reported by Yoshida et al., (21) and Fujita 
et al. (22), the treatment of cytochromes P- 
450 with Triton X-100 (or some other non­
ionic detergent, such as Lubrol W X  and 
Triton N-101) changes the spin state of cy­
tochromes P-450 from high- to low-spin 
form.
A major metabolite of the benzo[a]pyrene 
hydroxylase system is 3-hydroxybenzo[aj- 
pyrene (2). This enzyme system required two 
protein components: cytochrome P-450/P- 
448 and NADPH-cytochrome P-450 reduc-
(399)
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tase. The heat-stable factor (phospholipid), 0 03
which has been reported to associate 
with cytochrome P-450 and NADPH-cyto­
chrome P-450 reductase to form an active | ’
enzyme aggregate (23), was not needed in S
our studies for the purpose of reconstitution o.oi 
(Table 3). The residual nonionic detergent 
(Emulgen 911) content of cytochrome P-448 
seemed to suffice for active enzyme recon- o o.i 0.2 0.3 0.4 0.5 o.« 0.7 o.a 0.9 1.0
stitution (24). It was also necessary for flav- r
ine mononucleotide to be present in the _ ■ , „ L J .
, _  . . .  1 . 1 . FrG. 3. Scatchard plot of the equilibrium g e l filtration
buffer which was used to elute the cyto- of the bcnzoW pyrcnc-cytochromes /-4 5 0/M 4 8 com-
chrome P-450 reductase from the aminooc- plex. Closed circles, purified enzyme from yeast; open
tyl-Sephar0Se 4B column, and this was pres- circles, purified liver enzyme from phenobarbital-in-
ent, therefore, in the hydroxylation reaction duced rats,
mixture, where it supplements the action of 
the reductase.
The benzo[a]pyrene concentration was binding spectra was recorded (Fig. 2). The
used in the range 0-79 pM in the series of spectral dissociation constant (AT,) was found
rate determinations in the derivation of the to be 50 /xM for the yeast purified enzyme.
Liheweaver-Burk plot from these hydrox- This value agrees with the Ks value found
ylations. Even high concentrations of ben- by Woods and Wiseman (3) for crude sol-
zo[a]pyrene dissolve in the lipid or detergent ubilized yeast cytochrome P-448, and now
(0.1% Emulgen 911) present. This linear in our purified enzyme there is excellent
plot showed that the Michaelis constant agreement between the values of Kt (50 /xm)
{Km) for benzo[ajpyrene hydroxylation of and Km (33 /xm). The Ks value for the mi-
purified cytochrome P-450 was calculated crosomal cytochrome P-448 from yeast was
at 33 fiM. This value is-much smaller than 18 /xM. Even in purified systems, any dis-
that of the cytochrome P-448 measured in agreement would be due to the complexity 7
situ in the yeast microsomal fraction re- of the benzo[xz]pyrene-metabolizing system,
ported by Woods and Wiseman (1). Our because the K„ values for this system are the
value is similar to that reported for liver en- aggregate of several components: in a case
zyme (23 jxm) by Rickert and Fouts (25) reported by Kratz and Staudinger (27) the
(compare the value for liver enzyme of 1 AT, value for coumarin binding is found to
fiM reported by Robie et al. (26)); we find be 100 times greater than the Km for its
that the V (at 37°C) is 208 pmol 3-hydroxy- metabolism in an animal system.
benzo[a]pyrene formed/h/nmol of cyto- In equilibrium gel filtration of benzo-
chrome P-450. This value is more than 10 [a]pyrene-cytochrome P-450/P-448 com-
times greater than that reported (1,3) for plex, from the values of p, e, and c, thus
the yeast microsomal fraction, indicating the determined, p/e (7) and 7fc were calculated
problem in using an immobilized enzyme (Tables 4 and 5). Using 7 and 7Jc as the
(i.e., microsomal fraction) which includes a x and y axes the Scatchard plots were con-
diffusion effect, when compared with a sue- structed Fig. 3. The value of the number of
cessfully reconstituted system free of lipid. binding sites (n) is the intercept of the 7 axis
In the spectral titration of highly purified and the apparent average association con-
cytochrome P-450/P-448 from yeast and rat stant (k) is the slope.
' liver, the benzo[a]pyrene was used in a con- The nearest whole number values of n,
centration range of 7.9-39.5 ptM, and the determined for yeast microsomal and puri-
(400)
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fied cytochrome P-448, were 6 (as found too 
by Woods and Wiseman (3)) and I, respec­
tively. Yeast microsomal and purified en­
zyme bind 100% to benzofajpyrene so that 
the numbers of binding sites are 6 (micro­
somal) and 1 (purified) per enzyme molecule 
binding to benzo[a]pyrene, respectively. The 
numbers of binding sites for rat liver enzyme 
per molecule binding to benzo[a]pyrene, be­
cause only 16% of microsomal cytochrome 
P-450 and 53% of purified form bind to 
benzofajpyrene, were 6 (0.9 X 100/16) and 
1 (0.5 X 100/53) also (n values were 0.9 and 
0.5, respectively). This is a revision of the 
value of 20 for microsomal fractions calcu­
lated' by Woods and Wiseman (3), which 
was based on underestimates (values of 33% 
for yeast, 5% for liver) of extent of 
benzo(a]pyrene binding.
The apparent association constant (&) ob­
tained for yeast cytochrome P-448 was 0.08 
(microsomal fraction) and 0.027 nM ~' (pu­
rified form). These are equivalent to disso­
ciation constants (Ks) of 1.3 X  i0"8 and 3.7 
X  1CT8 m , respectively. For rat liver cyto­
chrome P-450 the corresponding K values 
are 0.064 and 0.023 mvT1 which are equi­
valent to dissociation constants (Ks). 1.6 
• X  10”8 (microsomal fraction) and 4.3 X*10"8 
M (purified form). The Ks values for the cor­
responding form of enzyme in the two sys­
tems are similar. Low values for all disso­
ciation constants suggest that the binding 
affinity is very high. These Ks values are 
much smaller than the spectral Ks values 18 
(microsomal) and 50 pM (purified) for yeast 
and corresponding values, 5 and 31 pM for 
rat liver.
The extra five binding sites found for 
bound form of enzymes (microsomes) is 
clearly due to high-affinity binding of 
benzo[a]pyrene to the lipid present, as af­
finity is lowered in purified enzyme.
The successful isolation of these small 
quantities (4 mg. 72 nmol) of homogeneous 
cytochrome P-448 from S. cerevisiae (from 
1.3 kg yeast) is the first step in a scale-up 
procedure using the large-scale fermentation
YEAST CYTOCHROME P-448 137
and disruption facilities available. Several 
applications exist for xenobiotic-metaboliz- 
ing cytochromes P-450 from microorgan­
isms (see review by Wiseman (28)). Our im­
mediate aims include a benzo[a]pyrene^  
specific enzyme electrode, employing this 
purified and highly specific cytochrome P- 
448 from S. cerevisiae No. 240. There is now 
considerable interest in the enzyme (29) and 
in yeast test systems for carcinogens using 
cytochrome P-450-containing yeasts (30,31).
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Table \£ J fe c t o fd ie th y l pyrocarbonate on DEAE<ellutose eiuate o f  human gastric mucosa and o f  stomach carcinoma
Proteolytic-activity-modification frwwlytic-activity-modification
Proteolytic rate constants coefficients
Sample activity* (in h '1) (pure numbers)
Normal Mucoaaf
5001 34 * ,« 8 .3 ! ,* ,« 0 C, *  0.68. C; *  0.32
580 15 .4 ,*  11.1, A, =  0.12 C ,* - 3 .9 .  C , *6.1
Adenocarcinoma (C.Z^
300 57.9 4, -2 1 .6 . k , - 0 3 5 C, *  0.44, C ,*  0.105
Adenocarcinoma (A.T.)
345 29.5. A, *23.0. A: *  0.350 C, *  0.50. C, *>0.105
475 49.4 10.0,4; =  0.620 C, *  0.60, Cj *  0.40
585 35.4 4, =  20 .3 ,4 ,*  1.14 C, =  —1.4. C ,* 3 .6
Adenocarcinoma (C.G.)
340 68.1 A, *9 .6 6 ,4 , *0.360 C, *  0.75, C ,*  0.25
' 505 I S —  4 ,*  1.43 —  C, *  0.60
640 2.5 —  — —  —  ‘
* In A 4 ,„  after 30 min o f incubation with haemoglobin, 
t  Average for two independent experiment*.
X The volume of effluent (in ml) corresponding to the peak of proteinase activity (also for all similar designations).
inactivation and/or activation process can be described by the 
equation (Rakitzis, 1977, 1980):
(E 1 /IE 1 ,*  £  C4e-*“  (1)
t-i
where (E l/lE l, is fractional enzyme activity, and t  is reaction 
time. The constants C  and k  were determined graphically 
(Defares & Sneddon, 1960). The results o f the effect o f diethyl 
pyrocarbonate on DEAE-celiulose column-chromatography 
fractions obtained from tw o samples o f  normal gastric mucosa 
and three samples o f stom ach adenocarcinoma are presented in 
summary form in Table 1.
It will be seen from T able I that, in some cases, the value for 
C, is negative and also is greater than unity. In this form, eqn. 
(1) describes a process o f  enzyme activation followed by 
inactivation. The maximum proteinase activation by diethyl 
pyrocarbonate was 400 -500%  o f initial proteinase activity. It 
will also be seen tha t the peak containing the diethyl pyro- 
carbonate-activated enzym e appeared, if at all, at around 580 ml 
o f  effluent produced from  the column. In experiments with 
enzyme from normal hum an m ucosa it was found that fractions
that could be activated with diethyl pyrocarbonate could also be 
activated by exposure to pH 3.5 (T. B. Malliopoulou & E. T . 
Rakitzis, unpublished work). Proteolytic activity at pH 3.5 may­
be due to pepsin 11 produced from pepsinogen 11 (Becker & 
Rapp, 1979), and it is therefore probable that the activation 
effect produced by diethyl pyrocarbonate on fractions obtained 
from normal human gastric mucosa and stomach carcinoma is 
due to an effect o f this compound on pepsinogen II.
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Studies on the procedure to measure accurately the binding properties of benzo[a]pyrene to 
cytochrome P-450/P-448
M AHM OOD R. A Z A R I and ALA N  W ISEM AN 
Division o f  Biochemistry, Department q f  Biochemistry, Univer­
sity  q f  Surrey, Guildford, Surrey GU2 SX H , U Ji.
Problems in the spectral study o f bcnzololpyrene binding to 
cytochrome P-450 (or P -448) have necessitated the search for 
an improved rrethod. A single-cell method was used to measure 
the binding properties o f  bcnzololpyrene to cytochrome P-450 
in rat liver microsomal fraction (Estabrook et al., 1978). The 
double-cell technique has been used previously by us for spectral 
investigation o f bcnzololpyrene binding to cytochrome P-448 
from yeast (.Saccharomyces cerevisiae) (W oods & Wiseman,
1979).
Cytochrome P-448 was solubilized from yeast 
(Saccharomyces cerevisiae) microsomal fraction and purified by 
using methods previously described by Azari &  Wiseman 
(1980) and W iseman &. Azari (1981) respectively. The
microsomal fraction was obtained from yeast cells grown under 
conditions of glucose repression as before (Wiseman & Lim,
1975).
When the binding spectrum o f  bcnzololpyrene to m icro­
somal cytochrome P-448 from yeast was recorded previously in 
this laboratory, a double-cell technique was adapted to remove 
the interference o f bcnzololpyrene, which absorbs in the 
wavelength range used (350-500 nm). Only the bufTcr solution 
was used in one o f the compartments o f  both the reference and 
the sample cuvettes to complement the enzyme solution in 
adjoining compartments. In order to  determine the dissociation 
constant (A',), the results o f spectral titrations at fixed 
wavelength a t a range of benzololpyrene concentrations were 
subjected to  a double-reciprocal plot. In this method the 
absorbance changes were calculated by adding up the spectral 
changes at peak and trough regions o f  the binding spectrum 
(A d ,(7. j n +  to  allow for changes in base-line during
V d . 10
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Table 1. Illustration o f  two alternative double-cell techniques fo r  measurement o f  the spectra! changes a t  different wavelength 
region: peak 3 8 7 -3 7 7 nm and trough 415-500 nm
Cytochrome P-448 was used in phosphate bufler, pH 7.0, containing 20% glycerol and 0.2%  Emulgen 911. Dcnaturation required 
to  eliminate any binding ofbem ololpyrene could be achieved with KOH (final concn. lSmM) a t 100°C  (followed by neutralization).
Sample cell Reference cell
Wavelength employed ,  -...........  . • a _ .... ..............  , % r .......... —   , , —i----------------- %
Peak and trough method
Trough method
Cytochrome P-448 
+benzo(o)pyrene 
Cytochrome P-448 
+benzolalpyrene
Denatured cytochrome 
P-448 + acetone 
Buffer + acetone
Cytochrome P-448 
•f acetone 
Cytochrome P-448 
+ acetone
Denatured cytochrome 
p-448 ♦ benzololpyrene 
Bufler benzololpyrene
the addition o f  benzololpyrene. Others have used only the 
spectral change in the trough region (A sf* ,,.,,,)  o f  the benzo­
lolpyrene binding spectrum but with only a  tingle-cell 
technique (Estabrook e/ oL. 1978).
Non-specific binding, however, produces a  maximum absor­
bance change in the 390-420 nm region (A 4 , . .  +
Ai4m»».«u-5« in this case), that is larger than the ^ b m w '- c m -1, 
the theoretical maximum absorption coefficient, which is 
used to  quantify the spectral change due to benzololpyrene 
specific binding in this region (Ciniti et al., 1979).
We have investigated the use o f a solution o f heat-denatured 
enzyme (devoid o f cytochrome P-450/P-448 o r o f cytochrome 
P-420) instead o f  the bufler in our double-cell method. 
Benzololpyrene (dissolved in acetone) was added to the 
active-enzyme compartment o f the sample cuvette and the 
inactive-enzyme compartment o f the reference cuvette. In 
addition, another series of readings were m ade against 
denatured cytochrome P-448 and phospholipid (instead o f 
active enzyme) with bufler in other cells in the double-cell 
method. O ur results indicate that (I )  non-specific binding is 
possibly the binding o f benzololpyrene to the phospholipid 
content o f the enzyme, and (2) this non-specific binding to 
phospholipid increases only the absorbance changes in the 
3 6 7 -3 8 7 nm region (i.e. at peak wavelength) and does not effect 
the spectral changes in the 4 15 -5 0 0 nm trough region.
Therefore, if  die A 4 mtl a t 415nm  is taken  to  determine the 
concentration o f cytochrom e P-448-benzo(alpyrene complex 
by using 57mM“ l *cm "1 as an absorption coefficient (Estabrook 
& Werringloer, 1978), it is not necessary to  use denatured 
enzyme in our double-cell technique as a reference to  eliminate 
the effect o f non-specific binding (Table 1). Spectral changes at 
this trough wavelength (415nm ) are due only to  the binding o f 
cytochrome P-448 to  benzololpyrene.
The substrate dissociation constant (K ,)  w as found to  be the 
same whether A 4 ) ,7. )TT+ A 4 4„ _ jM was used in the double- 
reciprocal plot (against benzolalpyrene concentration) or 
whether only the values were employed.
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Spectral comparisons of banzo[a]pyrene binding to cytochrome P-450/P-448 in microsomal 
fractions and in highly purified form
M AHM OOD R. AZA R I and ALAN W ISEM AN 
Division o f  Biochemistry, Department ofBiochemistry, Univer­
sity  o f  Surrey, Guildford, Surrey GU2 5XH , UJC.
The binding o f benzololpyrene to cytochrome P-450 has been 
shown by the production o f a novel type-I binding spectrum 
when microsomal P-450 from either rat liver (Estabrook et al., 
1978) o r yeast (Saccharomyces cerevisiae) (W oods & 
Wiseman, 1980) was used. We now report further studies on the 
binding properties o f benzololpyrene to microsomal and highly 
purified cytochrome P-450/P-448 from both the above- 
mentioned sources.
Saccharomyces cerevisiae (N.C.Y.C. 240) was grown for 
44 h under glucose repression in medium containing 20% 
glucose and mycological peptone and yeast extract by the 
method described previously (Wiseman &. Lim. 1975). Yeast 
microsomal fraction was separated, and cytochrome P-448 was 
solubilized from it (Azari & Wiseman, 1980). Yeast cyto­
chrome P-448 was purified to  homogeneity (97%  pure) 
(Wiseman & Azari, 1981).
The concentration o f cytochrome P-450/P-448 was deter­
mined by a  spectrophotometric method (Omura et al., 1965).
The binding spectrum o f benzololpyrene with microsomal 
and purified cytochrom e P -450/P-448 was recorded by using a 
double-cell technique (Azari &  W iseman, 1982). Spectral 
titrations a t fixed wavelength were subjected to  a  double­
reciprocal plot, and the spectral dissociation constant (AT,) and 
maximum absorbance changes were determined (Fig. 1). The 
absorbance changes used for construction o f  double-reciprocal 
plots were those a t the trough (A 4 4I3. J<)0) (Azari & Wiseman, 
1982).
Purified enzymes from both system s produced type-I spectral 
changes with benzololpyrene, and the extra peak appeared a t 
367 nm instead o f  a t 360 nm as with microsomal fractions.
The values obtained for dissociation constants were 5pM  for 
microsomal fraction and 31 pM for purified cytochrome P-450 
from liver o f  phenobarbital-induced ra t, and 18/jm for micro­
somal fraction and 50 pM for purified cytochrom e P-448 from 
yeast (Fig. 1). These results should be compared with those 
reported previously, namely 0.8 pM (Estabrook et al., 1978) and 
9pM (W oods & W iseman, 1979) for hepatic microsomal 
cytochrome P-450 from phenobarbital-induced rats, and 36 /a i 
(W oods & W iseman, 1979) for microsom al cytochrome P-448 
from yeast.
1982
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• Fig. 1. Comparison c f the benzo\a]pyrene-binding properties of 
cytochrome P-450fP-448 (M) microsomal fraction and (P) 
purified form
Benzololpyrene final concentration range was 7 .9-39.5pM. The 
concentration o f  these enzym es was 0 .7pM, and specific 
contents were 17.5 nm ol/m g (purified enzyme from yeast) and 
about 12 nmol/mg (Purified enzyme from ra t liver). Six portions 
o f benzololpyrene (2 m g/m l, in acetone) were added success­
fully.
The dissociation constant values obtained showed that, 
although the affinity o f cytochrom e P-450/P-448 for benzola]- 
pyrene is relatively high Qjc. low K t  values), the unusual ability 
to  achieve stoicheiometric titration o f cytoehrome P-450 by 
benzololpyrene tha t was dem onstrated for rat liver microsomal 
fraction (Estabrook et al., 1978) is not achieved here (especially 
for purified enzymes). A stoicheiometric titration (1:1 molar 
ratio) would require K % values o f about 0.2 pM and 0.4 pM for 
purified cytochromes P -450 (rat liver) and P-448 (yeast) 
respectively. Purified enzyme apparently has lost high-affinity 
binding capacity to benzololpyrene and has only one binding 
she (Wiseman &  Azari, 1982).
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It was found that 100% o f yeast purified cytochrome P-448 
and 53% o f rat liver purified cytochrome P-450 reacted with 
benzololpyrene, as shown by comparison o f benzololpyrene- 
binding absorption with CO-binding absorption. When micro­
somal fractions were used in place o f  purified enzymes, the 
corresponding values were 100% and 16% respectively. The 
absorption coefficient used for determination o f concentration o f 
benzolojpyrene-cytochrom e P-450/P-448 complex was 
57m M "'-cm _l for A d 413. JOO (Estabrook <fc W erringloer, 1978). 
The fact that a high percentage o f the cytochrome P-450/P-448 
in purified form reacts with benzololpyrene is not surprising, as 
much of the purified yeast cytochrome P-448 (M. R. Azari &. A . 
Wiseman, unpublished work) and purified hepatic cytochrome 
P-450 from phenobarbital-induced rats (Gibson & Tamburini,
1980) is found to  be in the low-spin state, which readily 
combines with type-I substrates such as benzololpyrene.
Purified and microsomal hepatic cytochrome P-450 from pheno- 
barbital-induced rats was generously given by our colleagues Mr. P. 
Tamburini and Dr. G. G. Gibson. We thank them too for most helpful 
discussions and advice.
Azari. M. R. & Wiseman, A. (1980) Biochem. Soc. Trans. 8,713-714 
Azari, M. R. & Wiseman, A. (1982) Biochem. Soc. Trans. 10.000-000 
Estabrook. R. W. Sc. Werringloer, J. (1978) Methods Enzrmol. 52. 
212-221
Estabrook R. W„ Werringloer, J., Capdevila. J. & Prough, R. A. 
(1978) in Polycyclic Hydrocarbons and Cancer (Gelboin. H. V. & 
Ts‘0 , P. O. P.. eds.), voi. 1, pp. 285-319. Academic Press. New York 
Gibson. G. G. & Tamburini, P. (1980) in Biochemistry, Biophysics and 
Regulation o f Cytochrome P-4 SO (Gustafsson. J. A.. Carlstedt, 
Duke. J., Mode. A. & Rafter, J.. eds.), pp. 133-136. Elsevier/ 
North-Holland Biomedical Press, Amsterdam 
Omura, T„ Sato, R., Copper, D_, Rosenthal, O. & Estabrook. R. W.
(1965) Fed. Froc.Fed.Am. Soc. Exp. Biol. 2 4 .1181-1189 
Wiseman, A. & Azari, M. R. (1981) Abstr. Congr. Eur. Fed.
Biotechnol. 2nd 172 
Wiseman. A. & Azari, M. R. (1982) Biochem Soc. Trans. 10.000-000 
Wiseman. A. L  Urn, T. K. (1975) Biochem. Soc. Trans. 3,974-977 
Woods, L. & Wiseman. A. (1979) Biochem. Soc. Trans. 7,124-127 
Woods, L. & Wiseman, A. (1980) Biochim. Biophys. Acta 613,52-61
A study of beiizo[a]py rene binding to m icro so m al and highly purified cytochrome 
P-450/P-448 by equilibrium gel filtration
ALAN W ISEM AN and M A H M O O D  R . AZA RI 
Division o f  Biochemistry, Department ofB iochem istry, Univer­
sity o f  Surrey, Guildford, S urrey  G U 25X H , UJC.
A spectra] study o f benzol olpyTene binding to  cytochrome 
P-4S0/P-448 has been reported by W oods & W iseman (1979) 
and Azari & Wiseman (1982). We now report further 
investigation on benzololpyrene interaction with microsomal 
and purified hepatic cytochrom e P-450 (phenobarbital-induced 
rats) and cytorhrom e P-448 (Saccharomyces cerevisiae) by 
using the method o f equilibrium gel filtration (Hummel & 
Dteyer, 1962). This m ethod has hitherto been used for 
investigation o f such interaction only With the microsomal 
fractions by Woods & Wiseman (1980).
Cytochrome P-448 was purified from yeast grown under 
glucose repression (W iseman & Azari, 1981). Gel filtration was 
performed on a small colum n (Pasteur pipette) packed with 
Sephadex G-25. The column was equilibrated with 0.2 m- 
phosphate buffer, pH  7.0, containing 10% (v/v) dioxan and 
benzololpyrene before each experiment. The benzololpyrene in 
the buffer consisted o f  a  fixed known amount o f  (G-
VoLlO
’Hlbenzolalpyrene and various known am ounts o f unlabelled 
benzololpyrene for each experiment. In each experiment after 
the column was equilibrated with benzololpyrene-containing 
bufTer, a 5 0 /i  sample was taken and the specific radioactivity 
was determined. In each experiment a  small volume o f 
microsomal suspension o r purified cytochrome P-450/P-44& 
(usually lOpl) was applied to  the column, and 2-drop (0.06 ml) 
samples were collected. These samples were counted for 
radioactivity in an LKB 1210 U ltrobeta scintillation counter 
after addition o f 4 ml o f  toluene/M etapol (2 :1 , v/v) scintillant 
containing 0.5% 2,5-diphenyioxazole and 0.2%  l,4-bis-(5- 
phenyloxazol-2-yl)benzene. From the specific radioactivity o f 
benzololpyrene, the amount bound to  enzyme (p ) was calcu­
lated. The same amount o f  cytochrome P-450/P-448 (e) was 
used in repeated experiments as the amount o f  benzololpyrene 
(r) was increased. From the values o f p . e  and c, thus 
determined, p /e  (y) and y /c  were calculated, and by using y and 
y/c as the x  and y  axes the Scatchard plots were constructed. 
The value o f the number o f binding sites (n) is the intercept on 
the y axis, and the apparent average association constant (X) is 
the slope.
(405)
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The nearest-whole-number values o f n determined for yeast 
microsomal and purified cytochrome P-448 were six (as found 
too by Woods & Wiseman, 1980) and one respectively. Yeast 
microsomal and purified enzyme bind 100% to benzololpyrene, 
so that the number o f binding sites is six (microsomal) and one 
(purified) per enzyme molecule binding to benzololpyrene. The 
number o f binding sites for rat liver enzyme per molecule 
binding to benzololpyrene, because only 16% o f microsomal 
cytochrome P-450 and 53% o f purified form bind to  benzo[ol- 
pyrene (Azari & Wiseman, 1982), was six (0.9 x 100/16) and 
one (0,5 x 100/53) also (n  values were 0.9 and 0.5 respectively). 
This is a revision o f the value of 20 for microsomal fractions 
calculated by Woods & Wiseman (1980), which was based on 
underestimates (values o f  33%  for yeast; 5%  for liver) o f  extent 
o f benzololpyrene binding (see modified technique; Azari & 
Wiseman, 1982).
The apparent association constant (AT) obtained for yeast 
cytochrome P-448 was 0.08 nM*' (microsomal fraction) and 
0.027 nM_l (purified form). These are equivalent to  dissociation 
constants (K ,) o f 1.3 X 10~*m and 3.7 x 10"*m respectively. For 
ra t liver cytochrome P-450 the corresponding K  values are 
0.064 nM“* and 0.024 nM-1, which are equivalent to dissociation 
constants (K ,) o f 1.6 x 10"*m (microsomal fraction) and
4.3 x I0"*m (purified form). The K t values for the corre­
sponding form o f enzyme in the two systems are similar. Low 
values for all dissociation constants suggest that the binding
affinity is very high. These values are much smaller than the 
spectral Kt 18/jm (microsomal) and 50/jm (purified) for yeast-  
and the corresponding values 5 po* and 31 (04 for rat liver (Azari 
&  Wiseman, 1982).
Lipid-bound enzymes (the microsomal fractions in both 
systems) have higher affinity than purified enzyme for benzolol­
pyrene (i.e. lower K % values) and give a  stoicheiometry o f 6:1 
(yeast) and 1:1 (rat liver). W hen the amount o f cytochrome 
P-450/P-448 th a t binds to  benzololpyrene is considered, the 
number o f binding sites found for microsomal fraction o f both 
systems is six. The extra  five binding sites found for the bound 
form o f the enzymes is dearly  due to  high-affinity binding o f 
benzololpyrene to  the lipid present, as affinity is lowered In 
purified enzyme.
Purified and microsomal hepatic cytochrome P-450 from pheno­
barbital-induced rats was generously given by our colleagues Mr. P. 
Tamburini and Dr. C. G. Gibson. We thank them too for most bdpfvS 
discussion and advice.
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Poly(hexamethylenebiguanide hydrochloride), a novel cationic complexating agent for the 
assay of acidic polysaccharides
JO H N  F. K EN N ED Y , S. ALAN BARKER and 
IAN J. B R A D S H A W
Research Laboratory fo r  the Chemistry o f  Bioactive Carbo­
hydrates and Proteins. Department o f  Chemistry, University 
o f  Birmingham, Birmingham B IS  2TT , UJC.
The lack o f a standard assay method suitable for the 
quantitative determination o f  a range o f acidic polysaccharide 
has been a continuing problem for a number o f years. 
Colorimetric methods employing reagents such as phenol 
(Dubois et a l ,  1965), carbazole (Dische, 1947; Bitter & Muir, 
1962) and m-hydroxydiphenyl (Biumenkrantz & Asboe- 
Hansen, 1973) have been used, but all suffer the disadvantage 
that various responses with different sugars are obtained. 
M ethods based on the evolution o f C O , have been developed in 
the past for carboxylated polysaccharides (National Research 
Council, 1972), but the procedure is laborious and preliminary 
purification o f the sample is sometimes necessary before 
analysis. In the present work we set out to  resolve the difficulties 
surrounding the aforementioned analytical problem.
Recently, we discovered (Kennedy et a l ,  1981) a novel 
cationic polymeric precipitating agent, PHM BH+Cl“, t  which 
was found to undergo a cross-linking reaction with a wide range 
o f acidic polysaccharides in aqueous solution. In particular, this 
reaction was found to be suitable for the isolation of xanthan 
gum, the polysaccharide produced by Xanthomonas 
campestris. Further application o f this same precipitating agent 
has resulted in the development o f a rapid method for the assay 
of acidic polysaccharides.
The new assay is based on the addition o f an excess amount 
o f PHMBH*C1" to solutions o f polysaccharide to quantita­
tively precipitate the sample and thereafter measuring the u.v.
• Present Address: Department of Microbiology, University of 
Edinburgh. Edinburgh EH9 3JG, Scotland. U.K.
t  Abbreviation: PHMBH*G~,poly(hexamethylenebiguanide hydro­
chloride).
absorption o f  the residua] complexating agent present in the 
supernatant. The procedure is carried out as follows. To a 
portion (5 ml) o f sample, PH M BH +C1~ solution (0.3% ; 10ml) in 
1% sodium acetate is added and the mixture agitated for 5 min 
to  allow formation o f  the acidic polysaccharide-PH M BH * 
complex. After removal o f  the form ed complex from solution
2 0.8 
' C|
| 08
x
0*
Polysaccharide precipitated (mg)
Fig. 1. Comparison q f  the responses o f  -various acidic poly­
saccharides to  the PH M B H *C t~  assay
Symbols: A , xanthan; A, jc-carrageenan; □ ,  chondroitin 
4/6-sulphate; ■ , sodium alginate. Values in parenthesis in the 
Figure art? the acidic g roup/sugar molecule ratios.
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THE INDUCTION OF CYTOCHROME P-448 DEPENDENT BENZO(a)PYRENE 
HYDROXYLASE IN SACCHAROMYCES CEREVISIAE
David J. King, Mahmood R. Azari and Alan Wiseman
Biochemistry Division, Department of Biochemistry, University of Surrey, 
Guildford, Surrey, U.K.
Received February 18, 1982
When grown in high concentrations of glucose, the yeast Saccharomyces 
cerevisiae produces a microsomal cytochrome P-450 monooxygenase system which 
is capable of hydroxylating benzo(a)pyrene. The addition of benzo(a)pyrene to the 
yeast during growth causes only a small increase in cytochrome P-448 levels but 
results in a dramatic improvement in the apparent kinetics of benzo(a)pyrene 
hydroxylation as measured by a decrease in the Michaelis constant and an increase 
in maximal velocity. Dimethylnitrosamine, phenobarbital and
3-methylcholanthrene also induce this enzyme to various degrees. Yeast 
pretreatment with 8-naphthoflavone did not affect this enzyme, yet pretreatment 
with lanosterol resulted in a decreased affinity for benzo(a)pyrene. The addition of 
benzo(a)pyrene to yeast growing at low glucose concentration does not induce 
cytochrome P-448. The implications of these findings with regard to the presence, 
of multiple forms of cytochromes P-448/P-45Q in yeast are briefly discussed.
INTRODUCTION
The yeast Saccharomyces cerevisiae possesses a microsomal cytochrome 
P-450 dependent mdnooxygenase system with many properties in common with that 
found in mammalian liver (1,2). This yeast enzyme system exhibits aryl 
hydrocarbon hydroxylase activity towards benzo(a)pyrene, the major metabolites 
being 3-hydroxybenzo(a)pyrene, 9-hydroxybenzo(a)pyrene and 7,8-dihydro- 
7,8-dihydroxybenzo(a)pyrene (3). We have found the absorption peak of this 
enzyme in the reduced carbon monoxide difference spectrum to be at 448 nm.
The production of cytochrome P-448/P-450 in Saccharomyces cerevisiae 
occurs under fermentative conditions where mitochondrial cytochrome a+a^ 
formation is repressed, for example anaerobic conditions or at high glucose 
concentrations (4,5). There is now evidence to suggest that the intracellular 
concentration of cyclic AMP controls the de novo synthesis of cytochrome 
P-448/P-450 in S. cerevisiae by repression, the level of 
cyclic AMP being determined by the glucose concentration in the growth medium
0 0 0 6 - 2 9 I X /8 2 /G 7 1 1 1 5 -0 7 S 0 1 .0 0 / 0  
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in an inverse relationship (6). This is supported by the direct relationship between 
cyclic AMP . and cytochrome a+a  ^ levels and their inverse relationship to 
cytochrome P-448/P-450 levels at various glucose concentrations (7). Karenlampi, 
et al. (8) have recently supported the need for fermentable sugar to be present 
before cytochrome P-448/P-45Q is produced.
The induction of mammalian cytochrome P-450 monooxygenase systems by
* %
various compounds has been very widely studied and is now beginning to be
explained in terms of multiple forms of the enzyme. Two of the most widely
studied inducers, phenobarbital and 3-methylcholanthrene induce different form3 
of the enzyme. Phenobarbital induces a form with a very wide specificity whereas 
3-methylcholanthrene induces a form with relatively narrow specificity, 
cytochrome P-448 (9). It is now known that cytochrome P-450 exists in more than 
two different forms. The evidence for this comes, for example, from studies with 
inducers, isolation and purification of different forms, immunological studies and 
kinetic and binding studies (10). Multiple forms of cytochrome P-450 exist with 
different but overlapping substrate specificities.
MATERIALS AND METHODS
Saccharomyces cerevisiae (NCYC No.24Q) was grown batch wise by the 
method previously described by Wiseman, et al. (6). Growth was for 44 hours in a 
medium containing 1% yeast extract, 2% mycological peptone and usually 20%
glucose. Inducing agents were added at the beginning of the growth period
dissolved in a small amount of dimethylformamide. An equivalent amount of 
dimethyiformamide was added to control experiments.
Microsomal preparations were obtained by differential centrifugation after 
disruption of yeast in a Vibromill disrupter by a method already described (11). 
Microsomal preparations were resuspended in 0.1 M potassium phosphate buffer 
pH 7.2 containing 20% glycerol, 0.001 M EDTA and 0.001 M dithiothreitol by use of 
a hand held Potter type homogeniser.
Cytochrome P-448/P-450 was determined by Ihe method of Omura, et 
al. (12) using an extinction coefficient of 91 mM" cm ' .
The measurement of benzo(a)pyrene hydroxylase was achieved by detecting 
the amount of 3-hydroxybenzo(a)pyrene produced by the fiuorimetric method of 
Dehnen, e ta l. (13) as modified by Wiseman and Woods (3).
RESULTS
The addition of benzo(a)pyrene to yeast growing in a medium containing 20% 
glucose affected the apparent kinetics of benzo(a)pyrene hydroxylation and also the
1 1 16
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TABLE 1: Induction o f 8enzo(a)pyrene Hydroxylase with
Benzo(a)py rene
Benzo(a)pyrene
Concentration
pM
Cytochrom e P-448  
nm oles/g w et w eight yeast
Km
pM
Vmax
pm oles
3-hydroxybenzo(a) 
pyrene/hour/n m ole  
P -448
0 3.36 + .24 111 167
16 3.66 + .41 100 220
32 3 .4 3 +  .31 65 333
63 3 .9 5 +  .14 56 500 •
95 4.36 + .23 42 444
190 + 32 580
Values o f cytochrom e P -448 are quoted + standard deviation , n = 8 .
* Thi3 concentration o f benzo(a)pyrene resulted in precipitation o f benzo(a)pyrene  
which interfered w ith the cytochrom e P -450 assays rendering them invalid.
level of cytochrome P-448/P-450 in the yeast (Table 1). The level of cytochrome 
P-448/P-450 as measured by carbon monoxide-reduced difference spectra of yeast 
suspensions was slightly higher in yeast treated with benzo(a)pyrene at high 
concentrations. The kinetics of benzo(a)pyrene hydroxylase activity as supported
V m ax 600
100 - 500
- 4 0 0
300 g60 ~
4 0 “ “  200
2 0 - “ 100
o.0 50 100 150 200
B enzo(a)py rene  C o n cen tra tio n  in G row th M edium  ( *M)
FIGURE 1: B en zo ta lp y ren e  Induction of the K inetic  P a ra m e te r s  of B en zo la )p y ren e  H y d ro x y la se
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TABLE Z: E ffe c t of Inducing Agents on Cytochrom e P -448 and
Benzo(a)pyrene Hydroxylase in Y east
Pre treatm ent Cytochrom e P -448  
nrnoles/g w et w eight yeast
Km
yM
Vmax
pm oles
3-hydroxybenzo(a) 
pyrene/hour/n m ole  
P-448
None 3.36 + .24 111 167
Qirnethylnitrosainine .108 yM 3.98 + .38 . 59 588
Dim ethylnitrosam ine 324 yM 4.64 + .38 40 476
3-M ethylcholanthrene 30 yM 3.48 + .27 27 154
3-M ethylchalanthrene 90 yM 3.32 + .35 20 174
Phenobarbital 32 yM 3.50 f .24 80 278
0 -Naphthaflavone 30 yM 3 .8 0 +  .38 114 182
Lanasterol 19 yM 3 .6 2 + .4 2 250 200
Values o f cytochrom e P-448 are quoted + standard deviation, n = 8 .
by NAD PH were investigated in microsomal fraction by means of double-reciprocal 
Lineweaver-Burke plots. The results show clearly that benzo(a)pyrene 
pretreatment of yeast results, in a lower Michaelis constant (Km) vi.e. higher 
affinity for benzo(a)pyrene and a higher maximal velocity (V ). These effects 
were clearly dependant on the concentration of benzo(a)pyrene in the medium 
(Table 1, Fig.l).
Yeast grown in 0.5% glucose containing medium usually contains no 
cytochrome P-448/P-45G. In an attempt to induce benzo(a)pyrene hydroxylase 
activity in yeast growing at low glucose concentration we added benzo(a)pyrene. 
We were unable to induce the production of cytochrome P-448/P-45Q in this 
growth medium even in the presence of a high concentration (95 yM) of 
benzo(a)pyrene.
Table 2 shows the effect of several other compounds on yeast cytochrome 
P-448/P-450 levels and the kinetics of microsomal benzo(a)pyrene hydroxylase. 
Pretreatment with dimethylnitrosamine appears to have a similar effect to 
pretreatment with benzo(a)pyrene in that the level of cytochrome P-448/P-45Q is
11 18
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slightly increased, the K for benzo(a)pyrene 13 decreased and the V value 3 ' m max
increased. Higher concentrations of dimethylnitrosamine are necessary to achieve
the same extent of induction as with benzo(a)pyrene. Yeast pretreatment with
3-methylcholanthrene is interesting as this results in no change in cytochrome
P-448/P-450 levels and no change in the V value yet a large decrease in >■<. max ‘ 3 m
for benzo(a)pyrene is observed. Phenobarbital also has no effect on yeast
cytochrome P-448/P-450 levels but improves both K and V for this enzyme.m max
Pretreatment of yeast with B-naphthoflavone has no effect on either 
cytochrome P-448/P-450 levels or benzo(a)pyrene kinetics. The addition of 
lanosterol to the yeast growth medium results in a higher for benzo(a)pyrene
than the control value and a slightly higher Vmax* in this case the affinity for 
.benzo(a)pyrene is reduced possibly due to induction of a different form of the 
enzyme to that induced by benzo(a)pyrene.
• DISCUSSION
Benzo(a)pyrene is well known as an inducer of benzo(a)pyrene hydroxylase in 
mammals, where similar effects to those reported here on the kinetics of this 
enzyme have been shown (14,15). This induction has been shown to be due to the 
selective induction of a form (or forms) of cytochrome P-450 with a high activity 
towards benzo(a)pyrene hydroxyiation, cytochrome P-448. This form of 
cytochrome P-450, which is also induced by 3-methylcholanthrene, is known to 
have a relatively narrow substrate specificity and to activate carcinogens such as 
benzo(a)pyrene, to metabolicaily active products. The results presented in this 
report suggest the induction by benzo(a)pyrene of a similar form of cytochrome 
P-450 with a high activity towards benzo(a)pyrene in the yeast Saccharomyces 
cerevisiae.
The inability of benzo(a)pyrene to induce cytochrome P-448 in yeast grown in 
a low glucose medium shows that a high glucose concentration, or conditions 
leading to a similar physiological state such as anaerobic conditions, is a 
prerequisite for cytochrome P-448 production. This would be as expected if the 
production of cytochrome P-448/P-450 was being controlled by the presence of 
cyclic AMP by repression as has been suggested (6). It would seem therefore that a
1119
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high glucose concentration lowers the level of cyclic AMP which allows 
cytochrome P-448 to be produced. The'induction observed with benzo(a)pyrene is 
due to an effect on the amount of a particular form of cytochrome P-448 
produced.
The addition of dimethylnitrosamine to yeast also showed considerable 
induction of benzo(a)pyrene hydroxylase in a similar manner to benzo(a}pyrene, 
suggesting that this compound was inducing the same form Of the enzyme as 
benzo(a)pyrene. 8-Naphthoflavone has been reported to indUfce a form of 
cytochrome P-450 in mammalian systems with a very high turnover number far 
benzo(a)pyrene which has an absorption maximum in the carbon monoxide-reduced 
difference spectrum at 446 nm and was hence termed cytochrome P-448 (16). 
However, we have been unable to demonstrate any induction of benzo(a)pyrene 
hydroxylase with this compound in Saccharomyces cerevisiae.
Pretreatment of yeast with 3-methylcholanthrene, a classical inducer of the 
cytochrome P-448 system in mammalian liver, was expected to induce 
benzo(a)pyrene hydroxylase also. A large decrease in Km was observed suggesting 
a higher affinity form of the enzyme yet no change in maximal velocity occurred. 
Phenobarbital, a classical inducer of the wide specificity cytochrome P-450 form 
in mammals did induce benzo(a)pyrene hydroxylase to some extent.
Lanosteral is thought to be an endogenous substrate for cytochrome 
P-448/P-450 in Saccharomyces cerevisiae (17). The addition of this compound to 
yeast media during growth resulted in a decreased affinity for benzo(a)pyrene, 
showing that the induction of another form of cytochrome P-450 could be 
occurring.
The presence of multiple forms of cytochrome P-448/P-45G in 
Saccharomyces cerevisiae is previously unreported although we have some evidence 
from purification studies of at least two forms present in uninduced yeast (18). 
The results of this study suggest that multiple forms of cytochrome P-448/P-450 
exist in 5accharomyces cerevisiae and extends the list of properties that the 
enzyme from this eukaryotic source shares with the mammalian system.
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P-448 from Saccharomyces cerevisiae 
using permeabilized whole cell, 
microsomal fraction and highly 
purified reconstituted forms, with 
benzopyrene-3-monooxygenase 
activity
Mahmood R. Azari and Alan Wiseman
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Cytochrom e P-448 from  Saccharomyces cerevisiae in permeabilized whole cell, microsomal fraction  
and in a highly purified reconstituted benzopyrene-3-monooxygenase (EC 1.14.14.1) system  have 
been immobilized on various supports. Calcium alginate was fo u n d  to  be especially useful and the  
kinetics o f  hydroxylation were close to that o f  the free enzym e system  w ith  ail three form s o f  
enzyme, even with permeabilized whole yeast cells (V max o f  664 pm ol 3-hydroxybenzo(& )pyrene  
produced per h per nm ol cytochrom e P-448 compared w ith 1000 fo r  free highly purified  
reconstituted enzym e system). Only the highly purified reconstituted fo rm  war successfully  
immobilized by BrCN-activated Sepharose-4B or by acrylamide. Both o f  these supports stabilized  
the highly purified reconstituted cytochrom e P-448 benzopyrene-3-monooxygenase activity in 
prolonged storage at 4°C. Applications fo r  various immobilized enzym es and cells are assessed.
Keywords: Chemical kinetics; cytochrome /M48; Saccharomyces cerevisiae; benzopyrene* 3-monooxygenase; 
immobilized enzyme; immobilized cells
Introduction
The importance o f  cytochrom e P-450/P-448 in the 
metabolism of drugs and xenobiotics is well known. We 
have already reported the occurrence o f  cytochrom e P-448 
in Saccharomyces cerevisiae along w ith a procedure for its 
solubilization and purification, and we have reported the 
m etabolites and kinetics of its benzopyrene-3-monooxy- 
genase (EC 1.14.14.11.1' 3
Immobilization prior to  application o f this enzyme has 
been attem pted by various workers. Schuber e ra /.4 have 
immobilized hepatic microsomal cytochrome P-450 by 
gelatin to construct an enzyme electrode for measurement 
o f oxygen uptake by this enzyme system. Bruner et al.5 
have immobilized purified reconstituted hydroxylase 
enzyme system to BrCN-activated Sepharose-4B and also 
by copolytncrization in acrylamide for the purpose o f 
increasing the stability. The simultaneous immobilization 
of cytochrome P-450 mononxygcnase system and glue- 
uronyl transferase to achieve the hydroxylation and subse­
quent glucuronidation o f lipophilic compounds has been 
reported by Lehman c ta l*  Several o ther workers have
also immobilized this enzym e in m icrosomal form on 
to  solid supports.7-9
We report here some procedures for the im mobilization 
o f  our yeast enzym e in permeabilized whole cell, in micro­
somal fraction and in purified reconstituted monooxygenase 
system. The feasibility o f  these m ethods is evaluated 
by comparison o f  the kinetics o f  benzopyrene-3-mono- 
oxygenase activity and the stability in storage o f  these 
immobilized forms which are derived from preparations at 
different levels o f  purification effort on this cytochrom e 
P-448 from Saccharomyces cerevisiae.
Materials and methods
Sodium cacodylate and BrCN were purchased from Aldrich 
Chemical Co. Dilauroyl phosphatidylcholine, dimethylamino- 
propionitrile. dithiothreitol. agarose-concanavalin A. micro- 
crystalline cellulose and sodium etiolate were obtained 
from Sigma Chemical Co. Sodium alginate and glutaralde- 
hyde were obtained from BDH Chemicals Ltd. Acrylamide. 
.V.V-methvlenc-bisacrvlamide and am m onium  persulphate
(414)
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were obtained from BioRad Lab. Sepharose-4B was from 
Pharmacia Fine Chemicals.
Permeabilization o f  yeast cells
Brewer’s yeast Saccharomyces cerevisiae (NCYC No. 240) 
was grown at 30°C for 44  h  under glucose regression in a 
medium containing 20% glucose, 2% mycological peptone, 
1% yeast ex tract and 0.5% NaCl, using the m ethod o f  
Wiseman and Lim.1 Yeast cells were harvested by centri­
fugation a t 25 0 0 g for 5 min. Cells were permeabilized using 
a m ethod described by Murakami et a l.,1? in which to  1 g 
o f packed yeast suspended in 4  ml 0.1 m  potassium phos­
phate buffer, pH 7.4, containing 0 .4  m  sorbitol. 15 ml 
toluene was added. The suspension was shaken at 40°C 
for 5 min and then cooled in ice. The cells were collected 
by  centrifugation a t 10000g  for 10 m in, resuspended and 
washed in 0.02 M sodium cacodylate buffer, pH 7.1, con­
taining 0.4 m  sorbitol. The toluenized cells were finally 
suspended in the above buffer to  a concentration corres­
ponding to  200 mg o f  original yeast/m l.
Preparation o f  microsom.es: solubilization and  
purification o f  cy tochrome P-448
Yeast cells were disrupted by a Vibro Mill,11 and then 
suspended in 0.1 m  potassium phosphate buffer, pH 7.2, 
containing 20% glycerol, 0.001 m  EDTA and 0.001 M 
dithiothreitol. After removal o f  the cell debris and nuclear 
material by centrifugation at 7500g  for 15 min, yeast 
microsomal fraction was obtained by centrifugation at 
1 6 0 9 0 0 g fo r  1 h. Cytochrome P-448 was solubilized by 
adding sodium cholate to  microsomal fraction (30  mg 
protein m i-1) up to  1% in concentration as previously 
described.12 Cytochrome P-448 and cytochrom e P-450(c) 
reductase were purified to  homogeneity using the m ethod 
reported by Wiseman and Azari.13 Cytochrome P-448 is 
assayed by the m ethod o f Omuia e ta L 14 using 91 litre 
mmol"1 cm*1 as the molar absorption coefficient and recon­
stitution o f  monooxygenase activity was accomplished by 
associating cytochrom e P-450(c) reductase to  cytochrom e 
P-448 (at a ratio o f one unit o f  cytochrom e P-450(c) 
reductase per nmol o f  cytochrom e P-448] by means o f  
30 fig dilauroyl phosphatidylcholine per ml o f  enzyme 
m ixture. One unit o f cytochrom e P-450(c) reductase is 
defined as the am ount that catalyses the reduction o f 
1.0 pmol ferricyanide per min, as assayed by the m ethod o f 
Mihara er al. 1 5
Immobilization o f  cytochrom e P-448 on calcium 
alginate
Permeabilized yeast cells, microsomal fraction and 
purified reconstituted hydroxylase system were entrapped 
by calcium alginate using a m ethod modified from that o f 
Kierstan e ta l .16 In each case, 5 ml o f suspended cells, 
microsomes, or purified reconstituted hydroxylase system 
(at 1 nmol cytochrom e P-448 m l"1) was mixed with IS ml 
1% sodium alginate and the total suspension was slowly 
extruded in to  a 0.05 m CaC12 solution containing 10%
(w/v) glucose using an Oxford Laboratories sample pipette 
with a tip having an orifice I mm in diameter. The fibres 
formed were separated from the solution by filtration and 
were dried o ff before use. When this enzyme, in all three 
forms, was immoHili/cd by calcium alginate, because o f 
the quick settling o f en /ym c/cjlcium  alginate heads, the 
retention yields could not be directly determined by 
CO-diffcTcnee spectrum of the reduced form. Therefore.
retention was measured by the am ount o f  cytochrom e 
P-448 which remained free.
Immobilization o f  cytochrom e P-448 in 
polyacrylamide, by  copolym erization with 
acrylamide m onomer
Copolymerization o f  cytochrom e P-448 in all three 
forms was carried ou t according to  the m ethod o f 
Brunner er aL5 Enzyme solution (4.5 ml) o r yeast 
suspension (1 nmol m l '1)  was mixed w ith 2.0 ml 2  M 
Tris—H Q  buffer* pH 7.4, and N2 was bubbled through for 
20 min at room tem peature. The solution was then cdoled 
down in an ice bath and 0.5 g acrylamide and 0 .034 g N J f-  
methylene-bisacryamide were added. The solution was 
stirred under N2-atm osphere until these tw o com pounds 
were completely dissolved. Copolymerization was started 
by the addition o f  0.25 ml 5% dim ethylam inopropionitrile 
and 0.25 ml o f  a 5% ammonium persulphate solution. The 
m ixture was stirred under N2-atmosphere at 4°C and, after 
the formation o f  the  gel, was granulated or meshed.
Immobilization o f  cytochrom e P-448 on 
BrCN-activated Sepharose-4B
Purified reconstituted monooxygenase system was 
immobilized by  BrCN-activated Sepharose-4B by a m ethod 
modified from tha t reported previously.5,17 Sepharose-4B 
(decanted) was mixed w ith an equal volume o f  w ater arid 
cyanogen bromide (100 mg per ml o f  settled Sepharose-4B) 
was added in an equal volume o f  water. The pH was imme­
diately adjusted to , and m aintained at, 11 by titration  w ith 
4 n  NaOH. When the  reaction had ended, the Sepharose-4B 
beads were washed w ith ~20 volumes o f  cold 0.1 m  NaHC0 2 
on a Buchner funnel under suction. The beads then  were 
suspendedin cold 0.1 m  potassium phosphate buffer, pH 7.5, 
containing 0.001 M dithiothreitol and 20% glycerol (these 
are stabilizers, we have noted) in a volume equal to  tha t o f  
the original Sepharosc-4B, and the enzym e preparation 
(1 nmol m l '1) was added with a ratio  o f  6 nm ol cytochrom e 
P-448 per g beads. The m ixture was stirred overnight and 
beads were then washed thoroughly and suspended again 
overnight in  0.1 M potassium phosphate buffer, pH 7.5, 
containing 0.1 m  glycine, 0.001 M dithio threito l and 20% 
glycerol. This buffer was used to  deactivate all the  remain­
ing binding groups on the  beads. The beads were finally 
stored until use in 0.1 M potassium phosphate buffer, 
pH 7.0, containing 20% glycerol.
Immobilization o f  cytochrom e P-448 by  
microcrystalline cellulose — crosslinking by  use o f  
glutaraldehyde
To 10 ml o f  purified reconstituted hydroxylase system 
(1 nmol ml-1 cytochrom e P-448) 1.5 g o f  cellulose (micro- 
crystalline) was added and mixed on a roller-mixer for 1 h. 
Crosslinking, was accomplished by adding 0.3 ml 0.25 M 
glutaraldehyde solution and mixing for a further hour.18 
Enzyme system bound to  cellulose was then collected by 
centrifugation at 1 2 0 0 0 g  for lO m in and was stored in 
0.1 M potassium phosphate buffer, pH 7.0 , containing 
20% glycerol.
Immobilization o f  cytochrom e P-448 by  
agarose-concanavalin A — crosslinking by use 
o f  glutaraldehyde
3.3 ml o f purified reconstituted monooxygenase system 
( I nm olm l-1 cytochrom e P-448) in 0.02 m  potassium
(415)
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phosphate buffer, pH 7.4, containing 0.1 S m  NaCl was 
stirred w ith 1 g o f packed agarose-concanavalin A at 
4°C for 30 min. The gel was washed with 300 ml 1 m  KG. 
Crosslinking o f  the agarose-concanavalin A -cytochrom e 
P-448 enzyme system conjugate with glutaraldehyde was 
accomplished by adding 0.01 ml 0.1 m  potassium phosphate 
buffer, pH 8 , and glutaraldehyde to  give the final concen­
tration o f  0.5%, and stin ing  for 30 min.
Medsuremen t o f  benzopyrene-3-monooxygenose 
activity o f  imm obilized cytochrom e P-448
This m easurem ent was carried out by a m ethod modified 
from that o f Woods and Wiseman.19 A known am ount o f 
immobilized enzyme (usually 1.5 nm ol cytochrom e P-448) 
was placed in a magnetically-stirred flask at 37°C, and 
therefore approximates to  a typical batch stirred tank 
reactor, T r is -H G  buffer. 0.1 M , pH 7.0 containing NADPH- 
regenerating system was added to  give a final concentration 
o f  0.001 m  NADP, 0.02 M D-glucose 6-phosphate, 0.001 M 
MgCl2 and 8 IU o f  glucose-6-phosphate dehydrogenase.
The reaction was started  by addition o f  benzo(a)pyrene 
from a stock  solution o f  2 mg m l"' in dimethylforma- 
mide, to  give a final concentration in the range 0—160 fiM 
benzo(<r)pyrene. Incubation was a t 37°C with stirring for 
15 min. The reaction was stopped by separating the immo­
bilized enzyme by centrifugation o r filtration. The super­
natant (or filtrate) was diluted 1:1 by addition o f ice-cold 
acetone. A 0 .6  ml aliquot o f  this acetone solution was 
added to  1.4 ml 10.7% (w/v) triethylamine solution in a 
fiuorim eter cuvette and scanned on the range 5 0 0 -5 6 0  nm 
(emission) a t 467 nm (excitation) in a Perkin-Elmer MPF3 
fluorescence spectrophotom eter to  find the peak at 523 r u m . ' 
Fluorescence was calculated relative to  10qg quinine 
sulphate/m l in 2 M H2SO4, which in turn was calibrated 
against a standard 3-hydroxybenzo(<i)pyrene solution.
Results and discussion
The kinetics (K m , P^ax) o f benzopyrene-3-monooxygenase 
activity for all three forms o f  cytochrom e P-448 immobi­
lized by various supports were obtained by Lineweaver—
Burk plot (Figure 1) and are shown in Table 1. This stability 
o f  immobilized cytochrome P-448 in storage at 4°C is 
shown in Figure 2.
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Figure  1 L inew eaver—Burk p lo r o l  rh#  b en z o p y re n e -3 -m o n o - 
o x y g en a se  a c tiv ity  ol im m o b ilized  c y to c h ro m e  P-448 on v arious 
su p p o rts . • ,  P erm ea b iliz ed  y e a s t ce lls  o n  ca lc iu m  alg in a te : ■, m ic ro - 
so m es o n  ca lc iu m .a lg in a te ; \  h igh ly  p u r if ie d  re c o n s t i tu te d  sy s tem  
o n  ca lc iu m  alq in a te : x . h ighly  p u rif ie d  re c o n s t i tu te d  sy s te m  o n  
S e p h a ro se -4 8 ; * , h igh ly  p u rif ie d  re c o n s t i tu te d  sy s te m  o n  a c ry lam id e . 
F o r V '-I8X a n d  Km  values o b ta in e d  see  Table I
T a b le  1 K in etics  o f  b e n z o p y re n e -3 -m o n o o x y g e n a se  a c tiv ity  in  
im m o b ilized  c y to c h ro m e  P -4 4 8 . Vm ax  v a lu e s  a re  e x p re s s e d  in  p m o l 
o f  3 -h y d ro x y b e n z o (a )p y re n e  p e r  h  p e r  n m o l o f  c y to c h ro m e  P -4 4 8  
(in itia l ra te  m e a su re d  a f te r  15  m in  o f  assay  in  b a tc h  s t ir r e d  ta n k  
re a c to r )
A c tiv ity
A p p a re n t re m a in in g  •
^ m a x A p p a re n t a f te r  4  w e ek s
(p m o l h ' 1 s to ra g e  a t
F o rm  o f  e n z y m e n m o l '1) (AM) 4 °C  t% ) •
P erm ea b iliz ed  y e a s t  ce lls 6 6 4 2 2 2 2 0
im m o b iliz e d  o n  ca lc iu m
alg in a te \  ’
M icro to m es
1 ‘F re e ’ e n z y m e 6 6 8 111 0
11 Im m o b iliz e d  o n 5 0 0 2 0 0 6 0
ca lc iu m  a lg in a te
P u rifie d  re c o n s ti tu te d
m o n o o x y g e n a se  sy s te m
1 F re e  e n z y m e 1 0 0 0 33 7
II Im m o b iliz ed  o n 7 4 0 5 0 1 5
ca lc iu m  a lg in a te
III Im m o b iliz e d  o n 6 6 4 6 6 5 8
S rC N -S ep h a ro se -4  B
IV Im m o b iliz e d  o n 5 4 0 3 3 4 0
a c ry la m id e
100
80
60
4 0
20
0 2 3 4
Weeks ot **C
F ig u re  2  S to ra g e  s ta b i l ity  o f  im m o b iliz e d  c y to c h ro m e  P - 4 4 8  o n  
v a r io u s  s u p p o r ts . • ,  P e rm ea b iliz ed  y e a s t  ce lls  o n  c a lc iu m  a lg in a te ;  
a ,  m ic ro to m e s  o n  c a lc iu m  a lg in a te ;  o ,  h ig h ly  p u r if ie d  r e c o n s t i tu te d  
sy s te m  o n  c a lc iu m  a lg in a te ;  x ,  h ig h ly  p u r i f ie d  re c o n s t i tu te d  sy s te m  
o n  S e p h a ro s e -4 8 ; * ,  h ig h ly  p u r if ie d  re c o n s t i tu te d  sy s te m  o n  a c ry la ­
m id e . All e n z y m e s  w e re  s to r e d  in  0 .1  M p o ta s s iu m  p h o s p h a te  b u f f e r ,  
p H  7 .0 ,  c o n ta in in g  20%  g ly ce ro l a s  s ta b il iz e r . In fre e  e n z y m e s  s to re d  
a t  4 °C  a ll th e  b e n z o p y re n e -3 -m o n o o x y g e n a se  a c tiv ity  w as lo s t, fo r  
p e rm e a b iliz e d  y e a s t  ce lls  a n d  m ic ro to m e s  a f te r  tw o  w e e k s  a n d  fo r  
p u rif ie d  c y to c h ro m e  P -4 4 8  a f te r  fo u r  w e ek s
The permeabilization o f  the yeast cells resulted in a 
retention o f  40% o f  the cytochrom e P-448 peak, measured 
by CO-difference spectrum  o f  reduced form , and 100% o f 
this was retained upon immobilization. When these cells 
were immobilized in calcium alginate they showed almost 
normal benzopyrene-3-monooxygenase activity com pared 
with the highly purified enzym e, w ith a Vmtx o f  664 pmol 
3-hydroxybenzcKa jpyrene per h per nmol cytochrom eP-448. 
Immobilized whole yeast cells or protoplast (prepared 
according to the m ethod o f  Wiseman and Woods20) did not 
show any benzopyrene-3-monooxygeanse activity. Imm obi­
lization o f permeabilized yeast cells in gelatin4 was not 
feasible as the gel depolymerized in a batch stirred tank 
reactor during incubation at 37°C. Permeabilized yeast cells
(416)
Papers
lost their benzopyrene-3-monooxygenase activity when 
copolymerized w ith acrylamide and they did not absorb 
onto cellulose or BrCN-activated Scpharose-4B. Permeabi- 
lizcd yeast cells immobilized by calcium alginate lost most 
o f  their benzopyrene-3-monooxygenase activity after 
4 weeks storage at 4°C.
Cytochrome P-448 in microsomal fraction is a membrane- 
bound immobilized enzyme and is no t easily immobilized 
to  o ther supports. However its entrapm ent by calcium 
alginate resulted in retention o f  all the cytochrom e P-448 
and m uch o f  the benzopyrene-3-monooxygenase activity 
(Vm3X 500 pmol h"1 nmol-1) and it lost only 40% o f  this 
activity after 4 weeks o f  storage at 4°C. The results (Table 
I )  indicate, however, a considerable diffusion lim itation in 
this system, with lowered Fmax and raised K m values.
Purified reconstituted monooxygenase system was 
successfully immobilized by a num ber o f  supports. Entrap­
m ent by calcium alginate (with 90% retention yield) gave a 
high Fmax o f  740 pm olh"1 nm ol ' 1 compared with the free 
purified reconstituted monooxygenase system, which had 
Knax.of 1000 pm olh ' 1 n m o l '1. The apparent K m (5 0 mm) 
was also close to  that o f  the free enzyme system (33 mm).
Immobilization o f the highly purified form on cellulose 
by absorption and crosslinking by glutaraldehyde gave the 
same results as previously obtained w ith the crude solubi­
lized form o f  the enzym e.18 Eighty per cent o f  the  cyto­
chrome P-448  did not bind to  this support (or was denatured 
in the process o f  immobilization). The enzyme which 
bound to  the cellulose lost some o f  its activity. Imm obi­
lization o f  the solubilized crude form o f  this enzyme on 
cellulose using the same procedure had resulted in a doubling 
o f  K m and a 35% decrease in  Fmax.18
A ttem pts were made to  immobilize the purified reconsti­
tu ted  monooxygenase system through its carbohydrate 
side-chain to  agarose-concanavalin A. Cytochrome P-450 
type enzymes are reported to be glycoproteins, containing 
1—2 molecules o f  sugars such as mannose, glucose o r gluco­
samine per molecule o f  the cytochrom e.21 We find that 
only 50% o f cytochrom e P-448 was bound to agarose- 
concanavalin A and most o f  the benzopyrene-3-mono- 
oxygenase activity was lost. Glutaraldehyde seems to  have a 
deleterious effect on cytochrom e P-448, and it may impose 
a high degree o f  steric hindrance onto  the active site o f this 
enzyme in purified form.
Highly purified reconstituted monooxygenase system 
along with NADPH has been immobilized by BrCN-activated 
Sepharose-48 beads.5,22 The intended application was for 
use as an extracorporeal shunt for blood during detoxica­
tion. This support proved to  be the m ost effective for our 
highly purified enzyme. Almost all the cytochrom e P-448 
used was retained on these beads, although NADPH did not 
bind, and it was necessary to  add this each time to the 
reaction mixture. Fmax was relatively high (6 6 4 p m o lh '1 
nm ol'*) and availability o f the enzyme system for binding 
benzo(a)pyrene was dem onstrated by the low K „  value 
obtained (SOptA). Immobilized highly purified reconsti­
tuted cytochrome P-448 on this support also showed a 
considerable degree of stabilization in storage at 4°C, and 
after 4 weeks only 42% o f the enzyme activity was lost, 
instead o f 93% for this enzyme preparation prior to 
immobilization.
The copolymerization o f purified reconstituted mono- 
oxygenase system with acrylamide resulted in the produc­
tion of an entrapped enzyme system I cytochrom e P-448 
retention. 60%) with a K „  for benzol a (pyrene the same as 
that o f the free enzyme (33 MM), but with a dfv't decrease
in Fmax. The low Fmax (w ith unchanged K m) might be due 
to the diffusional lim itation imposed by this support on the 
3-hydroxybenzo(a)pyrene availability in the assay mixture 
in presence o f  the swollen gel that forms during the assay.
The immobilization o f  cytochrom e P-448 highly 
purified reconstituted enzyme system using an effective 
support in stirred tank and o ther enzym e reactors will 
improve the proposed applications o f  this enzym e, includ­
ing the construction o f  an accurate'enzym e electrode. This 
could provide a rapid and specific assay for a substrate o f  
this enzyme and substrates o f  related enzym es present in 
foodstuffs and the environm ent. ’*•
Immobilized permeabilized yeast may be useful also in 
large-scale applications such as the removal o f  polyarom atic 
nuclear hydrocarbons from w ater and air. For some pur­
poses, the use o f  the immobilized microsomal system may 
prove convenient and appropriate, w ith high stability (bu t 
w ith diffusional lim itation problem s). We are developing 
methods for the large-scale rapid isolation o f  microsomal 
fraction w ithout recourse to  high g  centrifuges.
Further studies using o ther types o f  enzyme reactor are 
in progress, and the packed-bed type m ay prove to  be more 
useful in the use o f  these enzymes for p roduction  o f  quan­
tities o f  metabolites o r for carcinogen removal. The replace­
ment o f  expensive cofactors by coimmobilized enzym es 
will be essential for large-scale applications, and some 
success has been achieved on this problem.
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■JiARACTERIZATION OF CYTOCHROME P-448 FROM SACCHAROMYCES CEREVISIAE..
DAVID J. KING, MAHMOOO R. AZARI AND ALAN.'WISEMAN
Biochemistry Division, Department of Biochemistry, University of'Surrey, 
Guildford, Surrey, GU2 5XH, U.K.
INTRODUCTION
The eucaryotic microorganism Saccharomyces cerevisiae contains a micro- 
omally bound cytochrome P-448 which is part of a microsomal electron transport 
diainwith many properties is common with that of mammalian liver (1 , 2) .
This yeast cytochrome P-448 is produced under fermentative conditions* ( e . g .  
growth at high glucose concentration) "which lead to the. repression of mito­
chondrial cytochrome a + &3 .formation (3,4). Control of this process is 
bought to occur through cyclic AMP which exerts a repressive effect over 
de novo synthesis of cytochrome P-448, the level of cyclic AMP being determined 
by the glucose concentration in the growth medium in an inverse relationship 
(5).
This cytochrome P-448 system is capable of hydroxylating benzo(a)pyrene 
to a range of metabolites, principally 3-hydroxybenzo(a)pyrene, 9-hydroxy- 
benzo(a)pyrene and 7,8-dihydro-7,8-dihydroxybenzo(a) pyrene (6). We have 
recently shown that this enzyme system can be induced with benzo(a)pyrene and 
several other compounds to produce only slightly higher levels of cytochrome 
P-448 but.a great improvement in the efficiency of the enzyme at metabolizing 
benzo(a)pyTene,.suggesting that mote than one form of cytochrome P-450 can 
occur in this yeast (7). This finding has been backed up by the separation of 
two forms during purification studies (8 ). We have purified the major form of 
cytochrome P-448 from uninduced yeast to a high degree of purity (88-97% pure) 
and in this study we have undertaken to characterize this enzyme to allow a 
comparison with mammalian systems.
MATERIALS AND METHODS
Saccharomyces cerevisiae NCYC No. 240 was grown under glucose repression 
in a medium containing 1% yeast extract, 2% mycological peptone, O.S% NaCl and 
20% glucose for 44 hours at 30°C. Veast was harvested and microsoraes prepared 
from which cytochrome P-448 was purified as previously described (8). SDS- 
polyacrylamide gel electrophoresis was carried out by the method of Laemrali(9). 
Benzo (a)pyrene hydroxylase activity was determined by the fluoriraetric method 
of Dehnen ert aJL (10) as modified by Woods and Wiseman (6 ). A reconstituted
(417) 369
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enzyme system comprising of purified cytochrome P-448, purified NADPH:
• cytochrome P-450 reductase and dilauroylphosphatidyl'choline' (inmole cytochrome 
P-448 to IU of reductase).
RESULTS AND DISCUSSION
Cytochrome P-448 from uninduced Saccharomyces cerevisiae was purified to a 
specific content of I6—17.5nmole/mg protein. The homogeneity of this enzyme 
was shown bySDS-polyacrylamide gel electrophoresis, the molecular weight being 
determined as 53,500 using this method with several marker proteins. This 
molecular'weight is similar'to that of cytochrome P-448 from liver*microsomes 
of 3-methylcholanthrene treated rats (11). Using this molecular weight the 
purity of our enzyme is 88-97**. Our preparation was free of NADPH:cytochrome 
P-450 reductase, cytochrome b5 and cytochrome P-420. The soret peak of the ' 
reduced CO complex was at 448nm similarly to the fonn induced by. polycyclic 
aromatic hydrocarbons in mammalian liver. A similarity, to this enzyme is also 
suggested, by the. benzo (a)pyrene metabolite profile of the yeast enzyme (6 ).
The amino acid composition of yeast cytochrome P-448 was determined as shown 
in Table 1. This composition reveals 407 amino acid residues per molecule 
which leads to a-molecular weight of 53,000 (a difference of 4.5% from the • 
value determined by SDS-PAGE). The content of hydrophobic residues is 43% 
which is.almost.identical to the content of hydrophobic residues in-induced 
and uninduced cytochromes P-4S0 from both rat (11) and rabbit liver (12, 13).
1 . *
TABLE 1 ’ ;
' AMINO ACID COMPOSITION OF .YEAST CYTOCHROME P-448 .
Amino Acid No. Residues/Molecule Amino Acid No-. Residues/Molecule
Aspartic acid 41 Phenylalanine 20
Threonine 21 Leucine 23
Serine 24 . Isoleaci'ne 13
Glutamic acid 37 Histidine 17
Proline 23 Methionine 7
Glycine 42 Lysine 27
Alanine 27 Arginine 20
Valine 30 Tryptophan 12
Tyrosine IS Cysteine 3
Total 470
(419) 371
Benzo(a)pyrene gave rise to a type 1 binding spectrum with our purified 
cytochrome P-448 with an apparent spectral dissociation constant (Ks) of SOuM. 
lanosterol, ethylmorphine, phenobarbitalr dimethylnitrosamine and perhydro- 
fluorene aLso gave rise to type 1 binding spectra. • Benzo(a)pyrene hydroxylase 
activity of a*reconstituted system comprising of purified cytochrome P-448, 
purified NADPH: cytochrome P-450 reductase and'diluaroylphosphatidylcholine 
showed a Km of 33uM and a Vma^ of 16.7 pmol 3-hydroxybenzo(a)pyrene/min/nmole 
P-448 when supported by NADPH. The requirement for cofactor could be replaced 
by cumene hydroperoxide or hydrogen peroxide generated from a glucose oxidase 
system, in each case the Kra and Vraax are both increased (Table 2 ).
. • . • • * I
TABLE 9
BENZO(a)PYRENE HYDROXYLASE ACTIVITY OF CYTOCHROME P-448 IN A RECONSTITUTED 
SYSTEM
Km (WM)‘ Vmax(Pmo1 3-hydroxybenzo(a)pyrene/ 
min/nmole P-448
NADPH supported 33. 16.7
Cumene hydroperoxide 125 * 21.9
Hydrogen peroxide
(glucose oxidase) 200 '33.7
A good agreement between the Km of the NADPH supported reaction (33vM)
*nd the benzo (a)pyrene K.s (50uM) was observed. The rate of benzo(ajpyrene 
.ydroxylation observed with our enzyme is low compared to 3-methylcholantlirene 
induced (P-448) activities in rat liver, although it is comparable to forms . 
isolated from uninduced*mammalian sources (14, IS).
Yeast cytochrome P-448 is closely related to the family of enzymes from 
mammalian liver.’ The form of the enzyme which we have purified and studied 
in this report appears to resemble- a cytochrome P-448 type of the mammalian 
enzyme rather than a cytochrome P-450 form, in its soret peak in the reduced 
CO spectrum, narrow substrate specificity and the range of benzo(a)pyrene 
metabolites formed. The molecular weight a amino acid composition are also 
closer to a P-448 form, although the activity towards benzo(a)pyrene hydroxy­
lation is much loweT than a mammalian cytochTome P-448.
(420)
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Fig. I. Continuous H 2 photoproduciion fro m  ascorbate by 
Mastigocladus laminosus
Reaction mixtures (2 ml) contained 30//M-3-(3.4-dichIoro- 
phenylVl.l-dimethylurea. 40-mM-sodium ascorbate. 2-mM-Ar- 
tetramethyl-p-phenvlenediamine. 20-mM-dithiothreitol and 75- 
//M-Methyl Viologen in 50-mM-Hepes |4-(2-hydroxyethyl)-l- 
pipefazine-ethanesulphonic acid I buffer. pH 7.5. The reaction 
mixture in glass vials with Suba-Seal stoppers were flushed with 
N j and then saturating quantities o f D. desufuricans hydro- 
genase were injected into the vials. The H 2 evolved was assayed 
at intervals by using a gas chromatograph (Rao et al.. 1978). 
The temperature was 30°C and the light intensity 2.6 x 
104erg -s- , -cm _J. (a) Non-immobilized M. laminosus cells: (b) 
cells immobilized in calcium alginate: (cj cells immobilized in 
agar.
1980). Chloroplasts and hydrogenases adsorbed on poly­
urethane foam were found to leak out into the aqueous medium. 
However, when chloroplasts were treated with the foam in the 
presence of agar, they were firmly bound to the foam. These 
foams evolved H } at very low rates on illumination with water as 
electron donor. Polyurethane sponges containing embedded 
chloroplasts and hydrogenase were obtained by mixing chloro­
plasts, an acetone powder of C. pastcurianum  cells, and the 
ufethane prepolymer. Hypol 3000. These sponges were active in 
H , evolution on illumination, through the rates o f H , evolution 
were less than 10% of the control. These studies are in the 
preliminary stages and there are possibilities of improvement in 
H j production rates.
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Inhibition of highly purified benzo[a]pyrene hydroxylase from Saccharomyces cerevisiae by 
cytochrome P-448 binding compounds and by flavonoids
DAVID J. KING, M AHM OND R. AZARI and 
ALAN WISEMAN
Biochemistry Division. Department o f  Biochemistry. University 
o f  Surrey. Guildford. Surrey GU2 SXH. U.K.
Cytochrome P-448 dependent benzolalpyrene hydroxylase has 
been purified to homogeneity and characterized by Azari & 
Wiseman (1982). The kinetics o f NADPH-supported 
benzolalpyrene hydroxylation by this enzyme were reported for 
the purified reconstituted system consisting of the purified 
cytochrome P-448 component, purified N A D P H :cytochrome 
P-450(c) reductase and a phospholipid component. Using this 
system the Michaelis constant for benzolalpyrene was 33)/m 
and the maximal velocity 208 pmol o f 3-hydrobenzo|o!pyrene/h 
per nmol of cytochrome P-448. We have studied the binding of 
several putative substrates with this highly purified enzyme 
(Azari et al.. 1982) and in this communication we report that 
these compounds can act as inhibitors of benzolalpyrene 
hydroxylase.
The mechanism of inhibition/activation of mammnlinn 
benzolalpyrene hydroxylase by fiavonoids has been studied by 
Huang et al. (198la.h). We have examined the effect of two 
flavonoid compounds, flavone and 7,8-benzoflavone. both of 
which inhibit yeast cytochrome P-448 dependent 
benzolalpyrene hydroxylase.
Yeast (Saccharomyces ceret'isiae N.C.Y.C. no. 240) was 
grown under'glucose repression and used to  prepare microsomcs 
from which cytochrome P-448 was purified to homogeneity 
(97% pure) as previously described (Azari & Wiseman. 1982). 
Benzol a Ipytene hydroxylation activity was assayed on a
purified reconstituted system by the method o f Dehnen et al. 
(1973) as modified by Woods '& Wiseman (1979).
The percentage inhibition o f benzolalpyrene hydroxylase by 
binding compounds is shown in Table 1. along with the 
corresponding K t values. This table shows that dimethyl­
nitrosamine and lanosterol result in a high degree o f inhibition at 
2.5 m M  and 77,u m respectively. Both o f  these compounds result 
in type I interactions with purified yeast cytochrome P-448 with 
spectral dissociation constants (A's values) o f 220//M and 80 
respectively. Lanosterol has been reported to be an endogenous 
substrate o f yeast cytochrome P-448/P-450 by Aoyama & 
Yoshida (1978). Dimethylnitrosamine is an inducer of 
cytochrome P-448 and binding studies show evidence o f high 
affinity for this enzyme, but so far w'e have not shown a 
reproducible rate o f demethylation by using the Nash assay 
technique.
Our enzyme was not inhibited by 9-hydroxyellipticine. This 
compound has been found to inhibit mammalian cytochrome 
P-448 in vitro (Delaforge et al., 1980).
The interaction o f flavonoid compounds with benzolalpyrene 
hydroxylase from mammalian liver has been studied by Huang 
et al. (I98 la.h ). These workers found that flavone stimulated 
benzolalpyrene hydroxylase activity o f cytochrome P-450 
LM3c or LM4, yet inhibited the same activity catalyzed by 
cytochrome P-450 LM2. LM3b and LM6. 7.8 Benzoflavone 
stimulated benzolalpyrene hydroxylation by cytochrome P-450 
LM3c yet inhibited cytochrome P-450 LM6 . We have found 
that both flavone and 7.8-benzoflavone inhibit our enzyme 
strongly in a non-competitive fashion. 7.8-Benzofiavone is a 
more potent inhibitor than flavone. Double reciprocal plots of
Biochem. Soc.  T r a n s . ,  1982,  10,  529-530 .
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Table I . Inhibition o f  benzo\a\pyrene hydroxylase from  yeast
Cytochrome P-448 was used at I nmol per assay in a total 
volume of 1ml. NADPH icytochrome /’•450(c) reductase was 
added to I unit (I unit converts I//mol of cytochrome c to 
the reduced form per minute at 22°C): 30//g of dilauroyl- 
phosphatidylcholine was also added. Benzolalpyrene concen­
tration was 80 //m .
Concentration
Benzolalpyrene
hydroxylation AT,
- of activity (from Azari
Inhibitor added inhibitor (% of control) eta!.. 1982)
None —  ' 100 8/tm
Imidazole IraM 79 8//m
Aniline 0.5 mM 78 5/im
Phenobarbital 77//M 80 66/m
Perhydrofluorene 10mM 0 —
Lanosterol 7//M 55 80/jm
Ethylmorphine 1.25 mxt 73 166/im
Dimethylnitrosamine 2.5 mM 50 220//m
Benzphetamine 20mM 81 1.66 f/M
9-Hvdroxyellipticine 600mM 100 — .
Flavone 600 mM 50
7.8-Benzoflavone 176mM 50 - —
initial velocity versus benzololpyrene concentration at various 
concentrations of 7.8-benzoflavone have shown that the 
inhibition by this compound is non-competitive, as the for 
benzolalpyrene is unchanged whilst maximal velocity is
lowered. The inhibition constant. K t. for 7.8-benzoflavone was 
determined as 176//M (benzolalpyrene used in the range
4 0 -160^ m).
The inhibition o f benzolalpyrene hydroxylase by cytochrome 
P-448 binding compounds once again confirms the identity of 
this enzyme as a cytochrome P-448 dependent activity. The 
difference between mammalian cytochrome P-450 LM4 (a 
cytochrome P-448) and yeast cytochrome P-448 is shown by 
the effect of flavonoid compounds on benzolalpyrene hydroxyl­
ation by these systems. In this respect our yeast enzyme appears 
to resemble cytochrome P-450 LM6 which is produced in rabbit 
liver after induction with 2.3.7.8-tetrgchlorodibenzo-p-dioxin.
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Studies on the differences in thermal stability and critical temperature of cytochrome P-448 
from Saccharomyces cerevisiae in microsomal, solubilized and highly purified form
M AHM OOD R. AZARI. DAVID J. KING and 
ALAN WISEMAN
Biochemistry Division, Department o f  Biochemistry. University 
o f  Surrey. Guildford, Surrey GU2 5XH. U.K.
Studies on cytochrome P-448 from yeast microsomal Traction 
by Wiseman et al. (1975) revealed that this enzyme is less stable 
than that from rat liver toward thermal denaturation. This study 
also revealed that this enzyme from yeast or rat liver is 
considerably more stable toward thermal denaturation in the 
oxidized form than in the reduced form. We have previously 
reported the stabilization effect of Triton X-100 on yeast 
cytochrome P-448 during solubilization (Azari & Wiseman. 
1980. 1982). We now report the differences in thermal stability 
o f cytochrome P-448 from Saccharomyces cerevisiae in the 
form of microsomal, solubilized and purified enzyme as 
measured by both the content o f cytochrome P-448 and the 
activity of benzolalpyrene hydroxylase.
Yeast (Saccharomyces cerevisiae N.C.Y.C. no. 240) was 
grown and microsomcs prepared as previously described 
(Wiseman et al.. 1975). Microsomes were resuspended in 
0.1 M-potassium phosphate buffer. pH 7.2. containing 20% (v/'v) 
glycerol. 0.001 m-EDTA. 0.001 M-dithiothreitol and 0.1% 
glutathione. Cytochrome P-448 was stabilized by the addition of 
1% cholate to the microsomes followed by stirring at 4°C  under 
nitrogen for 1 h. This enzyme was purified to homogeneity by 
using the methods previously described (Azari & Wiseman. 
19821. Cytochrome P-448 was nssayed by the method of Omura 
et al. (1965) and benzolalpyrene hydroxylase measured by the 
method of Dehnen et al. (1973) as modified by Woods &
Wiseman (1979). Yeast cytochrome P-448 was more stable 
toward thermal denaturation when in the form of microsomes 
than when solubilized but not purified. After incubating 
microsomal enzymes even at 50°C . for 5 min only. 50% of the 
yeast cytochrome P-448 is lost (see Table I). In an equivalent 
experiment with ra t liver microsomal cytochrome P-450 no 
detectable loss was observed after 5 min at 50°C . This again 
shows the liver enzyme to be more stable than the yeast enzyme, 
as showm by Wiseman et al. (1975). When yeast microsomes are 
treated with 1% Triton X-100 only 10% of cytochrome P-448 
dependent benzolalpyrene hydroxylase is lost after 10 min 
incubation at 40°C . whereas untreated microsomes lose 50% of 
activity under these conditions.
Solubilized yeast cytochrome P-448 is far less resistant to 
thermal denaturation than is microsomal fraction, as is expected 
from the loss o f the lipid membrane (see Table 1). The stability 
of this solubilized enzyme was not significantly affected by the 
addition o f benzolalpyrene. which is a well-characterized 
substrate o f this enzyme (Azari & W iseman. 1982). The 
addition o f 0.1% Triton X-100 had only a slight effect on the 
temperature at which 50% of the cytochrome P-448 was lost in 
5 min incubation (Table la ) yet was successful in preventing 
100% loss o f cytochrome P-448 in 5 min until an incubation 
temperature of 60°C  is reached (Table 16). Solubilized 
cytochrome P-448 is 100% lost after 5min incubation at 45°C  
when no Triton X-100 is present. Triton X-100 at 0 .1% was not 
able to return the stability o f the soluble enzyme to that of the 
enzyme in microsomal fraction. The activity of benzolalpyrene 
hydroxylase also shows a stabilization effect in the presence of 
Triton X-100 (Table lc). This stabilization effect is probably
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Table 1. Thermal stability o f  different types ofpreparations o f  yeast cytochrome P-448
The enzyme preparations were pre-incubated for 5 min at a series of temperatures (0 -7 5°C). cooled and assayed for cytochrome 
P-448 level and benzolalpyrene hydroxylase activity. Curves of activity and cytochrome P-448 level versus temperature were 
constructed and showed a strong temperature dependent effect. Protein contents as determined by the Lowry method were, 
microsomal 6.5 mg/ml. solubilised 30mg/ml, purified SO^g/ml. Cytochrome P-450 level was the same in all preparations.
Form of yeast cytochrome P-448 
Microsomal 
Solubilized
Solubilized + 0.1 % Triton X-100 
+ 80//M-benzoialpyrene 
Solubilized + 80^M-benzofa|pyrene 
Purified
(a)
Temperature at which 
50% of cytochrome P-448 
lost (°C)
50
45
36
35
45
(b)
Critical temperature at which 
100% of cytochrome P-448 
lost (°C)
55
39
60
45
65
(c)
Temperature at which 
50% of benzolalpyrene 
hydroxylase lost (°C)
45
41
44
due to Triton X-100 substituting for lipid removed during 
solubilization, and hence protecting the conformation of the 
enzyme. Another possible reason for the relative instability of 
the solubilized enzyme is the presence o f 1% sodium cholate 
used for solubilizing the enzyme.
Surprisingly, purified cytochrome P-448 was more stable than 
solubilized enzyme (even when studied at a lower protein 
concentration) as measured by the temperature at which 50% of 
cytochrome P-448 is lost (Table la). This may be due to the 
absence o f ionic detergent (cholate) and the presence of a 
residual amount of non-ionic detergent (Emulgen 911) which is 
used during purification. This residual Emulgen may have a 
stabilizing effect due to protecting hydrophobic regions o f the 
enzyme from the aqueous environment.
Triton X-100 is known to bind to cytochrome P-450 as a 
modified-type II substrate, modulating the spin state o f 
cytochrome P-450 from high spin to low spin (Tamura et al.. 
1976). and is also known to protect enzymes by protecting the 
hydrophobic regions (Takeda et al.. 1972). Thiol reagents or 
high ionic strength cause a cytochrome P-450 spin state change 
from low to high spin and also cause a cytochrome P-450 to 
cytochrome P-420 conversion by destroying or removing the 
thiol ligand (Murakami & Mason, 1967: Yoshida & Kumaoka.
1972). Triton X-100 may therefore exert a stabilizing effect by 
retaining the low-spin state form and thus protecting the thiol 
ligand o f the haem group.
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Spectral binding studies on the interaction of some putative substrates with highly purified 
cytochrome P-448 from Saccharomyces cerevisiae
M AH M O O D R. AZARI. DAVID J. K ING and 
ALAN WISEMAN
Biochemistry Division, Department o f  Biochemistry, University 
o f  Surrey. Guildford, Surrey GU2 5XH. U.K.
Cytochromes P-450/P-448 undergo spectral changes due to 
their interaction with many different compounds (Schenkman et 
al.. 1981). Two major types of spectral interactions are 
observed, termed type I and type II. Type I interactions are 
thought to be due to the binding of cytochromes P 450/P-448 
substrates to the protein moiety of the enzyme, possibly at the 
active site. This interaction results in difference spectra with nn 
absorption peak at 385-390nm  and a trough at approx. 420nm. 
Type II interactions arc associated with the binding of a 
compound to the haem iron o f cytochrome P-450/P-448. often 
via an amino group. The difference spectra resulting from type 
II interactions have an absorption maximum at 425-435 nm and 
a minimum at 390-405 nm. We report here the interaction of 
some compounds which are known to bind to mammalian
cytochromes P-450/P-448 with highly purified cytochrome 
P-448 from Saccharomyces cerevisiae.
Cytochrome P-448 was solubilized from yeast 
(Saccharomyces cerevisiae N.C.Y.C. no. 240) microsomes and 
purified by using methods previously described by Azari & 
Wiseman (1980) and Azari & Wiseman (1982a) respectively. 
The microsomes were obtained from yeast cells grown under 
conditions of glucose repression as before (Wiseman et al.. 
1975). The binding characteristics o f each compound were 
determined by recording cytochrome P-448 difference spectra 
between 350nm and 500nm at various concentrations of the 
added compound. A double cell technique was used in several 
cases to eliminate interference, as previously described (Azari & 
Wiseman. 1982/0.
Table 1 describes the spectral binding type and charac 
teristics o f the interaction o f several compounds with highly 
purified yeast cytochrome P-448. We have previously described 
the binding of benzolalpyrene to this enzyme (Azari & 
Wiseman. 1982c). The spectral interaction o f lanosterol. which
1982
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1 Table 1. Binding properties o f  various compounds o f  yeast cytochrome P-448
One nmol o f cytochrome P-448 was used in a volume o f 1 ml. In the case o f benzolalpyrcne a split cell system was used to eliminate 
the absorption of benzolalpyrene itself at 350-420nm . and 4 mi,_ values were calculated by double reciprocal plotting o f the 
concentration o f the compounds against the absorbances of the enzyme-compound complex.
Difference spectrum Difference spectrum Type of
Compound maxima (nm) minima (nm) binding AT, 0/m ) Am...
Imidazole 429 407 II 8 0.06
Lanosterol 367.387 416 I 80 0.019
Ethylmorphine 355.382 412 1 166 0.006
Aniline 425 408 II 5 0.039
Phenobarbitone 367.387 417 I 66 0.021
Benzphetamine 422 406 II 1660 * 0.018
Dimethylnitrosamine 385 420 I 220 0.021
Perhydrofluorene 382 417 I —  ■ _
Benzolalpyrene 367.387 418 I so 0.122
is thought to be an endogenous substrate for cytochrome 
P-450/P-448 in Saccharomyces cerevisiae, has previously been 
described by Aoyama & Yoshida (1978). These authors also 
found that this compound gave rise to a type I interaction with 
purified cytochrome P-450IP-448 from baker’s yeast grown 
semi-anaerobically. although no value for the spectral dis­
sociation constant ( Kt) was quoted.
Type I binding spectra were observed with benzolalpyrene. 
lanosterol. ethylmorphine. sodium phenobarbitone. dimethyl 
nitrosamine and perhydrofluorene. Benzolalpyrene bound to  the 
greatest extent (almost 100% binding) and we have previously 
shown that this compound is metabolized by this enzyme, the 
major products being 3-hydroxybenzo|alpyrene. 9-hydroxy- 
benzolalpyrene and 7.8-dihydro-7.8-dihydroxybenzolalpyrene 
(Woods & Wiseman, 1979). So far we have been unable to 
detect the metabolism of any of the rest of these compounds 
using a reconstituted system. T y p e 'l l  spectral change was 
observed with imidazole, aniline and benzphetamine. 
Benzphetamine is a substrate o f mammalian cytochrome P-450. 
which gives rise to a type I spectrum with this enzyme (Goujon 
et al., 1972). We have also tested aminopyrine. 7-ethoxy- 
resorufin. /?-naphthofiavone. lauric acid, ethoxycoumarin. bi­
phenyl. isosafrole and hexobarbital for a spectral interaction with 
our purified cytochrome P-448. but no interaction was detected 
with these compounds.
We have previously reported the presence o f an extra peak at 
365 -375nm in the difference spectrum with benzolalpyrene 
(Woods & Wiseman. 1980) and a similar ‘extra peak’ has been 
reported for the interaction of this compound with rat liver 
cytochrome P-450 (Estabrook et al.. 1978). In these experi­
ments a similar double peak was observed with ethylmorphine. 
lanosterol and phenobarbitone.
Imidazole and aniline, both o f which gave rise to type II
spectral changes, had the highest affinity for yeast cyrochtome 
P-448 with spectral dissociation constants (K s values) o f 8 um 
and 5//m respectively. The extent o f binding of these com­
pounds, as measured by the XmiI- values, was lower than that of 
benzolalpyrene but higher than those o f other type I binding 
compounds. The two known substrates o f yeast cytochrome 
P-450/P-448, benzolalpyrene and lanosterol. show high affinity 
for the enzyme, although the extent o f binding of lanosterol is 
not very high.
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ATPases associated with Goigi membranes from lactating rat mammary gland: high-aftinity 
requirement for Ca2+ and Mg2+ ions
RICHARD A, EASOM. DAVID W. WEST nnd 
ROGER A. CLEGG
Department o f  Biochemistry. Hannah Research Institute. A ve 
KA6 5HL, Scotland. U.K.
In recent years highaffinity C a2*-stimulated Mg*’ -dependent 
ATPases have been demonstrated in plasma membranes fro:
Vol. 10
number of tissues (see Lotersztajn et al.. 1981. for references). 
Each is dependent on submicromolar concentrations of C a2* 
and on low Mg2* concentrations. We have reported (Easom & 
West. 1982) on the ATPase activities associated with a 
Golgi-membrane fraction from lactating rat mammary gland. 
We did not. however, distinguish between a C a2*-stimulated 
-dependent ATPase and a simple C a3*-ATPase (C a3*-
